<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>

<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31698509</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1099-1573</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Phytotherapy research : PTR</Title>
                <ISOAbbreviation>Phytother Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Dual inhibition of EGFR and MET by Echinatin retards cell growth and induces apoptosis of lung cancer cells sensitive or resistant to gefitinib.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/ptr.6530</ELocationID>
            <Abstract>
                <AbstractText>Patients with non-small-cell lung cancer (NSCLC) containing epidermal growth factor receptor (EGFR) amplification or sensitive mutations initially respond to tyrosine kinase inhibitor gefitinib; however, the treatment is less effective over time. Gefitinib resistance mechanisms include MET gene amplification. A therapeutic strategy targeting MET as well as EGFR can overcome resistance to gefitinib. In the present study we identified Echinatin (Ecn), a characteristic chalcone in licorice, which inhibited both EGFR and MET and strongly altered NSCLC cell growth. The antitumor efficacy of Ecn against gefitinib-sensitive or -resistant NSCLC cells with EGFR mutations and MET amplification was confirmed by suppressing cell proliferation and anchorage-independent colony growth. During the targeting of EGFR and MET, Ecn significantly blocked the kinase activity, which was validated with competitive ATP binding. Inhibition of EGFR and MET by Ecn decreases the phosphorylation of downstream target proteins ERBB3, AKT and ERK compared with total protein expression or control. Ecn induced the G2/M cell cycle arrest, and apoptosis via the intrinsic pathway of caspase-dependent activation. Ecn induced ROS production and GRP78, CHOP, DR5 and DR4 expression as well as depolarized the mitochondria membrane potential. Therefore, our results suggest that Ecn is a promising therapeutic agent in NSCLC therapy.</AbstractText>
                <CopyrightInformation>© 2019 John Wiley &amp; Sons, Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Oh</LastName>
                    <ForeName>Ha-Na</ForeName>
                    <Initials>HN</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacy, Mokpo National University, Jeonnam, 58554, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Mee-Hyun</ForeName>
                    <Initials>MH</Initials>
                    <AffiliationInfo>
                        <Affiliation>China-US (Henan) Hormel Cancer Institute, Zhengzhou, Henan, 450008, P.R. China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Basic Medical College, Zhengzhou University, Zhengzhou, 450001, Henan, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Eunae</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Pharmacy, Chosun University, Gwangju, 61452, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kwak</LastName>
                    <ForeName>Ah-Won</ForeName>
                    <Initials>AW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacy, Mokpo National University, Jeonnam, 58554, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Seo</LastName>
                    <ForeName>Ji-Hye</ForeName>
                    <Initials>JH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Dental Pharmacology, School of Dentistry and Institute of Oral Bioscience, BK21 Plus, Jeonbuk National University, Jeonju, 54896, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yoon</LastName>
                    <ForeName>Goo</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacy, Mokpo National University, Jeonnam, 58554, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cho</LastName>
                    <ForeName>Seung-Sik</ForeName>
                    <Initials>SS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacy, Mokpo National University, Jeonnam, 58554, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Choi</LastName>
                    <ForeName>Joon-Seok</ForeName>
                    <Initials>JS</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Pharmacy, Daegu Catholic University, Gyeongbuk, 38430, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Sang-Myeong</ForeName>
                    <Initials>SM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Biotechnology, College of Environmental and Bioresources, Jeonbuk National University, Iksan, 54596, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Seo</LastName>
                    <ForeName>Kang-Seok</ForeName>
                    <Initials>KS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Animal Science and Technology, Sunchon National University, Suncheon, 57922, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chae</LastName>
                    <ForeName>Jung-Il</ForeName>
                    <Initials>JI</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Dental Pharmacology, School of Dentistry and Institute of Oral Bioscience, BK21 Plus, Jeonbuk National University, Jeonju, 54896, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shim</LastName>
                    <ForeName>Jung-Hyun</ForeName>
                    <Initials>JH</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-4062-4016</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacy, Mokpo National University, Jeonnam, 58554, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>China-US (Henan) Hormel Cancer Institute, Zhengzhou, Henan, 450008, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>2019R1A2C1005899</GrantID>
                    <Agency>Basic Science Research program through the National Research Foundation Korea</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>PJ01270402</GrantID>
                    <Agency>Cooperative Research Program for Agriculture Science and Technology Development</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Phytother Res</MedlineTA>
            <NlmUniqueID>8904486</NlmUniqueID>
            <ISSNLinking>0951-418X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Apoptosis</Keyword>
            <Keyword MajorTopicYN="N">EGFR</Keyword>
            <Keyword MajorTopicYN="N">Echinatin</Keyword>
            <Keyword MajorTopicYN="N">MET</Keyword>
            <Keyword MajorTopicYN="N">Non-small cell lung cancer</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31698509</ArticleId>
            <ArticleId IdType="doi">10.1002/ptr.6530</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>

<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31698346</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1361-6560</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Physics in medicine and biology</Title>
                <ISOAbbreviation>Phys Med Biol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Multi-objective ensemble deep learning using electronic health records to predict outcomes after lung cancer radiotherapy.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1088/1361-6560/ab555e</ELocationID>
            <Abstract>
                <AbstractText>Accurately predicting treatment outcome is crucial for creating personalized treatment plans and follow-up schedules. Electronic health records (EHRs) contain valuable patient-specific information that can be leveraged to improve outcome prediction. We propose a reliable multi-objective ensemble deep learning (MoEDL) method that uses features extracted from EHRs to predict high risk of treatment failure after radiotherapy in patients with lung cancer. The dataset used in this study contains EHRs of 814 patients who had not achieved disease-free status and 193 patients who were disease-free with at least one year follow-up time after lung cancer radiation therapy. The proposed MoEDL consists of three phases: 1) training with dynamic ensemble deep learning; 2) model selection with adaptive multi-objective optimization; and 3) testing with evidential reasoning (ER) fusion. Specifically, in the training phase, we employ deep perceptron networks as base learners to handle various issues with EHR data. The architecture and key hyper-parameters of each base learner are dynamically adjusted to increase the diversity of learners while reducing the time spent tuning hyper-parameters. Furthermore, we integrate the Snapshot Ensembles (SE) restarting strategy, multi-objective optimization, and ER fusion to improve the prediction robustness and accuracy of individual networks. The SE restarting strategy can yield multiple candidate models at no additional training cost in the training stage. The multi-objective model simultaneously considers sensitivity, specificity, and AUC as objective functions, overcoming the limitations of single-objective-based model selection. For the testing stage, we utilized an analytic ER rule to fuse the output scores from each optimal model to obtain reliable and robust predictive results. Our experimental results demonstrate that MoEDL can perform better than other conventional methods.</AbstractText>
                <CopyrightInformation>© 2019 Institute of Physics and Engineering in Medicine.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Rongfang</ForeName>
                    <Initials>R</Initials>
                    <Identifier Source="ORCID">0000-0002-7253-7750</Identifier>
                    <AffiliationInfo>
                        <Affiliation>University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, UNITED STATES.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Weng</LastName>
                    <ForeName>Yaochung</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, UNITED STATES.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Zhiguo</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, UNITED STATES.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Liyuan</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, UNITED STATES.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hao</LastName>
                    <ForeName>Hongxia</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Computer Science and Technology, Xidian University, Xian, Shaanxi, CHINA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Jing</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, UNITED STATES.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Phys Med Biol</MedlineTA>
            <NlmUniqueID>0401220</NlmUniqueID>
            <ISSNLinking>0031-9155</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Electronic health records</Keyword>
            <Keyword MajorTopicYN="N">Ensemble deep learning</Keyword>
            <Keyword MajorTopicYN="N">Lung cancer radiotherapy</Keyword>
            <Keyword MajorTopicYN="N">Multi-objective optimization</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31698346</ArticleId>
            <ArticleId IdType="doi">10.1088/1361-6560/ab555e</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31698319</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1950-6007</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>120</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>04</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie</Title>
                <ISOAbbreviation>Biomed. Pharmacother.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Huganpian, a traditional chinese medicine, inhibits liver cancer growth in vitro and in vivo by inducing autophagy and cell cycle arrest.</ArticleTitle>
            <Pagination>
                <MedlinePgn>109469</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0753-3322(19)31986-9</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biopha.2019.109469</ELocationID>
            <Abstract>
                <AbstractText>Huganpian (HGP), a traditional chinese medicine composed of 6 herbs, possesses excellent therapeutic effects in clinical application. In this study, we aimed to elucidate the anti-tumor activity and the underlying mechanisms of HGP in liver cancer. The results of this study indicated that HGP effectively inhibited liver cancer growth in vitro and in vivo in a dose-dependent manner. Mechanistically, HGP exerted its anti-tumor effects by triggering autophagy with increased LC3Ⅱ and beclin1 levels and arrested the cell cycle on G0-G1 phase by downregulating the expressions of cyclin-dependent kinase 2 (CDK2), cyclin-dependent kinase 4 (CDK4) and cyclinE1 in vitro and in vivo. Meanwhile, HGP did not induce apoptosis significantly. Importantly, we also confirmed that there were fewer side effects of HGP on immune system. Taken together, our findings suggest for the first time that HGP may become a promising drug or adjuvant drug with a lower toxicity for liver cancer treatment in the future.</AbstractText>
                <CopyrightInformation>Copyright © 2019. Published by Elsevier Masson SAS.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Gao</LastName>
                    <ForeName>Xue</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmaceutical Sciences, Binzhou Medical University, Yantai 264003, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Yuyang</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Forensic Medicine and Laboratory Medicine, Jining Medical University, Jining 272067, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Yuxin</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmaceutical Sciences, Binzhou Medical University, Yantai 264003, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Yansong</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmaceutical Sciences, Binzhou Medical University, Yantai 264003, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yan</LastName>
                    <ForeName>Miaomiao</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmaceutical Sciences, Binzhou Medical University, Yantai 264003, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sun</LastName>
                    <ForeName>Hongliu</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmaceutical Sciences, Binzhou Medical University, Yantai 264003, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Shayan</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Laboratory Science, Tianjin Medical University NanKai Hospital, Tianjin 300100, China; Tianjin Key Laboratory of Acute Abdomen Disease Associated Organ Injury and ITCWM Repair, Tianjin Medical University NanKai Hospital, Tianjin 300100, China. Electronic address: chenshayan@126.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pan</LastName>
                    <ForeName>Xiaohong</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmaceutical Sciences, Binzhou Medical University, Yantai 264003, China. Electronic address: panxh_2008@126.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>04</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>France</Country>
            <MedlineTA>Biomed Pharmacother</MedlineTA>
            <NlmUniqueID>8213295</NlmUniqueID>
            <ISSNLinking>0753-3322</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Autophagy</Keyword>
            <Keyword MajorTopicYN="N">Cell cycle</Keyword>
            <Keyword MajorTopicYN="N">Huganpian</Keyword>
            <Keyword MajorTopicYN="N">Liver cancer</Keyword>
            <Keyword MajorTopicYN="N">Tumor growth</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31698319</ArticleId>
            <ArticleId IdType="pii">S0753-3322(19)31986-9</ArticleId>
            <ArticleId IdType="doi">10.1016/j.biopha.2019.109469</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31698313</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1879-0461</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>144</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                        <Day>26</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Critical reviews in oncology/hematology</Title>
                <ISOAbbreviation>Crit. Rev. Oncol. Hematol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Clinical pharmacology of monoclonal antibodies targeting anti-PD-1 axis in urothelial cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn>102812</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S1040-8428(19)30185-4</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.critrevonc.2019.09.004</ELocationID>
            <Abstract>
                <AbstractText>Chemotherapy is the reference treatment for patients with advanced urothelial carcinoma, both in the neo-adjuvant and adjuvant settings; however, the overall outcome remains poor in this patient population. In the last few years, the addition of immune checkpoint inhibitors into the therapeutic armamentarium has changed the therapeutic landscape of several tumor types, including urothelial carcinoma. Many different molecules have been introduced on the market and several questions about immunotherapies are currently open and deserve a critical analysis. The current review article is aimed at describing the clinical pharmacology of monoclonal antibodies targeting PD-1 axis in urothelial malignancies to underline possible pharmacodynamic and pharmacokinetic differences among them.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Rofi</LastName>
                    <ForeName>Eleonora</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Italy. Electronic address: eleonora0106@inwind.it.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Del Re</LastName>
                    <ForeName>Marzia</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Italy. Electronic address: marzia.delre@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Arrigoni</LastName>
                    <ForeName>Elena</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Italy. Electronic address: elena.arrigoni@hotmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rizzo</LastName>
                    <ForeName>Mimma</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Urology, University of Trieste, Cattinara Hospital, Trieste, Italy. Electronic address: rizzo.mimma@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fontanelli</LastName>
                    <ForeName>Lorenzo</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Italy. Electronic address: eimi.lore@me.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Crucitta</LastName>
                    <ForeName>Stefania</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Italy. Electronic address: stefania.crucitta@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gianfilippo</LastName>
                    <ForeName>Giulia</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Italy. Electronic address: g.gianfilippo10@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Restante</LastName>
                    <ForeName>Giuliana</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Italy. Electronic address: giuliana.restante@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fogli</LastName>
                    <ForeName>Stefano</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Italy. Electronic address: stefano.fogli@unipi.it.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Porta</LastName>
                    <ForeName>Camillo</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, University of Pavia, Italy; Division of Translational Oncology, I.R.C.C.S. Istituti Clinici Scientifici Maugeri, Pavia, Italy. Electronic address: camillo.porta@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Danesi</LastName>
                    <ForeName>Romano</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Unit of Clinical Pharmacology and Pharmacogenetics, Department of Clinical and Experimental Medicine, University of Pisa, Italy. Electronic address: romano.danesi@unipi.it.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schmidinger</LastName>
                    <ForeName>Manuela</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Unit of Medical Oncology, Department of Internal Medicine, University of Wien, Austria. Electronic address: manuela.schmidinger@meduniwien.ac.at.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>26</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Crit Rev Oncol Hematol</MedlineTA>
            <NlmUniqueID>8916049</NlmUniqueID>
            <ISSNLinking>1040-8428</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">PD-L1 inhibitors</Keyword>
            <Keyword MajorTopicYN="N">Pharmacodynamics</Keyword>
            <Keyword MajorTopicYN="N">Pharmacokinetics</Keyword>
            <Keyword MajorTopicYN="N">Urothelial cancer</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>04</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31698313</ArticleId>
            <ArticleId IdType="pii">S1040-8428(19)30185-4</ArticleId>
            <ArticleId IdType="doi">10.1016/j.critrevonc.2019.09.004</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31698236</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1879-0534</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>115</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Computers in biology and medicine</Title>
                <ISOAbbreviation>Comput. Biol. Med.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A computational approach for investigating the mutational landscape of RAC-alpha serine/threonine-protein kinase (AKT1) and screening inhibitors against the oncogenic E17K mutation causing breast cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn>103513</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0010-4825(19)30376-2</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.compbiomed.2019.103513</ELocationID>
            <Abstract>
                <AbstractText>Breast cancer (BC) is the most commonly diagnosed cancer among females worldwide, and among the BC-associated mutations in various proteins, mutations in the RAC-alpha serine/threonine-protein kinase (AKT1) remain the most dominant. We thus attempted to understand the potential molecular pathogenicity profile of the mutations in AKT1 using a comprehensive computational protocol involving analyses of biochemistry-disruption and destabilizing properties and conservation. Our predictions revealed that E17K, R67W, V164G, E319G, R391G, D32Y, L52H, L52R, and W80R were the most pathogenic mutations. In addition, the change of glutamate to lysine at position 17 of AKT1 (E17K) was found to be highly predominant. An extensive two-step molecular dynamics (simple and complex) simulation (MDS) using GROMACS (GROningen MAchine for Chemical Simulations) was then initiated to analyze and understand the structural impact of the E17K mutation on the function of AKT1. The simple MDS analysis revealed that the E17K mutation decreases the compactness and intramolecular hydrogen bonds of the protein. We also performed a virtual screening analysis with 19 AKT inhibitors obtained from the Selleck Chemicals website those satisfied the Lipinski rule of 5. Among these 19 compounds, Akti-1/2 exhibited the best binding affinity with both native AKT1 and the E17K mutant. The molecular interaction study also revealed that the co-crystallized AKT1 inhibitor N-(4-(5-(3-acetamidophenyl)-2-(2-aminopyridin-3-yl)-3H-imidazo [4,5-b]pyridin-3-yl)benzyl)-3-fluorobenzamide (12j) exhibited a better interaction with native AKT1 compared with the E17K mutant AKT1 protein, whereas, Akti-1/2 exhibited the opposite effects, i.e., a better interaction with the E17K mutant AKT1 than the native AKT1. These findings from the interaction analysis were further supported by the complex MDS, which measured the compactness and intermolecular hydrogen bonds of the proteins. The results obtained in this study suggest that Akti-1/2 might be a better inhibitor for the treatment of BC caused by the E17K mutation in AKT1.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Thirumal Kumar</LastName>
                    <ForeName>D</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of BioSciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jain</LastName>
                    <ForeName>Nikita</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of BioSciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Evangeline</LastName>
                    <ForeName>Judith</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of BioSciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kamaraj</LastName>
                    <ForeName>Balu</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neuroscience Technology, College of Applied Medical Sciences, Imam Abdulrahman Bin Faisal University, Jubail, 35816, Saudi Arabia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Siva</LastName>
                    <ForeName>R</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of BioSciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zayed</LastName>
                    <ForeName>Hatem</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomedical Sciences, College of Health and Sciences, Qatar University, Doha, Qatar. Electronic address: hatem.zayed@qu.edu.qa.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>George Priya Doss</LastName>
                    <ForeName>C</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of BioSciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India. Electronic address: georgepriyadoss@vit.ac.in.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Comput Biol Med</MedlineTA>
            <NlmUniqueID>1250250</NlmUniqueID>
            <ISSNLinking>0010-4825</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">AKT1</Keyword>
            <Keyword MajorTopicYN="N">E17K</Keyword>
            <Keyword MajorTopicYN="N">Molecular dynamics simulation analysis</Keyword>
            <Keyword MajorTopicYN="N">Variant classification</Keyword>
            <Keyword MajorTopicYN="N">Virtual screening analysis</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31698236</ArticleId>
            <ArticleId IdType="pii">S0010-4825(19)30376-2</ArticleId>
            <ArticleId IdType="doi">10.1016/j.compbiomed.2019.103513</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31698185</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-3344</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>202</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>23</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of inorganic biochemistry</Title>
                <ISOAbbreviation>J. Inorg. Biochem.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Zn(II) and Co(II) derivatives anchored with scorpionate precursor: Antiproliferative evaluation in human cancer cell lines.</ArticleTitle>
            <Pagination>
                <MedlinePgn>110881</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0162-0134(19)30389-7</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jinorgbio.2019.110881</ELocationID>
            <Abstract>
                <AbstractText>A 'scorpionate' type precursor [bdtbpza = bis(3,5-di-t-butylpyrazol-1-yl)acetate] has been employed to synthesize two mononuclear Zn<sup>II</sup> and Co<sup>II</sup> derivatives, namely [Zn(bdtbpza)<sub>2</sub> (H<sub>2</sub>O)<sub>2</sub>]·2.5CH<sub>3</sub>OH·2[(CH<sub>3</sub>)<sub>3</sub>C-C<sub>3</sub>H<sub>2</sub>N<sub>2</sub>-C(CH<sub>3</sub>)<sub>3</sub>] (1) and [Co(bdtbpza)<sub>2</sub>(CH<sub>3</sub>OH)<sub>4</sub>] (2) in good yield. Single crystal X-ray diffraction analysis reveals that in 1, the Zn<sup>II</sup> atom is tetrahedrally surrounded by a pair of O<sub>acetate</sub> atoms of two bis(pyrazol-1-yl)acetate units and two water molecules; while in 2, the Co<sup>II</sup> atom shows an octahedral environment coordinating a pair of O<sub>acetate</sub> atoms of two bis(pyrazol-1-yl)acetate units along with four methanol molecules. The EPR spectra of 2 recorded at 77 and 298 K confirmed the tetragonal symmetry of the high spin Co(II). The DFT (Density functional theory) computation is in good agreement with the geometry proposed for compounds 1 and 2. Both the compounds display a high antiproliferative activity against HCT116 (colorectal carcinoma) and A2780 (ovarian carcinoma) cell lines compared to human normal dermal fibroblasts. In the case of A2780 cells, compounds 1 and 2 exhibit IC<sub>50</sub> values that are similar to those described for cisplatin, a widely used chemotherapeutic drug. Exposure of A2780 cells to the IC<sub>50</sub> concentration of each compound led to an increase of the number of apoptotic and autophagic cells. In the case of compound 1, the accumulation of intracellular ROS (Reactive oxygen species) is responsible for triggering A2780 cell death.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Das</LastName>
                    <ForeName>Kuheli</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Chemistry, Academia Sinica, Nankang, Taipei 115, Taiwan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Datta</LastName>
                    <ForeName>Amitabha</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Chemistry, Academia Sinica, Nankang, Taipei 115, Taiwan. Electronic address: amitd_ju@yahoo.co.in.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Frontera</LastName>
                    <ForeName>Antonio</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departament de Química, Universitat de les Illes Balears, Crta de Valldemossa km 7.5, 07122 Palma de Mallorca (Baleares), Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wen</LastName>
                    <ForeName>Yuh-Sheng</ForeName>
                    <Initials>YS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Chemistry, Academia Sinica, Nankang, Taipei 115, Taiwan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Roma-Rodrigues</LastName>
                    <ForeName>Catarina</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>UCIBIO, DCV, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Campus de Caparica, 2829-516 Caparica, Portugal.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Raposo</LastName>
                    <ForeName>Luis R</ForeName>
                    <Initials>LR</Initials>
                    <AffiliationInfo>
                        <Affiliation>UCIBIO, DCV, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Campus de Caparica, 2829-516 Caparica, Portugal.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fernandes</LastName>
                    <ForeName>Alexandra R</ForeName>
                    <Initials>AR</Initials>
                    <AffiliationInfo>
                        <Affiliation>UCIBIO, DCV, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Campus de Caparica, 2829-516 Caparica, Portugal. Electronic address: ma.fernandes@fct.unl.pt.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hung</LastName>
                    <ForeName>Chen-Hsiung</ForeName>
                    <Initials>CH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Chemistry, Academia Sinica, Nankang, Taipei 115, Taiwan. Electronic address: chhung@gate.sinica.edu.tw.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Inorg Biochem</MedlineTA>
            <NlmUniqueID>7905788</NlmUniqueID>
            <ISSNLinking>0162-0134</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Antiproliferative</Keyword>
            <Keyword MajorTopicYN="N">Autophagy, ROS</Keyword>
            <Keyword MajorTopicYN="N">Cancer cell lines</Keyword>
            <Keyword MajorTopicYN="N">Co(II)</Keyword>
            <Keyword MajorTopicYN="N">Zn(II)</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31698185</ArticleId>
            <ArticleId IdType="pii">S0162-0134(19)30389-7</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jinorgbio.2019.110881</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31698174</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1532-1967</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>81</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Jun</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cancer treatment reviews</Title>
                <ISOAbbreviation>Cancer Treat. Rev.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Androgen receptor plasticity and its implications for prostate cancer therapy.</ArticleTitle>
            <Pagination>
                <MedlinePgn>101871</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0305-7372(19)30064-7</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ctrv.2019.05.001</ELocationID>
            <Abstract>
                <AbstractText>Acquired resistance to a drug treatment is a common problem across many cancers including prostate cancer (PCa) - one of the major factors for male mortality. The androgen receptor (AR) continues to be the main therapeutic PCa target and despite the success of modern targeted therapies such as enzalutamide, resistance to these drugs eventually develops. The AR has found many ways to adapt to treatments including overexpression and production of functional, constitutively active splice variants. However, of particular importance are point mutations in the ligand binding domain of the protein that convert anti-androgens into potent AR agonists. This mechanism appears to be especially prevalent with the AR in spite of some distant similarities to other hormone nuclear receptors. Despite the AR being one of the most studied and attended targets in cancer, those gain-of-function mutations in the receptor remain a significant challenge for the development of PCa therapies. This drives the need to fully characterize such mutations and to consistently screen PCa patients for their occurrence to prevent adverse reactions to anti-androgen drugs. Novel treatments should also be developed to overcome this resistance mechanism and more attention should be given to the possibility of similar occurrences in other cancers.</AbstractText>
                <CopyrightInformation>Copyright © 2019. Published by Elsevier Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Snow</LastName>
                    <ForeName>Oliver</ForeName>
                    <Initials>O</Initials>
                    <AffiliationInfo>
                        <Affiliation>Vancouver Prostate Centre, University of British Columbia, 2660 Oak St, Vancouver V6H 3Z6, BC, Canada; School of Computing Science, Simon Fraser University, 8888 University Drive, Burnaby V5A 1S6, BC, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lallous</LastName>
                    <ForeName>Nada</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Vancouver Prostate Centre, University of British Columbia, 2660 Oak St, Vancouver V6H 3Z6, BC, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Singh</LastName>
                    <ForeName>Kriti</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Vancouver Prostate Centre, University of British Columbia, 2660 Oak St, Vancouver V6H 3Z6, BC, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lack</LastName>
                    <ForeName>Nathan</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Vancouver Prostate Centre, University of British Columbia, 2660 Oak St, Vancouver V6H 3Z6, BC, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rennie</LastName>
                    <ForeName>Paul</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Vancouver Prostate Centre, University of British Columbia, 2660 Oak St, Vancouver V6H 3Z6, BC, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cherkasov</LastName>
                    <ForeName>Artem</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Vancouver Prostate Centre, University of British Columbia, 2660 Oak St, Vancouver V6H 3Z6, BC, Canada. Electronic address: artc@interchange.ubc.ca.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Cancer Treat Rev</MedlineTA>
            <NlmUniqueID>7502030</NlmUniqueID>
            <ISSNLinking>0305-7372</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Agonist switch</Keyword>
            <Keyword MajorTopicYN="N">Androgen receptor</Keyword>
            <Keyword MajorTopicYN="N">Antiandrogen</Keyword>
            <Keyword MajorTopicYN="N">Cancer resistance</Keyword>
            <Keyword MajorTopicYN="N">Enzalutamide</Keyword>
            <Keyword MajorTopicYN="N">Prostate cancer</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>04</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31698174</ArticleId>
            <ArticleId IdType="pii">S0305-7372(19)30064-7</ArticleId>
            <ArticleId IdType="doi">10.1016/j.ctrv.2019.05.001</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31698088</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1096-3650</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>04</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Seminars in cancer biology</Title>
                <ISOAbbreviation>Semin. Cancer Biol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Tumor antigenS heterogeneity and immune response-targeting neoantigens in breast cancer.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S1044-579X(19)30299-8</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.semcancer.2019.10.023</ELocationID>
            <Abstract>
                <AbstractText>Breast cancer is both the most common type of cancer and the most frequent cause of cancer mortality in women, mainly because of its heterogeneity and limited immunogenicity. The aim of specific active cancer immunotherapy is to stimulate the host's immune response against cancer cells directly using a vaccine platform carrying one or more tumor antigens. In particular, the ideal tumor antigen should be able to elicit T cell and B cell responses, be specific for the tumor and be expressed at high levels on cancer cells. Neoantigens are ideal targets for immunotherapy because they are exclusive to individual patient's tumors, are absent in healthy tissues and are not subject to immune tolerance mechanisms. Thus, neoantigens should generate a specific reaction towards tumors since they constitute the largest fraction of targets of tumor-infiltrating T cells. In this review, we describe the technologies used for neoantigen discovery, the heterogeneity of neoantigens in breast cancer and recent studies of breast cancer immunotherapy targeting neoantigens.</AbstractText>
                <CopyrightInformation>Copyright © 2019. Published by Elsevier Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Benvenuto</LastName>
                    <ForeName>Monica</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Sciences and Translational Medicine, University of Rome &quot;Tor Vergata&quot;, Via Montpellier 1, 00133, Rome, Italy; Saint Camillus International University of Health and Medical Sciences, via di Sant'Alessandro 8, 00131, Rome, Italy. Electronic address: monica.benvenuto@unicamillus.org.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Focaccetti</LastName>
                    <ForeName>Chiara</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Human Science and Promotion of the Quality of Life, University San Raffaele Rome, Via di Val Cannuta 247, 00166, Rome, Italy. Electronic address: chiara.focaccetti@uniroma5.it.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Izzi</LastName>
                    <ForeName>Valerio</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Cell-Matrix Research, Biocenter Oulu, Faculty of Biochemistry and Molecular Medicine, University of Oulu, Aapistie 7C, FI-90230, Oulu, Finland. Electronic address: valerio.izzi@oulu.fi.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Masuelli</LastName>
                    <ForeName>Laura</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Experimental Medicine, University of Rome &quot;Sapienza&quot;, Viale Regina Elena 324, 00161 Rome, Italy. Electronic address: laura.masuelli@uniroma1.it.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Modesti</LastName>
                    <ForeName>Andrea</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Sciences and Translational Medicine, University of Rome &quot;Tor Vergata&quot;, Via Montpellier 1, 00133, Rome, Italy. Electronic address: modesti@med.uniroma2.it.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bei</LastName>
                    <ForeName>Roberto</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Sciences and Translational Medicine, University of Rome &quot;Tor Vergata&quot;, Via Montpellier 1, 00133, Rome, Italy. Electronic address: bei@med.uniroma2.it.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>04</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Semin Cancer Biol</MedlineTA>
            <NlmUniqueID>9010218</NlmUniqueID>
            <ISSNLinking>1044-579X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Neoantigens</Keyword>
            <Keyword MajorTopicYN="N">cancer vaccine</Keyword>
            <Keyword MajorTopicYN="N">immune response</Keyword>
            <Keyword MajorTopicYN="N">immunotherapy</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31698088</ArticleId>
            <ArticleId IdType="pii">S1044-579X(19)30299-8</ArticleId>
            <ArticleId IdType="doi">10.1016/j.semcancer.2019.10.023</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31698087</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1096-3650</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>04</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Seminars in cancer biology</Title>
                <ISOAbbreviation>Semin. Cancer Biol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Current progress and future perspectives of polypharmacology : From the view of non-small cell lung cancer.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S1044-579X(19)30148-8</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.semcancer.2019.10.019</ELocationID>
            <Abstract>
                <AbstractText>A pre-eminent subtype of lung carcinoma, Non-small cell lung cancer accounts for paramount causes of cancer-associated mortality worldwide. Undeterred by the endeavour in the treatment strategies, the overall cure and survival rates for NSCLC remain substandard, particularly in metastatic diseases. Moreover, the emergence of resistance to classic anticancer drugs further deteriorates the situation. These demanding circumstances culminate the need of extended and revamped research for the establishment of upcoming generation cancer therapeutics. Drug repositioning introduces an affordable and efficient strategy to discover novel drug action, especially when integrated with recent systems biology driven stratagem. This review illustrates the trendsetting approaches in repurposing along with their numerous success stories with an emphasize on the NSCLC therapeutics. Indeed, these novel hits, in combination with conventional anticancer agents, will ideally make their way the clinics and strengthen the therapeutic arsenal to combat drug resistance in the near future.</AbstractText>
                <CopyrightInformation>Copyright © 2019. Published by Elsevier Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ramanathan</LastName>
                    <ForeName>K</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biotechnology, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore 632014, Tamil Nadu, India. Electronic address: kramanathan@vit.ac.in.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shanthi</LastName>
                    <ForeName>V</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biotechnology, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore 632014, Tamil Nadu, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Maiti</LastName>
                    <ForeName>Sayoni</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biotechnology, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore 632014, Tamil Nadu, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shin</LastName>
                    <ForeName>Woong-Hee</ForeName>
                    <Initials>WH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Computer Science, Purdue University, West Lafayette, IN, 47907, USA; Department of Chemistry Education, Sunchon National University, Suncheon 57922, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kihara</LastName>
                    <ForeName>Daisuke</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biological Science, Purdue University, West Lafayette, IN, 47907, USA; Department of Computer Science, Purdue University, West Lafayette, IN, 47907, USA; Purdue University, Center for Cancer Research, West Lafayette, IN, 47907, USA; Department of Pediatrics, University of Cincinnati, Cincinnati, OH, 45229, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>04</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Semin Cancer Biol</MedlineTA>
            <NlmUniqueID>9010218</NlmUniqueID>
            <ISSNLinking>1044-579X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Drug Discovery</Keyword>
            <Keyword MajorTopicYN="N">Drug Repurposing</Keyword>
            <Keyword MajorTopicYN="N">Drug Resistance</Keyword>
            <Keyword MajorTopicYN="N">Lung Cancer</Keyword>
            <Keyword MajorTopicYN="N">Repositioned hits</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31698087</ArticleId>
            <ArticleId IdType="pii">S1044-579X(19)30148-8</ArticleId>
            <ArticleId IdType="doi">10.1016/j.semcancer.2019.10.019</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31697757</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>14</Volume>
                    <Issue>11</Issue>
                    <PubDate>
                        <Year>2019</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Increased cell size, structural complexity and migration of cancer cells acquiring fibroblast organelles by cell-projection pumping.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e0224800</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0224800</ELocationID>
            <Abstract>
                <AbstractText>We recently described a hydrodynamic mechanism for cytoplasmic transfer between cells, termed cell-projection pumping (CPP). Earlier image analysis related altered SAOS-2 osteosarcoma cell morphology, to what we now recognize as CPP uptake of fibroblast cytoplasm. We here examine SAOS-2 phenotype following co-culture with human dermal fibroblasts (HDF) in which organelles were pre-labelled with a fluorescent lipophilic marker. Fluorescence activated cell sorting (FACS) analysis was performed of HDF and SAOS-2, cultured either alone or together. FACS forward scatter is proportionate to cell size, and increased for SAOS-2 with high levels of HDF fluorescence uptake (p &lt; 0.004). FACS side scatter is proportionate to internal cell complexity, and increased in SAOS-2 with increasing uptake of HDF fluorescence (p &lt; 0.004), consistent with uptake of HDF organelles. Scratch migration assays revealed that HDF migrated more quickly than SAOS-2 in both isolated cell culture, and following co-culture (p &lt; 0.004). Notably, SAOS-2 with high levels of HDF labelling migrated faster compared with SAOS-2 with low HDF labelling (p &lt; 0.008). A slight and unconvincing reduction in SAOS-2 proliferation was seen (p &lt; 0.02). Similar results were obtained in single additional experiments with A673 and H312 cancer cells. Forward and side scatter results suggest organellar transfer by CPP increases cancer cell morphological diversity. This may contribute to histological pleomorphism relevant to cancer diagnosis and prognosis. Also, increased migration of sub-populations of cancer cells with high CPP organellar uptake, may contribute to invasion and metastasis in-vivo. We thus suggest relevance of CPP to cancer diagnosis and progression.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Zoellner</LastName>
                    <ForeName>Hans</ForeName>
                    <Initials>H</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-4804-2464</Identifier>
                    <AffiliationInfo>
                        <Affiliation>The Cellular and Molecular Pathology Research Unit, Oral Pathology and Oral Medicine, School of Dentistry, Faculty of Medicine and Health, The University of Sydney, Westmead Hospital, Westmead, NSW, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Cell Biology, The Memorial Sloan Kettering Cancer Center, New York, NY, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chami</LastName>
                    <ForeName>Belal</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>The Cellular and Molecular Pathology Research Unit, Oral Pathology and Oral Medicine, School of Dentistry, Faculty of Medicine and Health, The University of Sydney, Westmead Hospital, Westmead, NSW, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kelly</LastName>
                    <ForeName>Elizabeth</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>The Cellular and Molecular Pathology Research Unit, Oral Pathology and Oral Medicine, School of Dentistry, Faculty of Medicine and Health, The University of Sydney, Westmead Hospital, Westmead, NSW, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Moore</LastName>
                    <ForeName>Malcolm A S</ForeName>
                    <Initials>MAS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cell Biology, The Memorial Sloan Kettering Cancer Center, New York, NY, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CoiStatement>The authors have declared that no competing interests exist.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate><PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31696978</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1600-0625</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Experimental dermatology</Title>
                <ISOAbbreviation>Exp. Dermatol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The sirtuin 6: An overture in skin cancer.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/exd.14057</ELocationID>
            <Abstract>
                <AbstractText>In the recent past, the sirtuins have been under intense investigation for their roles in biology and disease, including cancer. The sirtuin SIRT6 is comparatively a lesser studied member of this family of seven proteins. Like certain other sirtuins, SIRT6 isemerging to have an oncogenic function as well as tumor suppressor roles in cancer. Limited studies have been conducted assessing the role and functional significance of SIRT6 in melanoma and non-melanoma skin cancers. In this review, we have attempted to critically dissect the potential role and significance of SIRT6 in skin carcinogenesis. With limited available information to date, SIRT6 appears to have a pro-proliferative function in non-melanoma skin cancers (NMSCs), including squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). In addition, SIRT6 is also emerging to have an oncogenic function in melanoma. Moreover, we have provided information regarding the available SIRT6 inhibitors. Conclusively, it appears that additional comprehensive studies are needed to establish the role of SIRT6 in skin biology and skin diseases, including cancer. Further, concerted efforts are needed to characterize the stage-specific role of SIRT6 in skin cancers.</AbstractText>
                <CopyrightInformation>© 2019 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Garcia-Peterson</LastName>
                    <ForeName>Liz M</ForeName>
                    <Initials>LM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Dermatology, University of Wisconsin, Madison, Wisconsin, 53706, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Guzmán-Pérez</LastName>
                    <ForeName>Glorimar</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Dermatology, University of Wisconsin, Madison, Wisconsin, 53706, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Krier</LastName>
                    <ForeName>Cassandre R</ForeName>
                    <Initials>CR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Dermatology, University of Wisconsin, Madison, Wisconsin, 53706, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ahmad</LastName>
                    <ForeName>Nihal</ForeName>
                    <Initials>N</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-4239-9887</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Dermatology, University of Wisconsin, Madison, Wisconsin, 53706, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>William S. Middleton VA Medical Center, Madison, Wisconsin, 53705, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Denmark</Country>
            <MedlineTA>Exp Dermatol</MedlineTA>
            <NlmUniqueID>9301549</NlmUniqueID>
            <ISSNLinking>0906-6705</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Melanoma</Keyword>
            <Keyword MajorTopicYN="N">SIRT6</Keyword>
            <Keyword MajorTopicYN="N">Skin</Keyword>
            <Keyword MajorTopicYN="N">Skin Cancer</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31696978</ArticleId>
            <ArticleId IdType="doi">10.1111/exd.14057</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31696964</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1097-4644</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of cellular biochemistry</Title>
                <ISOAbbreviation>J. Cell. Biochem.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Ring1 promotes the transformation of hepatic progenitor cells into cancer stem cells through the Wnt/β-catenin signaling pathway.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/jcb.29496</ELocationID>
            <Abstract>
                <AbstractText>The proliferation of hepatic progenitor cells (HPCs) is observed in reactive conditions of the liver and primary liver cancers. Ring1 as a member of polycomb-group proteins which play vital roles in carcinogenesis and stem cell self-renewal was increased in HCC patients and promoted proliferation and survival of cancer cell by degrading p53. However, the mechanisms of Ring1 driving the progression of hepatocarcinogenesis have not been elucidated. In this study, forced expression Ring1 and Ring1 siRNA lentiviral vectors were utilized to stably overexpression and silence Ring1 in HPC cell line (WB-F344), respectively. Our finding indicated that overexpression of Ring1 in HPCs promoted colony formation, cell multiplication, and invasion in vitro, conversely depletion of Ring1 repressed the biological functions of HPCs relative to controls. The expression of β-catenin was upregulated in the HPCs with overexpression of Ring1, and the correlation analysis also showed that β-catenin and Ring1 had a significant correlation in the liver cancer tissues and adjacent tissues. The activation of the Wnt/β-catenin signaling pathway significantly increased the expression of liver cancer stem cells related (LCSCs)-related molecular markers CD90 and EpCAM, which led to the transformation of HPCs into LCSCs. Most importantly, the injection of HPCs with overexpressed Ring1 into the subcutaneous of nude mice leads to the formation of poorly differentiated HCC neoplasm. Our findings elucidate that overexpression of Ring1 the activated Wnt/β-catenin signaling pathway and drove the transformation of HPCs into cancer stem cell-like cells, suggesting Ring1 has extraordinary potential in early diagnosis of HCC.</AbstractText>
                <CopyrightInformation>© 2019 Wiley Periodicals, Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Zhu</LastName>
                    <ForeName>Kai</ForeName>
                    <Initials>K</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-9437-5254</Identifier>
                    <AffiliationInfo>
                        <Affiliation>National &amp; Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Shaanxi Provincial Engineering Research Center of Biotherapy &amp; Translational Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Jiangwei</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>National &amp; Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Jun</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>National &amp; Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Shaanxi Provincial Engineering Research Center of Biotherapy &amp; Translational Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sun</LastName>
                    <ForeName>Jin</ForeName>
                    <Initials>J</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-4332-2870</Identifier>
                    <AffiliationInfo>
                        <Affiliation>National &amp; Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Shaanxi Provincial Engineering Research Center of Biotherapy &amp; Translational Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Guo</LastName>
                    <ForeName>Ying</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>National &amp; Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Shaanxi Provincial Engineering Research Center of Biotherapy &amp; Translational Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tian</LastName>
                    <ForeName>Hongwei</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>National &amp; Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Shaanxi Provincial Engineering Research Center of Biotherapy &amp; Translational Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Liang</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>National &amp; Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Chen</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>National &amp; Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shi</LastName>
                    <ForeName>Mengjiao</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>National &amp; Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kong</LastName>
                    <ForeName>Guangyao</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>National &amp; Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Shaanxi Provincial Engineering Research Center of Biotherapy &amp; Translational Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Zongfang</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>National &amp; Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Shaanxi Provincial Engineering Research Center of Biotherapy &amp; Translational Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>81802784</GrantID>
                    <Agency>National Natural Science Foundation of China</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>81502136</GrantID>
                    <Agency>National Natural Science Foundation of China</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>91842307</GrantID>
                    <Agency>National Natural Science Foundation of China</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>2019JQ-508</GrantID>
                    <Agency>National Natural Science Foundation of Shaanxi Province</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>xjj2017075</GrantID>
                    <Agency>Fundamental Research Funds for the Central Universities, Xi'an Jiaotong University</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>2017ZDCXL-SF-02-05</GrantID>
                    <Agency>Key Research and Development Program of Shaanxi Province of China</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Cell Biochem</MedlineTA>
            <NlmUniqueID>8205768</NlmUniqueID>
            <ISSNLinking>0730-2312</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Ring1</Keyword>
            <Keyword MajorTopicYN="N">Wnt/β-catenin</Keyword>
            <Keyword MajorTopicYN="N">hepatic progenitor cells</Keyword>
            <Keyword MajorTopicYN="N">hepatocellular carcinoma</Keyword>
            <Keyword MajorTopicYN="N">malignant transformation</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31696964</ArticleId>
            <ArticleId IdType="doi">10.1002/jcb.29496</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31696760</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1555-8576</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cancer biology &amp; therapy</Title>
                <ISOAbbreviation>Cancer Biol. Ther.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>STEAP2 is down-regulated in breast cancer tissue and suppresses PI3K/AKT signaling and breast cancer cell invasion in vitro and in vivo.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1-14</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/15384047.2019.1685290</ELocationID>
            <Abstract>
                <AbstractText>The six-transmembrane epithelial antigen of prostate 2 (STEAP2) protein was identified in advanced prostate cancer, and is highly over-expressed in various types of cancer. This study aimed to investigate the prognostic value and the function of STEAP2 in breast cancer. STEAP2 mRNA and protein expressions in breast normal and cancer tissues, breast cancer cell lines (MCF-7, BT-549, BT-474, MDA-MB-361, HCC1937, and MDA-MB-468) and normal mammary epithelial cell lines (HBL-100 and MCF-10A) were evaluated by immunohistochemistry, real time RT-qPCR and western blotting. The expression of STEAP2 in breast cancer tissues and its value of evaluating the prognosis of breast cancer patients was validated in the Public Databases (Oncomine and Kaplan-Meier plotter database). Lentiviral vectors with STEAP2 cDNA and shRNA were constructed and used to infect breast cancer cell lines and normal mammary epithelial cell line to investigate the effects of STEAP2 up- and down- regulation on the biological behavior of breast cells. The low expression of STEAP2 was detected in breast cancer tissues, which was associated with malignant phenotype and poor prognosis of breast cancer. The public databases analyses were consistent with our findings. STEAP2 up-regulation hindered cellular proliferation, invasion and metastasis abilities by inhibiting EMT process and suppressing PI3K/AKT/mTOR signaling pathway. On the other hand, STEAP2 down-regulation could promote cell proliferation and invasion by inducing EMT and activating the PI3K/AKT/mTOR signaling pathway. Collectively, STEAP2 acted as an anti-oncogene in breast cancer development, which suggested a new research objective for the future studies.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Qing</ForeName>
                    <Initials>Q</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Breast and Thyroid Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ji</LastName>
                    <ForeName>Guoxin</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics, Qingdao Municipal Hospital, Qingdao University, Qingdao, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Jiyu</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Breast and Thyroid Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Cancer Biol Ther</MedlineTA>
            <NlmUniqueID>101137842</NlmUniqueID>
            <ISSNLinking>1538-4047</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">EMT</Keyword>
            <Keyword MajorTopicYN="N">PI3K/AKT/mTOR signaling pathway</Keyword>
            <Keyword MajorTopicYN="N">STEAP2</Keyword>
            <Keyword MajorTopicYN="N">breast cancer</Keyword>
            <Keyword MajorTopicYN="N">invasion</Keyword>
            <Keyword MajorTopicYN="N">lentiviral transfection</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31696760</ArticleId>
            <ArticleId IdType="doi">10.1080/15384047.2019.1685290</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31696664</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1939-0041</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology</Title>
                <ISOAbbreviation>Wiley Interdiscip Rev Nanomed Nanobiotechnol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Nanotechnology platforms for cancer immunotherapy.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e1590</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/wnan.1590</ELocationID>
            <Abstract>
                <AbstractText>Various cancer therapies have advanced remarkably over the past decade. Unlike the direct therapeutic targeting of tumor cells, cancer immunotherapy is a new strategy that boosts the host's immune system to detect specific cancer cells for efficient elimination. Nanoparticles incorporating immunomodulatory agents can activate immune cells and modulate the tumor microenvironment to enhance antitumor immunity. Such nanoparticle-based cancer immunotherapies have received considerable attention and have been extensively studied in recent years. This review thus focuses on nanoparticle-based platforms (especially naturally derived nanoparticles and synthetic nanoparticles) utilized in recent advances; summarizes delivery systems that incorporate various immune-modulating agents, including peptides and nucleic acids, immune checkpoint inhibitors, and other small immunostimulating agents; and introduces combinational cancer immunotherapy with nanoparticles, especially nanoparticle-based photo-immunotherapy and nanoparticle-based chemo-immunotherapy. Undoubtedly, the recent studies introduced in this review prove that nanoparticle-incorporated cancer immunotherapy is a highly promising treatment modality for patients with cancer. Nonetheless further research is needed to solve safety concerns and improve efficacy of nanoplatform-based cancer immunotherapy for future clinical application. This article is categorized under: Therapeutic Approaches and Drug Discovery &gt; Nanomedicine for Oncologic Disease.</AbstractText>
                <CopyrightInformation>© 2019 Wiley Periodicals, Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Zhaogang</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, Texas.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ma</LastName>
                    <ForeName>Yifan</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, Ohio.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhao</LastName>
                    <ForeName>Hai</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yuan</LastName>
                    <ForeName>Yuan</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Engineering Research Center for Biomaterials of Ministry of Education, East China University of Science and Technology, Shanghai, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Betty Y S</ForeName>
                    <Initials>BYS</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0001-6890-8355</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>BC181476</GrantID>
                    <Agency>Congressionally Directed Medical Research Programs</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>R01 NS104315</GrantID>
                    <Acronym>NS</Acronym>
                    <Agency>NINDS NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Wiley Interdiscip Rev Nanomed Nanobiotechnol</MedlineTA>
            <NlmUniqueID>101508311</NlmUniqueID>
            <ISSNLinking>1939-0041</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">cancer immunotherapy</Keyword>
            <Keyword MajorTopicYN="N">immunomodulatory agents</Keyword>
            <Keyword MajorTopicYN="N">nanoplatforms</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31696664</ArticleId>
            <ArticleId IdType="doi">10.1002/wnan.1590</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31696517</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>08</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1097-0215</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>International journal of cancer</Title>
                <ISOAbbreviation>Int. J. Cancer</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Transcriptome-wide association study reveals candidate causal genes for lung cancer.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/ijc.32771</ELocationID>
            <Abstract>
                <AbstractText>We have recently completed the largest GWAS on lung cancer including 29,266 cases and 56,450 controls of European descent. The goal of this study has been to integrate the complete GWAS results with a large-scale expression quantitative trait loci (eQTL) mapping study in human lung tissues (n=1,038) to identify candidate causal genes for lung cancer. We performed transcriptome-wide association study (TWAS) for lung cancer overall, by histology (adenocarcinoma, squamous cell carcinoma, small cell lung cancer) and smoking subgroups (never- and ever-smokers). We performed replication analysis using lung data from the Genotype-Tissue Expression (GTEx) project. DNA damage assays were performed in human lung fibroblasts for selected TWAS genes. As expected, the main TWAS signal for all histological subtypes and ever-smokers was on chromosome 15q25. The gene most strongly associated with lung cancer at this locus using the TWAS approach was IREB2 (P<sub>TWAS</sub> =1.09E-99), where lower predicted expression increased lung cancer risk. A new lung adenocarcinoma susceptibility locus was revealed on 9p13.3 and associated with higher predicted expression of AQP3 (P<sub>TWAS</sub> =3.72E-6). Among the 45 previously described lung cancer GWAS loci, we mapped candidate target gene for 17 of them. The association AQP3-adenocarcinoma on 9p13.3 was replicated using GTEx (P<sub>TWAS</sub> =6.55E-5). Consistent with the effect of risk alleles on gene expression levels, IREB2 knockdown and AQP3 overproduction promote endogenous DNA damage. These findings indicate genes whose expression in lung tissue directly influence lung cancer risk. This article is protected by copyright. All rights reserved.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Bossé</LastName>
                    <ForeName>Yohan</ForeName>
                    <Initials>Y</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-3067-3711</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Quebec City, Canada.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Medicine, Laval University, Quebec City, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Zhonglin</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Quebec City, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xia</LastName>
                    <ForeName>Jun</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>The Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Manem</LastName>
                    <ForeName>Venkata</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Quebec City, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Carreras-Torres</LastName>
                    <ForeName>Robert</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>International Agency for Research on Cancer, World Health Organization, Lyon, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gabriel</LastName>
                    <ForeName>Aurélie</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>International Agency for Research on Cancer, World Health Organization, Lyon, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gaudreault</LastName>
                    <ForeName>Nathalie</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Quebec City, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Albanes</LastName>
                    <ForeName>Demetrius</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Aldrich</LastName>
                    <ForeName>Melinda C</ForeName>
                    <Initials>MC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Thoracic Surgery, Division of Epidemiology, Vanderbilt University Medical Center, Nashville, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Andrew</LastName>
                    <ForeName>Angeline</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurology, Dartmouth-Hitchcock Medical Center, Lebanon, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Arnold</LastName>
                    <ForeName>Susanne</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Markey Cancer Center, University of Kentucky, Lexington, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bickeböller</LastName>
                    <ForeName>Heike</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Genetic Epidemiology, University Medical Center Goettingen, Goettingen, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bojesen</LastName>
                    <ForeName>Stig E</ForeName>
                    <Initials>SE</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-4061-4133</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Biochemistry, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Brennan</LastName>
                    <ForeName>Paul</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>International Agency for Research on Cancer, World Health Organization, Lyon, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Brunnstrom</LastName>
                    <ForeName>Hans</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Clinical Sciences, Lund University, Lund, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Caporaso</LastName>
                    <ForeName>Neil</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Chu</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Christiani</LastName>
                    <ForeName>David C</ForeName>
                    <Initials>DC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Epidemiology, Harvard T.H. Chan School of Public Health, Boston, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Field</LastName>
                    <ForeName>John K</ForeName>
                    <Initials>JK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular and Clinical Cancer Medicine, Roy Castle Lung Cancer Research Programme, The University of Liverpool Institute of Translational Medicine, Liverpool, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Goodman</LastName>
                    <ForeName>Gary</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health Sciences Division, Swedish Cancer Institute, Seattle, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Grankvist</LastName>
                    <ForeName>Kjell</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Biosciences, Umeå University, Umea, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Houlston</LastName>
                    <ForeName>Richard</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>German Research Center for Environmental Health, Institute for Cancer Research, London, United Kingdom.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Johansson</LastName>
                    <ForeName>Mattias</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>International Agency for Research on Cancer, World Health Organization, Lyon, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Johansson</LastName>
                    <ForeName>Mikael</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiation Sciences, Umeå University, Umea, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kiemeney</LastName>
                    <ForeName>Lambertus A</ForeName>
                    <Initials>LA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Radboud Institute for Health Sciences, Radboud university medical center, Nijmegen, Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lam</LastName>
                    <ForeName>Stephen</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Integrative Oncology, British Columbia Cancer Agency, Vancouver, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Landi</LastName>
                    <ForeName>Maria Teresa</ForeName>
                    <Initials>MT</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Cancer Institute, Bethesda, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lazarus</LastName>
                    <ForeName>Philip</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Le Marchand</LastName>
                    <ForeName>Loic</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Epidemiology, University of Hawaii Cancer Center, Honolulu, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Geoffrey</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Epidemiology Division, Princess Margaret Cancer Center, Toronto, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Melander</LastName>
                    <ForeName>Olle</ForeName>
                    <Initials>O</Initials>
                    <AffiliationInfo>
                        <Affiliation>Clinical Sciences, Lund University, Lund, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rennert</LastName>
                    <ForeName>Gadi</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Technion Faculty of Medicine, Carmel Medical Center, Haifa, Israel.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Risch</LastName>
                    <ForeName>Angela</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Center Cluster Salzburg at PLUS, Department of Molecular Biology, University of Salzburg, Heidelberg, Austria.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rosenberg</LastName>
                    <ForeName>Susan M</ForeName>
                    <Initials>SM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schabath</LastName>
                    <ForeName>Matthew B</ForeName>
                    <Initials>MB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shete</LastName>
                    <ForeName>Sanjay</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Epidemiology, The University of Texas, MD Anderson Cancer Center, Houston, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Song</LastName>
                    <ForeName>Zhuoyi</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stevens</LastName>
                    <ForeName>Victoria L</ForeName>
                    <Initials>VL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Epidemiology Research Program, American Cancer Society, Atlanta, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tardon</LastName>
                    <ForeName>Adonina</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, University of Oviedo and CIBERESP, Oviedo, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wichmann</LastName>
                    <ForeName>H-Erich</ForeName>
                    <Initials>HE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Epidemiology, Helmholtz Center Munich, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Woll</LastName>
                    <ForeName>Penella</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Academic Unit of Clinical Oncology, University of Sheffield, Sheffield, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zienolddiny</LastName>
                    <ForeName>Shan</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Institute of Occupational Health (STAMI), Norway.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Obeidat</LastName>
                    <ForeName>Ma'en</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>The University of British Columbia Centre for Heart Lung Innovation, St Paul's Hospital, Vancouver, BC, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Timens</LastName>
                    <ForeName>Wim</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Groningen, University Medical Center Groningen, Department of Pathology and Medical Biology, GRIAC Research Institute, Groningen, the Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hung</LastName>
                    <ForeName>Rayjean J</ForeName>
                    <Initials>RJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Prosserman Centre for Population Health Research, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Joubert</LastName>
                    <ForeName>Philippe</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval, Quebec City, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Amos</LastName>
                    <ForeName>Christopher I</ForeName>
                    <Initials>CI</Initials>
                    <AffiliationInfo>
                        <Affiliation>The Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>McKay</LastName>
                    <ForeName>James D</ForeName>
                    <Initials>JD</Initials>
                    <AffiliationInfo>
                        <Affiliation>International Agency for Research on Cancer, World Health Organization, Lyon, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>P30 CA076292</GrantID>
                    <Acronym>CA</Acronym>
                    <Agency>NCI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>P50 CA119997</GrantID>
                    <Acronym>CA</Acronym>
                    <Agency>NCI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Int J Cancer</MedlineTA>
            <NlmUniqueID>0042124</NlmUniqueID>
            <ISSNLinking>0020-7136</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">GWAS</Keyword>
            <Keyword MajorTopicYN="N">Lung cancer</Keyword>
            <Keyword MajorTopicYN="N">lung eQTL</Keyword>
            <Keyword MajorTopicYN="N">transcriptome-wide association study</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>09</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31696517</ArticleId>
            <ArticleId IdType="doi">10.1002/ijc.32771</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">31696402</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2365-421X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>4</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>EJNMMI radiopharmacy and chemistry</Title>
                <ISOAbbreviation>EJNMMI Radiopharm Chem</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Tracers for non-invasive radionuclide imaging of immune checkpoint expression in cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn>29</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1186/s41181-019-0078-z</ELocationID>
            <Abstract>
                <AbstractText>Immunotherapy with checkpoint inhibitors demonstrates impressive improvements in the treatment of several types of cancer. Unfortunately, not all patients respond to therapy while severe immune-related adverse effects are prevalent. Currently, patient stratification is based on immunotherapy marker expression through immunohistochemical analysis on biopsied material. However, expression can be heterogeneous within and between tumor lesions, amplifying the sampling limitations of biopsies. Analysis of immunotherapy target expression by non-invasive quantitative molecular imaging with PET or SPECT may overcome this issue. In this review, an overview of tracers that have been developed for preclinical and clinical imaging of key immunotherapy targets, such as programmed cell death-1, programmed cell death ligand-1, IDO1 and cytotoxic T lymphocyte-associated antigen-4 is presented. We discuss important aspects to consider when developing such tracers and outline the future perspectives of molecular imaging of immunotherapy markers. Current techniques in immune checkpoint imaging and its potential for future applications.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Wierstra</LastName>
                    <ForeName>Peter</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, P.O. Box 9101, 6500, HB, Nijmegen, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sandker</LastName>
                    <ForeName>Gerwin</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, P.O. Box 9101, 6500, HB, Nijmegen, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Aarntzen</LastName>
                    <ForeName>Erik</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, P.O. Box 9101, 6500, HB, Nijmegen, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gotthardt</LastName>
                    <ForeName>Martin</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, P.O. Box 9101, 6500, HB, Nijmegen, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Adema</LastName>
                    <ForeName>Gosse</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiation Oncology, Radboud university medical center, Radboud Institute for Molecular Life Sciences, P.O. Box 9101, 6500, HB, Nijmegen, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bussink</LastName>
                    <ForeName>Johan</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiation Oncology, Radboud university medical center, Radboud Institute for Molecular Life Sciences, P.O. Box 9101, 6500, HB, Nijmegen, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Raavé</LastName>
                    <ForeName>René</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, P.O. Box 9101, 6500, HB, Nijmegen, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Heskamp</LastName>
                    <ForeName>Sandra</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Radboud Institute for Molecular Life Sciences, P.O. Box 9101, 6500, HB, Nijmegen, The Netherlands. Sandra.Heskamp@radboudumc.nl.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>10099</GrantID>
                    <Agency>KWF Kankerbestrijding (NL)</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>116106</GrantID>
                    <Agency>Innovative Medicines Initiative ()</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>91617039</GrantID>
                    <Agency>Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NL)</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>EJNMMI Radiopharm Chem</MedlineTA>
            <NlmUniqueID>101714628</NlmUniqueID>
            <ISSNLinking>2365-421X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">A2aR</Keyword>
            <Keyword MajorTopicYN="N">CD276</Keyword>
            <Keyword MajorTopicYN="N">CD80</Keyword>
            <Keyword MajorTopicYN="N">CTLA-4</Keyword>
            <Keyword MajorTopicYN="N">IDO1</Keyword>
            <Keyword MajorTopicYN="N">Immune checkpoint</Keyword>
            <Keyword MajorTopicYN="N">Immune checkpoint imaging</Keyword>
            <Keyword MajorTopicYN="N">OX40</Keyword>
            <Keyword MajorTopicYN="N">PD-1</Keyword>
            <Keyword MajorTopicYN="N">PD-L1</Keyword>
            <Keyword MajorTopicYN="N">PET</Keyword>
            <Keyword MajorTopicYN="N">SPECT</Keyword>
            <Keyword MajorTopicYN="N">Tumor expression</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31696402</ArticleId>
            <ArticleId IdType="doi">10.1186/s41181-019-0078-z</ArticleId>
            <ArticleId IdType="pii">10.1186/s41181-019-0078-z</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31696201</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1745-7270</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Acta biochimica et biophysica Sinica</Title>
                <ISOAbbreviation>Acta Biochim. Biophys. Sin. (Shanghai)</ISOAbbreviation>
            </Journal>
            <ArticleTitle>FBXL19-AS1 promotes cell proliferation and inhibits cell apoptosis via miR-876-5p/FOXM1 axis in breast cancer.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">gmz110</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1093/abbs/gmz110</ELocationID>
            <Abstract>
                <AbstractText>As the most common cancer and one of the leading causes of cancer-associated mortality, breast cancer continues to need more key molecules to regulate its progression. F-box and leucine-rich repeat protein 19 antisense RNA 1 (known as FBXL19-AS1) is a long non-coding RNA (lncRNA) which has been reported as an oncogene in several types of human cancers. However, the specific downstream targets of FBXL19-AS1 remain unknown. In this study, we set out to find more reliable downstream molecules of FBXL19-AS1 in breast cancer. FBXL19-AS1 was expressed at a high level in breast cancer cells. Loss-of-function experiments revealed that silencing FBXL19-AS1 could impair cell proliferation and induce cell apoptosis in breast cancer. In addition, the location of FBXL19-AS1 in the cytoplasm was detected by fluorescent in situ hybridization assay, while FBXL19-AS1 regulated the expression of Forkhead box M1 (FOXM1) by directly absorbing miR-876-5p. Through rescue assays, it was observed that FOXM1 overexpression recovered the inhibited tumor growth caused by FBXL19-AS1 downregulation. We affirmed the function of FBXL19-AS1 in breast cancer and described the mechanism of the FBXL19-AS1/miR-876-5p/FOXM1 axis. The current work presents the molecular mechanism which underlies FBXL19-AS1 in breast cancer and suggests a comprehensive, feasible FBXL19-AS1-mediated therapeutic approach for treating breast cancer.</AbstractText>
                <CopyrightInformation>© The Author(s) 2019. Published by Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Dong</LastName>
                    <ForeName>Guolei</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin 300060, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University (Ministry of Education), Tianjin 300060, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pan</LastName>
                    <ForeName>Teng</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>The 3rd Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin 300060, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University (Ministry of Education), Tianjin 300060, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Dongdong</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>The 3rd Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin 300060, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University (Ministry of Education), Tianjin 300060, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Chunyan</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>The 3rd Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin 300060, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University (Ministry of Education), Tianjin 300060, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Jingjing</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>The 3rd Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin 300060, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University (Ministry of Education), Tianjin 300060, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Jin</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>The 3rd Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin 300060, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University (Ministry of Education), Tianjin 300060, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>China</Country>
            <MedlineTA>Acta Biochim Biophys Sin (Shanghai)</MedlineTA>
            <NlmUniqueID>101206716</NlmUniqueID>
            <ISSNLinking>1672-9145</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">FBXL19-AS1</Keyword>
            <Keyword MajorTopicYN="N">FOXM1</Keyword>
            <Keyword MajorTopicYN="N">breast cancer</Keyword>
            <Keyword MajorTopicYN="N">miR-876-5p</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>04</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31696201</ArticleId>
            <ArticleId IdType="pii">5613542</ArticleId>
            <ArticleId IdType="doi">10.1093/abbs/gmz110</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31696188</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2050-7518</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of materials chemistry. B</Title>
                <ISOAbbreviation>J Mater Chem B</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Bypassing pro-survival and resistance mechanisms of autophagy in EGFR-positive lung cancer cells by targeted delivery of 5FU using theranostic Ag<sub>2</sub>S quantum dots.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1039/c9tb01602c</ELocationID>
            <Abstract>
                <AbstractText>Targeted drug delivery systems that combine imaging and therapeutic functions in a single structure have become very popular in nanomedicine. Near-infrared (NIR) emitting Ag2S quantum dots (QDs) are excellent candidates for this task. Here, we have developed PEGylated Ag2S QDs functionalized with Cetuximab (Cet) antibody and loaded with an anticancer drug, 5-fluorouracil (5FU). These theranostic QDs were used for targeted NIR imaging and treatment of lung cancer using low (H1299) and high (A549) Epidermal Growth Factor Receptor (EGFR) overexpressing cell lines. The Cet conjugated QDs effectively and selectively delivered 5FU to A549 cells and provided significantly enhanced cell death associated with apoptosis. Interestingly, while treatment of cells with free 5FU activated autophagy, a cellular mechanism conferring resistance to cell death, these EGFR targeting multimodal QDs significantly overcame drug resistance compared to 5FU treatment alone. The improved therapeutic outcome of 5FU delivered to A549 cells by Cet conjugated Ag2S QDs is suggested as the synergistic outcome of enhanced receptor mediated uptake of nanoparticles, and hence the drug, coupled with suppressed autophagy even in the absence of addition of an autophagy suppressor.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Duman</LastName>
                    <ForeName>Fatma Demir</ForeName>
                    <Initials>FD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Koc University, Department of Chemistry, 34450 Istanbul, Turkey. fyagci@ku.edu.tr.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Akkoc</LastName>
                    <ForeName>Yunus</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sabanci University, Faculty of Engineering and Natural Sciences, Molecular Biology, Genetics and Bioengineering Programs, 34956 Istanbul, Turkey. dgozuacik@sabanciuniv.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Demirci</LastName>
                    <ForeName>Gozde</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Koc University, Graduate School of Materials Science and Engineering, Rumelifeneri Yolu, Sariyer, 34450 Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bavili</LastName>
                    <ForeName>Nima</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Koc University, Department of Physics, Rumelifeneri Yolu, Sarıyer, 34450 Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kiraz</LastName>
                    <ForeName>Alper</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-7977-1286</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Koc University, Graduate School of Materials Science and Engineering, Rumelifeneri Yolu, Sariyer, 34450 Istanbul, Turkey and Koc University, Department of Physics, Rumelifeneri Yolu, Sarıyer, 34450 Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gozuacik</LastName>
                    <ForeName>Devrim</ForeName>
                    <Initials>D</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-7739-2346</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Sabanci University, Faculty of Engineering and Natural Sciences, Molecular Biology, Genetics and Bioengineering Programs, 34956 Istanbul, Turkey. dgozuacik@sabanciuniv.edu and Sabanci University, Center of Excellence for Functional Surfaces and Interfaces for NanoDiagnostics (EFSUN), 34956 Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Acar</LastName>
                    <ForeName>Havva Yagci</ForeName>
                    <Initials>HY</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-5601-8814</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Koc University, Department of Chemistry, 34450 Istanbul, Turkey. fyagci@ku.edu.tr and Koc University, Graduate School of Materials Science and Engineering, Rumelifeneri Yolu, Sariyer, 34450 Istanbul, Turkey and KUYTAM, Koc University Surface Science and Technology Center, 34450 Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>J Mater Chem B</MedlineTA>
            <NlmUniqueID>101598493</NlmUniqueID>
            <ISSNLinking>2050-750X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31696188</ArticleId>
            <ArticleId IdType="doi">10.1039/c9tb01602c</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31696169</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1364-5528</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Analyst</Title>
                <ISOAbbreviation>Analyst</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The construction of DNAzyme-based logic gates for amplified microRNA detection and cancer recognition.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1039/c9an01977d</ELocationID>
            <Abstract>
                <AbstractText>Benefiting from the simple DNAzyme and a duplex-specific nuclease, a series of microRNA-stimulated DNAzyme logic gates were rationally assembled for the highly accurate detection of multiple low-abundant microRNA biomarkers that correspond to the specific aberrant microRNA expression patterns of cancer tissues, thus showing a great potential in early diagnosis.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Wu</LastName>
                    <ForeName>Lingyu</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Chemistry and Molecular Sciences, Key Laboratory of Biomedical Polymers of Ministry of Education, Wuhan University, Wuhan, Hubei 430072, P. R. China. xzhou@whu.edu.cn fuanwang@whu.edu.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pan</LastName>
                    <ForeName>Min</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Chemistry and Molecular Sciences, Key Laboratory of Biomedical Polymers of Ministry of Education, Wuhan University, Wuhan, Hubei 430072, P. R. China. xzhou@whu.edu.cn fuanwang@whu.edu.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Yuqi</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Chemistry and Molecular Sciences, Key Laboratory of Biomedical Polymers of Ministry of Education, Wuhan University, Wuhan, Hubei 430072, P. R. China. xzhou@whu.edu.cn fuanwang@whu.edu.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huang</LastName>
                    <ForeName>Haiyan</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Chemistry and Molecular Sciences, Key Laboratory of Biomedical Polymers of Ministry of Education, Wuhan University, Wuhan, Hubei 430072, P. R. China. xzhou@whu.edu.cn fuanwang@whu.edu.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Xiaoe</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Chemistry and Molecular Sciences, Key Laboratory of Biomedical Polymers of Ministry of Education, Wuhan University, Wuhan, Hubei 430072, P. R. China. xzhou@whu.edu.cn fuanwang@whu.edu.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Fuan</ForeName>
                    <Initials>F</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-3063-2485</Identifier>
                    <AffiliationInfo>
                        <Affiliation>College of Chemistry and Molecular Sciences, Key Laboratory of Biomedical Polymers of Ministry of Education, Wuhan University, Wuhan, Hubei 430072, P. R. China. xzhou@whu.edu.cn fuanwang@whu.edu.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Xiang</ForeName>
                    <Initials>X</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-1829-9368</Identifier>
                    <AffiliationInfo>
                        <Affiliation>College of Chemistry and Molecular Sciences, Key Laboratory of Biomedical Polymers of Ministry of Education, Wuhan University, Wuhan, Hubei 430072, P. R. China. xzhou@whu.edu.cn fuanwang@whu.edu.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Analyst</MedlineTA>
            <NlmUniqueID>0372652</NlmUniqueID>
            <ISSNLinking>0003-2654</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31696169</ArticleId>
            <ArticleId IdType="doi">10.1039/c9an01977d</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>

        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31697757</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0224800</ArticleId>
            <ArticleId IdType="pii">PONE-D-19-21420</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31696210</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1745-7270</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Acta biochimica et biophysica Sinica</Title>
                <ISOAbbreviation>Acta Biochim. Biophys. Sin. (Shanghai)</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Wogonoside inhibits tumor growth and metastasis in endometrial cancer via ER stress-Hippo signaling axis.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">gmz109</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1093/abbs/gmz109</ELocationID>
            <Abstract>
                <AbstractText>Wogonoside, a bioactive flavonoid component derived from Scutellaria baicalensis Georgi, has been reported to inhibit tumor growth in mice bearing various types of cancer cells such as breast cancer, lung cancer, and leukemia cells. However, whether wogonoside could inhibit tumor growth of endometrial cancer has not been elucidated. In this study, we explored the function of wogonoside on tumor growth and the underlying mechanism on endometrial cancer. Firstly, we investigated the effect of wogonoside on endometrial cancer cells and found that wogonoside could significantly decrease cell proliferation and metastasis. Mechanistically, wogonoside could aggravate the extent of ER stress and upregulate the phosphorylation level of Mammalian Ste20-like kinase 1, leading to the activation of the Hippo signaling pathway. Taken together, in vitro and in vivo data demonstrated that wogonoside could be a potent inducer of ER stress and could be further developed into a promising therapy for endometrial cancer.</AbstractText>
                <CopyrightInformation>© The Author(s) 2019. Published by Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Shaorong</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, the Second Affiliated Hospital, Fujian Medical University, Quanzhou 362000, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wu</LastName>
                    <ForeName>Zhuna</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, the Second Affiliated Hospital, Fujian Medical University, Quanzhou 362000, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ke</LastName>
                    <ForeName>Yumin</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, the Second Affiliated Hospital, Fujian Medical University, Quanzhou 362000, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shu</LastName>
                    <ForeName>Pingping</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, the Second Affiliated Hospital, Fujian Medical University, Quanzhou 362000, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Caihong</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, the Second Affiliated Hospital, Fujian Medical University, Quanzhou 362000, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lin</LastName>
                    <ForeName>Ruying</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, the Second Affiliated Hospital, Fujian Medical University, Quanzhou 362000, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shi</LastName>
                    <ForeName>Qirong</ForeName>
                    <Initials>Q</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, the Second Affiliated Hospital, Fujian Medical University, Quanzhou 362000, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>China</Country>
            <MedlineTA>Acta Biochim Biophys Sin (Shanghai)</MedlineTA>
            <NlmUniqueID>101206716</NlmUniqueID>
            <ISSNLinking>1672-9145</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Hippo signaling</Keyword>
            <Keyword MajorTopicYN="N">endometrial cancer</Keyword>
            <Keyword MajorTopicYN="N">endoplasmic reticulum stress</Keyword>
            <Keyword MajorTopicYN="N">wogonoside</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>04</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>8</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31696210</ArticleId>
            <ArticleId IdType="pii">5613543</ArticleId>
            <ArticleId IdType="doi">10.1093/abbs/gmz109</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">31686838</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>08</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Print">1178-6930</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>12</Volume>
                    <PubDate>
                        <Year>2019</Year>
                    </PubDate>
                </JournalIssue>
                <Title>OncoTargets and therapy</Title>
                <ISOAbbreviation>Onco Targets Ther</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Metabolomics: a promising diagnostic and therapeutic implement for breast cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn>6797-6811</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.2147/OTT.S215628</ELocationID>
            <Abstract>
                <AbstractText>Breast cancer (BC) is the most commonly diagnosed cancer among women and the leading cause of cancer death. Despite the advent of numerous diagnosis and treatment methods in recent years, this heterogeneous disease still presents great challenges in early diagnosis, curative treatments and prognosis monitoring. Thus, finding promising early diagnostic biomarkers and therapeutic targets and approaches is meaningful. Metabolomics, which focuses on the analysis of metabolites that change during metabolism, can reveal even a subtle abnormal change in an individual. In recent decades, the exploration of cancer-related metabolomics has increased. Metabolites can be promising biomarkers for the screening, response evaluation and prognosis of BC. In this review, we summarized the workflow of metabolomics, described metabolite signatures based on molecular subtype as well as reclassification and then discussed the application of metabolomics in the early diagnosis, monitoring and prognosis of BC to offer new insights for clinicians in breast cancer diagnosis and treatment.</AbstractText>
                <CopyrightInformation>© 2019 Chen et al.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Zhanghan</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Zehuan</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Haoran</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jiang</LastName>
                    <ForeName>Ying</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>New Zealand</Country>
            <MedlineTA>Onco Targets Ther</MedlineTA>
            <NlmUniqueID>101514322</NlmUniqueID>
            <ISSNLinking>1178-6930</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">biomarkers</Keyword>
            <Keyword MajorTopicYN="N">diagnosis</Keyword>
            <Keyword MajorTopicYN="N">metabolites</Keyword>
            <Keyword MajorTopicYN="N">treatment</Keyword>
        </KeywordList>
        <CoiStatement>The authors report no conflicts of interest in this work.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>6</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31686838</ArticleId>
            <ArticleId IdType="doi">10.2147/OTT.S215628</ArticleId>
            <ArticleId IdType="pii">215628</ArticleId>
            <ArticleId IdType="pmc">PMC6709037</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Sci Rep. 2017 Dec 19;7(1):17831</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29259228</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Gen Physiol. 1927 Mar 7;8(6):519-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19872213</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Breast Cancer Res. 2016 May 28;18(1):57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27233359</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Trends Biotechnol. 2004 May;22(5):245-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15109811</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biol Res Nurs. 2018 Mar;20(2):227-236</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29258398</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Metabolism. 2019 Feb;91:18-29</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30468782</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Commun. 2017 Oct 11;8(1):864</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29021522</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Front Oncol. 2016 Jan 28;6:17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26858940</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Annu Rev Pharmacol Toxicol. 2008;48:653-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18184107</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Anal Chim Acta. 2018 Aug 27;1021:69-77</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29681286</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Cancer Res. 2017 Mar 15;23(6):1422-1431</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28082280</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncogenesis. 2017 Jul 10;6(7):e356</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28692032</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Amino Acids. 2016 Jun;48(6):1339-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27033065</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Sci Rep. 2017 Mar 03;7:43969</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28256598</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Onco Targets Ther. 2018 Oct 11;11:6827-6838</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30349315</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Proteome Res. 2014 Feb 7;13(2):883-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24364541</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Mar;1864(3):344-357</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30578966</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Cycle. 2011 Apr 15;10(8):1271-86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21512313</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Rapid Commun Mass Spectrom. 2018 Oct 15;32(19):1683-1692</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30003601</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncotarget. 2016 Mar 1;7(9):9925-38</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26848530</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Breast Cancer Res Treat. 2018 Oct;171(3):657-666</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29946863</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Anal Bioanal Chem. 2016 Aug;408(21):5843-5854</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27379392</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Am J Clin Nutr. 2017 Aug;106(2):637-649</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28659298</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>BMC Genomics. 2006 Jun 08;7:142</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16762068</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Nutr Food Res. 2017 Apr;61(4):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27860207</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Curr Opin Biotechnol. 2016 Jun;39:198-206</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27135552</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Breast Cancer Res. 2017 Nov 28;19(1):125</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29183390</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biomed Chromatogr. 2016 Jan;30(1):42-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26179699</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Mol Sci. 2018 Mar 19;19(3):null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29562706</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Metabolites. 2017 Jun 07;7(2):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28590405</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Crit Rev Anal Chem. 2016 Jul 3;46(4):342-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26337255</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Onco Targets Ther. 2016 Mar 11;9:1389-98</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27042107</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>BMC Cancer. 2010 Nov 16;10:628</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21080935</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2018 Nov 16;13(11):e0207474</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30444915</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Res. 2012 Nov 15;72(22):5712-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22986741</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncotarget. 2016 Oct 11;7(41):67111-67128</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27564096</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Eur J Epidemiol. 2016 Aug;31(8):717-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27230258</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Comp Funct Genomics. 2001;2(3):155-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18628911</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Pharm Biomed Anal. 2018 Apr 15;152:234-241</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29428809</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Anal Bioanal Chem. 2018 Jul;410(18):4459-4468</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29732495</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Sci. 2018 Jul;109(7):2315-2326</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29737597</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biochim Biophys Acta Rev Cancer. 2017 Dec;1868(2):412-419</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28887205</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Brief Bioinform. 2007 Sep;8(5):279-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17626065</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Mol Cell Biol. 2012 Mar 22;13(4):263-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22436749</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biosci Rep. 2016 Jun 30;36(3):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27160081</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Metabolites. 2017 May 16;7(2):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28509845</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Treat Rev. 2018 Jun;67:88-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29775779</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Histopathology. 2018 Jan;72(2):183-190</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28771772</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Bioinformatics. 2009 Dec 1;25(23):3151-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19783829</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncotarget. 2018 Feb 7;9(14):11677-11690</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29545929</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Breast Cancer Res. 2010;12(2):R16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20205716</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Drug Discov Today. 2017 Feb;22(2):463-470</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27919805</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Chem. 1978 Oct;24(10):1663-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">359193</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Breath Res. 2016 Dec 19;:null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27991859</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Biol Sci. 2017 Nov 1;13(11):1387-1397</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29209143</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Biomark. 2018;23(2):255-268</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30103303</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biomarkers. 2004 Jan-Feb;9(1):1-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15204308</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>BMJ. 2017 Feb 28;356:j477</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28246088</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Sci Rep. 2016 Jul 13;6:29662</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27406679</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Intern Med. 2018 Oct;284(4):346-357</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29923256</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biopreserv Biobank. 2016 Dec;14(6):480-490</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27403896</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Front Oncol. 2018 May 28;8:174</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29892572</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Metabolomics. 2016;12(10):149</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27642271</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proteomics Clin Appl. 2017 Sep;11(9-10):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28627779</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Proteome Res. 2017 Feb 3;16(2):1097-1104</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28067522</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Breast Cancer Res. 2017 Mar 11;19(1):28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28284224</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Breast Cancer. 2018 Sep 30;2018:2063540</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30363973</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Adv Exp Med Biol. 2017;965:145-161</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28132179</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Proteomics. 2018 Apr 30;178:82-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29122727</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Metab. 2016 May 10;23(5):867-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27133130</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Trends Biotechnol. 2011 Jun;29(6):267-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21435731</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Theranostics. 2016 Sep 12;6(12):2161-2169</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27924154</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Adv Clin Chem. 2016;74:1-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27117659</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Genome Med. 2012 Apr 30;4(4):37</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22546809</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Cancer. 2019 Jun 1;144(11):2833-2842</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30426507</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Curr Opin Biotechnol. 2017 Feb;43:34-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27580257</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Talanta. 2016 Sep 1;158:351-360</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27343615</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Chin J Cancer. 2017 Mar 29;36(1):36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28356139</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Cancer Ther. 2018 Jan;17(1):264-275</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29021292</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Metabolomics. 2017 Dec 1;14(1):7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30830321</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Breast Cancer Res. 2017 Mar 29;19(1):44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28356166</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Natl Cancer Inst. 2018 Jun 1;110(6):588-597</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29325144</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Trends Pharmacol Sci. 2015 Dec;36(12):822-846</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26538316</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncotarget. 2017 Dec 23;9(2):2678-2696</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29416801</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Toxicol Res (Camb). 2017 Aug 29;6(6):843-853</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30090547</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Proteomics. 2013 Dec 6;94:279-88</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24125731</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncotarget. 2016 Jun 28;7(26):39809-39822</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27223427</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Res. 2006 May 15;66(10):5419-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16707470</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biomaterials. 2018 Apr;162:144-153</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29448142</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Sci Rep. 2017 May 11;7(1):1715</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28496143</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Endocrinology. 2017 Mar 1;158(3):477-489</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27967239</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Chromatogr A. 2016 Jan 22;1430:80-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26763302</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>CA Cancer J Clin. 2018 Nov;68(6):394-424</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30207593</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Dis Markers. 2017;2017:7687851</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29434411</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Breast Cancer Res. 2018 Dec 4;20(1):148</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30514398</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Epidemiol. 2018 Apr 1;47(2):484-494</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29365091</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Treat Rev. 2012 Oct;38(6):698-707</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22178455</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Toxicol Lett. 2018 May 15;288:65-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29454887</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Oncol. 2016 Dec;49(6):2245-2254</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27748798</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Chim Acta. 2016 Jan 15;452:18-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26523874</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Metabolomics. 2010 Mar;6(1):78-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20300169</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Eur J Pharmacol. 2014 Oct 5;740:364-78</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25058905</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Cancer Res. 2009 Nov 1;15(21):6716-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19861449</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Rapid Commun Mass Spectrom. 2016 Feb 28;30(4):533-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26777684</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Mol Sci. 2018 Feb 21;19(2):null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29466297</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Transl Oncol. 2013 Dec 01;6(6):757-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24466379</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31693087</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>06</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1573-4935</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Bioscience reports</Title>
                <ISOAbbreviation>Biosci. Rep.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Emerging roles of the long non-coding RNA 01296/microRNA-143-3p/MSI2 axis in development of thyroid cancer.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">BSR20182376</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1042/BSR20182376</ELocationID>
            <Abstract>
                <AbstractText>Thyroid cancer (TC) is an endocrine malignancy with rising incidence. Long non-coding RNAs (lncRNAs) can serve as diagnostic and prognostic biomarkers for TC. Thus, we studied roles of LINC01296 in TC progression. Initially, the Gene Expression Omnibus database was used to detect the differentially expressed genes in human TC samples and the potential mechanism. Expression of LINC01296 and miR-143-3p in TC tissues and cells was measured. The transfection of TC cells was conducted with si-LINC01296, si-MSI2, mimic or inhibitor of miR-143-3p to determine their effects on TC cell proliferation, migration, invasion, apoptosis and the AKT/STAT3 signaling pathway. Finally, in vivo assay was performed to verify role of miR-143-3p in tumorigenesis of TC cells in nude mice. LINC01296 was predicted to bind to miR-143-3p to modulate MSI2 expression, thus regulating the occurrence and development of TC. LINC01296 was upregulated, while miR-143-3p was downregulated in TC cells and tissues. LNC01296 specifically bound to miR-143-3p and MSI2 was a target of miR-143-3p. Besides, LINC01296 silencing or miR-143-3p overexpression inhibited migration, invasion, proliferation and advanced apoptosis of TC cells. Additionally, silenced LINC01296 or overexpressed miR-143-3p reduced phosphorylated STAT3/STAT3, phosphorylated AKT/AKT, Bcl-2 and CyclinD1 levels but elevated Bax, Cleaved Caspase3 and Caspase3 levels. Also, tumorigenesis of TC cells in nude mice was inhibited with the silencing of LINC01296. In summary, LINC01296/miR-143-3p/MSI2 axis regulated development of TC through the AKT/STAT3 signaling pathway.</AbstractText>
                <CopyrightInformation>Copyright 2019 The Author(s).</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Zheng-Lin</ForeName>
                    <Initials>ZL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Zhongshan Hospital, Fudan University, Shanghai, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Cong</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Zhongshan Hospital, Fudan University, Shanghai, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Wei</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Zhongshan Hospital, Fudan University, Shanghai, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ai</LastName>
                    <ForeName>Zhi-Long</ForeName>
                    <Initials>ZL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Zhongshan Hospital, Fudan University, Shanghai, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Biosci Rep</MedlineTA>
            <NlmUniqueID>8102797</NlmUniqueID>
            <ISSNLinking>0144-8463</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">AKT/STAT3 signaling pathway</Keyword>
            <Keyword MajorTopicYN="N">Competing endogenous RNA</Keyword>
            <Keyword MajorTopicYN="N">Long non-coding RNA 01296</Keyword>
            <Keyword MajorTopicYN="N">Musashi 2</Keyword>
            <Keyword MajorTopicYN="N">Thyroid cancer</Keyword>
            <Keyword MajorTopicYN="N">microRNA-143-3p</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>09</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31693087</ArticleId>
            <ArticleId IdType="pii">221036</ArticleId>
            <ArticleId IdType="doi">10.1042/BSR20182376</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31693185</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>06</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1097-0215</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>06</Day>
                    </PubDate>
                </JournalIssue>
                <Title>International journal of cancer</Title>
                <ISOAbbreviation>Int. J. Cancer</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Consumption of sugar-sweetened and artificially-sweetened soft drinks and risk of cancers not related to obesity.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/ijc.32772</ELocationID>
            <Abstract>
                <AbstractText>Consumption of sugary drinks increases the risk of obesity. Previously we reported a positive association between sugar-sweetened soft drink consumption and obesity-related cancer but this association was not fully explained by obesity; in contrast, we found no association for consumption of artificially-sweetened soft drinks. Our aim was to determine whether the consumption of sugar-sweetened or artificially-sweetened soft drinks was associated with cancers other than those currently identified as being related to obesity. We used data from the Melbourne Collaborative Cohort Study. Participants completed a 121-item food-frequency questionnaire (FFQ) at baseline including separate questions about the number of times in the past year they had consumed sugar-sweetened and artificially-sweetened soft drinks. Cox regression models were fitted to estimate hazard ratios (HR) and 95% confidence intervals (CI) for the risk of cancers not related to obesity. During 19 years of follow-up, there were 35,109 eligible participants who developed 4,789 cancers not related to obesity. There was no association between frequency of consuming sugar-sweetened soft drinks and the risk of these cancers, but an unexpected positive association was observed for consumption of artificially-sweetened soft drinks. Although, we did not find an association with sugar-sweetened soft drinks, we previously reported a positive association with obesity-related cancers, not fully explained by obesity. These findings leave unresolved the question of whether consumption of sugar-sweetened soft drinks influences cancer risk independently of their influence on body size. This article is protected by copyright. All rights reserved.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Bassett</LastName>
                    <ForeName>Julie K</ForeName>
                    <Initials>JK</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-0799-4821</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Cancer Epidemiology Division, Cancer Council Victoria, 615 St Kilda Rd, Melbourne, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Milne</LastName>
                    <ForeName>Roger L</ForeName>
                    <Initials>RL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Epidemiology Division, Cancer Council Victoria, 615 St Kilda Rd, Melbourne, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Centre for Epidemiology and Biostatistics, Level 3, 207 Bouverie St, The University of Melbourne 3010, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>English</LastName>
                    <ForeName>Dallas R</ForeName>
                    <Initials>DR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Epidemiology Division, Cancer Council Victoria, 615 St Kilda Rd, Melbourne, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Centre for Epidemiology and Biostatistics, Level 3, 207 Bouverie St, The University of Melbourne 3010, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Giles</LastName>
                    <ForeName>Graham G</ForeName>
                    <Initials>GG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Epidemiology Division, Cancer Council Victoria, 615 St Kilda Rd, Melbourne, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Centre for Epidemiology and Biostatistics, Level 3, 207 Bouverie St, The University of Melbourne 3010, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hodge</LastName>
                    <ForeName>Allison M</ForeName>
                    <Initials>AM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Epidemiology Division, Cancer Council Victoria, 615 St Kilda Rd, Melbourne, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Centre for Epidemiology and Biostatistics, Level 3, 207 Bouverie St, The University of Melbourne 3010, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Int J Cancer</MedlineTA>
            <NlmUniqueID>0042124</NlmUniqueID>
            <ISSNLinking>0020-7136</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Sugar-sweetened soft drinks</Keyword>
            <Keyword MajorTopicYN="N">artificially-sweetened soft drinks</Keyword>
            <Keyword MajorTopicYN="N">cancer</Keyword>
            <Keyword MajorTopicYN="N">prospective study</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31693185</ArticleId>
            <ArticleId IdType="doi">10.1002/ijc.32772</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">31692980</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>08</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">2049-9450</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>11</Volume>
                    <Issue>6</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Dec</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Molecular and clinical oncology</Title>
                <ISOAbbreviation>Mol Clin Oncol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Investigating the association between radiological images and the pathology of rectal cancer treated with neoadjuvant chemotherapy.</ArticleTitle>
            <Pagination>
                <MedlinePgn>573-579</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3892/mco.2019.1931</ELocationID>
            <Abstract>
                <AbstractText>In patients with rectal cancer treated with neoadjuvant chemotherapy (NAC), differences are often observed between high and low radiological image reduction effects. It may be suggested that high radiological image reduction indicates a beneficial response to chemotherapy. However, the pathological investigation of the differences between high and low radiological cancer volume reduction cases remains limited. In the current study, a total of 50 patients with rectal cancer, treated with NAC, were examined. The approximate pathological primary cancer area and the radiological cancer volume reduction ratio were measured using CT and/or MRI imaging and the donut-shaped measurement method. Immunostaining of cytokeratin AE1/AE3 was performed to quantitatively measure the cancer cell mass in the largest section of rectal cancer. Cytokeratin AE1/AE3-stained area (P=0.04), mitosis (P=0.0027) and radiological donut-shaped images after NAC (P=0.010) were lower in the high radiological cancer volume reduction ratio group compared with the low radiological cancer volume reduction ratio group. These findings indicate that the radiological images had some ability to determine the treatment effect and clinicopathological characteristics of patients with rectal cancer treated with NAC.</AbstractText>
                <CopyrightInformation>Copyright: © Morohashi et al.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Morohashi</LastName>
                    <ForeName>Satoko</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology and Bioscience, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori 036-8562, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Morohashi</LastName>
                    <ForeName>Hajime</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterological Surgery, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori 036-8562, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Seino</LastName>
                    <ForeName>Hiroko</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiology, Aomori National Hospital, Namioka, Aomori 038-1331, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yoshizawa</LastName>
                    <ForeName>Tadashi</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology and Bioscience, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori 036-8562, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Haga</LastName>
                    <ForeName>Toshihiro</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology and Bioscience, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori 036-8562, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Goto</LastName>
                    <ForeName>Shintaro</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology and Bioscience, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori 036-8562, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wu</LastName>
                    <ForeName>Yunyan</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology and Bioscience, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori 036-8562, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sakamoto</LastName>
                    <ForeName>Yoshiyuki</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterological Surgery, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori 036-8562, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hakamada</LastName>
                    <ForeName>Kenichi</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterological Surgery, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori 036-8562, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kijima</LastName>
                    <ForeName>Hiroshi</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology and Bioscience, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori 036-8562, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>04</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Mol Clin Oncol</MedlineTA>
            <NlmUniqueID>101613422</NlmUniqueID>
            <ISSNLinking>2049-9450</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">neoadjuvant chemotherapy</Keyword>
            <Keyword MajorTopicYN="N">pathology</Keyword>
            <Keyword MajorTopicYN="N">radiological images</Keyword>
            <Keyword MajorTopicYN="N">rectal cancer</Keyword>
            <Keyword MajorTopicYN="N">reduction ratio</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>02</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31692980</ArticleId>
            <ArticleId IdType="doi">10.3892/mco.2019.1931</ArticleId>
            <ArticleId IdType="pii">MCO-0-0-1931</ArticleId>
            <ArticleId IdType="pmc">PMC6826269</ArticleId>
        </ArticleIdList>
        <?pmcsd?>
        <ReferenceList>
            <Reference>
                <Citation>J Natl Cancer Inst. 2017 Dec 1;109(12):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29206996</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Radiat Oncol Biol Phys. 2002 Jul 1;53(3):664-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12062610</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Jpn J Clin Oncol. 2015 Sep;45(9):884-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26142437</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Ann Surg Oncol. 2017 Nov;24(12):3587-3595</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28685354</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2017 Aug 10;12(8):e0182883</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28797063</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Aust N Z J Surg. 1995 Oct;65(10):732-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7487714</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Clin Oncol. 2005 Sep 1;23(25):6199-206</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16135487</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Ann Surg. 1994 Nov;220(5):676-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7979617</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):752-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15936556</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1122-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16406393</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Dis Colon Rectum. 2011 Nov;54(11):1423-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21979189</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Clin Oncol. 2005 Dec 1;23(34):8688-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16246976</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Dis Colon Rectum. 2003 Nov;46(11):1492-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14605568</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Colorectal Dis. 1997;12(1):19-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9112145</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer. 1994 Jun 1;73(11):2680-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8194005</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">31692945</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>08</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">2049-9450</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>11</Volume>
                    <Issue>6</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Dec</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Molecular and clinical oncology</Title>
                <ISOAbbreviation>Mol Clin Oncol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Nutritional benefit of laparoscopic jejunostomy during neoadjuvant chemotherapy for obstructing esophageal cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn>612-616</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3892/mco.2019.1938</ELocationID>
            <Abstract>
                <AbstractText>Neoadjuvant chemotherapy (NAC) confers a survival benefit in esophageal carcinoma, but it is difficult to perform in patients who cannot receive enteral feeding due to an esophageal obstruction. In the current study, the nutritional benefit of laparoscopic jejunostomy (Lap-J) was evaluated in patients with NAC for obstructing esophageal cancer. A total of 91 patients with esophageal cancer who received NAC between 2009 and 2017 were included in the present study. Lap-J was performed prior to NAC in 15 patients (16.5%) with an obstructing tumor. Patients with NAC without Lap-J were used as the control group (n=76). Nutritional parameters and surgical outcomes of the two groups were compared retrospectively. In the patients with Lap-J, 14 of the 15 patients (93.3%) did not experience any procedure-associated complications. No mortalities were associated with Lap-J. Significant decreases in total serum protein, albumin, hemoglobin concentrations and prognostic nutritional index (PNI) occurred following NAC in the control but not in the Lap-J group. Serum albumin and the improved modified Glasgow prognostic score increased significantly after NAC in the Lap-J group but not in the control group. In conclusion, perioperative nutritional support with Lap-J was safe and effective in patients with NAC for obstructing esophageal cancer.</AbstractText>
                <CopyrightInformation>Copyright © 2019, Spandidos Publications.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Nagata</LastName>
                    <ForeName>Ken</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tsujimoto</LastName>
                    <ForeName>Hironori</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nagata</LastName>
                    <ForeName>Hiromi</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Harada</LastName>
                    <ForeName>Manabu</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ito</LastName>
                    <ForeName>Nozomi</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nomura</LastName>
                    <ForeName>Shinsuke</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Horiguchi</LastName>
                    <ForeName>Hiroyuki</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hiraki</LastName>
                    <ForeName>Shuichi</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Aosasa</LastName>
                    <ForeName>Suefumi</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hase</LastName>
                    <ForeName>Kazuo</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ueno</LastName>
                    <ForeName>Hideki</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>16</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Mol Clin Oncol</MedlineTA>
            <NlmUniqueID>101613422</NlmUniqueID>
            <ISSNLinking>2049-9450</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">enteral nutrition</Keyword>
            <Keyword MajorTopicYN="N">esophageal cancer</Keyword>
            <Keyword MajorTopicYN="N">laparoscopic jejunostomy</Keyword>
            <Keyword MajorTopicYN="N">minimal invasive surgery</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>08</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31692945</ArticleId>
            <ArticleId IdType="doi">10.3892/mco.2019.1938</ArticleId>
            <ArticleId IdType="pii">MCO-0-0-1938</ArticleId>
            <ArticleId IdType="pmc">PMC6826271</ArticleId>
        </ArticleIdList>
        <?pmcsd?>
        <ReferenceList>
            <Reference>
                <Citation>Ann Surg. 2004 Nov;240(5):791-800</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15492560</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Ann Surg. 2014 Aug;260(2):259-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24743609</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer. 1981 May 15;47(10):2375-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">6791801</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Gastroenterol. 2015 Dec;50(12):1206-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25820219</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Surg Res. 2017 Mar;209:37-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28032569</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Ann Surg Oncol. 2010 Feb;17(2):470-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19859771</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Ann Thorac Surg. 2004 Oct;78(4):1177-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15464466</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Clin Oncol. 2015 Nov;3(6):1307-1310</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26807238</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Surg Endosc. 2005 Jul;19(7):951-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15920697</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Eur J Cancer. 2011 Nov;47(17):2633-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21724383</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Ann Surg Oncol. 2009 Nov;16(11):3161-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19636630</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>World J Surg. 2015 Feb;39(2):441-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25270346</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Surgery. 2012 May;151(5):667-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22244180</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Ann Surg Oncol. 2012 Jan;19(1):68-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21879261</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>World J Surg. 2009 Jul;33(7):1432-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19387726</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>BMC Surg. 2017 Mar 20;17(1):25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28320382</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Surg Laparosc Endosc Percutan Tech. 2005 Sep;15(5):263-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16215483</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Surg. 2014 Nov;12(11):1172-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25263267</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">31692930</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>08</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1949-2553</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>10</Volume>
                    <Issue>58</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>22</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Oncotarget</Title>
                <ISOAbbreviation>Oncotarget</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Integrated copy number and miRNA expression analysis in triple negative breast cancer of Latin American patients.</ArticleTitle>
            <Pagination>
                <MedlinePgn>6184-6203</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.18632/oncotarget.27250</ELocationID>
            <Abstract>
                <AbstractText>Triple negative breast cancer (TNBC), a clinically aggressive breast cancer subtype, affects 15-35% of women from Latin America. Using an approach of direct integration of copy number and global miRNA profiling data, performed simultaneously in the same tumor specimens, we identified a panel of 17 miRNAs specifically associated with TNBC of ancestrally characterized patients from Latin America, Brazil. This panel was differentially expressed between the TNBC and non-TNBC subtypes studied (<i>p</i> ≤ 0.05, FDR ≤ 0.25), with their expression levels concordant with the patterns of copy number alterations (CNAs), present mostly frequent at 8q21.3-q24.3, 3q24-29, 6p25.3-p12.2, 1q21.1-q44, 5q11.1-q22.1, 11p13-p11.2, 13q12.11-q14.3, 17q24.2-q25.3 and Xp22.33-p11.21. The combined 17 miRNAs presented a high power (AUC = 0.953 (0.78-0.99);95% CI) in discriminating between the TNBC and non-TNBC subtypes of the patients studied. In addition, the expression of 14 and 15 of the 17miRNAs was significantly associated with tumor subtype when adjusted for tumor stage and grade, respectively. In conclusion, the panel of miRNAs identified demonstrated the impact of CNAs in miRNA expression levels and identified miRNA target genes potentially affected by both CNAs and miRNA deregulation. These targets, involved in critical signaling pathways and biological functions associated specifically with the TNBC transcriptome of Latina patients, can provide biological insights into the observed differences in the TNBC clinical outcome among racial/ethnic groups, taking into consideration their genetic ancestry.</AbstractText>
                <CopyrightInformation>Copyright: © 2019 Sugita et al.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sugita</LastName>
                    <ForeName>Bruna M</ForeName>
                    <Initials>BM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Genetics, Federal University of Paraná, Curitiba, PR, Brazil.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculdades Pequeno Príncipe, Instituto de Pesquisa Pelé Pequeno Príncipe, Curitiba, PR, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pereira</LastName>
                    <ForeName>Silma R</ForeName>
                    <Initials>SR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biology, Federal University of Maranhão, São Luis, MA, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>de Almeida</LastName>
                    <ForeName>Rodrigo C</ForeName>
                    <Initials>RC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomedical Data Sciences, Section Molecular Epidemiology, Leiden University Medical Center, Leiden, Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gill</LastName>
                    <ForeName>Mandeep</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington DC, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mahajan</LastName>
                    <ForeName>Akanksha</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington DC, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Duttargi</LastName>
                    <ForeName>Anju</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington DC, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kirolikar</LastName>
                    <ForeName>Saurabh</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington DC, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fadda</LastName>
                    <ForeName>Paolo</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Genomics Shared Resource, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>de Lima</LastName>
                    <ForeName>Rubens S</ForeName>
                    <Initials>RS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Breast Unit, Hospital Nossa Senhora das Graças, Curitiba, PR, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Urban</LastName>
                    <ForeName>Cicero A</ForeName>
                    <Initials>CA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Breast Unit, Hospital Nossa Senhora das Graças, Curitiba, PR, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Makambi</LastName>
                    <ForeName>Kepher</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University Medical Center, Washington DC, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Madhavan</LastName>
                    <ForeName>Subha</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington DC, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Innovation Center for Biomedical Informatics (ICBI), Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington DC, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Boca</LastName>
                    <ForeName>Simina M</ForeName>
                    <Initials>SM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington DC, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University Medical Center, Washington DC, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Innovation Center for Biomedical Informatics (ICBI), Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington DC, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gusev</LastName>
                    <ForeName>Yuriy</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington DC, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Innovation Center for Biomedical Informatics (ICBI), Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington DC, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cavalli</LastName>
                    <ForeName>Iglenir J</ForeName>
                    <Initials>IJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Genetics, Federal University of Paraná, Curitiba, PR, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ribeiro</LastName>
                    <ForeName>Enilze M S F</ForeName>
                    <Initials>EMSF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Genetics, Federal University of Paraná, Curitiba, PR, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cavalli</LastName>
                    <ForeName>Luciane R</ForeName>
                    <Initials>LR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Faculdades Pequeno Príncipe, Instituto de Pesquisa Pelé Pequeno Príncipe, Curitiba, PR, Brazil.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington DC, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Oncotarget</MedlineTA>
            <NlmUniqueID>101532965</NlmUniqueID>
            <ISSNLinking>1949-2553</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">copy number</Keyword>
            <Keyword MajorTopicYN="N">disparities</Keyword>
            <Keyword MajorTopicYN="N">latinas</Keyword>
            <Keyword MajorTopicYN="N">microRNA</Keyword>
            <Keyword MajorTopicYN="N">triple-negative breast cancer</Keyword>
        </KeywordList>
        <CoiStatement>CONFLICTS OF INTEREST All the authors declare no conflicts of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>11</Month>
                <Day>7</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31692930</ArticleId>
            <ArticleId IdType="doi">10.18632/oncotarget.27250</ArticleId>
            <ArticleId IdType="pii">27250</ArticleId>
            <ArticleId IdType="pmc">PMC6817452</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Gene Regul Syst Bio. 2016 Apr 27;10(Suppl 1):11-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27147820</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Breast Cancer. 2017 Sep;24(5):673-682</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28138801</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Medicine (Baltimore). 2016 Aug;95(35):e4614</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27583878</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Breast Cancer Res. 2013 Apr 19;15(2):R33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23601657</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Oncol. 2015 Aug;9(7):1287-300</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25907805</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nucleic Acids Res. 2015 Jul 1;43(W1):W460-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25977294</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Oncol. 2015 Mar;46(3):927-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25571912</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2013 Sep 09;8(9):e70656</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24039706</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Commun. 2014 Oct 20;5:5260</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25327703</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2012 Nov 1;491(7422):56-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23128226</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Epidemiol Biomarkers Prev. 2014 Feb;23(2):316-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24296856</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Genet Mol Biol. 2014 Mar;37(1 Suppl):151-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24764751</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancers (Basel). 2015 Apr 09;7(2):598-616</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25860815</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Clin Oncol. 2015 Dec 20;33(36):4267-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26598753</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Drug Dev Res. 2015 Nov;76(7):368-74</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26310899</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nucleic Acids Res. 2015 Jan;43(Database issue):D146-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25378301</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Oncol. 2014 Feb;8(1):93-104</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24148764</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2014 Nov 12;9(11):e109973</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25390939</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Genet. 2014 May;207(5):177-87</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24947980</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Mol Epidemiol Genet. 2014 Feb 17;5(1):31-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24596595</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Asian Pac J Cancer Prev. 2013;14(5):3197-203</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23803104</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Bioinformatics. 2010 Nov 15;26(22):2927-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20926419</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Natl Cancer Inst. 2015 Mar 30;107(6):djv048</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25825511</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Genet. 2014 Sep 25;10(9):e1004572</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25254375</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Breast Cancer Res Treat. 2013 Oct;141(3):447-59</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24062209</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Breast Cancer Res Treat. 2014 Jul;146(1):183-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24842266</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Prostate. 2013 Jan;73(1):11-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22549899</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cytogenet Genome Res. 2008;122(1):16-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18931481</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Womens Health (Lond). 2013 Jul;9(4):335-48; quiz 349-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23826775</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Cancer Res. 2010 Dec 15;16(24):6100-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21169259</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Biol Rep. 2018 Dec;45(6):2345-2358</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30250996</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Gigascience. 2015 Feb 25;4:7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25722852</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncotarget. 2016 Nov 29;7(48):79274-79291</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27813494</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Am J Hum Biol. 2015 Sep-Oct;27(5):674-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25820814</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Breast Cancer Res Treat. 2014 Apr;144(3):689-99</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24604094</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Sci Rep. 2018 Aug 16;8(1):12252</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30115973</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Ann Oncol. 2012 Mar;23(3):618-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21642515</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biomed Res Int. 2013;2013:591931</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23586049</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncologist. 2010;15(5):466-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20427382</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Breast Cancer Res Treat. 2014 Feb;144(1):179-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24481682</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):632-641</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27956436</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Arch Pathol Lab Med. 2014 Feb;138(2):241-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24099077</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Am J Pathol. 2013 Jun;182(6):2058-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23623609</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>BMC Cancer. 2014 Jul 21;14:529</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25047087</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Breast. 2015 Oct;24(5):594-600</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26144637</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Control. 2016 Oct;23(4):327-337</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27842322</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Oncol. 2016 May;48(5):1997-2006</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26934863</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Breast Cancer Res Treat. 2016 Aug;159(1):109-18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27449492</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1731-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26364163</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Exp Ther Med. 2013 Mar;5(3):813-818</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23408138</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Ginekol Pol. 2017;88(10):530-536</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29192413</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Genome Res. 2003 Nov;13(11):2498-504</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14597658</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Breast Cancer Res Treat. 2017 Nov;166(1):185-193</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28698973</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Asian Pac J Cancer Prev. ;18(6):1585-1593</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28669172</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Genet. 2015 Dec 04;11(12):e1005602</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26636962</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Breast Cancer Res Treat. 2015 Apr;150(3):655-66</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25809092</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Cell Int. 2018 Jan 30;18:16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29434522</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncologist. 2013;18(3):248-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23442305</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2010 Nov 11;363(20):1938-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21067385</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Am J Hum Genet. 2016 Jan 7;98(1):165-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26748518</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Control. 2016 Oct;23(4):359-372</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27842325</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>BMC Genomics. 2015 Jul 07;16:501</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26148557</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2013 Mar 21;495(7441):333-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23446348</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Tumour Biol. 2016 Feb;37(2):1599-607</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26298722</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Jpn J Clin Oncol. 2012 Apr;42(4):256-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22323552</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Health Commun. 2015;20(7):851-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26010727</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2011 Feb 22;6(2):e16915</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21364938</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2013 Dec 04;8(12):e82460</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24324792</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Tissue Res. 2013 Jan;351(1):85-98</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23111773</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Genet. 2006 Dec;2(12):e190</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17194218</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1853-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23950213</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Elife. 2015 Aug 12;4:null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26267216</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Cancer. 2010 Dec 20;9:317</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21172025</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Mol Sci. 2013 Nov 11;14(11):22202-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24284394</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Behav Med. 2017 Apr;40(2):343-351</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27572092</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>BMC Womens Health. 2014 Sep 12;14:110</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25216732</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Breast Cancer (Auckl). 2014 Jul 29;8:103-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25125980</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Sci Rep. 2014 Oct 23;4:6566</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25338681</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Breast Cancer Res Treat. 2017 Jan;161(2):321-331</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27837379</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Epidemiol Biomarkers Prev. 2018 Jan;27(1):3-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29054978</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncotarget. 2017 Oct 6;8(59):99978-99989</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29245954</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Adv Cancer Res. 2017;133:51-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28052821</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Tumour Biol. 2014 Jul;35(7):6235-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24938874</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Sci Rep. 2018 Feb 1;8(1):2073</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29391441</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Biol Ther. 2017 Oct 3;18(10):801-805</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28876975</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>BMC Med Genomics. 2014 Aug 28;7:53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25169894</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2013 Dec 05;8(12):e82160</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24340000</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer. 2011 Aug 15;117(16):3658-69</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21387260</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Causes Control. 2014 Aug;25(8):959-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24839049</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Carcinogenesis. 2015 Oct;36(10):1144-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26168820</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Breast Cancer. 2017 Jun;17(3):e95-e102</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28065398</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Causes Control. 2016 Jan;27(1):115-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26518195</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Genes Chromosomes Cancer. 2008 Jun;47(6):490-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18314908</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Cancer Epidemiol. 2016;2016:8784040</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27672394</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Biosci. 2015 Jun 20;5:32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26146543</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Causes Control. 2013 Oct;24(10):1821-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23864487</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2017 Oct 4;12(10):e0185503</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28977000</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>F1000Res. 2014 Jul 01;3:145</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25383185</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Breast Cancer Res. 2009;11(3):R27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19432961</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Genome Biol. 2007;8(10):R214</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17922911</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Lett. 2014 Nov 1;354(1):1-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25107641</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Breast Cancer Res Treat. 2016 May;157(1):167-78</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27116186</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Contemp Clin Trials. 2016 Jan;46:106-113</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26655430</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biomed Pharmacother. 2015 Oct;75:111-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26297544</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Carcinogenesis. 2016 May;37(5):461-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26785733</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nucleic Acids Res. 2013 Jul;41(Web Server issue):W169-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23680784</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Breast. 2015 Oct;24(5):539-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26067350</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>CA Cancer J Clin. 2015 Nov-Dec;65(6):457-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26375877</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Cell Physiol. 2019 Jul;234(7):10819-10826</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30624764</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2012;7(3):e34286</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22479588</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Clin Oncol. 2010 Jun 1;28(16):2784-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20404251</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Transl Oncol. 2013 May;15(5):335-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22914907</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Med Sci. 2018 Mar 9;15(6):536-548</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29725243</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Invest. 2014 Nov;32(9):439-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25254601</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Gene. 2015 Feb 10;556(2):192-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25485717</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Racial Ethn Health Disparities. 2016 Nov 18;:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27864808</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>BMC Womens Health. 2014 Aug 29;14:102</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25174527</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Lab Invest. 2019 Sep;99(9):1296-1308</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31024042</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31548659</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1471-0064</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                        <Day>23</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Nature reviews. Genetics</Title>
                <ISOAbbreviation>Nat. Rev. Genet.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Context is everything: aneuploidy in cancer.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41576-019-0171-x</ELocationID>
            <Abstract>
                <AbstractText>Cancer is driven by multiple types of genetic alterations, which range in size from point mutations to whole-chromosome gains and losses, known as aneuploidy. Chromosome instability, the process that gives rise to aneuploidy, can promote tumorigenesis by increasing genetic heterogeneity and promoting tumour evolution. However, much less is known about how aneuploidy itself contributes to tumour formation and progression. Unlike some pan-cancer oncogenes and tumour suppressor genes that drive transformation in virtually all cell types and cellular contexts, aneuploidy is not a universal promoter of tumorigenesis. Instead, recent studies suggest that aneuploidy is a context-dependent, cancer-type-specific oncogenic event that may have clinical relevance as a prognostic marker and as a potential therapeutic target.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ben-David</LastName>
                    <ForeName>Uri</ForeName>
                    <Initials>U</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. ubendavid@tauex.tau.ac.il.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Amon</LastName>
                    <ForeName>Angelika</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-9837-0314</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA. angelika@mit.edu.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA. angelika@mit.edu.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Howard Hughes Medical Institute, Chevy Chase, MD, USA. angelika@mit.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Nat Rev Genet</MedlineTA>
            <NlmUniqueID>100962779</NlmUniqueID>
            <ISSNLinking>1471-0056</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31548659</ArticleId>
            <ArticleId IdType="doi">10.1038/s41576-019-0171-x</ArticleId>
            <ArticleId IdType="pii">10.1038/s41576-019-0171-x</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31548657</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1476-5500</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                        <Day>24</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cancer gene therapy</Title>
                <ISOAbbreviation>Cancer Gene Ther.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41417-019-0137-3</ELocationID>
            <Abstract>
                <AbstractText>Classical chemotherapy for lung cancer needs new strategies to enhance its antitumor effect. The cytotoxicity, nonspecificity, and low bioavailability of paclitaxel (PTX) limits their use in this type of cancer. Suicide gene therapy using tumor-specific promoters may increase treatment effectiveness. We used carcinoembryonic antigen (CEA) as a tumor-specific promoter to drive the bacteriophage E gene (pCEA-E) towards lung cancer cells (A-549 human and LL2 mice cell lines) but not normal lung cells (L132 human embryonic lung cell line), in association with PTX as a combined treatment. The study was carried out using cell cultures, tumor spheroid models (MTS), subcutaneous induced tumors and lung cancer stem cells (CSCs). pCEA-E induced significant inhibition of A-549 and LL2 cell proliferation in comparison to L132 cells, which have lower CEA expression levels. Moreover, pCEA-E induced an important decrease in volume growth of A-549 and LL2 MTS producing intense apoptosis, in comparison to L132 MTS. In addition, pCEA-E enhanced the antitumor effects of PTX when combined, showing a synergistic effect. This effect was also observed in A-549 CSCs, which have been related to the recurrence of cancer. The in vivo study corroborated the effectiveness of the pCEA-E-PTX combined therapy, inducing a greater decrease in tumor volume compared to PTX and pCEA-E alone. Our results suggest that the CEA promoter is an excellent candidate for directing E gene expression specifically towards lung cancer cells, and may be used to enhance the effectiveness of PTX against this type of tumor.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Rosa Rama</LastName>
                    <ForeName>Ana</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-3698-2013</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute of Biopathology and Regenerative Medicine (IBIMER), Center of Biomedical Research (CIBM), University of Granada, Granada, Spain. arama@ujaen.es.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Health Science, University of Jaén, Jaén, Spain. arama@ujaen.es.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hernández</LastName>
                    <ForeName>Rosa</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Biopathology and Regenerative Medicine (IBIMER), Center of Biomedical Research (CIBM), University of Granada, Granada, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Biosanitary Institute of Granada (ibs. GRANADA), SAS-Universidad de Granada, Granada, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Anatomy and Embryology, Faculty of Medicine, University of Granada, Granada, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Perazzoli</LastName>
                    <ForeName>Gloria</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Biopathology and Regenerative Medicine (IBIMER), Center of Biomedical Research (CIBM), University of Granada, Granada, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Biosanitary Institute of Granada (ibs. GRANADA), SAS-Universidad de Granada, Granada, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cabeza</LastName>
                    <ForeName>Laura</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Biopathology and Regenerative Medicine (IBIMER), Center of Biomedical Research (CIBM), University of Granada, Granada, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Biosanitary Institute of Granada (ibs. GRANADA), SAS-Universidad de Granada, Granada, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Anatomy and Embryology, Faculty of Medicine, University of Granada, Granada, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Melguizo</LastName>
                    <ForeName>Consolación</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Biopathology and Regenerative Medicine (IBIMER), Center of Biomedical Research (CIBM), University of Granada, Granada, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Biosanitary Institute of Granada (ibs. GRANADA), SAS-Universidad de Granada, Granada, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Anatomy and Embryology, Faculty of Medicine, University of Granada, Granada, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vélez</LastName>
                    <ForeName>Celia</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Biopathology and Regenerative Medicine (IBIMER), Center of Biomedical Research (CIBM), University of Granada, Granada, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Biosanitary Institute of Granada (ibs. GRANADA), SAS-Universidad de Granada, Granada, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Anatomy and Embryology, Faculty of Medicine, University of Granada, Granada, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Prados</LastName>
                    <ForeName>Jose</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Biopathology and Regenerative Medicine (IBIMER), Center of Biomedical Research (CIBM), University of Granada, Granada, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Biosanitary Institute of Granada (ibs. GRANADA), SAS-Universidad de Granada, Granada, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Anatomy and Embryology, Faculty of Medicine, University of Granada, Granada, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>PP2015-13</GrantID>
                    <Agency>Universidad de Granada (University of Granada)</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>24</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Cancer Gene Ther</MedlineTA>
            <NlmUniqueID>9432230</NlmUniqueID>
            <ISSNLinking>0929-1903</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31548657</ArticleId>
            <ArticleId IdType="doi">10.1038/s41417-019-0137-3</ArticleId>
            <ArticleId IdType="pii">10.1038/s41417-019-0137-3</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31548613</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1476-5594</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                        <Day>23</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Oncogene</Title>
                <ISOAbbreviation>Oncogene</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Comprehensive characterization of the rRNA metabolism-related genes in human cancer.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41388-019-1026-9</ELocationID>
            <Abstract>
                <AbstractText>Although rRNA metabolism-related genes have been reported to be associated with human cancer, a systematic assessment of rRNA metabolism-related genes across human cancers is lacking. Thus, we performed a Pan-cancer analysis of rRNA metabolism-related genes across 20 human cancers. Here, we examined mRNA expression, mutation, DNA methylation, copy number variation (CNV) and clinical landscape of rRNA metabolism-related genes in more than 8600 patients across 20 human cancers from The Cancer Genome Atlas (TCGA) dataset. Besides, ten independent Gene Expression Omnibus (GEO) datasets, Cancer Cell Line Encyclopedia (CCLE) dataset and Project Achilles dataset were used to verify our study. A landscape of rRNA metabolism-related genes was established across 20 human cancers. The results suggest that rRNA metabolism-related genes are upregulated in multiple cancers, particularly in digestive and respiratory system cancers. Most of the upregulated genes were driven by CNV gain rather than mutation or DNA hypomethylation. We systematically identified CNV-driven rRNA metabolism-related genes with clinical relevance, including EXOSC8. Finally, functional experiments confirmed the oncogenic roles of EXOSC8 in colorectal carcinoma. Our study highlights the important roles of rRNA metabolism-related genes in tumorigenesis as prognostic biomarkers.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Cui</LastName>
                    <ForeName>Kaisa</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan, 430072, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Medical Research Institute, School of Medicine, Wuhan University, Wuhan, 430071, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Cheng</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan, 430072, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Medical Research Institute, School of Medicine, Wuhan University, Wuhan, 430071, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Xu</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan, 430072, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Medical Research Institute, School of Medicine, Wuhan University, Wuhan, 430071, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Qiang</ForeName>
                    <Initials>Q</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan, 430072, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Medical Research Institute, School of Medicine, Wuhan University, Wuhan, 430071, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Youjun</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan, 430072, China. liy7@whu.edu.cn.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Medical Research Institute, School of Medicine, Wuhan University, Wuhan, 430071, China. liy7@whu.edu.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Oncogene</MedlineTA>
            <NlmUniqueID>8711562</NlmUniqueID>
            <ISSNLinking>0950-9232</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31548613</ArticleId>
            <ArticleId IdType="doi">10.1038/s41388-019-1026-9</ArticleId>
            <ArticleId IdType="pii">10.1038/s41388-019-1026-9</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31548612</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1476-5594</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                        <Day>23</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Oncogene</Title>
                <ISOAbbreviation>Oncogene</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Active PLK1-driven metastasis is amplified by TGF-β signaling that forms a positive feedback loop in non-small cell lung cancer.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41388-019-1023-z</ELocationID>
            <Abstract>
                <AbstractText>Early findings that PLK1 is highly expressed in cancer have driven an exploration of its functions in metastasis. However, whether PLK1 induces metastasis in vivo and its underlying mechanisms in NSCLC have not yet been determined. Here, we show that the expression of active PLK1 phosphorylated at T210, abundant in TGF-β-treated lung cells, potently induced metastasis in a tail-vein injection model. Active PLK1 with intact polo-box and ATP-binding domains accelerated cell motility and invasiveness by triggering EMT reprogramming, whereas a phosphomimetic version of p-S137-PLK1 did not, indicating that the phosphorylation status of PLK1 may determine the cell traits. Active PLK1-driven invasiveness upregulated TGF-β signaling and TSG6 encoded by TNFAIP6. Loss of TNFAIP6 disturbed the metastatic activity induced by active PLK1 or TGF-β. Clinical relevance shows that PLK1 and TNFAIP6 are strong predictors of poor survival rates in metastatic NSCLC patients. Therefore, we suggest that active PLK1 promotes metastasis by upregulating TGF-β signaling, which amplifies its metastatic properties by forming a positive feedback loop and that the PLK1/TGF-β-driven metastasis is effectively blocked by targeting PLK1 and TSG6, providing PLK1 and TSG6 as negative markers for prognostics and therapeutic targets in metastatic NSCLC.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Shin</LastName>
                    <ForeName>Sol-Bi</ForeName>
                    <Initials>SB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacy, College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-do, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jang</LastName>
                    <ForeName>Hay-Ran</ForeName>
                    <Initials>HR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacy, College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-do, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xu</LastName>
                    <ForeName>Rong</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacy, College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-do, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Won</LastName>
                    <ForeName>Jae-Yeon</ForeName>
                    <Initials>JY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacy, College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-do, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yim</LastName>
                    <ForeName>Hyungshin</ForeName>
                    <Initials>H</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-7945-3472</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacy, College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan, Gyeonggi-do, Korea. hsyim@hanyang.ac.kr.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Oncogene</MedlineTA>
            <NlmUniqueID>8711562</NlmUniqueID>
            <ISSNLinking>0950-9232</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="ErratumIn">
                <RefSource>Oncogene. 2019 Oct 8;:</RefSource>
                <PMID Version="1">31595031</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>04</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31548612</ArticleId>
            <ArticleId IdType="doi">10.1038/s41388-019-1023-z</ArticleId>
            <ArticleId IdType="pii">10.1038/s41388-019-1023-z</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31548601</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1759-4782</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                        <Day>23</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Nature reviews. Clinical oncology</Title>
                <ISOAbbreviation>Nat Rev Clin Oncol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>HER2-targeted therapies - a role beyond breast cancer.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41571-019-0268-3</ELocationID>
            <Abstract>
                <AbstractText>HER2 is an established therapeutic target in a large subset of women with breast cancer; a variety of agents including trastuzumab, pertuzumab, lapatinib, neratinib and trastuzumab emtansine (T-DM1) have been approved for the treatment of HER2-positive breast cancer. HER2 is also overexpressed in subsets of patients with other solid tumours. Notably, the addition of trastuzumab to first-line chemotherapy has improved the overall survival of patients with HER2-positive gastric cancer, and has become the standard-of-care treatment for this group of patients. However, trials involving pertuzumab, lapatinib and T-DM1 have failed to provide significant improvements in the outcomes of patients with HER2-positive gastric cancer. HER2-targeted therapies are also being tested in patients with other solid tumours harbouring HER2 overexpression, and/or amplifications or other mutations of the gene encoding HER2 (ERBB2), including biliary tract, colorectal, non-small-cell lung and bladder cancers. The experience with gastric cancer suggests that the successes observed in HER2-positive breast cancer might not be replicated in these other tumour types, owing to differences in the level of HER2 overexpression and other aspects of disease biology. In this Review, we describe the current role of HER2-targeted therapies beyond breast cancer and also highlight the potential of novel HER2-targeted agents that are currently in clinical development.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Oh</LastName>
                    <ForeName>Do-Youn</ForeName>
                    <Initials>DY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bang</LastName>
                    <ForeName>Yung-Jue</ForeName>
                    <Initials>YJ</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-6000-4597</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea. bangyj@snu.ac.kr.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Nat Rev Clin Oncol</MedlineTA>
            <NlmUniqueID>101500077</NlmUniqueID>
            <ISSNLinking>1759-4774</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31548601</ArticleId>
            <ArticleId IdType="doi">10.1038/s41571-019-0268-3</ArticleId>
            <ArticleId IdType="pii">10.1038/s41571-019-0268-3</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
        <PMID Version="1">31548585</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>03</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2041-1723</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>10</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                        <Day>23</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Nature communications</Title>
                <ISOAbbreviation>Nat Commun</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Publisher Correction: Shared heritability and functional enrichment across six solid cancers.</ArticleTitle>
            <Pagination>
                <MedlinePgn>4386</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-019-12095-8</ELocationID>
            <Abstract>
                <AbstractText>An amendment to this paper has been published and can be accessed via a link at the top of the paper.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Jiang</LastName>
                    <ForeName>Xia</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, 677 Huntington Ave, Boston, MA, 02115, USA. xiajiang@hsph.harvard.edu.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Unit of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Nobels vagen 13, 17177, Stockholm, Sweden. xiajiang@hsph.harvard.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Finucane</LastName>
                    <ForeName>Hilary K</ForeName>
                    <Initials>HK</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-3864-9828</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, 677 Huntington Ave, Boston, MA, 02115, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 75 Ames St, Cambridge, MA, 02142, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schumacher</LastName>
                    <ForeName>Fredrick R</ForeName>
                    <Initials>FR</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-3073-7463</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Population and Quantitative Health Sciences, Case Western Reserve University, 10900 Eucid Avenue, Cleveland, OH, 44106, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Seidman Cancer Center, University Hospitals, Cleveland, OH, 44106, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schmit</LastName>
                    <ForeName>Stephanie L</ForeName>
                    <Initials>SL</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-5931-1194</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Dr. MRC-CANCONT, Tampa, FL, 33612, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Dr. MRC-CANCONT, Tampa, FL, 33612, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tyrer</LastName>
                    <ForeName>Jonathan P</ForeName>
                    <Initials>JP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Worts' Causeway, Cambridge, CB1 8RN, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Han</LastName>
                    <ForeName>Younghun</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomedical Data Science, The Geisel School of Medicine at Dartmouth, 1 Medical Center Drive, Lebanon, NH, 03756, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Michailidou</LastName>
                    <ForeName>Kyriaki</ForeName>
                    <Initials>K</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-7065-1237</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Worts' Causeway, Cambridge, CB1 8RN, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Electron Microscopy/Molecular Pathology, The Cyprus Institute of Neurology and Genetics, 1683, Nicosia, Cyprus.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lesseur</LastName>
                    <ForeName>Corina</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Genetic Epidemiology Group, International Agency for Research on Cancer, 150 Cours Albert Thomas, 69008, Lyon, France.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Section of Genetics, International Agency for Research on Cancer, 150 cours Albert Thomas, 69008, Lyon, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kuchenbaecker</LastName>
                    <ForeName>Karoline B</ForeName>
                    <Initials>KB</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-9726-603X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Psychiatry, University College London, Maple House, 149 Tottenham Court Road, London, W1T 7NF, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>UCL Genetics Institute, University College London, Gower Street, London, WC1E 6BT, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dennis</LastName>
                    <ForeName>Joe</ForeName>
                    <Initials>J</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-4591-1214</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Worts' Causeway, Cambridge, CB1 8RN, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Conti</LastName>
                    <ForeName>David V</ForeName>
                    <Initials>DV</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, 48109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Casey</LastName>
                    <ForeName>Graham</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health Sciences, University of Virginia, P.O. Box 800717, Charlottesville, VI, 22908, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Center for Public Health Genomics, University of Virginia, P.O. Box 800717, Charlottesville, VI, 22908, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gaudet</LastName>
                    <ForeName>Mia M</ForeName>
                    <Initials>MM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Epidemiology Research Program, American Cancer Society, 250 Williams Street NW, Atlanta, GA, 30303, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huyghe</LastName>
                    <ForeName>Jeroen R</ForeName>
                    <Initials>JR</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-6027-9806</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Public Health Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., Seattle, WA, 98109-1024, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Albanes</LastName>
                    <ForeName>Demetrius</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Dr, Rockville, MD, 20850, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Aldrich</LastName>
                    <ForeName>Melinda C</ForeName>
                    <Initials>MC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Thoracic Surgery, Division of Epidemiology, Vanderbilt University Medical Center, 609 Oxford House, Nashville, TN, 37232, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Andrew</LastName>
                    <ForeName>Angeline S</ForeName>
                    <Initials>AS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Neurology, Dartmouth-Hitchcock Medical Center, 7927 Rubin Building, Room 860, One Medical Center Drive, Lebanon, NH, 3756, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Andrulis</LastName>
                    <ForeName>Irene L</ForeName>
                    <Initials>IL</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-4226-6435</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Fred ALitwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, 600 University Avenue, Toronto, ON, M5G1X5, Canada.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Genetics, University of Toronto, 1 King's College Circle, Toronto, ON, M5S1A8, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Anton-Culver</LastName>
                    <ForeName>Hoda</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology, Genetic Epidemiology Research Institute, University of California Irvine, 224 Irvine Hall, Irvine, CA, 92617, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Antoniou</LastName>
                    <ForeName>Antonis C</ForeName>
                    <Initials>AC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Worts' Causeway, Cambridge, CB1 8RN, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Antonenkova</LastName>
                    <ForeName>Natalia N</ForeName>
                    <Initials>NN</Initials>
                    <AffiliationInfo>
                        <Affiliation>NNAlexandrov Research Institute of Oncology and Medical Radiology, Settlement of Lesnoy-2, 223040, Minsk, Belarus.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Arnold</LastName>
                    <ForeName>Susanne M</ForeName>
                    <Initials>SM</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-6542-9551</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Markey Cancer Center, University of Kentucky, 800 Rose Street, cc445, Lexington, KY, 40508, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Aronson</LastName>
                    <ForeName>Kristan J</ForeName>
                    <Initials>KJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Public Health Sciences, and Cancer Research Institute, Queen's University, 10 Stuart Street, Kingston, ON, K7L 3N6, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Arun</LastName>
                    <ForeName>Banu K</ForeName>
                    <Initials>BK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, 1155 Pressler St, Houston, TX, 77030, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bandera</LastName>
                    <ForeName>Elisa V</ForeName>
                    <Initials>EV</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey, 195 Little Albany Street, Room 5568, New Brunswick, NJ, 08903, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Barkardottir</LastName>
                    <ForeName>Rosa B</ForeName>
                    <Initials>RB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Landspitali University Hospital, Hringbraut, Reykjavik, 101, Iceland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Vatnsmyrarvegi 16, Reykjavik, 101, Iceland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Barnes</LastName>
                    <ForeName>Daniel R</ForeName>
                    <Initials>DR</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-3781-7570</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Worts' Causeway, Cambridge, CB1 8RN, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Batra</LastName>
                    <ForeName>Jyotsna</ForeName>
                    <Initials>J</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-4646-6247</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Australian Prostate Cancer Research Centre-Qld, Translational Research Institute, 37 Kent St, Woolloongabba, QLD, 4102, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Institute of Health and Biomedical Innovation and School of Biomedical Science, Queensland University of Technology, 60 Musk Ave, Kelvin Grove, QLD, 4059, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Beckmann</LastName>
                    <ForeName>Matthias W</ForeName>
                    <Initials>MW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen Nuremberg, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Universitaetsstrasse 21-23, 91054, Erlangen, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Benitez</LastName>
                    <ForeName>Javier</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Calle de Melchor Fernández Almagro, 3, 28029, Madrid, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Biomedical Network on Rare Diseases (CIBERER), AvMonforte de Lemos, 3-5Pabellón 11Planta 0, 28029, Madrid, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Benlloch</LastName>
                    <ForeName>Sara</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Worts' Causeway, Cambridge, CB1 8RN, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Genetics and Epidemiology, The Institute of Cancer Research, 15 Cotswold Road, London, SM2 5NG, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Berchuck</LastName>
                    <ForeName>Andrew</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, Duke University Medical Center, 25171 Morris Bldg, Durham, NC, 27710, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Berndt</LastName>
                    <ForeName>Sonja I</ForeName>
                    <Initials>SI</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Dr, Rockville, MD, 20850, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bickeböller</LastName>
                    <ForeName>Heike</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Genetic Epidemiology, University Medical Center Goettingen, Humboldtallee 32, 37073, Goettingen, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bien</LastName>
                    <ForeName>Stephanie A</ForeName>
                    <Initials>SA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., Seattle, WA, 98109-1024, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>School of Public Health, University of Washington, 1959 NE Pacific Street, Health Science Buidling, F-350, Seattle, WA, 98195, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Blomqvist</LastName>
                    <ForeName>Carl</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Oncology, Helsinki University Hospital, University of Helsinki, Haartmaninkatu 4, 00290, Helsinki, Finland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Oncology, Örebro University Hospital, 70185, Örebro, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Boccia</LastName>
                    <ForeName>Stefania</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Roma, Italy.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Università Cattolica del Sacro Cuore, 00168, Roma, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bogdanova</LastName>
                    <ForeName>Natalia V</ForeName>
                    <Initials>NV</Initials>
                    <AffiliationInfo>
                        <Affiliation>NNAlexandrov Research Institute of Oncology and Medical Radiology, Settlement of Lesnoy-2, 223040, Minsk, Belarus.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiation Oncology, Hannover Medical School, Carl-Neuberg-Straße 1, 30625, Hannover, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Gynaecology Research Unit, Hannover Medical School, Carl-Neuberg-Straße 1, 30625, Hannover, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bojesen</LastName>
                    <ForeName>Stig E</ForeName>
                    <Initials>SE</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-4061-4133</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev Ringvej 75, 2730, Herlev, Denmark.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev Ringvej 75, 2730, Herlev, Denmark.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bolla</LastName>
                    <ForeName>Manjeet K</ForeName>
                    <Initials>MK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Worts' Causeway, Cambridge, CB1 8RN, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Brauch</LastName>
                    <ForeName>Hiltrud</ForeName>
                    <Initials>H</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-7531-2736</Identifier>
                    <AffiliationInfo>
                        <Affiliation>DrMargarete Fischer-Bosch-Institute of Clinical Pharmacology, Auerbachstr112, 70376, Stuttgart, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>University of Tübingen, Geschwister-Scholl-Platz, 72074, Tübingen, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Brenner</LastName>
                    <ForeName>Hermann</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Brenton</LastName>
                    <ForeName>James D</ForeName>
                    <Initials>JD</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-5738-6683</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, CB2 0RE, Cambridge, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Brook</LastName>
                    <ForeName>Mark N</ForeName>
                    <Initials>MN</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-8969-2378</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Genetics and Epidemiology, The Institute of Cancer Research, 15 Cotswold Road, London, SM2 5NG, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Brunet</LastName>
                    <ForeName>Joan</ForeName>
                    <Initials>J</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-1945-3512</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI (Institut d'Investigació Biomèdica de Girona), Catalan Institute of Oncology, CIBERONC, AvFrança s/n, 17007, Girona, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Brunnström</LastName>
                    <ForeName>Hans</ForeName>
                    <Initials>H</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-7402-138X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Clinical Sciences, Lund University, Box 117, 221 00, Lund, Sweden.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Genetics and Pathology, Division of Laboratory Medicine, 221 85, Lund, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Buchanan</LastName>
                    <ForeName>Daniel D</ForeName>
                    <Initials>DD</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-2225-6675</Identifier>
                    <AffiliationInfo>
                        <Affiliation>University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Parkville, VIC, 3010, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Colorectal Oncogenomics Group, Department of Clinical Pathology, The University of Melbourne, Parkville, VIC, 3010, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Genomic Medicine and Family Cancer Clinic, Royal Melbourne Hospital, Parkville, VIC, 3010, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Burwinkel</LastName>
                    <ForeName>Barbara</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, University of Heidelberg, Im Neuenheimer Feld 440, 69120, Heidelberg, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Butzow</LastName>
                    <ForeName>Ralf</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, University of Helsinki and Helsinki University Hospital, Biomedicum Helsinki 4th Floor, Haartmaninkatu 8, 00029, Helsinki, Finland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cadoni</LastName>
                    <ForeName>Gabriella</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Roma, Italy.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Università Cattolica del Sacro Cuore, 00168, Roma, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Caldés</LastName>
                    <ForeName>Trinidad</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Calle del Prof Martín Lagos, 28040, Madrid, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Caligo</LastName>
                    <ForeName>Maria A</ForeName>
                    <Initials>MA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, via Roma 67, 56126, Pisa, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Campbell</LastName>
                    <ForeName>Ian</ForeName>
                    <Initials>I</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-7773-4155</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Peter MacCallum Cancer Center, 305 Grattan Street, Melbourne, VIC, 3000, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Sir Peter MacCallum Department of Oncology, The University of Melbourne, 305 Grattan Street, Melbourne, VIC, 3000, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Campbell</LastName>
                    <ForeName>Peter T</ForeName>
                    <Initials>PT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Epidemiology Research Program, American Cancer Society, 250 Williams Street NW, Atlanta, GA, 30303, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cancel-Tassin</LastName>
                    <ForeName>Géraldine</ForeName>
                    <Initials>G</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-9583-6382</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Sorbonne Université, GRC N°5 ONCOTYPE-URO, Tenon Hospital, 75020, Paris, France.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>CeRePP, Tenon Hospital, 75020, Paris, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cannon-Albright</LastName>
                    <ForeName>Lisa</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Genetic Epidemiology, Department of Medicine, University of Utah School of Medicine, Salt Lake City, UT, 84112, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>George EWahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT, 84112, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Campa</LastName>
                    <ForeName>Daniele</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Biology, University of Pisa, 56126, Pisa, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Caporaso</LastName>
                    <ForeName>Neil</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Dr, Rockville, MD, 20850, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Carvalho</LastName>
                    <ForeName>André L</ForeName>
                    <Initials>AL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Oncology Research Center, Barretos Cancer Hospital, Rua Antenor Duarte Villela, 1331, Barretos, SP, 784-400, Brazil.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Head and Neck Surgery Department, Barretos Cancer Hospital, Pio XII, 1331, Antenor Duarte Villela St, Barretos, SP, 14784-400, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chan</LastName>
                    <ForeName>Andrew T</ForeName>
                    <Initials>AT</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-7284-6767</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Gastroenterology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 181 Longwood Avenue, Boston, MA, 02115, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chang-Claude</LastName>
                    <ForeName>Jenny</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chanock</LastName>
                    <ForeName>Stephen J</ForeName>
                    <Initials>SJ</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-2324-3393</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Dr, Rockville, MD, 20850, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Chu</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Christiani</LastName>
                    <ForeName>David C</ForeName>
                    <Initials>DC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, 677 Huntington Ave, Boston, MA, 02115, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Claes</LastName>
                    <ForeName>Kathleen B M</ForeName>
                    <Initials>KBM</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-0841-7372</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Centre for Medical Genetics, Ghent University, De Pintelaan 185, 9000, Gent, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Claessens</LastName>
                    <ForeName>Frank</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Endocrinology Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, 3000, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Clements</LastName>
                    <ForeName>Judith</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Australian Prostate Cancer Research Centre-Qld, Translational Research Institute, 37 Kent St, Woolloongabba, QLD, 4102, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Institute of Health and Biomedical Innovation and School of Biomedical Science, Queensland University of Technology, 60 Musk Ave, Kelvin Grove, QLD, 4059, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Collée</LastName>
                    <ForeName>J Margriet</ForeName>
                    <Initials>JM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Genetics, Erasmus University Medical Center, Wytemaweg 80, 3015, Rotterdam, CN, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Correa</LastName>
                    <ForeName>Marcia Cruz</ForeName>
                    <Initials>MC</Initials>
                    <AffiliationInfo>
                        <Affiliation>University of Puerto Rico Medical Sciences Campus and Comprehensive Cancer Center, San Juan, PR, 00936, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Couch</LastName>
                    <ForeName>Fergus J</ForeName>
                    <Initials>FJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First StSW, Rochester, MN, 55905, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cox</LastName>
                    <ForeName>Angela</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sheffield Institute for Nucleic Acids (SInFoNiA), Department of Oncology and Metabolism, University of Sheffield, Western Bank, Sheffield, S10 2TN, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cunningham</LastName>
                    <ForeName>Julie M</ForeName>
                    <Initials>JM</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-8159-3025</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First StSW, Rochester, MN, 55905, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cybulski</LastName>
                    <ForeName>Cezary</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, ulUnii Lubelskiej 1, 71-252, Szczecin, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Czene</LastName>
                    <ForeName>Kamila</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Karolinska Univ Hospital, 171 76, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Daly</LastName>
                    <ForeName>Mary B</ForeName>
                    <Initials>MB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Genetics, Fox Chase Cancer Center, 333 Cottman Ave, Philadelphia, PA, 19111, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>deFazio</LastName>
                    <ForeName>Anna</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, 176 Hawkesbury Rd, Sydney, NSW, 2145, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Gynaecological Oncology, Westmead Hospital, Hawkesbury Rd &amp; Darcy Rd, Sydney, NSW, 2145, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Devilee</LastName>
                    <ForeName>Peter</ForeName>
                    <Initials>P</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-8023-2009</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Human Genetics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Diez</LastName>
                    <ForeName>Orland</ForeName>
                    <Initials>O</Initials>
                    <AffiliationInfo>
                        <Affiliation>Oncogenetics Group, Clinical and Molecular Genetics Area, Vall d'Hebron Institute of Oncology (VHIO), University Hospital, Vall d'Hebron, Passeig de la Vall d'Hebron 119-129, 08035, Barcelona, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gago-Dominguez</LastName>
                    <ForeName>Manuela</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de Santiago, SERGAS, Travesía da Choupana S/N, 15706, Santiago de Compostela, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Moores Cancer Center, University of California, San Diego, 3855 Health Sciences Drive, La Jolla, CA, 92037, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Donovan</LastName>
                    <ForeName>Jenny L</ForeName>
                    <Initials>JL</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Social and Community Medicine, University of Bristol, Bristol, BS8 1TH, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dörk</LastName>
                    <ForeName>Thilo</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Gynaecology Research Unit, Hannover Medical School, Carl-Neuberg-Straße 1, 30625, Hannover, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Duell</LastName>
                    <ForeName>Eric J</ForeName>
                    <Initials>EJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO-IDIBELL), AvGran Via 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dunning</LastName>
                    <ForeName>Alison M</ForeName>
                    <Initials>AM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Worts' Causeway, Cambridge, CB1 8RN, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dwek</LastName>
                    <ForeName>Miriam</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomedical Sciences, Faculty of Science and Technology, University of Westminster, 309 Regent Street, London, W1B 2HW, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Eccles</LastName>
                    <ForeName>Diana M</ForeName>
                    <Initials>DM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Tremona Road, Southampton, SO16 6YD, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Edlund</LastName>
                    <ForeName>Christopher K</ForeName>
                    <Initials>CK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, 90033, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Edwards</LastName>
                    <ForeName>Digna R Velez</ForeName>
                    <Initials>DRV</Initials>
                    <AffiliationInfo>
                        <Affiliation>Vanderbilt Epidemiology Center, Vanderbilt Genetics Institute, Department of Obstetrics and Gynecology, Vanderbilt University Medical Center, 2525 West End Avenue, Suite 600, Nashville, TN, 37203, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ellberg</LastName>
                    <ForeName>Carolina</ForeName>
                    <Initials>C</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-7297-0645</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Cancer Epidemiology, Clinical Sciences, Lund University, Barngatan 4, Skånes universitetssjukhus, 222 42, Lund, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Evans</LastName>
                    <ForeName>D Gareth</ForeName>
                    <Initials>DG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Manchester Centre for Genomic Medicine, Division of Evolution and Genomic Sciences, University of Manchester, St Mary's Hospital, Central Manchester University Hospitals NHS Foundation Trust, Oxford Road, Manchester, M13 9WL, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fasching</LastName>
                    <ForeName>Peter A</ForeName>
                    <Initials>PA</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-4885-8471</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen Nuremberg, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Universitaetsstrasse 21-23, 91054, Erlangen, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, 10833 Le Conte Ave, Los Angeles, CA, 90095, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ferris</LastName>
                    <ForeName>Robert L</ForeName>
                    <Initials>RL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Otolaryngology, UPMC Hillman Cancer Center, Cancer Pavilion, University of Pittsburgh, Suite 500, 5150 Centre Avenue, Pittsburgh, PA, 15232, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liloglou</LastName>
                    <ForeName>Triantafillos</ForeName>
                    <Initials>T</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-0460-1404</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Molecular and Clinical Cancer Medicine, Roy Castle Lung Cancer Research Programme, The University of Liverpool Institute of Translational Medicine, The Wiliam Duncan Building, 6 West Derby Street, Liverpool, L69 3BX, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Figueiredo</LastName>
                    <ForeName>Jane C</ForeName>
                    <Initials>JC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA, 90048, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Keck School of Medicine, University of Southern California, 1450 Biggy Street, Los Angeles, CA, 90033, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fletcher</LastName>
                    <ForeName>Olivia</ForeName>
                    <Initials>O</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-9387-7116</Identifier>
                    <AffiliationInfo>
                        <Affiliation>The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fortner</LastName>
                    <ForeName>Renée T</ForeName>
                    <Initials>RT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fostira</LastName>
                    <ForeName>Florentia</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritos', Neapoleos 10, AgParaskevi, Athens, 15310, Greece.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Franceschi</LastName>
                    <ForeName>Silvia</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Section of Infections, International Agency for Research on Cancer, 150 cours Albert Thomas, 69008, Lyon, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Friedman</LastName>
                    <ForeName>Eitan</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>The Susanne Levy Gertner Oncogenetics Unit, Chaim Sheba Medical Center, Emek HaEla St 1, 52621, Ramat Gan, Israel.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Sackler Faculty of Medicine, Tel Aviv University, Haim Levanon 30, 69978, Ramat Aviv, Israel.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gallinger</LastName>
                    <ForeName>Steven J</ForeName>
                    <Initials>SJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Surgery, Mount Sinai Hospital, 600 University Avenue, Toronto, ON, M5G 1X5, Canada.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Samuel Lunenfeld Research Institute, 600 University Avenue, Toronto, ON, M5G 1X5, Canada.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>University Health Network Toronto General Hospital, 200 Elizabeth St, Toronto, ON, M5G 2C4, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ganz</LastName>
                    <ForeName>Patricia A</ForeName>
                    <Initials>PA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Schools of Medicine and Public Health, Division of Cancer Prevention &amp; Control Research, Jonsson Comprehensive Cancer Centre, UCLA, 650 Charles Young Drive South, Los Angeles, CA, 90095-6900, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Garber</LastName>
                    <ForeName>Judy</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Risk and Prevention Clinic, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>García-Sáenz</LastName>
                    <ForeName>José A</ForeName>
                    <Initials>JA</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-6880-0301</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Calle del Prof Martín Lagos, 28040, Madrid, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gayther</LastName>
                    <ForeName>Simon A</ForeName>
                    <Initials>SA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 1975 Zonal Ave, Los Angeles, CA, 90033, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Center for Cancer Prevention and Translational Genomics, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Spielberg Building, 8725 Alden Dr, Los Angeles, CA, 90048, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomedical Sciences, Cedars-Sinai Medical Center, Spielberg Building, 8725 Alden Dr, Los Angeles, CA, 90048, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Giles</LastName>
                    <ForeName>Graham G</ForeName>
                    <Initials>GG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Epidemiology &amp; Intelligence Division, Cancer Council Victoria, 615 St Kilda Road, Melbourne, VIC, 3004, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Level 1, 723 Swanston Street, Melbourne, VIC, 3010, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Godwin</LastName>
                    <ForeName>Andrew K</ForeName>
                    <Initials>AK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, 3901 Rainbow Blvd, Kansas City, KS, 66160, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Goldberg</LastName>
                    <ForeName>Mark S</ForeName>
                    <Initials>MS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, McGill University, 1001 Decarie Boulevard, Montréal, QC, H4A3J1, Canada.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Clinical Epidemiology, Royal Victoria Hospital, McGill University, 1001 Decarie Boulevard, Montréal, QC, H4A3J1, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Goldgar</LastName>
                    <ForeName>David E</ForeName>
                    <Initials>DE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, 2000 Circle of Hope, Salt Lake City, UT, 84112, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Goode</LastName>
                    <ForeName>Ellen L</ForeName>
                    <Initials>EL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Health Sciences Research, Mayo Clinic, 200 First StSW, Rochester, MN, 55905, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Goodman</LastName>
                    <ForeName>Marc T</ForeName>
                    <Initials>MT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Prevention and Control, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Room 1S37, Los Angeles, CA, 90048, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Community and Population Health Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Room 1S37, Los Angeles, CA, 90048, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Goodman</LastName>
                    <ForeName>Gary</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health Sciences Division, Swedish Cancer Institute, 1221 Madison StSte 300, Seattle, WA, 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Grankvist</LastName>
                    <ForeName>Kjell</ForeName>
                    <Initials>K</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-4289-2097</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Unit of Clinical Chemistry, Department of Medical Biosciences, Umeå University, By 6M van 2, Sjukhusomradet, Umea universitet, 901 85, Umea, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Greene</LastName>
                    <ForeName>Mark H</ForeName>
                    <Initials>MH</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-1852-9239</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Clinical Genetics Branch, National Cancer Institute, DCEG, 9609 Medical Center Dr, Bethesda, MD, 20850-9772, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gronberg</LastName>
                    <ForeName>Henrik</ForeName>
                    <Initials>H</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-1073-2753</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Karolinska Univ Hospital, 171 76, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gronwald</LastName>
                    <ForeName>Jacek</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, ulUnii Lubelskiej 1, 71-252, Szczecin, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Guénel</LastName>
                    <ForeName>Pascal</ForeName>
                    <Initials>P</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-8359-518X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Cancer &amp; Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, 94805, Villejuif, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Håkansson</LastName>
                    <ForeName>Niclas</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Environmental Medicine, Division of Nutritional Epidemiology, Karolinska Institutet, Nobels väg 13, SE-171 77, SE-171, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hall</LastName>
                    <ForeName>Per</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Karolinska Univ Hospital, 171 76, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Oncology, Södersjukhuset, Sjukhusbacken 10, 118 83, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hamann</LastName>
                    <ForeName>Ute</ForeName>
                    <Initials>U</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120, Heidelberg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hamdy</LastName>
                    <ForeName>Freddie C</ForeName>
                    <Initials>FC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Nuffield Department of Surgical Sciences, Faculty of Medical Science, John Radcliffe Hospital, University of Oxford, Oxford, OX1 2JD, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hamilton</LastName>
                    <ForeName>Robert J</ForeName>
                    <Initials>RJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Surgical Oncology, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, Ontario, M5G2M9, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hampe</LastName>
                    <ForeName>Jochen</ForeName>
                    <Initials>J</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-2421-6127</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine 1, University Hospital Dresden, Technische Universität Dresden (TU Dresden), 01307, Dresden, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Haugen</LastName>
                    <ForeName>Aage</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Institute of Occupational Health (STAMI), Gydas vei 8, 0033, Oslo, Norway.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Heitz</LastName>
                    <ForeName>Florian</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gynecology and Gynecologic Oncology, DrHorst Schmidt Kliniken Wiesbaden, Ludwig-Erhard-Straße 100, 65199, Wiesbaden, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte/EvangHuyssens-Stiftung/Knappschaft GmbH, Henricistrasse 92, 45136, Essen, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Herrero</LastName>
                    <ForeName>Rolando</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Early Detection and Prevention Section, International Agency for Research on Cancer, 150 cours Albert Thomas, 69008, Lyon, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hillemanns</LastName>
                    <ForeName>Peter</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Gynaecology Research Unit, Hannover Medical School, Carl-Neuberg-Straße 1, 30625, Hannover, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hoffmeister</LastName>
                    <ForeName>Michael</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Høgdall</LastName>
                    <ForeName>Estrid</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Strandboulevarden 49, DK-2100, Copenhagen, Denmark.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Molecular Unit, Department of Pathology, Herlev Hospital, University of Copenhagen, Herlev Ringvej 75, DK-2730, Herlev, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hong</LastName>
                    <ForeName>Yun-Chul</ForeName>
                    <Initials>YC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Preventive Medicine, Seoul National University College of Medicine, 1 Gwanak-ro, Gwanak-gu, Seoul, 151 742, Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hopper</LastName>
                    <ForeName>John L</ForeName>
                    <Initials>JL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Level 1, 723 Swanston Street, Melbourne, VIC, 3010, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Houlston</LastName>
                    <ForeName>Richard</ForeName>
                    <Initials>R</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-5268-0242</Identifier>
                    <AffiliationInfo>
                        <Affiliation>German Research Center for Environmental Health, Institute for Cancer Research, Ingolstadter Landstr1, London, SM2 5NG, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hulick</LastName>
                    <ForeName>Peter J</ForeName>
                    <Initials>PJ</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-8397-4078</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Center for Medical Genetics, NorthShore University HealthSystem, 1000 Central St, Evanston, IL, 60201, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>The University of Chicago Pritzker School of Medicine, 924 E 57th St, Chicago, IL, 60637, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hunter</LastName>
                    <ForeName>David J</ForeName>
                    <Initials>DJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, 677 Huntington Ave, Boston, MA, 02115, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huntsman</LastName>
                    <ForeName>David G</ForeName>
                    <Initials>DG</Initials>
                    <AffiliationInfo>
                        <Affiliation>British Columbia's Ovarian Cancer Research (OVCARE) Program, Vancouver General Hospital, BC Cancer Agency and University of British Columbia, #3427-600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Oncology, BC Cancer Agency Research Centre, #3427-600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology and Laboratory Medicine, University of British Columbia, #3427-600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Idos</LastName>
                    <ForeName>Gregory</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, 48109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Imyanitov</LastName>
                    <ForeName>Evgeny N</ForeName>
                    <Initials>EN</Initials>
                    <AffiliationInfo>
                        <Affiliation>NNPetrov Institute of Oncology, Leningradskaya ul, 68, StPetersburg, Russia, 197758.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ingles</LastName>
                    <ForeName>Sue Ann</ForeName>
                    <Initials>SA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, 48109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Isaacs</LastName>
                    <ForeName>Claudine</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Lombardi Comprehensive Cancer Center, Georgetown University, 3800 Reservoir Road, Washington, DC, 20007, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jakubowska</LastName>
                    <ForeName>Anna</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, ulUnii Lubelskiej 1, 71-252, Szczecin, Poland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Rybacka 1, 70-204, Szczecin, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>James</LastName>
                    <ForeName>Paul</ForeName>
                    <Initials>P</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-4361-4657</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Sir Peter MacCallum Department of Oncology, The University of Melbourne, 305 Grattan Street, Melbourne, VIC, 3000, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Parkville Familial Cancer Centre, Peter MacCallum Cancer Center, 305 Grattan Street, Melbourne, VIC, 3000, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jenkins</LastName>
                    <ForeName>Mark A</ForeName>
                    <Initials>MA</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-8964-6160</Identifier>
                    <AffiliationInfo>
                        <Affiliation>University of Melbourne Centre for Cancer Research, Victorian Comprehensive Cancer Centre, Parkville, VIC, 3010, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Level 1, 723 Swanston Street, Melbourne, VIC, 3010, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Johansson</LastName>
                    <ForeName>Mattias</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Section of Genetics, International Agency for Research on Cancer, 150 cours Albert Thomas, 69008, Lyon, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Johansson</LastName>
                    <ForeName>Mikael</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiation Sciences, Umeå University, By 6M van 2, Sjukhusomradet, Umea universitet, 901 85, Umea, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>John</LastName>
                    <ForeName>Esther M</ForeName>
                    <Initials>EM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Division of Oncology and Stanford Cancer Institute, Stanford University School of Medicine, 780 Welch Rd, Stanford, CA, 94304, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Joshi</LastName>
                    <ForeName>Amit D</ForeName>
                    <Initials>AD</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-7581-6934</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, 677 Huntington Ave, Boston, MA, 02115, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, 02114, Boston, MA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kaneva</LastName>
                    <ForeName>Radka</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Medicine Center, Department of Medical Chemistry and Biochemistry, Medical Faculty, Medical University of Sofia, Sofia, 1504, Bulgaria.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Karlan</LastName>
                    <ForeName>Beth Y</ForeName>
                    <Initials>BY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA, 90048, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kelemen</LastName>
                    <ForeName>Linda E</ForeName>
                    <Initials>LE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hollings Cancer Center and Department of Public Health Sciences, Medical University of South Carolina, 68 President Street Bioengineering Building, MSC955, Charleston, SC, 29425, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kühl</LastName>
                    <ForeName>Tabea</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Epidemiology, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Khaw</LastName>
                    <ForeName>Kay-Tee</ForeName>
                    <Initials>KT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Clinical Gerontology, Department of Public Health and Primary Care, University of Cambridge, 2 Worts' Causeway, Cambridge, CB1 8RN, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Khusnutdinova</LastName>
                    <ForeName>Elza</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Genetics and Fundamental Medicine, Bashkir State University, ulZaki Validi 32, Ufa, Russia, 450076.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Institute of Biochemistry and Genetics, Ufa Scientific Center of Russian Academy of Sciences, 71 prosp Oktyabrya, Ufa, Russia, 450054.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kibel</LastName>
                    <ForeName>Adam S</ForeName>
                    <Initials>AS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Urologic Surgery, Brigham and Womens Hospital, Boston, Massachusettes, 02115, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kiemeney</LastName>
                    <ForeName>Lambertus A</ForeName>
                    <Initials>LA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Radboud Institute for Health Sciences, Radboud University Medical Center, Geert Grooteplein 21, 6525 EZ, Nijmegen, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Jeri</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, 1155 Pressler St, Houston, TX, 77030, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kjaer</LastName>
                    <ForeName>Susanne K</ForeName>
                    <Initials>SK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Strandboulevarden 49, DK-2100, Copenhagen, Denmark.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Gynaecology, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, DK-2100, Copenhagen, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Knight</LastName>
                    <ForeName>Julia A</ForeName>
                    <Initials>JA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Prosserman Centre for Population Health Research, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, 60 Murray Street, Toronto, Ontario, M5T 3L9, Canada.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, 155 College Street, Toronto, ON, M5T3M7, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kogevinas</LastName>
                    <ForeName>Manolis</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Biomedical Network on Rare Diseases (CIBERER), AvMonforte de Lemos, 3-5Pabellón 11Planta 0, 28029, Madrid, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Centre for Research in Environmental Epidemiology (CREAL), ISGlobal, 08036, Barcelona, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>IMIM (Hospital del Mar Research Institute), Barcelona, 08003, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Universitat Pompeu Fabra (UPF), Barcelona, 08002, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kote-Jarai</LastName>
                    <ForeName>Zsofia</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Genetics and Epidemiology, The Institute of Cancer Research, 15 Cotswold Road, London, SM2 5NG, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Koutros</LastName>
                    <ForeName>Stella</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Department of Health and Human Services, National Institutes of Health, 9609 Medical Center Dr, Bethesda, MD, 20892, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kristensen</LastName>
                    <ForeName>Vessela N</ForeName>
                    <Initials>VN</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Ullernchausseen 70, 0379, Oslo, Norway.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Kirkeveien 166, 0450, Oslo, Norway.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Molecular Biology, Oslo University Hospital, University of Oslo, Kirkeveien 166, 0450, Oslo, Norway.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kupryjanczyk</LastName>
                    <ForeName>Jolanta</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology and Laboratory Diagnostics, the Maria Sklodowska-Curie Institute - Oncology Center, Roentgena 5, 02-781, Warsaw, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lacko</LastName>
                    <ForeName>Martin</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Head and Neck Surgery, Department of Otorhinolaryngology, Maastricht University Medical Center, PDebyelaan 25, POBox 5800, 6202 AZ, Maastricht, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lam</LastName>
                    <ForeName>Stephan</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Integrative Oncology, British Columbia Cancer Agency, Room 10-111 675 West 10th Avenue, Vancouver, BC, V5Z1L3, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lambrechts</LastName>
                    <ForeName>Diether</ForeName>
                    <Initials>D</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-3429-302X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>VIB Center for Cancer Biology, VIB, Herestraat 49, 3001, Leuven, Belgium.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Laboratory for Translational Genetics, Department of Human Genetics, University of Leuven, Oude Markt 13, 3000, Leuven, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Landi</LastName>
                    <ForeName>Maria Teresa</ForeName>
                    <Initials>MT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Integrative Tumor Epidemiology Branch, DCEG, National Cancer Institute, 9609 Medical Center Drive, Room SG/7E106, Rockville, MD, 20850, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lazarus</LastName>
                    <ForeName>Philip</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Pharmacy, Washington State University, PBS 431 PO Box 1495, Spokane, WA, 99210-1495, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Le</LastName>
                    <ForeName>Nhu D</ForeName>
                    <Initials>ND</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Control Research, BC Cancer Agency, 675 West 10th Avenue, Vancouver, BC, V5Z 1L3, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Eunjung</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 1975 Zonal Ave, Los Angeles, CA, 90033, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lejbkowicz</LastName>
                    <ForeName>Flavio</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Clalit Health Services, Clalit National Israeli Cancer Control Center, Carmel Medical Center, 2 Horev Street, 3436212, Haifa, Israel.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lenz</LastName>
                    <ForeName>Heinz-Josef</ForeName>
                    <Initials>HJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, 90033, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Leslie</LastName>
                    <ForeName>Goska</ForeName>
                    <Initials>G</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-5756-6222</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Worts' Causeway, Cambridge, CB1 8RN, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lessel</LastName>
                    <ForeName>Davor</ForeName>
                    <Initials>D</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-4496-244X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lester</LastName>
                    <ForeName>Jenny</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA, 90048, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Levine</LastName>
                    <ForeName>Douglas A</ForeName>
                    <Initials>DA</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-1038-8232</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Gynecologic Oncology, Laura and Isaac Pearlmutter Cancer Center, NYU Langone Medical Center, 240 East 38th Street 19th Floor, New York, NY, 10016, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Li</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Family Medicine and Community Health, Mary Ann Swetland Center for Environmental Health, Case Western Reserve University, Cleveland, OH, 44106, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Servicio Galego de Saude (SERGAS), Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), 15706, Santiago De Compostela, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Christopher I</ForeName>
                    <Initials>CI</Initials>
                    <AffiliationInfo>
                        <Affiliation>Translational Research Program, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lindblom</LastName>
                    <ForeName>Annika</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska Univ Hospital, 171 76, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lindor</LastName>
                    <ForeName>Noralane M</ForeName>
                    <Initials>NM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Health Sciences Research, Mayo Clinic Arizona, 13400 EShea Blvd, Scottsdale, AZ, 85259, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Geoffrey</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Epidemiology Division, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON, M5G2M9, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Loupakis</LastName>
                    <ForeName>Fotios</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Unit of Oncology 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto IRCCS, 35122, Padua, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lubiński</LastName>
                    <ForeName>Jan</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, ulUnii Lubelskiej 1, 71-252, Szczecin, Poland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Maehle</LastName>
                    <ForeName>Lovise</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Genetics, Oslo University Hospital, Kirkeveien 166, 0450, Oslo, Norway.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Maier</LastName>
                    <ForeName>Christiane</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Human Genetics, University Hospital Ulm, Prittwitzstrasse 43, 89075, Ulm, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mannermaa</LastName>
                    <ForeName>Arto</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Translational Cancer Research Area, University of Eastern Finland, Yliopistonranta 1, 70210, Kuopio, Finland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Yliopistonranta 1, 70210, Finland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Puijonlaaksontie 2, 70210, Kuopio, Finland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Marchand</LastName>
                    <ForeName>Loic Le</ForeName>
                    <Initials>LL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Epidemiology Program, University of Hawaii Cancer Center, 701 Ilalo St, Honolulu, HI, 96813, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Margolin</LastName>
                    <ForeName>Sara</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, 17177, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>May</LastName>
                    <ForeName>Taymaa</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Gynecologic Oncology, University Health Network, Princess Margaret Hospital, 610 University Avenue, OPG Wing, 6-811, Toronto, ON, M5G 2M9, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>McGuffog</LastName>
                    <ForeName>Lesley</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Worts' Causeway, Cambridge, CB1 8RN, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Meindl</LastName>
                    <ForeName>Alfons</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Gynaecology and Obstetrics, , Technische Universität München, Arcisstraße 21, 80333, Munich, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Middha</LastName>
                    <ForeName>Pooja</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, University of Heidelberg, In Neuenheimer Feld 672, 69120, Heidelberg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Miller</LastName>
                    <ForeName>Austin</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-9739-8462</Identifier>
                    <AffiliationInfo>
                        <Affiliation>NRG Oncology, Statistics and Data Management Center, Roswell Park Cancer Institute, Elm &amp; Carlton Streets, Buffalo, NY, 14263, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Milne</LastName>
                    <ForeName>Roger L</ForeName>
                    <Initials>RL</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-5764-7268</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Cancer Epidemiology &amp; Intelligence Division, Cancer Council Victoria, 615 St Kilda Road, Melbourne, VIC, 3004, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Level 1, 723 Swanston Street, Melbourne, VIC, 3010, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>MacInnis</LastName>
                    <ForeName>Robert J</ForeName>
                    <Initials>RJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Epidemiology &amp; Intelligence Division, Cancer Council Victoria, 615 St Kilda Road, Melbourne, VIC, 3004, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Level 1, 723 Swanston Street, Melbourne, VIC, 3010, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Modugno</LastName>
                    <ForeName>Francesmary</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Womens Cancer Research Center, Magee-Womens Research Institute and Hillman Cancer Center, Pittsburgh, PA, 15213, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, 300 Halket Street, Pittsburgh, PA, 15213, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Montagna</LastName>
                    <ForeName>Marco</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Via Gattamelata 64, Padua, 35128, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Moreno</LastName>
                    <ForeName>Victor</ForeName>
                    <Initials>V</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-2818-5487</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP) and University of Barcelona, Barcelona, 08908, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Moysich</LastName>
                    <ForeName>Kirsten B</ForeName>
                    <Initials>KB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Cancer Prevention and Control, Roswell Park Cancer Institute, Elm &amp; Carlton Streets, Buffalo, NY, 14263, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mucci</LastName>
                    <ForeName>Lorelei</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, 677 Huntington Ave, Boston, MA, 02115, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Muir</LastName>
                    <ForeName>Kenneth</ForeName>
                    <Initials>K</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-6429-988X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Population Health, Health Services Research and Primary Care, University of Manchester, Oxford Road, Manchester, M13 9PL, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mulligan</LastName>
                    <ForeName>Anna Marie</ForeName>
                    <Initials>AM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Laboratory Medicine and Pathobiology, University of Toronto, 1 King's College Circle, Toronto, ON, M5S1A8, Canada.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Laboratory Medicine Program, University Health Network, 200 Elizabeth Street, Toronto, ON, M5G2C4, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nathanson</LastName>
                    <ForeName>Katherine L</ForeName>
                    <Initials>KL</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-6740-0901</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, 3400 Civic Center Boulevard, Philadelphia, PA, 19104, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Neal</LastName>
                    <ForeName>David E</ForeName>
                    <Initials>DE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, CB2 0RE, Cambridge, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Nuffield Department of Surgical Sciences, Faculty of Medical Science, John Radcliffe Hospital, University of Oxford, Oxford, OX1 2JD, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Oncology, Addenbrooke's Hospital, University of Cambridge, Cambridge, CB1 8RN, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ness</LastName>
                    <ForeName>Andrew R</ForeName>
                    <Initials>AR</Initials>
                    <AffiliationInfo>
                        <Affiliation>NIHR Bristol Biomedical Research Centre Nutrition Theme, University of Bristol, Upper Maudlin Street, Bristol, BS2 8AE, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Neuhausen</LastName>
                    <ForeName>Susan L</ForeName>
                    <Initials>SL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Population Sciences, Beckman Research Institute of City of Hope, 1500 E Duarte, Duarte, CA, 91010, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nevanlinna</LastName>
                    <ForeName>Heli</ForeName>
                    <Initials>H</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-0916-2976</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Haartmaninkatu 8, 00290, Helsinki, Finland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Newcomb</LastName>
                    <ForeName>Polly A</ForeName>
                    <Initials>PA</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-8786-0043</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Public Health Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., Seattle, WA, 98109-1024, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>School of Public Health, University of Washington, 1959 NE Pacific Street, Health Science Buidling, F-350, Seattle, WA, 98195, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Newcomb</LastName>
                    <ForeName>Lisa F</ForeName>
                    <Initials>LF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., Seattle, WA, 98109-1024, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Urology, University of Washington, Seattle, Washington, 98195, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nielsen</LastName>
                    <ForeName>Finn Cilius</ForeName>
                    <Initials>FC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, DK-2100, Copenhagen, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nikitina-Zake</LastName>
                    <ForeName>Liene</ForeName>
                    <Initials>L</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-2491-5187</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Latvian Biomedical Research and Study Centre, Ratsupites str 1, Riga, LV-1067, Latvia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nordestgaard</LastName>
                    <ForeName>Børge G</ForeName>
                    <Initials>BG</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-1954-7220</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev Ringvej 75, 2730, Herlev, Denmark.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev Ringvej 75, 2730, Herlev, Denmark.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nussbaum</LastName>
                    <ForeName>Robert L</ForeName>
                    <Initials>RL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Genetics and Prevention Program, University of California San Francisco, 1600 Divisadero St, San Francisco, CA, 94143-1714, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Offit</LastName>
                    <ForeName>Kenneth</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Olah</LastName>
                    <ForeName>Edith</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Genetics, National Institute of Oncology, Ráth György u7-9, 1122, Budapest, Hungary.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Olama</LastName>
                    <ForeName>Ali Amin Al</ForeName>
                    <Initials>AAA</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-7178-3431</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Worts' Causeway, Cambridge, CB1 8RN, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Neurosciences, University of Cambridge, Cambridge, CB2 0QQ, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Olopade</LastName>
                    <ForeName>Olufunmilayo I</ForeName>
                    <Initials>OI</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-9936-1599</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Center for Clinical Cancer Genetics, The University of Chicago, 5841S Maryland Ave, Chicago, IL, 60637, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Olshan</LastName>
                    <ForeName>Andrew F</ForeName>
                    <Initials>AF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, 135 Dauer Dr, Chapel Hill, NC, 27599-7435, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>UNC Lineberger Comprehensive Cancer Center, 450 West Dr, Chapell Hill, NC, 27599, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Olsson</LastName>
                    <ForeName>Håkan</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cancer Epidemiology, Clinical Sciences, Lund University, Barngatan 4, Skånes universitetssjukhus, 222 42, Lund, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Osorio</LastName>
                    <ForeName>Ana</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Calle de Melchor Fernández Almagro, 3, 28029, Madrid, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Biomedical Network on Rare Diseases (CIBERER), AvMonforte de Lemos, 3-5Pabellón 11Planta 0, 28029, Madrid, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pandha</LastName>
                    <ForeName>Hardev</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>The University of Surrey, Guildford, Surrey, GU2 7XH, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Park</LastName>
                    <ForeName>Jong Y</ForeName>
                    <Initials>JY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cancer Epidemiology, HLee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL, 33612, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pashayan</LastName>
                    <ForeName>Nora</ForeName>
                    <Initials>N</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-0843-2468</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Applied Health Research, University College London, 1-19 Torrington Place, London, WC1E 6BT, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Centre for Cancer Genetic Epidemiology, Department of Oncology, Strangeways Laboratory, University of Cambridge, Cambridge, CB1 8RN, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Parsons</LastName>
                    <ForeName>Michael T</ForeName>
                    <Initials>MT</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-3242-8477</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, 300 Herston Road, Brisbane, QLD, 4006, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pejovic</LastName>
                    <ForeName>Tanja</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, Oregon Health &amp; Science University, 3181 SW Sam Jackson Park Road, L-466, Portland, OR, 97239, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Knight Cancer Institute, Oregon Health &amp; Science University, 3181 SW Sam Jackson Park Road, L-466, Portland, OR, 97239, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Penney</LastName>
                    <ForeName>Kathryn L</ForeName>
                    <Initials>KL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 181 Longwood Avenue, Boston, MA, 02115, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Peters</LastName>
                    <ForeName>Wilbert H M</ForeName>
                    <Initials>WHM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterology, Radboud University Nijmegen Medical Center, Geert Grooteplein Zuid 10, Internal BOBox 433, 6525 GA, Nijmegen, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Phelan</LastName>
                    <ForeName>Catherine M</ForeName>
                    <Initials>CM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cancer Epidemiology, HLee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL, 33612, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Phipps</LastName>
                    <ForeName>Amanda I</ForeName>
                    <Initials>AI</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., Seattle, WA, 98109-1024, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology, University of Washington School of Public Health, 1959 NE Pacific St, Seattle, WA, 98195, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Plaseska-Karanfilska</LastName>
                    <ForeName>Dijana</ForeName>
                    <Initials>D</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-8877-2416</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Research Centre for Genetic Engineering and Biotechnology 'Georgi DEfremov', Macedonian Academy of Sciences and Arts, Boulevard Krste Petkov Misirkov, 1000, Skopje, Republic of Macedonia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pring</LastName>
                    <ForeName>Miranda</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Bristol Dental School, University of Bristol, Lower Maudlin Street, Bristol, BS1 2LY, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Prokofyeva</LastName>
                    <ForeName>Darya</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Genetics and Fundamental Medicine, Bashkir State University, ulZaki Validi 32, Ufa, Russia, 450076.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Radice</LastName>
                    <ForeName>Paolo</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Via Giacomo Venezian 1, 20133, Milan, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stefansson</LastName>
                    <ForeName>Kari</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Decode genetics, Sturlugata 8, IS-101 Reykjavik, Reykjavik, Iceland, Iceland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ramus</LastName>
                    <ForeName>Susan J</ForeName>
                    <Initials>SJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Women's and Children's Health, Faculty of Medicine, University of NSW Sydney, 18 High St, Sydney, NSW, 2052, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>The Kinghorn Cancer Centre, Garvan Institute of Medical Research, 384 Victoria Street, Sydney, NSW, 2010, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Raskin</LastName>
                    <ForeName>Leon</ForeName>
                    <Initials>L</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-1195-7214</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 1161 21st Ave S # D3300, Nashville, TN, 37232, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rennert</LastName>
                    <ForeName>Gad</ForeName>
                    <Initials>G</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-8512-068X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Clalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, 7 Michal Street, 34362, Haifa, Israel.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rennert</LastName>
                    <ForeName>Hedy S</ForeName>
                    <Initials>HS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Clalit National Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, 7 Michal Street, 34362, Haifa, Israel.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>van Rensburg</LastName>
                    <ForeName>Elizabeth J</ForeName>
                    <Initials>EJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Genetics, University of Pretoria, Private Bag X323, Arcadia, 0007, South Africa.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Riggan</LastName>
                    <ForeName>Marjorie J</ForeName>
                    <Initials>MJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, Duke University Medical Center, 25171 Morris Bldg, Durham, NC, 27710, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Risch</LastName>
                    <ForeName>Harvey A</ForeName>
                    <Initials>HA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Chronic Disease Epidemiology, Yale School of Public Health, 60 College St, New Haven, CT, 06510, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Risch</LastName>
                    <ForeName>Angela</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-8026-5505</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Cancer Center Cluster Salzburg at PLUS, Department of Molecular Biology, University of Salzburg, Billrothstr11, 5020, Salzburg, Austria.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Epigenomics and Cancer Risk Factors, DKFZ - German Cancer Research Center, Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Member of the German Center for Lung Research (DZL), Translational Lung Research Center Heidelberg (TLRC-H), 69120, Heidelberg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Roobol</LastName>
                    <ForeName>Monique J</ForeName>
                    <Initials>MJ</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-6967-1708</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Urology, Erasmus University Medical Center, Wytemaweg 80, 3015 CN, Rotterdam, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rosenstein</LastName>
                    <ForeName>Barry S</ForeName>
                    <Initials>BS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, New York, NY, 10029, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, New York, NY, 10029, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rossing</LastName>
                    <ForeName>Mary Anne</ForeName>
                    <Initials>MA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology, University of Washington, M4 C308, 1100 Fairview Ave N, Seattle, WA, 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>De Ruyck</LastName>
                    <ForeName>Kim</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine and Health Sciences, Basic Medical Sciences, Ghent University, De Pintelaan 185, 9000, Gent, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Saloustros</LastName>
                    <ForeName>Emmanouil</ForeName>
                    <Initials>E</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-0485-0120</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Hereditary Cancer Clinic, University Hospital of Heraklion, Voutes, 711 10, Heraklion, Greece.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sandler</LastName>
                    <ForeName>Dale P</ForeName>
                    <Initials>DP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Epidemiology Branch, National Institute of Environmental Health Sciences, NIH, 111TWAlexander Drive, Research Triangle Park, NC, 27709, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sawyer</LastName>
                    <ForeName>Elinor J</ForeName>
                    <Initials>EJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Research Oncology, Guy's Hospital, King's College London, Guy's Hospital Great Maze Pond, London, SE1 9RT, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schabath</LastName>
                    <ForeName>Matthew B</ForeName>
                    <Initials>MB</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-3241-3216</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Cancer Epidemiology, HLee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL, 33612, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schleutker</LastName>
                    <ForeName>Johanna</ForeName>
                    <Initials>J</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-1863-0305</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute of Biomedicine, University of Turku, 20014, Turku, Finland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Laboratory, Department of Medical Genetics, Turku University Hospital, 20014, Turku, Finland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Prostate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere, 33014, Tampere, Finland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schmidt</LastName>
                    <ForeName>Marjanka K</ForeName>
                    <Initials>MK</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-2228-429X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Setiawan</LastName>
                    <ForeName>V Wendy</ForeName>
                    <Initials>VW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 1450 Biggy Street, Los Angeles, CA, 90033, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shen</LastName>
                    <ForeName>Hongbing</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology and Biostatistics, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, School of Public Health, Nanjing Medical University, 101 Longmian Ave, Jiangning District, 211166, Nanjing, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Siegel</LastName>
                    <ForeName>Erin M</ForeName>
                    <Initials>EM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Dr. MRC-CANCONT, Tampa, FL, 33612, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sieh</LastName>
                    <ForeName>Weiva</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Genetics and Genomic Sciences, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, 1425 Madison Avenue, 2nd floor, New York, NY, 10029, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Singer</LastName>
                    <ForeName>Christian F</ForeName>
                    <Initials>CF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Dept of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Slattery</LastName>
                    <ForeName>Martha L</ForeName>
                    <Initials>ML</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, University of Utah Health Sciences Center, 295 Chipeta Way, Salt Lake City, UT, 84132, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sorensen</LastName>
                    <ForeName>Karina Dalsgaard</ForeName>
                    <Initials>KD</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-4902-5490</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Medicine, Aarhus University Hospital, DK-8200, Aarhus, Denmark.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Medicine, Aarhus University, DK-8200, Aarhus, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Southey</LastName>
                    <ForeName>Melissa C</ForeName>
                    <Initials>MC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, 246 Clayton Road, Clayton, VIC, 3168, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Pathology, The University of Melbourne, Cnr Grattan Street and Royal Parade, Melbourne, VIC, 3010, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Spurdle</LastName>
                    <ForeName>Amanda B</ForeName>
                    <Initials>AB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, 300 Herston Road, Brisbane, QLD, 4006, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stanford</LastName>
                    <ForeName>Janet L</ForeName>
                    <Initials>JL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., Seattle, WA, 98109-1024, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology, University of Washington School of Public Health, 1959 NE Pacific St, Seattle, WA, 98195, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stevens</LastName>
                    <ForeName>Victoria L</ForeName>
                    <Initials>VL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Epidemiology Research Program, American Cancer Society, 250 Williams Street NW, Atlanta, GA, 30303, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stintzing</LastName>
                    <ForeName>Sebastian</ForeName>
                    <Initials>S</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-3297-5801</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine III, University Hospital, LMU Munich, Marchioninistr15, 81377, Munich, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stone</LastName>
                    <ForeName>Jennifer</ForeName>
                    <Initials>J</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-5077-0124</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Level 1, 723 Swanston Street, Melbourne, VIC, 3010, Australia.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>The Curtin UWA Centre for Genetic Origins of Health and Disease, Curtin University and University of Western Australia, 35 Stirling Hwy, Perth, WA, 6000, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sundfeldt</LastName>
                    <ForeName>Karin</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, Sahlgrenska Cancer Center, Inst Clinical Scienses, University of Gothenburg, Blå stråket 6, 41345, Gothenburg, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sutphen</LastName>
                    <ForeName>Rebecca</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Epidemiology Center, College of Medicine, University of South Florida, 3650 Spectrum Blvd, Suite 100, Tampa, FL, 33612, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Swerdlow</LastName>
                    <ForeName>Anthony J</ForeName>
                    <Initials>AJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Genetics and Epidemiology, The Institute of Cancer Research, 15 Cotswold Road, London, SM2 5NG, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Breast Cancer Research, The Institute of Cancer Research, London, SW7 3RP, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tajara</LastName>
                    <ForeName>Eloiza H</ForeName>
                    <Initials>EH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Molecular Biology, School of Medicine of São José do Rio Preto, Av Brig Faria Lima 5416 Vila São Pedro, São José do Rio Preto, SP, 15090-000, Brazil.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Genetics and Evolutive Biology, Institute of Biosciences, University of São Paulo, Rua do Matão, 321, São Paulo, SP, 05508-090, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tangen</LastName>
                    <ForeName>Catherine M</ForeName>
                    <Initials>CM</Initials>
                    <AffiliationInfo>
                        <Affiliation>SWOG Statistical Center, Fred Hutchinson Cancer Research Center, Seattle, Washington, 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tardon</LastName>
                    <ForeName>Adonina</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-5150-1209</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, University of Oviedo and CIBERESP, Campus del Cristo s/n, 33006, Oviedo, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Taylor</LastName>
                    <ForeName>Jack A</ForeName>
                    <Initials>JA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Epidemiology Branch, National Institute of Environmental Health Sciences, NIH, 111TWAlexander Drive, Research Triangle Park, NC, 27709, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Epigenetic and Stem Cell Biology Laboratory, National Institute of Environmental Health Sciences, NIH, 111TWAlexander Drive, Research Triangle Park, NC, 27709, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Teare</LastName>
                    <ForeName>M Dawn</ForeName>
                    <Initials>MD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Statistics Group, School of Health and Related Research (ScHARR), University of Sheffield, Regent Court, 30 Regent Street, Sheffield, S1 4DA, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Teixeira</LastName>
                    <ForeName>Manuel R</ForeName>
                    <Initials>MR</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-4896-5982</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Genetics, Portuguese Oncology Institute, Rua DrAntónio Bernardino de Almeida 62, 4220-072, Porto, Portugal.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Biomedical Sciences Institute (ICBAS), University of Porto, RJorge de Viterbo Ferreira 228, 4050-013, Porto, Portugal.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Terry</LastName>
                    <ForeName>Mary Beth</ForeName>
                    <Initials>MB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 West 168th Street, New York, NY, 10032, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Terry</LastName>
                    <ForeName>Kathryn L</ForeName>
                    <Initials>KL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, 221 Longwood Avenue RFB 368, Boston, MA, 02115, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Harvard THChan School of Public Health, 221 Longwood Avenue RFB 368, Boston, MA, 02115, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Thibodeau</LastName>
                    <ForeName>Stephen N</ForeName>
                    <Initials>SN</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First StSW, Rochester, MN, 55905, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Thomassen</LastName>
                    <ForeName>Mads</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Genetics, Odense University Hospital, Sonder Boulevard 29, 5000, Odence C, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bjørge</LastName>
                    <ForeName>Line</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gynecology and Obstetrics, Haukeland University Hospital, 5021, Bergen, Norway.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Centre for Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, 5021, Bergen, Norway.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tischkowitz</LastName>
                    <ForeName>Marc</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, 1001 Decarie Boulevard, Montréal, QC, H4A3J1, Canada.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Genetics, Cambridge University, Hills Road, Cambridge, CB2 0QQ, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Toland</LastName>
                    <ForeName>Amanda E</ForeName>
                    <Initials>AE</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-0271-1792</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Cancer Biology and Genetics, The Ohio State University, 460W12th Avenue, Columbus, OH, 43210, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Torres</LastName>
                    <ForeName>Diana</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, 69120, Heidelberg, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Institute of Human Genetics, Pontificia Universidad Javeriana, Carrera 7 No40-90, Bogota, Colombia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Townsend</LastName>
                    <ForeName>Paul A</ForeName>
                    <Initials>PA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Cancer Sciences, Manchester Cancer Research Centre, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Health Innovation Manchester, University of Manchester, Manchester, M20 4GJ, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Travis</LastName>
                    <ForeName>Ruth C</ForeName>
                    <Initials>RC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, OX3 7LF, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tung</LastName>
                    <ForeName>Nadine</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Oncology, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA, 02215, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tworoger</LastName>
                    <ForeName>Shelley S</ForeName>
                    <Initials>SS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, 677 Huntington Ave, Boston, MA, 02115, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Cancer Epidemiology, HLee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL, 33612, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ulrich</LastName>
                    <ForeName>Cornelia M</ForeName>
                    <Initials>CM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., Seattle, WA, 98109-1024, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Huntsman Cancer Institute and Department of Population Health Sciences, University of Utah, 2000 Circle of Hope, Rm 4125, Salt Lake City, UT, 84112, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Usmani</LastName>
                    <ForeName>Nawaid</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Oncology, Cross Cancer Institute, University of Alberta, 116 St &amp; 85 Ave, Edmonton, AB T6G 2R3, Canada.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Radiation Oncology, Cross Cancer Institute, University of Alberta, 116 St &amp; 85 Ave, Edmonton, AB T6G 2R3, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vachon</LastName>
                    <ForeName>Celine M</ForeName>
                    <Initials>CM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Health Sciences Research, Mayo Clinic, 200 First StSW, Rochester, MN, 55905, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Van Nieuwenhuysen</LastName>
                    <ForeName>Els</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Gynecologic Oncology, Department of Obstetrics and Gynaecology and Leuven Cancer Institute, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vega</LastName>
                    <ForeName>Ana</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Biomedical Network on Rare Diseases (CIBERER), AvMonforte de Lemos, 3-5Pabellón 11Planta 0, 28029, Madrid, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Fundación Pública Galega Medicina Xenómica &amp; Instituto de Investigación Sanitaria de Santiago de Compostela, calle Choupana s/n, 15706, Santiago De Compostela, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Aguado-Barrera</LastName>
                    <ForeName>Miguel Elías</ForeName>
                    <Initials>ME</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-7822-6726</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Fundación Pública Galega Medicina Xenómica &amp; Instituto de Investigación Sanitaria de Santiago de Compostela, calle Choupana s/n, 15706, Santiago De Compostela, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Qin</ForeName>
                    <Initials>Q</Initials>
                    <AffiliationInfo>
                        <Affiliation>Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Worts' Causeway, Cambridge, CB1 8RN, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Webb</LastName>
                    <ForeName>Penelope M</ForeName>
                    <Initials>PM</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-0733-5930</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Population Health Department, QIMR Berghofer Medical Research Institute, 300 Herston Road, Brisbane, QLD, 4006, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Weinberg</LastName>
                    <ForeName>Clarice R</ForeName>
                    <Initials>CR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, NIH, 111TWAlexander Drive, Research Triangle Park, NC, 27709, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Weinstein</LastName>
                    <ForeName>Stephanie</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Dr, Rockville, MD, 20850, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Weissler</LastName>
                    <ForeName>Mark C</ForeName>
                    <Initials>MC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Otolaryngology/Head and Neck Surgery, University of North Carolina at Chapel Hill, Chapel Hill, 27514, NC, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Weitzel</LastName>
                    <ForeName>Jeffrey N</ForeName>
                    <Initials>JN</Initials>
                    <AffiliationInfo>
                        <Affiliation>City of Hope Clinical Cancer Genomics Community Research Network, 1500 East Duarte Road, Duarte, CA, 91010, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>West</LastName>
                    <ForeName>Catharine M L</ForeName>
                    <Initials>CML</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Cancer Sciences, University of Manchester, Manchester Cancer Research Centre, Manchester Academic Health Science Centre,, The Christie Hospital NHS Foundation Trust, Manchester, M13 9PL, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>White</LastName>
                    <ForeName>Emily</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA, 98109, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology, University of Washington, 1100 Fairview Ave N, Seattle, WA, 98109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Whittemore</LastName>
                    <ForeName>Alice S</ForeName>
                    <Initials>AS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, 259 Campus Drive, Stanford, CA, 94305, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Biomedical Data Science, Stanford University School of Medicine, 259 Campus Drive, Stanford, CA, 94305, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wichmann</LastName>
                    <ForeName>H-Erich</ForeName>
                    <Initials>HE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Informatics, Biometry and Epidemiology, Chair of Epidemiology, Ludwig Maximilians University, Neuherberg D-85764, Munich, 803539, Bavaria, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Helmholtz Zentrum Munchen, German Research Center for Environmental Health (GmbH), Institute of Epidemiology, Ingolstadter Landstr1, 85764, Neuherberg, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Institute of Medical Statistics and Epidemiology, Technical University Munich, Munich, 80333, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wiklund</LastName>
                    <ForeName>Fredrik</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Karolinska Univ Hospital, 171 76, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Winqvist</LastName>
                    <ForeName>Robert</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu, Aapistie 5A, 90220, Oulu, Finland.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre Oulu, Aapistie 5A, 90220, Oulu, Finland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wolk</LastName>
                    <ForeName>Alicja</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-7387-6845</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Environmental Medicine, Division of Nutritional Epidemiology, Karolinska Institutet, Nobels väg 13, SE-171 77, SE-171, Stockholm, Sweden.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Surgical Sciences, Uppsala University, 751 85, Uppsala, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Woll</LastName>
                    <ForeName>Penella</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Academic Unit of Clinical Oncology, University of Sheffield, Weston Park Hospital, Whitham Road, Sheffield, S10 2SJ, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Woods</LastName>
                    <ForeName>Michael</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Discipline of Genetics, Memorial University of Newfoundland, StJohn's, NL, A1C 5S7, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wu</LastName>
                    <ForeName>Anna H</ForeName>
                    <Initials>AH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 1975 Zonal Ave, Los Angeles, CA, 90033, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wu</LastName>
                    <ForeName>Xifeng</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology, Division of Cancer Prevention and Population Science, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yannoukakos</LastName>
                    <ForeName>Drakoulis</ForeName>
                    <Initials>D</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-7509-3510</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research 'Demokritos', Neapoleos 10, AgParaskevi, Athens, 15310, Greece.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zheng</LastName>
                    <ForeName>Wei</ForeName>
                    <Initials>W</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-1226-070X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 1161 21st Ave S # D3300, Nashville, TN, 37232, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zienolddiny</LastName>
                    <ForeName>Shanbeh</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Institute of Occupational Health (STAMI), Gydas vei 8, 0033, Oslo, Norway.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ziogas</LastName>
                    <ForeName>Argyrios</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-4529-3727</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology, Genetic Epidemiology Research Institute, University of California Irvine, 224 Irvine Hall, Irvine, CA, 92617, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zorn</LastName>
                    <ForeName>Kristin K</ForeName>
                    <Initials>KK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Magee-Womens Hospital, University of Pittsburgh School of Medicine, 300 Halket St, Pittsburgh, PA, 15213, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lane</LastName>
                    <ForeName>Jacqueline M</ForeName>
                    <Initials>JM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 75 Ames St, Cambridge, MA, 02142, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Center for Genomic Medicine and Department of Anasthesia, Massachusetts General Hospital, Boston, MA, 02114, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Saxena</LastName>
                    <ForeName>Richa</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 75 Ames St, Cambridge, MA, 02142, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Center for Genomic Medicine and Department of Anasthesia, Massachusetts General Hospital, Boston, MA, 02114, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Thomas</LastName>
                    <ForeName>Duncan</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 1975 Zonal Ave, Los Angeles, CA, 90033, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hung</LastName>
                    <ForeName>Rayjean J</ForeName>
                    <Initials>RJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Prosserman Centre for Population Health Research, Lunenfeld-Tanenbaum Research Institute, Sinai Health System, 60 Murray Street, Toronto, Ontario, M5T 3L9, Canada.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, 155 College Street, Toronto, ON, M5T3M7, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Diergaarde</LastName>
                    <ForeName>Brenda</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Human Genetics, Graduate School of Public Health, University of Pittsburgh, UPMC Cancer Pavilion, Suite 4C, Office # 467, 5150 Centre Avenue, Pittsburgh, PA, 15232, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>UPMC Hillman Cancer Center, Pittsburgh, 15232, PA, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>McKay</LastName>
                    <ForeName>James</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Genetic Cancer Susceptibility Group, International Agency for Research on Cancer, 150 cours Albert Thomas, 69008, Lyon, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Peters</LastName>
                    <ForeName>Ulrike</ForeName>
                    <Initials>U</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-5666-9318</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology, University of Washington School of Public Health, 1959 NE Pacific St, Seattle, WA, 98195, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hsu</LastName>
                    <ForeName>Li</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., Seattle, WA, 98109-1024, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>García-Closas</LastName>
                    <ForeName>Montserrat</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Dr, Rockville, MD, 20850, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Eeles</LastName>
                    <ForeName>Rosalind A</ForeName>
                    <Initials>RA</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-3698-6241</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Genetics and Epidemiology, The Institute of Cancer Research, 15 Cotswold Road, London, SM2 5NG, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Downs Road, Sutton, SM2 5NG, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chenevix-Trench</LastName>
                    <ForeName>Georgia</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, 300 Herston Road, Brisbane, QLD, 4006, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Brennan</LastName>
                    <ForeName>Paul J</ForeName>
                    <Initials>PJ</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-0518-8714</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Section of Genetics, International Agency for Research on Cancer, 150 cours Albert Thomas, 69008, Lyon, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Haiman</LastName>
                    <ForeName>Christopher A</ForeName>
                    <Initials>CA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, 48109, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Simard</LastName>
                    <ForeName>Jacques</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Genomics Center, Centre Hospitalier Universitaire de Québec - Université Laval Research Center, 2705 Laurier Boulevard, Québec City, QC, G1V4G2, Canada.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Easton</LastName>
                    <ForeName>Douglas F</ForeName>
                    <Initials>DF</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-2444-3247</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Worts' Causeway, Cambridge, CB1 8RN, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Worts' Causeway, Cambridge, CB1 8RN, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gruber</LastName>
                    <ForeName>Stephen B</ForeName>
                    <Initials>SB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 1975 Zonal Ave, Los Angeles, CA, 90033, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pharoah</LastName>
                    <ForeName>Paul D P</ForeName>
                    <Initials>PDP</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-8494-732X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, 2 Worts' Causeway, Cambridge, CB1 8RN, UK.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Worts' Causeway, Cambridge, CB1 8RN, UK.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Price</LastName>
                    <ForeName>Alkes L</ForeName>
                    <Initials>AL</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-2971-7975</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, 677 Huntington Ave, Boston, MA, 02115, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, 677 Huntington Ave, Boston, MA, 02115, USA.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, 75 Ames St, Cambridge, MA, 02142, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pasaniuc</LastName>
                    <ForeName>Bogdan</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>UCLA Path and Lab Med, University of California, 10833 Le Conte Ave, Los Angeles, CA, 190095, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Amos</LastName>
                    <ForeName>Christopher I</ForeName>
                    <Initials>CI</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, Epidemiology Section, Institute for Clinical and Translational Research, Baylor Medical College, One Baylor Plaza, MS: BCM451, Suite 100D, Houston, TX, 77030-3411, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kraft</LastName>
                    <ForeName>Peter</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, 677 Huntington Ave, Boston, MA, 02115, USA. pkraft@hsph.harvard.edu.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology, Harvard T.H. Chan School of Public Health, 677 Huntington Ave, Boston, MA, 02115, USA. pkraft@hsph.harvard.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lindström</LastName>
                    <ForeName>Sara</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Public Health Sciences Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., Seattle, WA, 98109-1024, USA. saralind@uw.edu.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Epidemiology, University of Washington School of Public Health, 1959 NE Pacific St, Seattle, WA, 98195, USA. saralind@uw.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016425">Published Erratum</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Nat Commun</MedlineTA>
            <NlmUniqueID>101528555</NlmUniqueID>
            <ISSNLinking>2041-1723</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="ErratumFor">
                <RefSource>Nat Commun. 2019 Jan 25;10(1):431</RefSource>
                <PMID Version="1">30683880</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31548585</ArticleId>
            <ArticleId IdType="doi">10.1038/s41467-019-12095-8</ArticleId>
            <ArticleId IdType="pii">10.1038/s41467-019-12095-8</ArticleId>
            <ArticleId IdType="pmc">PMC6757065</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31548577</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2045-2322</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                        <Day>23</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Scientific reports</Title>
                <ISOAbbreviation>Sci Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Low CYP24A1 mRNA expression and its role in prognosis of breast cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn>13714</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-019-50214-z</ELocationID>
            <Abstract>
                <AbstractText>Breast cancer is the most common malignant cancer in women. CYP24A1 expression regulates cellular response to vitamin D, which has antitumor effects against breast cancer. This study aimed to identify the correlation between CYP24A1 mRNA expression and prognosis of breast cancer. This study enrolled 1102 patients, including 1090 females and 12 males, from TCGA-BRCA cohort. The Cancer Genome Atlas database was used to study CYP24A1 mRNA expression in breast cancer, and Chi-squared tests were performed to test the correlation between clinical features and CYP24A1 expression. The prognostic value of CYP24A1 in breast cancer was assessed using Kaplan-Meier curves and Cox analysis. Low CYP24A1 expression was associated with age, molecular subtype, ER, PR, HER2, menopause status, N classification, vital status, overall survial and relapse-free survival. CYP24A1 presented a moderate diagnostic ability in breast cancer. Furthermore, low CYP24A1 expression was correlated with poor prognosis. CYP24A1 was an independent risk factor for breast cancer. CYP24A1 plays an important role in prognosis of breast cancer. CYP24A1 has the potential to be a biomarker, especially in predicting prognosis.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Cai</LastName>
                    <ForeName>Hongqiao</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of Jilin University, Changchun, Jilin, 130021, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jiao</LastName>
                    <ForeName>Yan</ForeName>
                    <Initials>Y</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-6914-7949</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of Jilin University, Changchun, Jilin, 130021, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Yanqing</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathophysiology, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, 130021, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Zhaoying</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Breast Surgery, China-Japan Union Hospital of Jilin University, 126 Xiantai Street, Changchun, 130033, P. R. China. zhaoyingyang@163.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>He</LastName>
                    <ForeName>Miao</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Anesthesia, The Second Hospital of Jilin University, Changchun, 130022, P. R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Yahui</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of Jilin University, Changchun, Jilin, 130021, P.R. China. liuyahui2008@yeah.net.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>2017Q035(ZY)</GrantID>
                    <Agency>Department of Science and Technology of Jilin Province (Jilin Province Science and Technology Department)</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Sci Rep</MedlineTA>
            <NlmUniqueID>101563288</NlmUniqueID>
            <ISSNLinking>2045-2322</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>04</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>09</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31548577</ArticleId>
            <ArticleId IdType="doi">10.1038/s41598-019-50214-z</ArticleId>
            <ArticleId IdType="pii">10.1038/s41598-019-50214-z</ArticleId>
            <ArticleId IdType="pmc">PMC6757028</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>BMC Cancer. 2010 Sep 11;10:483</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20831823</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Cancer. 2014 May;14(5):342-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24705652</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Cell Endocrinol. 2017 Sep 15;453:88-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28579119</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Anticancer Res. 2006 Jul-Aug;26(4A):2755-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16886688</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Anticancer Agents Med Chem. 2014 Jan;14(1):109-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23869778</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Ann Oncol. 2017 Feb 1;28(2):400-407</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27831506</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2019 Jan 29;14(1):e0211291</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30695070</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncol Rep. 2016 Nov;36(5):2755-2762</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27600601</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Anticancer Res. 2015 Feb;35(2):805-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25667460</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>JAMA Oncol. 2017 Aug 1;3(8):1138-1139</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28594965</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Manag Res. 2019 Apr 08;11:2795-2802</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31114333</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Thorac Oncol. 2017 Feb;12(2):269-280</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27793774</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Histochem Cytochem. 2010 Mar;58(3):277-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19901270</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Dig Dis Sci. 2019 Jan;64(1):137-143</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30284652</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Steroid Biochem Mol Biol. 2017 Oct;173:337-340</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28093352</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Hum Pathol. 2016 Apr;50:101-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26997443</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):76-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20398751</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Med Rep. 2017 Jan;15(1):467-473</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27922682</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Onco Targets Ther. 2019 May 27;12:4141-4152</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31213833</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>JAMA Oncol. 2017 Aug 1;3(8):1138</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28594987</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet Oncol. 2010 Feb;11(2):174-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20152769</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet. 2017 Mar 18;389(10074):1134-1150</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27865536</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Adv Clin Chem. 2015;71:1-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26411409</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Steroid Biochem Mol Biol. 2018 Mar;177:15-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28746837</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Manag Res. 2018 Nov 20;10:6003-6014</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30538549</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Medicine (Baltimore). 2019 May;98(19):e15698</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31083274</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Causes Control. 2014 Sep;25(9):1131-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24952509</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2019 Jan 3;380(1):33-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30415629</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PeerJ. 2019 Jun 11;7:e7070</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31218127</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31548566</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2045-2322</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                        <Day>23</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Scientific reports</Title>
                <ISOAbbreviation>Sci Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Mutation profiling of cancer drivers in Brazilian colorectal cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn>13687</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-019-49611-1</ELocationID>
            <Abstract>
                <AbstractText>The molecular basis of colorectal cancer (CRC) can guide patient prognosis and therapy. In Brazil, knowledge on the CRC mutation landscape is limited. Here, we investigated the mutation profile of 150 cancer-related genes by next-generation sequencing and associated with microsatellite instability (MSI) and genetic ancestry in a series of 91 Brazilian CRC patients. Driver mutations were found in the APC (71.4%), TP53 (56.0%), KRAS (52.7%), PIK3CA (15.4%) and FBXW7 (10.9%) genes. Overall, genes in the MAPK/ERK, PIK3/AKT, NOTCH and receptor tyrosine kinase signaling pathways were mutated in 68.0%, 23.1%, 16.5%, and 15.3% of patients, respectively. MSI was found in 13.3% of tumors, most of which were proximal (52.4%, P&lt; 0.001) and had a high mutation burden. European genetic ancestry was predominant (median of 83.1%), followed by Native American (4.1%), Asian (3.4%) and African (3.2%). NF1 and BRAF mutations were associated with African ancestry, while TP53 and PIK3CA mutations were inversely correlated with Native American ancestry. Our study suggests that Brazilian CRC patients exhibit a mutation profile similar to other populations and identify the most frequently mutated genes, which could be useful in future target therapies and molecular cancer screening strategies.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Dos Santos</LastName>
                    <ForeName>Wellington</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sobanski</LastName>
                    <ForeName>Thais</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>de Carvalho</LastName>
                    <ForeName>Ana Carolina</ForeName>
                    <Initials>AC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Evangelista</LastName>
                    <ForeName>Adriane Feijó</ForeName>
                    <Initials>AF</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-4731-2082</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Matsushita</LastName>
                    <ForeName>Marcus</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Barretos Cancer Hospital, Barretos, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Berardinelli</LastName>
                    <ForeName>Gustavo Nóriz</ForeName>
                    <Initials>GN</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>de Oliveira</LastName>
                    <ForeName>Marco Antonio</ForeName>
                    <Initials>MA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Reis</LastName>
                    <ForeName>Rui Manuel</ForeName>
                    <Initials>RM</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-9639-7940</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil. ruireis.hcb@gmail.com.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Life and Health Sciences Research Institute (ICVS), Medical School, University of Minho, Braga, 4710-057, Portugal. ruireis.hcb@gmail.com.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>3ICVS/3B's-PT Government Associate Laboratory, Braga, 4710-057, Portugal. ruireis.hcb@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Guimarães</LastName>
                    <ForeName>Denise Peixoto</ForeName>
                    <Initials>DP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil. guimaraes.dp@gmail.com.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Endoscopy, Barretos Cancer Hospital, Barretos, Brazil. guimaraes.dp@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Sci Rep</MedlineTA>
            <NlmUniqueID>101563288</NlmUniqueID>
            <ISSNLinking>2045-2322</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31548566</ArticleId>
            <ArticleId IdType="doi">10.1038/s41598-019-49611-1</ArticleId>
            <ArticleId IdType="pii">10.1038/s41598-019-49611-1</ArticleId>
            <ArticleId IdType="pmc">PMC6757044</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Bioinformatics. 2009 Jul 15;25(14):1754-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19451168</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2004 Oct 8;306(5694):269-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15472075</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Transl Gastroenterol. 2017 Oct 19;8(10):e124</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29048416</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Eur J Hum Genet. 2014 Jul;22(7):875-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24193342</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Med. 2015 Nov;21(11):1350-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26457759</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Clin Oncol. 2010 Jul 10;28(20):3219-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20498393</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2012 Aug 30;488(7413):660-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22895193</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2015 Dec 17;10(12):e0144456</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26680774</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Clin Oncol. 2013 Mar;10(3):143-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23400000</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>BMC Gastroenterol. 2014 Apr 10;14:73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24720724</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell. 2018 Apr 5;173(2):371-385.e18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29625053</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Br J Cancer. 2016 Jul 26;115(3):273-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27380134</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer. 2010 Nov 15;116(22):5207-18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20665495</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2012;7(1):e29684</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22272242</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2015 Jun 25;372(26):2509-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26028255</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Gastroenterol Hepatol. 2011 Feb;8(2):90-100</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21293509</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Genome Biol. 2016 Jun 06;17(1):122</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27268795</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>JCO Precis Oncol. 2017 Jul;2017:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28890946</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Cancer. 2002 Jul;2(7):489-501</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12094235</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Database (Oxford). 2011 Sep 19;2011:bar026</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21930502</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Cancer. 2014 Mar;14(3):173-86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24561444</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Trends Cancer. 2017 Mar;3(3):181-197</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28718431</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Genet. 2009 Oct;41(10):1127-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19718025</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Cell. 2018 Apr 9;33(4):721-735.e8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29622466</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Gastroenterology. 2010 Sep;139(3):929-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20638938</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Clin Oncol. 2005 Oct 20;23(30):7518-28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16172461</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Discov. 2016 Jan;6(1):36-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26546295</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2013 Jun 13;8(6):e65479</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23785428</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2002 Jun 27;417(6892):949-54</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12068308</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Cancer. 2014 Mar 1;134(5):1232-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23960014</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Cell. 2018 Mar 12;33(3):450-462.e10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29533785</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Gut. 2017 Apr;66(4):683-691</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26818619</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Ann Oncol. 2014 Oct;25(10):1995-2001</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25057166</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Clin Pathol. 2016 Sep;69(9):767-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26797410</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Gastroenterology. 2015 May;148(6):1244-60.e16</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25575572</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Cancer. 2008 Feb;8(2):83-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18094723</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Commun. 2014 Sep 10;5:4846</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25204415</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Exp Med. 2011 Feb 14;208(2):295-312</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21282377</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell. 2004 Mar 19;116(6):855-67</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15035987</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Genome Med. 2018 Mar 28;10(1):25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29592813</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncotarget. 2018 Jun 19;9(47):28691-28701</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29983889</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Gastrointest Oncol. 2016 Dec;7(6):882-902</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28078112</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mod Pathol. 2013 Jun;26(6):825-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23348904</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncotarget. 2017 Jun 13;8(24):39268-39279</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28424412</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Cancer. 2004 Jan;4(1):79-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14708028</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Med. 2019 May;8(5):2114-2122</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30897307</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Anticancer Res. 2018 Apr;38(4):2235-2240</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29599344</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2012 Jul 18;487(7407):330-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22810696</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncotarget. 2017 Sep 21;8(49):86356-86368</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29156800</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Epidemiol Biomarkers Prev. 2000 Nov;9(11):1193-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11097226</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Discov. 2016 Oct;6(10):1118-1133</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27432227</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Dis Esophagus. 2017 Apr 1;30(4):1-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28375484</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Cancer Res. 2018 Mar 1;24(5):1062-1072</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29180604</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Cell. 2013 May 13;23(5):603-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23680147</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Sci Signal. 2013 Apr 02;6(269):pl1</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23550210</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Natl Cancer Inst. 2017 Dec 1;109(12):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29370427</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Rep. 2016 Apr 26;15(4):857-865</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27149842</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncol Rep. 2014 Oct;32(4):1419-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25050586</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biomed Pharmacother. 2017 Jun;90:548-554</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28407575</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Dis Colon Rectum. 2010 Jan;53(1):57-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20010352</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Genome Res. 2012 Mar;22(3):568-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22300766</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Sci. 2009 May;100(5):920-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19445024</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Drugs. 2015 Oct;75(15):1739-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26347132</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Ecol Evol. 2018 Oct;2(10):1661-1672</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30177804</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>CA Cancer J Clin. 2018 Nov;68(6):394-424</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30207593</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Cancer Res. 2016 Dec 15;22(24):5983-5991</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27401242</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2007 Jul 26;448(7152):439-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17611497</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Discov. 2014 May;4(5):554-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24631838</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Br J Cancer. 2009 Aug 18;101(4):715-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19603018</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2017 Aug 10;548(7666):234-238</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28783719</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncotarget. 2018 Jun 8;9(44):27412-27422</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29937994</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31548545</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2056-676X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>5</Volume>
                    <Issue>1</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                        <Day>23</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Nature reviews. Disease primers</Title>
                <ISOAbbreviation>Nat Rev Dis Primers</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Breast cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn>66</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41572-019-0111-2</ELocationID>
            <Abstract>
                <AbstractText>Breast cancer is the most frequent malignancy in women worldwide and is curable in ~70-80% of patients with early-stage, non-metastatic disease. Advanced breast cancer with distant organ metastases is considered incurable with currently available therapies. On the molecular level, breast cancer is a heterogeneous disease; molecular features include activation of human epidermal growth factor receptor 2 (HER2, encoded by ERBB2), activation of hormone receptors (oestrogen receptor and progesterone receptor) and/or BRCA mutations. Treatment strategies differ according to molecular subtype. Management of breast cancer is multidisciplinary; it includes locoregional (surgery and radiation therapy) and systemic therapy approaches. Systemic therapies include endocrine therapy for hormone receptor-positive disease, chemotherapy, anti-HER2 therapy for HER2-positive disease, bone stabilizing agents, poly(ADP-ribose) polymerase inhibitors for BRCA mutation carriers and, quite recently, immunotherapy. Future therapeutic concepts in breast cancer aim at individualization of therapy as well as at treatment de-escalation and escalation based on tumour biology and early therapy response. Next to further treatment innovations, equal worldwide access to therapeutic advances remains the global challenge in breast cancer care for the future.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Harbeck</LastName>
                    <ForeName>Nadia</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>LMU Munich, University Hospital, Department of Obstetrics and Gynecology, Breast Center and Comprehensive Cancer Center (CCLMU), Munich, Germany. nadia.harbeck@med.uni-muenchen.de.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Penault-Llorca</LastName>
                    <ForeName>Frédérique</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre, UMR INSERM 1240, University Clermont Auvergne, Clermont-Ferrand, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cortes</LastName>
                    <ForeName>Javier</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>IOB Institute of Oncology, Quironsalud Group, Madrid and Barcelona, Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Vall d´Hebron Institute of Oncology, Barcelona, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gnant</LastName>
                    <ForeName>Michael</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Houssami</LastName>
                    <ForeName>Nehmat</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sydney School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Poortmans</LastName>
                    <ForeName>Philip</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Radiation Oncology, Institut Curie, Paris, France.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Université PSL, Paris, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ruddy</LastName>
                    <ForeName>Kathryn</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Oncology, Mayo Clinic, Rochester, MN, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tsang</LastName>
                    <ForeName>Janice</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hong Kong Breast Oncology Group, The University of Hong Kong, Hong Kong, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cardoso</LastName>
                    <ForeName>Fatima</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Nat Rev Dis Primers</MedlineTA>
            <NlmUniqueID>101672103</NlmUniqueID>
            <ISSNLinking>2056-676X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31548545</ArticleId>
            <ArticleId IdType="doi">10.1038/s41572-019-0111-2</ArticleId>
            <ArticleId IdType="pii">10.1038/s41572-019-0111-2</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31548433</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1945-4589</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>11</Volume>
                    <Issue>18</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                        <Day>23</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Aging</Title>
                <ISOAbbreviation>Aging (Albany NY)</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Identification of a novel microRNA recurrence-related signature and risk stratification system in breast cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn>7525-7536</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.18632/aging.102268</ELocationID>
            <Abstract>
                <AbstractText>Increasing evidence has revealed that microRNAs (miRNAs) play vital roles in breast cancer (BC) prognosis. Thus, we aimed to identify recurrence-related miRNAs and establish accurate risk stratification system in BC patients. A total of 381 differentially expressed miRNAs were confirmed by analyzing 1044 BC tissues and 102 adjacent normal samples from The Cancer Genome Atlas (TCGA). Then, based on the association between each miRNAs and disease-free survival (DFS), we identified miRNA recurrence-related signature to construct a novel prognostic nomogram using Cox regression model. Target genes of the four miRNAs were analyzed via Gene Ontology and KEGG pathway analyses. Time-dependent receiver operating characteristic analysis indicated that a combination of the miRNA signature and tumor-node-metastasis (TNM) stage had better predictive performance than that of TNM stage (0.710 vs 0.616, <i>P</i>&lt;0.0001). Furthermore, risk stratification analysis suggested that the miRNA-based model could significantly classify patients into the high- and low-risk groups in the two cohorts (all <i>P</i>&lt;0.0001), and was independent of other clinical features. Functional enrichment analysis demonstrated that the 46 target genes mainly enrichment in important cell biological processes, protein binding and cancer-related pathways. The miRNA-based prognostic model may facilitate individualized treatment decisions for BC patients.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lai</LastName>
                    <ForeName>Jianguo</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Bo</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Guochun</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Yulei</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mok</LastName>
                    <ForeName>Hsiaopei</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wen</LastName>
                    <ForeName>Lingzhu</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pan</LastName>
                    <ForeName>Zihao</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Thoracic Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Su</LastName>
                    <ForeName>Fengxi</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liao</LastName>
                    <ForeName>Ning</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Aging (Albany NY)</MedlineTA>
            <NlmUniqueID>101508617</NlmUniqueID>
            <ISSNLinking>1945-4589</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">breast cancer</Keyword>
            <Keyword MajorTopicYN="N">microRNA</Keyword>
            <Keyword MajorTopicYN="N">model</Keyword>
            <Keyword MajorTopicYN="N">recurrence</Keyword>
            <Keyword MajorTopicYN="N">survival</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31548433</ArticleId>
            <ArticleId IdType="pii">102268</ArticleId>
            <ArticleId IdType="doi">10.18632/aging.102268</ArticleId>
            <ArticleId IdType="pmc">PMC6781975</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Transl Med. 2014 Jun 04;12:159</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24893932</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet Oncol. 2015 Apr;16(4):e173-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25846097</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Oncol. 2018 Dec;12(12):2072-2084</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30242969</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Ann Surg Oncol. 2018 Dec;25(13):4037-4046</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30311168</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Carcinogenesis. 2014 Dec;35(12):2756-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25322872</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet Oncol. 2016 Aug;17(8):1137-1146</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27402147</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nucleic Acids Res. 2015 Jan;43(Database issue):D146-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25378301</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Breast Cancer Res. 2018 Jul 11;20(1):72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29996899</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>BMC Genomics. 2015 Sep 29;16:735</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26416693</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>EBioMedicine. 2018 Sep;35:189-197</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30166271</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Ann Surg Oncol. 2014 Sep;21(9):2928-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24743910</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Cancer. 2006 Apr;6(4):259-69</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16557279</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Oncol. 2012 Aug;6(4):445-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22552153</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nucleic Acids Res. 2018 Jan 4;46(D1):D296-D302</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29126174</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Res. 2011 Sep 1;71(17):5635-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21737487</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>EBioMedicine. 2016 Sep;11:199-209</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27566954</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Manag Res. 2018 Dec 21;11:179-190</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30613165</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Cell Biochem. 2019 Mar;120(3):3958-3968</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30242879</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncotarget. 2016 Aug 23;7(34):55231-55248</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27409424</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet Oncol. 2018 Mar;19(3):382-393</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29428165</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biomed Pharmacother. 2019 Aug;116:108997</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31146111</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2014 Mar 14;9(3):e91884</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24632820</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet Oncol. 2012 Jun;13(6):633-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22560814</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nucleic Acids Res. 2009 Jan;37(1):1-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19033363</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Clin Oncol. 2008 Mar 10;26(8):1364-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18323559</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Elife. 2015 Aug 12;4:null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26267216</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Cancer Res. 2004 Nov 1;10(21):7252-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15534099</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Cancer. 2014 Mar 15;134(6):1359-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23999999</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>CA Cancer J Clin. 2018 Nov;68(6):394-424</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30207593</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Ann Transl Med. 2019 Apr;7(8):179</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31168460</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell. 2004 Jan 23;116(2):281-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14744438</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2005 Oct 27;353(17):1784-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16251534</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Sci Rep. 2018 Apr 18;8(1):6157</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29670141</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biometrics. 2000 Jun;56(2):337-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10877287</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Br J Cancer. 2017 Jan 3;116(1):77-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27907930</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Oncol. 2018 Jun;12(7):1125-1137</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29719937</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Cancer. 2013 Jun 15;132(12):2901-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23175214</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet Oncol. 2013 Dec;14(13):1295-306</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24239208</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31548432</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1091-6490</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>116</Volume>
                    <Issue>41</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>08</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Proceedings of the National Academy of Sciences of the United States of America</Title>
                <ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Aldh1b1 expression defines progenitor cells in the adult pancreas and is required for Kras-induced pancreatic cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn>20679-20688</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1901075116</ELocationID>
            <Abstract>
                <AbstractText>The presence of progenitor or stem cells in the adult pancreas and their potential involvement in homeostasis and cancer development remain unresolved issues. Here, we show that mouse centroacinar cells can be identified and isolated by virtue of the mitochondrial enzyme Aldh1b1 that they uniquely express. These cells are necessary and sufficient for the formation of self-renewing adult pancreatic organoids in an Aldh1b1-dependent manner. Aldh1b1-expressing centroacinar cells are largely quiescent, self-renew, and, as shown by genetic lineage tracing, contribute to all 3 pancreatic lineages in the adult organ under homeostatic conditions. Single-cell RNA sequencing analysis of these cells identified a progenitor cell population, established its molecular signature, and determined distinct differentiation pathways to early progenitors. A distinct feature of these progenitor cells is the preferential expression of small GTPases, including Kras, suggesting that they might be susceptible to Kras-driven oncogenic transformation. This finding and the overexpression of Aldh1b1 in human and mouse pancreatic cancers, driven by activated Kras, prompted us to examine the involvement of Aldh1b1 in oncogenesis. We demonstrated genetically that ablation of <i>Aldh1b1</i> completely abrogates tumor development in a mouse model of Kras<sup>G12D</sup>-induced pancreatic cancer.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Mameishvili</LastName>
                    <ForeName>Ekaterina</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Paul Langerhans Institute Dresden, Helmholtz Center Munich at the University Clinic Carl Gustav Carus of Technische Universität Dresden, German Research Center for Environmental Health, Helmholtz Zentrum München, D-85764 Neuherberg, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>German Centre for Diabetes Research (DZD e.V.), D-85764 Neuherberg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Serafimidis</LastName>
                    <ForeName>Ioannis</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Biomedical Research Foundation of the Academy of Athens, 115 27 Athens, Greece.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Iwaszkiewicz</LastName>
                    <ForeName>Sara</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Paul Langerhans Institute Dresden, Helmholtz Center Munich at the University Clinic Carl Gustav Carus of Technische Universität Dresden, German Research Center for Environmental Health, Helmholtz Zentrum München, D-85764 Neuherberg, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>German Centre for Diabetes Research (DZD e.V.), D-85764 Neuherberg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lesche</LastName>
                    <ForeName>Mathias</ForeName>
                    <Initials>M</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-3274-7163</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Paul Langerhans Institute Dresden, Helmholtz Center Munich at the University Clinic Carl Gustav Carus of Technische Universität Dresden, German Research Center for Environmental Health, Helmholtz Zentrum München, D-85764 Neuherberg, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>German Centre for Diabetes Research (DZD e.V.), D-85764 Neuherberg, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Biotechnology Center, Technische Universität Dresden, 01307 Dresden, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Reinhardt</LastName>
                    <ForeName>Susanne</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Biotechnology Center, Technische Universität Dresden, 01307 Dresden, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bölicke</LastName>
                    <ForeName>Nora</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Paul Langerhans Institute Dresden, Helmholtz Center Munich at the University Clinic Carl Gustav Carus of Technische Universität Dresden, German Research Center for Environmental Health, Helmholtz Zentrum München, D-85764 Neuherberg, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Center for Regenerative Therapies Dresden, Faculty of Medicine, Technische Universität Dresden, 01307 Dresden, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Büttner</LastName>
                    <ForeName>Maren</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Computational Biology, German Research Center for Environmental Health, Helmholtz Zentrum München, D-85764 Neuherberg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stellas</LastName>
                    <ForeName>Dimitris</ForeName>
                    <Initials>D</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-9587-6288</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Biomedical Research Foundation of the Academy of Athens, 115 27 Athens, Greece.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Papadimitropoulou</LastName>
                    <ForeName>Adriana</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Biomedical Research Foundation of the Academy of Athens, 115 27 Athens, Greece.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Szabolcs</LastName>
                    <ForeName>Matthias</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology and Cell Biology, Columbia University Medical Center, NY 10032.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Anastassiadis</LastName>
                    <ForeName>Konstantinos</ForeName>
                    <Initials>K</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-9814-0559</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Biotechnology Center, Technische Universität Dresden, 01307 Dresden, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dahl</LastName>
                    <ForeName>Andreas</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Biotechnology Center, Technische Universität Dresden, 01307 Dresden, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Theis</LastName>
                    <ForeName>Fabian</ForeName>
                    <Initials>F</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-2419-1943</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute of Computational Biology, German Research Center for Environmental Health, Helmholtz Zentrum München, D-85764 Neuherberg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Efstratiadis</LastName>
                    <ForeName>Argiris</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Biomedical Research Foundation of the Academy of Athens, 115 27 Athens, Greece.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gavalas</LastName>
                    <ForeName>Anthony</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Paul Langerhans Institute Dresden, Helmholtz Center Munich at the University Clinic Carl Gustav Carus of Technische Universität Dresden, German Research Center for Environmental Health, Helmholtz Zentrum München, D-85764 Neuherberg, Germany; anthony.gavalas@tu-dresden.de.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>German Centre for Diabetes Research (DZD e.V.), D-85764 Neuherberg, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Center for Regenerative Therapies Dresden, Faculty of Medicine, Technische Universität Dresden, 01307 Dresden, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Proc Natl Acad Sci U S A</MedlineTA>
            <NlmUniqueID>7505876</NlmUniqueID>
            <ISSNLinking>0027-8424</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">adult stem and progenitor cells</Keyword>
            <Keyword MajorTopicYN="N">aldehyde dehydrogenase</Keyword>
            <Keyword MajorTopicYN="N">organoids</Keyword>
            <Keyword MajorTopicYN="N">pancreatic ductal adenocarcinoma</Keyword>
            <Keyword MajorTopicYN="N">single-cell RNA sequencing</Keyword>
        </KeywordList>
        <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pmc-release">
                <Year>2020</Year>
                <Month>03</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31548432</ArticleId>
            <ArticleId IdType="pii">1901075116</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.1901075116</ArticleId>
            <ArticleId IdType="pmc">PMC6789925</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Stem Cell Reports. 2018 Mar 13;10(3):712-724</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29539434</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Free Radic Biol Med. 2013 Mar;56:89-101</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23195683</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Bioinformatics. 2016 Apr 15;32(8):1241-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26668002</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Immunity. 2013 Apr 18;38(4):792-804</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23601688</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Stem Cell. 2010 Sep 3;7(3):279-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20804964</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Cell. 2003 Jun;3(6):565-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12842085</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Dev Cell. 2009 Dec;17(6):849-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20059954</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19915-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19052237</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Rep. 2016 Mar 15;14(10):2325-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26947075</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Stem Cell. 2014 Aug 7;15(2):139-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25105579</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Protoc. 2016 Sep;11(9):1724-43</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27560176</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Syst. 2016 Oct 26;3(4):346-360.e4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27667365</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Stem Cell. 2016 Apr 7;18(4):441-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27058937</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Methods. 2017 May;14(5):483-486</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28346451</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Development. 2011 Feb;138(4):653-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21266405</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Methods. 2013 Nov;10(11):1096-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24056875</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Gut. 2014 Apr;63(4):656-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23645620</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2011;6(6):e20636</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21695188</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Genes Dev. 2014 Jan 1;28(1):85-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24395249</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18907-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19028876</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Diabetes. 2015 Oct;64(10):3499-509</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26153247</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2016 Mar 3;531(7592):47-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26909576</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Dis Primers. 2016 Apr 21;2:16022</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27158978</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Gastroenterology. 2018 Jul;155(1):194-209.e2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29604291</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Stem Cells. 2019 May;37(5):640-651</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30681750</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell. 2008 Jan 25;132(2):197-207</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18243096</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Cell. 2007 Mar;11(3):291-302</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17349585</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Pancreas. 2016 Jan;45(1):117-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26566217</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Natl Cancer Inst. 2014 Nov 27;106(12):null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25430851</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Cell. 2005 Sep;8(3):185-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16169464</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Hum Genomics. 2011 May;5(4):283-303</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21712190</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Natl Cancer Inst. 2014 Oct 11;106(12):null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25306215</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Gastroenterology. 2018 Apr;154(5):1509-1523.e5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29273451</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Biol Toxicol. 2019 Apr;35(2):161-177</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30220009</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>EMBO J. 2014 Sep 17;33(18):2057-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25092767</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2010 Apr 30;328(5978):593-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20360068</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Diabetologia. 2016 Mar;59(3):522-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26693711</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Metab. 2015 Oct 6;22(4):590-605</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26365176</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Annu Rev Physiol. 2015;77:229-49</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25386992</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Semin Cell Dev Biol. 2012 Aug;23(6):711-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22743232</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>EMBO J. 2013 Oct 16;32(20):2708-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24045232</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Stem Cell Reports. 2018 Mar 13;10(3):725-738</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29478894</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Biotechnol. 2014 Jan;32(1):76-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24240391</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Development. 2011 Feb;138(3):431-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21205788</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Methods. 2016 Oct;13(10):845-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27571553</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Gastroenterol Hepatol. 2017 May;14(5):296-304</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28270694</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Elife. 2015 Jul 07;4:null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26151762</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Dev Biol. 2013 Feb 1;374(1):153-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23142317</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2016 Jun 06;534(7607):407-411</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27281208</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Gastroenterology. 2009 Apr;136(4):1368-78</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19249398</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Genes Dev. 2003 Dec 15;17(24):3112-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14681207</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Elife. 2013 Nov 19;2:e00940</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24252877</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Drug Metab Dispos. 2010 Oct;38(10):1679-87</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20616185</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2008 Oct 2;455(7213):627-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18754011</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):75-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20018761</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18913-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19028870</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Dev Biol. 2016 May 1;413(1):8-15</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26963675</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Cell. 2003 Dec;4(6):437-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14706336</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Dev Cell. 2016 Nov 7;39(3):289-301</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27923766</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Stem Cells. 2011 Apr;29(4):570-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21308868</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Diabetologia. 2016 Jan;59(1):139-150</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26518685</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Development. 2013 Feb;140(4):751-64</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23325761</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Cell. 2012 Dec 11;22(6):737-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23201164</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Cell Biol. 2016 Mar;18(3):238-45</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26911907</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31548407</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1091-6490</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>116</Volume>
                    <Issue>41</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>08</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Proceedings of the National Academy of Sciences of the United States of America</Title>
                <ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Cell division rates decrease with age, providing a potential explanation for the age-dependent deceleration in cancer incidence.</ArticleTitle>
            <Pagination>
                <MedlinePgn>20482-20488</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1905722116</ELocationID>
            <Abstract>
                <AbstractText>A new evaluation of previously published data suggested to us that the accumulation of mutations might slow, rather than increase, as individuals age. To explain this unexpected finding, we hypothesized that normal stem cell division rates might decrease as we age. To test this hypothesis, we evaluated cell division rates in the epithelium of human colonic, duodenal, esophageal, and posterior ethmoid sinonasal tissues. In all 4 tissues, there was a significant decrease in cell division rates with age. In contrast, cell division rates did not decrease in the colon of aged mice, and only small decreases were observed in their small intestine or esophagus. These results have important implications for understanding the relationship between normal stem cells, aging, and cancer. Moreover, they provide a plausible explanation for the enigmatic age-dependent deceleration in cancer incidence in very old humans but not in mice.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Tomasetti</LastName>
                    <ForeName>Cristian</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Biostatistics and Bioinformatics, Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21205; bertvog@gmail.com ctomasetti@jhu.edu.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21205.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Poling</LastName>
                    <ForeName>Justin</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pathology, Williamson Medical Center, Brentwood, TN 37207.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Roberts</LastName>
                    <ForeName>Nicholas J</ForeName>
                    <Initials>NJ</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-8709-0664</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21205.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University, Baltimore, MD 21231.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>London</LastName>
                    <ForeName>Nyall R</ForeName>
                    <Initials>NR</Initials>
                    <Suffix>Jr</Suffix>
                    <AffiliationInfo>
                        <Affiliation>Department of Otolaryngology, Johns Hopkins University School of Medicine, Baltimore, MD 21205.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pittman</LastName>
                    <ForeName>Meredith E</ForeName>
                    <Initials>ME</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Haffner</LastName>
                    <ForeName>Michael C</ForeName>
                    <Initials>MC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21205.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, The Johns Hopkins University, Baltimore, MD 21231.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rizzo</LastName>
                    <ForeName>Anthony</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, The Johns Hopkins University, Baltimore, MD 21231.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Baras</LastName>
                    <ForeName>Alex</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, The Johns Hopkins University, Baltimore, MD 21231.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Karim</LastName>
                    <ForeName>Baktiar</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pathology &amp; Histotechnology Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Antonio</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21205.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Heaphy</LastName>
                    <ForeName>Christopher M</ForeName>
                    <Initials>CM</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-4264-1810</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21205.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, The Johns Hopkins University, Baltimore, MD 21231.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Meeker</LastName>
                    <ForeName>Alan K</ForeName>
                    <Initials>AK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21205.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, The Johns Hopkins University, Baltimore, MD 21231.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hruban</LastName>
                    <ForeName>Ralph H</ForeName>
                    <Initials>RH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21205.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University, Baltimore, MD 21231.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, The Johns Hopkins University, Baltimore, MD 21231.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Ludwig Center, Johns Hopkins University School of Medicine, Baltimore, MD 21205.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Howard Hughes Medical Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21205.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Iacobuzio-Donahue</LastName>
                    <ForeName>Christine A</ForeName>
                    <Initials>CA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Rubenstein Center for Pancreatic Cancer Research, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vogelstein</LastName>
                    <ForeName>Bert</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21205; bertvog@gmail.com ctomasetti@jhu.edu.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Ludwig Center, Johns Hopkins University School of Medicine, Baltimore, MD 21205.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Howard Hughes Medical Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21205.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Proc Natl Acad Sci U S A</MedlineTA>
            <NlmUniqueID>7505876</NlmUniqueID>
            <ISSNLinking>0027-8424</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">aging</Keyword>
            <Keyword MajorTopicYN="N">cancer</Keyword>
            <Keyword MajorTopicYN="N">cell division</Keyword>
            <Keyword MajorTopicYN="N">mutation rate</Keyword>
        </KeywordList>
        <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pmc-release">
                <Year>2020</Year>
                <Month>03</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31548407</ArticleId>
            <ArticleId IdType="pii">1905722116</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.1905722116</ArticleId>
            <ArticleId IdType="pmc">PMC6789572</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Exp Cell Res. 1995 Apr;217(2):317-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7698231</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Gerontol. 1972 Apr;27(2):162-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">5060717</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2015 Jan 2;347(6217):78-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25554788</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Cancer. 1969 Jan 15;4(1):93-112</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">5346480</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer. 1988 Dec 1;62(11):2373-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3179952</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Pathol. 2007 Jan;211(2):114-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17200948</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Res. 2005 Sep 15;65(18):8111-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16166284</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Humangenetik. 1972;16(1):87-110</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">4647448</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Stem Cell. 2012 Oct 5;11(4):452-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23040474</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 1998 May 8;280(5365):855-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9599158</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Demography. 1998 Nov;35(4):391-412</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9850465</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mutat Res. 1994 Jan;304(1):33-105</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7506357</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell. 2012 Jul 20;150(2):264-78</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22817890</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):1999-2004</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23345422</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2014 May 9;344(6184):649-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24797481</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc R Soc Lond B Biol Sci. 1965 Apr 13;162:223-39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14282645</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Br J Cancer. 1954 Mar;8(1):1-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">13172380</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Br J Cancer. 1953 Mar;7(1):68-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">13051507</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Popul Stud (Camb). 2015;69(1):7-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25396304</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2015 Feb 13;347(6223):729-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25678653</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Commun. 2016 Aug 12;7:12157</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27515585</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Gerontology. 2002 Jul-Aug;48(4):204-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12053108</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mech Ageing Dev. 1998 Aug 1;104(1):1-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9751428</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2017 Aug 9;548(7666):E13-E14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28796214</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Toxicol Ind Health. 2011 Apr;27(3):265-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20947655</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Annu Rev Genet. 1990;24:305-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">2088171</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2017 Mar 24;355(6331):1330-1334</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28336671</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2013 Nov 21;503(7476):392-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24141946</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Stem Cell. 2015 Feb 5;16(2):111-2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25658366</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Chromosoma. 1997 Nov;106(6):348-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9362543</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Genetics. 1998 Apr;148(4):1667-86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9560386</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biogerontology. 2013 Dec;14(6):573-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24085521</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell. 2005 Dec 16;123(6):1121-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16360040</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2017 May 16;12(5):e0175535</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28520721</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Aging Cell. 2008 Mar;7(2):250-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18221414</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31548401</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1091-6490</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>116</Volume>
                    <Issue>41</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>08</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Proceedings of the National Academy of Sciences of the United States of America</Title>
                <ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The structure of the colorectal cancer-associated enzyme GalNAc-T12 reveals how nonconserved residues dictate its function.</ArticleTitle>
            <Pagination>
                <MedlinePgn>20404-20410</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1902211116</ELocationID>
            <Abstract>
                <AbstractText>Polypeptide <i>N-</i>acetylgalactosaminyl transferases (GalNAc-Ts) initiate mucin type <i>O</i>-glycosylation by catalyzing the transfer of <i>N</i>-acetylgalactosamine (GalNAc) to Ser or Thr on a protein substrate. Inactive and partially active variants of the isoenzyme GalNAc-T12 are present in subsets of patients with colorectal cancer, and several of these variants alter nonconserved residues with unknown functions. While previous biochemical studies have demonstrated that GalNAc-T12 selects for peptide and glycopeptide substrates through unique interactions with its catalytic and lectin domains, the molecular basis for this distinct substrate selectivity remains elusive. Here we examine the molecular basis of the activity and substrate selectivity of GalNAc-T12. The X-ray crystal structure of GalNAc-T12 in complex with a di-glycosylated peptide substrate reveals how a nonconserved GalNAc binding pocket in the GalNAc-T12 catalytic domain dictates its unique substrate selectivity. In addition, the structure provides insight into how colorectal cancer mutations disrupt the activity of GalNAc-T12 and illustrates how the rules dictating GalNAc-T12 function are distinct from those for other GalNAc-Ts.</AbstractText>
                <CopyrightInformation>Copyright © 2019 the Author(s). Published by PNAS.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Fernandez</LastName>
                    <ForeName>Amy J</ForeName>
                    <Initials>AJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Section on Biological Chemistry, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Daniel</LastName>
                    <ForeName>Earnest James Paul</ForeName>
                    <Initials>EJP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biochemistry, Case Western Reserve University, Cleveland, OH 44106.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mahajan</LastName>
                    <ForeName>Sai Pooja</ForeName>
                    <Initials>SP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Chemical and Biomolecular Engineering, The Johns Hopkins University, Baltimore, MD 21218.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gray</LastName>
                    <ForeName>Jeffrey J</ForeName>
                    <Initials>JJ</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-6380-2324</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Chemical and Biomolecular Engineering, The Johns Hopkins University, Baltimore, MD 21218.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Program in Molecular Biophysics, The Johns Hopkins University, Baltimore, MD 21218.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gerken</LastName>
                    <ForeName>Thomas A</ForeName>
                    <Initials>TA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biochemistry, Case Western Reserve University, Cleveland, OH 44106.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Chemistry, Case Western Reserve University, Cleveland, OH 44106.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tabak</LastName>
                    <ForeName>Lawrence A</ForeName>
                    <Initials>LA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Section on Biological Chemistry, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Samara</LastName>
                    <ForeName>Nadine L</ForeName>
                    <Initials>NL</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-7152-2939</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Structural Biochemistry Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, 20892 nadine.samara@nih.gov.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <DataBankList CompleteYN="Y">
                <DataBank>
                    <DataBankName>PDB</DataBankName>
                    <AccessionNumberList>
                        <AccessionNumber>6PXU</AccessionNumber>
                    </AccessionNumberList>
                </DataBank>
            </DataBankList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Proc Natl Acad Sci U S A</MedlineTA>
            <NlmUniqueID>7505876</NlmUniqueID>
            <ISSNLinking>0027-8424</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">GalNAc-Ts</Keyword>
            <Keyword MajorTopicYN="N">colorectal cancer</Keyword>
            <Keyword MajorTopicYN="N">enzyme catalysis</Keyword>
            <Keyword MajorTopicYN="N">mucin-type O-glycosylation</Keyword>
            <Keyword MajorTopicYN="N">substrate selectivity</Keyword>
        </KeywordList>
        <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31548401</ArticleId>
            <ArticleId IdType="pii">1902211116</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.1902211116</ArticleId>
            <ArticleId IdType="pmc">PMC6789641</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>J Biol Chem. 2011 Apr 22;286(16):14493-507</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21349845</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Glycoconj J. 2009 Apr;26(3):325-34</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18695988</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Cell Proteomics. 2014 Feb;13(2):397-406</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24309898</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Glycobiology. 2003 Jan;13(1):1R-16R</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12634319</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Diseases. 2018 Dec 11;6(4):null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30544946</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Gastroenterology. 2016 Jul;151(1):152-164.e11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27059389</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Glycobiology. 2016 Apr;26(4):360-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26610890</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Glycobiology. 2012 Jun;22(6):736-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22183981</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Biol Chem. 2017 Dec 29;292(52):21304-21319</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29061849</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12921-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19617566</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Gastrointest Oncol. 2018 Aug;9(4):769-777</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30151274</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Biol Chem. 1999 Mar 5;274(10):6797-803</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10037781</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Mol Sci. 2017 Jun 20;18(6):null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28632155</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Ecancermedicalscience. 2018 Sep 05;12:865</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30263056</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncology. 2004;67(3-4):271-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15557789</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Clin Gastroenterol. 2019 Jul;53(6):434-440</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29782466</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biomolecules. 2016 Jul 11;6(3):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27409642</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Biol Chem. 2013 Jul 5;288(27):19900-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23689369</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Mol Biol. 2006 Jun 9;359(3):708-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16650853</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Hum Mutat. 2018 Aug;39(8):1092-1101</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29749045</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Hum Mutat. 2012 Jul;33(7):1056-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22461326</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Chemistry. 2018 Jun 12;24(33):8382-8392</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29601100</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Commun. 2017 Dec 5;8(1):1959</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29208955</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Biol Chem. 2006 Mar 31;281(13):8613-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16434399</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Biol Chem. 2008 Aug 22;283(34):22942-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18562306</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>ACS Cent Sci. 2018 Sep 26;4(9):1274-1290</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30276263</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Adv Cancer Res. 2015;126:53-135</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25727146</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Commun. 2018 Aug 29;9(1):3508</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30158631</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Mol Biol. 2007 Oct 19;373(2):439-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17850816</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31548386</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>08</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1091-6490</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>116</Volume>
                    <Issue>44</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>29</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Proceedings of the National Academy of Sciences of the United States of America</Title>
                <ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Discovering long noncoding RNA predictors of anticancer drug sensitivity beyond protein-coding genes.</ArticleTitle>
            <Pagination>
                <MedlinePgn>22020-22029</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1909998116</ELocationID>
            <Abstract>
                <AbstractText>Large-scale cancer cell line screens have identified thousands of protein-coding genes (PCGs) as biomarkers of anticancer drug response. However, systematic evaluation of long noncoding RNAs (lncRNAs) as pharmacogenomic biomarkers has so far proven challenging. Here, we study the contribution of lncRNAs as drug response predictors beyond spurious associations driven by correlations with proximal PCGs, tissue lineage, or established biomarkers. We show that, as a whole, the lncRNA transcriptome is equally potent as the PCG transcriptome at predicting response to hundreds of anticancer drugs. Analysis of individual lncRNAs transcripts associated with drug response reveals nearly half of the significant associations are in fact attributable to proximal <i>cis</i>-PCGs. However, adjusting for effects of <i>cis-</i>PCGs revealed significant lncRNAs that augment drug response predictions for most drugs, including those with well-established clinical biomarkers. In addition, we identify lncRNA-specific somatic alterations associated with drug response by adopting a statistical approach to determine lncRNAs carrying somatic mutations that undergo positive selection in cancer cells. Lastly, we experimentally demonstrate that 2 lncRNAs, <i>EGFR-AS1</i> and <i>MIR205HG,</i> are functionally relevant predictors of anti-epidermal growth factor receptor (EGFR) drug response.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Nath</LastName>
                    <ForeName>Aritro</ForeName>
                    <Initials>A</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-3225-4203</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Experimental and Clinical Pharmacology, University of Minnesota Minneapolis, MN 55455.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lau</LastName>
                    <ForeName>Eunice Y T</ForeName>
                    <Initials>EYT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong SAR, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Adam M</ForeName>
                    <Initials>AM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Experimental and Clinical Pharmacology, University of Minnesota Minneapolis, MN 55455.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Geeleher</LastName>
                    <ForeName>Paul</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Computational Biology, St. Jude Children's Research Hospital Memphis, TN 38105.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cho</LastName>
                    <ForeName>William C S</ForeName>
                    <Initials>WCS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong SAR, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huang</LastName>
                    <ForeName>R Stephanie</ForeName>
                    <Initials>RS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Experimental and Clinical Pharmacology, University of Minnesota Minneapolis, MN 55455; rshuang@umn.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Proc Natl Acad Sci U S A</MedlineTA>
            <NlmUniqueID>7505876</NlmUniqueID>
            <ISSNLinking>0027-8424</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">drug response prediction</Keyword>
            <Keyword MajorTopicYN="N">long noncoding RNA</Keyword>
            <Keyword MajorTopicYN="N">machine learning</Keyword>
            <Keyword MajorTopicYN="N">pharmacogenomics</Keyword>
        </KeywordList>
        <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pmc-release">
                <Year>2020</Year>
                <Month>03</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31548386</ArticleId>
            <ArticleId IdType="pii">1909998116</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.1909998116</ArticleId>
            <ArticleId IdType="pmc">PMC6825320</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Cell. 2011 Sep 16;43(6):904-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21925379</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Struct Mol Biol. 2015 Jan;22(1):5-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25565026</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nucleic Acids Res. 2015 Jan;43(Database issue):D168-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25332394</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2012 Mar 28;483(7391):603-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22460905</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Genes Dev. 2008 Mar 15;22(6):756-69</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18347095</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Sci Rep. 2015 Jul 08;5:11924</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26152796</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Sci Rep. 2015 May 11;5:10159</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25959498</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Cancer Res. 2017 Jul;15(7):789-799</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28396462</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Br J Cancer. 2010 Oct 12;103(8):1284-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20859285</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2012 Sep 6;489(7414):101-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22955620</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncogene. 2009 Aug;28 Suppl 1:S24-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19680293</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Genomics. 2001 Jan 1;71(1):1-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11161793</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>RNA Biol. 2012 Jun;9(6):703-19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22664915</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Death Dis. 2015 Jul 16;6:e1823</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26181203</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Gene. 2015 Dec 15;574(2):330-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26275944</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Genome Res. 2012 Sep;22(9):1775-89</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22955988</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13306-11</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15329413</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncotarget. 2017 Jan 24;8(4):6589-6607</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28035057</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell. 2013 Aug 29;154(5):1151-1161</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23993102</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Med. 2017 Oct;23(10):1167-1175</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28920960</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Cancer. 2007 Mar;7(3):169-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17318210</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncotarget. 2014 Sep 30;5(18):8027-38</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25275300</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Genet. 2013 Jun;45(6):580-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23715323</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Genome Res. 2017 Oct;27(10):1743-1751</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28847918</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncotarget. 2017 Feb 21;8(8):13690-13702</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28099146</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2004 Jun 4;304(5676):1497-500</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15118125</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2015 Oct 15;526(7573):343-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26469045</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Med. 2015 Nov;21(11):1253-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26540387</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncotarget. 2016 Feb 9;7(6):7120-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26760768</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Sci Rep. 2017 Jan 27;7:41544</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28128360</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>RNA Biol. 2010 May-Jun;7(3):300-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20436283</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell. 2018 Jan 25;172(3):393-407</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29373828</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2013 Oct 14;8(10):e77293</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24155936</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2015 May 20;10(5):e0114586</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25992654</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Sci Signal. 2010 Feb 02;3(107):ra8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20124551</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Commun. 2018 Aug 9;9(1):3192</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30093685</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biochim Biophys Acta. 2006 Dec;1766(2):217-29</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17045403</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2012 Mar 28;483(7391):570-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22460902</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet Oncol. 2005 May;6(5):279-86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15863375</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Discov. 2015 Nov;5(11):1210-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26482930</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Genet. 2015 Mar;47(3):199-208</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25599403</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Med. 2005 Mar;2(3):e73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15737014</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Cell. 2015 Oct 12;28(4):529-540</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26461095</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncol Rep. 2017 Sep;38(3):1383-1392</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28731151</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Biotechnol. 2014 Dec;32(12):1202-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24880487</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Cell. 2016 Apr 11;29(4):452-463</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27070700</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Elife. 2017 Mar 31;6:</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28362259</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell. 2016 Jul 28;166(3):740-754</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27397505</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31548378</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1091-6490</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>116</Volume>
                    <Issue>41</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                        <Day>08</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Proceedings of the National Academy of Sciences of the United States of America</Title>
                <ISOAbbreviation>Proc. Natl. Acad. Sci. U.S.A.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The FBXW2-MSX2-SOX2 axis regulates stem cell property and drug resistance of cancer cells.</ArticleTitle>
            <Pagination>
                <MedlinePgn>20528-20538</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1905973116</ELocationID>
            <Abstract>
                <AbstractText>SOX2 is a key transcription factor that plays critical roles in maintaining stem cell property and conferring drug resistance. However, the underlying mechanisms by which SOX2 level is precisely regulated remain elusive. Here we report that MLN4924, also known as pevonedistat, a small-molecule inhibitor of neddylation currently in phase II clinical trials, down-regulates SOX2 expression via causing accumulation of MSX2, a known transcription repressor of SOX2 expression. Mechanistic characterization revealed that MSX2 is a substrate of FBXW2 E3 ligase. FBXW2 binds to MSX2 and promotes MSX2 ubiquitylation and degradation. Likewise, FBXW2 overexpression shortens the protein half-life of MSX2, whereas FBXW2 knockdown extends it. We further identified hypoxia as a stress condition that induces VRK2 kinase to facilitate MSX2-FBXW2 binding and FBXW2-mediated MSX2 ubiquitylation and degradation, leading to SOX2 induction via derepression. Biologically, expression of FBXW2 or SOX2 promotes tumor sphere formation, which is blocked by MSX2 expression. By down-regulating SOX2 through inactivation of FBXW2 E3 ligase, MLN4924 sensitizes breast cancer cells to tamoxifen in both in vitro and in vivo cancer cell models. Thus, a negative cascade of the FBXW2-MSX2-SOX2 axis was established, which regulates stem cell property and drug resistance. Finally, an inverse correlation of expression was found between FBXW2 and MSX2 in lung and breast cancer tissues. Collectively, our study revealed an anticancer mechanism of MLN4924. By inactivating FBXW2, MLN4924 caused MSX2 accumulation to repress SOX2 expression, leading to suppression of stem cell property and sensitization of breast cancer cells to tamoxifen.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Yin</LastName>
                    <ForeName>Yuan</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Wuxi Cancer Institute, Affiliated Hospital of Jiangnan University, Wuxi 214062, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xie</LastName>
                    <ForeName>Chuan-Ming</ForeName>
                    <Initials>CM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Institute of Hepatobiliary Surgery, Southwest Hospital, The Third Military Medical University (Army Medical University), Chongqing, 400038, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Hua</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tan</LastName>
                    <ForeName>Mingjia</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Guoan</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Medicine, Southern University of Science and Technology, Shenzhen 518055, Guangdong, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schiff</LastName>
                    <ForeName>Rachel</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Lester and Sue Smith Breast Center, Department of Medicine, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Lester and Sue Smith Breast Center, Department of Molecular and Cellular Biology, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX 77030.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xiong</LastName>
                    <ForeName>Xiufang</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Institute of the Second Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, 310058, Zhejiang, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sun</LastName>
                    <ForeName>Yi</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109; sunyi@umich.edu.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Cancer Institute of the Second Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, 310058, Zhejiang, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Proc Natl Acad Sci U S A</MedlineTA>
            <NlmUniqueID>7505876</NlmUniqueID>
            <ISSNLinking>0027-8424</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">FBXW2</Keyword>
            <Keyword MajorTopicYN="N">MSX2</Keyword>
            <Keyword MajorTopicYN="N">SOX2</Keyword>
            <Keyword MajorTopicYN="N">degradation</Keyword>
            <Keyword MajorTopicYN="N">ubiquitylation</Keyword>
        </KeywordList>
        <CoiStatement>Conflict of interest statement: R.S. has received research funding from AstraZeneca, GlaxoSmithKline, Gilead Sciences, and PUMA Biotechnology and is a consulting/advisory committee member for Macrogenics and Eli Lilly. These funds, however, had no impact on the content of this study.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pmc-release">
                <Year>2020</Year>
                <Month>03</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31548378</ArticleId>
            <ArticleId IdType="pii">1905973116</ArticleId>
            <ArticleId IdType="doi">10.1073/pnas.1905973116</ArticleId>
            <ArticleId IdType="pmc">PMC6789910</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Curr Cancer Drug Targets. 2011 Mar;11(3):347-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21247385</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Commun. 2017 Jan 16;8:14002</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28090088</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):E6600-E6609</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27791031</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Death Differ. 2016 Mar;23(3):393-404</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26292759</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Stem Cell. 2014 Mar 6;14(3):306-21</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24607405</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Am J Cancer Res. 2016 May 01;6(5):1078-88</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27294000</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Hepatology. 2016 Sep;64(3):814-27</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27312708</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Stem Cell. 2013 Apr 4;12(4):440-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23499385</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Med. 2008 Aug;14(8):822-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18641660</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Res. 2007 Apr 15;67(8):3616-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17440073</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Cell Biol. 2010 Oct;30(19):4687-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20679487</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Mol Cell Biol. 2004 Sep;5(9):739-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15340381</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Expert Opin Investig Drugs. 2012 Oct;21(10):1563-73</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22799561</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Commun. 2019 Mar 27;10(1):1382</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30918250</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biol Chem. 2015 Aug;396(8):883-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25781683</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Mol Sci. 2017 Dec 01;18(12):null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29194401</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Cancer. 2005 Apr;5(4):275-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15803154</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Antioxid Redox Signal. 2014 Dec 10;21(17):2383-400</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24410571</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Br J Cancer. 2019 Feb;120(3):331-339</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30555156</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncology (Williston Park). 2014 Dec;28(12):1101-7, 1110</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25510809</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Lett. 2017 Feb 28;387:69-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27089987</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Signal. 2018 Apr;44:92-102</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29331584</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Cell Biochem. 2010 Dec 1;111(5):1346-58</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20803545</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Clin Invest. 2014 Feb;124(2):835-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24430184</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Semin Oncol. 2015 Apr;42 Suppl 1:S3-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25839664</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2009 Apr 9;458(7239):732-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19360080</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2010 Apr 22;5(4):e10312</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20421987</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Res. 2015 Dec;25(12):1314-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26427715</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2016 May 24;113(21):E2935-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27162365</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Genomics. 1997 Oct 15;45(2):327-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9344656</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Commun. 2018 Nov 7;9(1):4648</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30405104</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncogene. 2012 Mar 15;31(11):1354-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21822303</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Neuropsychiatry. 2018 Dec;4(3):119-133</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30643786</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Cancer. 2013 Oct;13(10):727-38</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24060864</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Genet. 2009 Nov;41(11):1238-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19801978</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Cancer. 2016 Dec 12;15(1):81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27955654</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Signal. 2013 May;25(5):1264-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23416461</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Biol Chem. 2019 Jan 11;294(2):476-489</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30442713</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Genet. 2000 Apr;24(4):391-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10742104</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Cell. 2014 Aug 21;55(4):537-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25042802</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>EMBO Mol Med. 2014 Jan;6(1):66-79</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24178749</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Hum Pathol. 2012 Sep;43(9):1405-12</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22401770</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Stem Cell. 2013 Jan 3;12(1):15-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23290134</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Expert Opin Ther Targets. 2018 Dec;22(12):983-991</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30366514</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Stem Cell. 2013 Jan 3;12(1):88-100</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23260487</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncogene. 2018 Oct;37(40):5367-5386</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29872222</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2015 May 14;10(5):e0127348</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25973895</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Death Dis. 2013 Feb 28;4:e513</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23449449</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>FEBS J. 2006 Jun;273(11):2487-504</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16704422</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Genes Dev. 2004 Nov 1;18(21):2573-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15520277</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Stem Cell. 2009 Nov 6;5(5):504-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19896441</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Cell Biol. 2015 Jun 8;209(5):721-37</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26056141</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Curr Pharm Des. 2013;19(18):3215-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23151137</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31548301</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1540-9538</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                        <Day>23</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of experimental medicine</Title>
                <ISOAbbreviation>J. Exp. Med.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Primary prostate cancer educates bone stroma through exosomal pyruvate kinase M2 to promote bone metastasis.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">jem.20190158</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1084/jem.20190158</ELocationID>
            <Abstract>
                <AbstractText>Prostate cancer (PCa) metastasizes selectively to bone through unknown mechanisms. In the current study, we identified exosome-mediated transfer of pyruvate kinase M2 (PKM2) from PCa cells into bone marrow stromal cells (BMSCs) as a novel mechanism through which primary tumor-derived exosomes promote premetastatic niche formation. We found that PKM2 up-regulates BMSC CXCL12 production in a HIF-1α-dependent fashion, which subsequently enhances PCa seeding and growth in the bone marrow. Furthermore, serum-derived exosomes from patients with either primary PCa or PCa metastasis, as opposed to healthy men, reveal that increased exosome PKM2 expression is associated with metastasis, suggesting clinical relevance of exosome PKM2 in PCa. Targeting the exosome-induced CXCL12 axis diminished exosome-mediated bone metastasis. In summary, primary PCa cells educate the bone marrow to create a premetastatic niche through primary PCa exosome-mediated transfer of PKM2 into BMSCs and subsequent up-regulation of CXCL12. This novel mechanism indicates the potential for exosome PKM2 as a biomarker and suggests therapeutic targets for PCa bone metastasis.</AbstractText>
                <CopyrightInformation>© 2019 Dai et al.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Dai</LastName>
                    <ForeName>Jinlu</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Urology, Medical School, University of Michigan, Ann Arbor, MI.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Escara-Wilke</LastName>
                    <ForeName>June</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Urology, Medical School, University of Michigan, Ann Arbor, MI.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Keller</LastName>
                    <ForeName>Jill M</ForeName>
                    <Initials>JM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Urology, Medical School, University of Michigan, Ann Arbor, MI.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Unit for Laboratory Animal Medicine, University of Michigan, Ann Arbor, MI.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jung</LastName>
                    <ForeName>Younghun</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Periodontics and Oral Medicine, School of Dentistry, University of Michigan, Ann Arbor, MI.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Taichman</LastName>
                    <ForeName>Russell S</ForeName>
                    <Initials>RS</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-7890-0020</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Periodontics and Oral Medicine, School of Dentistry, University of Michigan, Ann Arbor, MI.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pienta</LastName>
                    <ForeName>Kenneth J</ForeName>
                    <Initials>KJ</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-4138-2186</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Urology, Brady Urological Institute, Johns Hopkins University, Baltimore, MD.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Keller</LastName>
                    <ForeName>Evan T</ForeName>
                    <Initials>ET</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-7592-7535</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Urology, Medical School, University of Michigan, Ann Arbor, MI etkeller@umich.edu.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Unit for Laboratory Animal Medicine, University of Michigan, Ann Arbor, MI.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Biointerfaces Institute, University of Michigan, Ann Arbor, MI.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Exp Med</MedlineTA>
            <NlmUniqueID>2985109R</NlmUniqueID>
            <ISSNLinking>0022-1007</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>01</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31548301</ArticleId>
            <ArticleId IdType="pii">jem.20190158</ArticleId>
            <ArticleId IdType="doi">10.1084/jem.20190158</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31548293</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1538-8514</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                        <Day>23</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Molecular cancer therapeutics</Title>
                <ISOAbbreviation>Mol. Cancer Ther.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Inhibition of autotaxin with GLPG1690 increases the efficacy of radiotherapy and chemotherapy in a mouse model of breast cancer.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">molcanther.0386.2019</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1158/1535-7163.MCT-19-0386</ELocationID>
            <Abstract>
                <AbstractText>Autotaxin catalyzes the formation of lysophosphatidic acid, which stimulates tumor growth and metastasis and decreases the effectiveness of cancer therapies. In breast cancer, autotaxin is secreted mainly by breast adipocytes, especially when stimulated by inflammatory cytokines produced by tumors. In this work, we studied the effects of an ATX inhibitor, GLPG1690, which is in Phase 3 clinical trials for idiopathic pulmonary fibrosis, on responses to radiotherapy and chemotherapy in a syngeneic orthotopic mouse model of breast cancer. Tumors were treated with fractionated external beam irradiation, which was optimized to decrease tumor weight by ~80%. Mice were also dosed twice daily with GLPG1690 or vehicle beginning at one day before the radiation until 4 days after radiation was completed. GLPG1690 combined with irradiation did not decrease tumor growth further compared to radiation alone. However, GLPG1690 decreased the uptake of 3'-deoxy-3'-[18F]-fluorothymidine by tumors and the percentage of Ki67 positive cells. This was also associated with increased cleaved caspase-3 and decreased Bcl-2 levels in these tumors. GLPG1690 decreased irradiation-induced C-C motif chemokine ligand-11 in tumors and levels of interleukin-9, interleukin-12p40, macrophage colony-stimulating factor and interferon γ in adipose tissue adjacent to the tumor. In other experiments, mice were treated with doxorubicin every 2 days after the tumors developed. GLPG1690 acted synergistically with doxorubicin to decrease tumor growth and the percentage of Ki67 positive cells. GLPG1690 also increased 4-hydroxynonenal-protein adducts in these tumors. These results indicate that inhibiting ATX provides a promising adjuvant to improve the outcomes of radiotherapy and chemotherapy for breast cancer.</AbstractText>
                <CopyrightInformation>Copyright ©2019, American Association for Cancer Research.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Tang</LastName>
                    <ForeName>Xiaoyun</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Pharmacology, University of Iowa.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wuest</LastName>
                    <ForeName>Melinda</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Oncology, University of Alberta.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Benesch</LastName>
                    <ForeName>Matthew Gk</ForeName>
                    <Initials>MG</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-1326-684X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Biochemistry, University of Alberta.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dufour</LastName>
                    <ForeName>Jennifer</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Oncology, University of Alberta.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhao</LastName>
                    <ForeName>YuanYuan</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Agricultural, Food and Nutritional Science, University of Alberta.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Curtis</LastName>
                    <ForeName>Jonathan M</ForeName>
                    <Initials>JM</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-8863-5611</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Agricultural, Food and Nutritional Science, University of Alberta.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Monjardet</LastName>
                    <ForeName>Alain</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Galapagos RMV.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Heckmann</LastName>
                    <ForeName>Bertrand</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Galapagos RMV.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Murray</LastName>
                    <ForeName>David</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Research Institute of Northern Alberta, University of Alberta.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wuest</LastName>
                    <ForeName>Frank</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Oncology, University of Alberta.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Brindley</LastName>
                    <ForeName>David N</ForeName>
                    <Initials>DN</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biochemistry, University of Alberta david.brindley@ualberta.ca.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Mol Cancer Ther</MedlineTA>
            <NlmUniqueID>101132535</NlmUniqueID>
            <ISSNLinking>1535-7163</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>04</Month>
                <Day>09</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31548293</ArticleId>
            <ArticleId IdType="pii">1535-7163.MCT-19-0386</ArticleId>
            <ArticleId IdType="doi">10.1158/1535-7163.MCT-19-0386</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31546441</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-0191</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>105</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Dec</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Materials science &amp; engineering. C, Materials for biological applications</Title>
                <ISOAbbreviation>Mater Sci Eng C Mater Biol Appl</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Poly(N,N-diethyl acrylamide)/functionalized graphene quantum dots hydrogels loaded with doxorubicin as a nano-drug carrier for metastatic lung cancer in mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>110094</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0928-4931(18)33136-9</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.msec.2019.110094</ELocationID>
            <Abstract>
                <AbstractText>Cancer has emanated as a daunting menace to human-kind even though medicine, science, and technology has reached its zenith. Subsequent scarcity in the revelation of new drugs, the exigency of salvaging formerly discovered toxic drugs such as doxorubicin has emerged. The invention of drug carrier has made drug delivery imminent which is ascribable to its characteristic traits of specific targeting, effective response to stimuli and biocompatibility. In this paper, the nanoscale polymeric drug carrier poly(N,N-diethyl acrylamide) nanohydrogel has been synthesized by inverse emulsion polymerization. Lower critical solution temperature of the polymeric carrier has been modified using graphene quantum. The particle size of pure nanohydrogel was in the range of 47 to 59.5 nm, and graphene quantum dots incorporated nanohydrogels was in the range of 68.1 to 87.5 nm. Doxorubicin (hydroxyl derivative of anthracycline) release behavior as a function of time and temperature was analyzed, and the Lower critical solution temperature of the synthesized nanohydrogels has been found to be in the range of 28-42 °C. Doxorubicin release characteristics have improved significantly as the surrounding temperature of the release media was increased near to physiological temperature. Further, the cumulative release profile was fitted in the different kinetic model and found to follow a Fickian diffusion release mechanism. The hydrogel was assessed for its cytotoxicity in B16F10 cells by MTT assay. In-vivo studies were done to study the lung metastasis by melanoma cancer and the results showed a rational favorable prognosis which was confirmed by evaluating hematological parameters and the non-immunogenic nature of nanohydrogel by cytokine assay. Comprehensively, the results suggested that poly(N,N-diethyl acrylamide) nanohydrogels have potential application as an intelligent drug carrier for melanoma cancer.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Havanur</LastName>
                    <ForeName>Sushma</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Chemical Engineering, National Institute of Technology Karnataka, Surathkal, Mangalore, Karnataka, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Batish</LastName>
                    <ForeName>Inayat</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Chemical Engineering, National Institute of Technology Karnataka, Surathkal, Mangalore, Karnataka, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cheruku</LastName>
                    <ForeName>Sri Pragnya</ForeName>
                    <Initials>SP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gourishetti</LastName>
                    <ForeName>Karthik</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>P E</LastName>
                    <ForeName>JagadeeshBabu</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Chemical Engineering, National Institute of Technology Karnataka, Surathkal, Mangalore, Karnataka, India. Electronic address: jagadeesh_78@yahoo.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kumar</LastName>
                    <ForeName>Nitesh</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Mater Sci Eng C Mater Biol Appl</MedlineTA>
            <NlmUniqueID>101484109</NlmUniqueID>
            <ISSNLinking>0928-4931</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Doxorubicin</Keyword>
            <Keyword MajorTopicYN="N">Drug carrier</Keyword>
            <Keyword MajorTopicYN="N">Graphene quantum dots</Keyword>
            <Keyword MajorTopicYN="N">Melanoma</Keyword>
            <Keyword MajorTopicYN="N">Nanohydrogel</Keyword>
            <Keyword MajorTopicYN="N">Poly(N,N-diethyl acrylamide)</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31546441</ArticleId>
            <ArticleId IdType="pii">S0928-4931(18)33136-9</ArticleId>
            <ArticleId IdType="doi">10.1016/j.msec.2019.110094</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31546428</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-0191</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>105</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Dec</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Materials science &amp; engineering. C, Materials for biological applications</Title>
                <ISOAbbreviation>Mater Sci Eng C Mater Biol Appl</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Current and emerging applications of nanostructured metal-organic frameworks in cancer-targeted theranostics.</ArticleTitle>
            <Pagination>
                <MedlinePgn>110091</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0928-4931(19)31023-9</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.msec.2019.110091</ELocationID>
            <Abstract>
                <AbstractText>Nanostructured metal-organic frameworks (N-MOFs) are crystalline coordination nanopolymers in which metals are conjugated with organic and inorganic linker molecules. At present, N-MOFs have attracted significant interest owing to their intrinsically high porosity and ultrahigh surface areas, which allow them to be loaded with a broad array of materials, including drug molecules. In addition, N-MOFs possess other unique properties, such as good mobility, high reactivity, outstanding stability, real-time intracellular pH sensitivity, photosensitization, and penetration ability, which make them suitable candidates as drug delivery carriers for cancer and other targeted therapies. The opportunity for using a diverse array of chemical building components in N-MOFs facilitates the formation of structures with preferred properties for targeted therapy. In this review, we focus on the synthesis, characterization and other potential applications of N-MOFs in targeted theranostic nanodrug for cancer therapy.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lakshmi</LastName>
                    <ForeName>Buddolla Anantha</ForeName>
                    <Initials>BA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Bionanotechnology, Gachon University, San 65, Bokjeong-Dong, Sujeong-Gu, Seongnam-Si, Gyeonggi-Do 461-701, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Sanghyo</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Bionanotechnology, Gachon University, San 65, Bokjeong-Dong, Sujeong-Gu, Seongnam-Si, Gyeonggi-Do 461-701, Republic of Korea. Electronic address: samkim@gachon.ac.kr.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Mater Sci Eng C Mater Biol Appl</MedlineTA>
            <NlmUniqueID>101484109</NlmUniqueID>
            <ISSNLinking>0928-4931</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Cancer-targeted therapy</Keyword>
            <Keyword MajorTopicYN="N">Drug delivery</Keyword>
            <Keyword MajorTopicYN="N">Nanostructured metal–organic frameworks</Keyword>
            <Keyword MajorTopicYN="N">Photosensitization</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>03</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31546428</ArticleId>
            <ArticleId IdType="pii">S0928-4931(19)31023-9</ArticleId>
            <ArticleId IdType="doi">10.1016/j.msec.2019.110091</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31546406</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-0191</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>105</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Dec</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Materials science &amp; engineering. C, Materials for biological applications</Title>
                <ISOAbbreviation>Mater Sci Eng C Mater Biol Appl</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Design of DNA-intercalators based copper(II) complexes, investigation of their potential anti-cancer activity and sub-chronic toxicity.</ArticleTitle>
            <Pagination>
                <MedlinePgn>110079</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0928-4931(19)30184-5</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.msec.2019.110079</ELocationID>
            <Abstract>
                <AbstractText>In the present paper, we synthesized and characterized four N-donor polypyridyl copper(II) complexes (C1-C4); [Cu(mono-CN-PIP)<sub>2</sub>]<sup>2+</sup> (C1), [Cu(tri-OMe-PIP)<sub>2</sub>]<sup>2+</sup> (C2), [Cu(di-CF<sub>3</sub>-PIP)<sub>2</sub>]<sup>2+</sup> (C3) and [Cu(DPPZ)<sub>2</sub>]<sup>2+</sup> (C4). The (Calf-Thymus) CT-DNA binding studies depicted that the complexes could interact with DNA via intercalative mode. All the complexes, particularly C3 and C4 attenuated the proliferation as well as migration of various cancer cells, indicating their anti-cancer and anti-metastatic activity. Additionally, chick embryo angiogenesis (CEA) assay exhibited the inhibition of vascular sprouting in presence of C3 and C4, suggesting their potential in inhibiting the blood vessel growth. Mechanistic studies revealed that the complexes induced the excessive production of cellular reactive oxygen species (ROS) leading to apoptosis through up regulation of p53 and downregulation of Bcl-xL, which might be the plausible mechanisms underlying their anti-cancer properties. To understand the feasibility of practical application of anti-cancer copper complexes C3 and C4, in vivo sub-chronic toxicity study (4 weeks) was performed in C57BL6 mice and the results exhibited almost non-toxic effects induced by these complexes in terms of haematology and serum biochemical analyses, suggesting their biocompatible nature. The current study provides the basis for future advancement of other novel biocompatible metal complexes that could be employed for the therapy of different cancers.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Bollu</LastName>
                    <ForeName>Vishnu Sravan</ForeName>
                    <Initials>VS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, Uppal Road, Tarnaka, Hyderabad 500007, Telangana State, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bathini</LastName>
                    <ForeName>Thulasiram</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Inorganic &amp; Physical Chemistry Division, CSIR-Indian Institute of Chemical Technology, Uppal Road, Tarnaka, Hyderabad 500007, Telangana State, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Barui</LastName>
                    <ForeName>Ayan Kumar</ForeName>
                    <Initials>AK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, Uppal Road, Tarnaka, Hyderabad 500007, Telangana State, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Roy</LastName>
                    <ForeName>Arpita</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, Uppal Road, Tarnaka, Hyderabad 500007, Telangana State, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ragi</LastName>
                    <ForeName>Nagarjuna Chary</ForeName>
                    <Initials>NC</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Centre for Mass Spectrometry, CSIR-Indian Institute of Chemical Technology, Uppal Road, Tarnaka, Hyderabad 500007, Telangana State, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Maloth</LastName>
                    <ForeName>Swamy</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Inorganic &amp; Physical Chemistry Division, CSIR-Indian Institute of Chemical Technology, Uppal Road, Tarnaka, Hyderabad 500007, Telangana State, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sripadi</LastName>
                    <ForeName>Prabhakar</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>National Centre for Mass Spectrometry, CSIR-Indian Institute of Chemical Technology, Uppal Road, Tarnaka, Hyderabad 500007, Telangana State, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sreedhar</LastName>
                    <ForeName>Bojja</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Inorganic &amp; Physical Chemistry Division, CSIR-Indian Institute of Chemical Technology, Uppal Road, Tarnaka, Hyderabad 500007, Telangana State, India. Electronic address: sreedharb@iict.res.in.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nagababu</LastName>
                    <ForeName>Penumaka</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Inorganic &amp; Physical Chemistry Division, CSIR-Indian Institute of Chemical Technology, Uppal Road, Tarnaka, Hyderabad 500007, Telangana State, India; Environmental Materials Division, CSIR-National Environmental Engineering Research Institute (NEERI), Nagpur 440020, Maharashtra, India. Electronic address: p.nagababu@neeri.res.in.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Patra</LastName>
                    <ForeName>Chitta Ranjan</ForeName>
                    <Initials>CR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, Uppal Road, Tarnaka, Hyderabad 500007, Telangana State, India. Electronic address: crpatra@iict.res.in.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Mater Sci Eng C Mater Biol Appl</MedlineTA>
            <NlmUniqueID>101484109</NlmUniqueID>
            <ISSNLinking>0928-4931</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Anti-cancer</Keyword>
            <Keyword MajorTopicYN="N">Copper (II) polypyridyl complexes</Keyword>
            <Keyword MajorTopicYN="N">DNA binding</Keyword>
            <Keyword MajorTopicYN="N">In vivo toxicity</Keyword>
            <Keyword MajorTopicYN="N">Reactive oxygen species</Keyword>
            <Keyword MajorTopicYN="N">p53 protein</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>01</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31546406</ArticleId>
            <ArticleId IdType="pii">S0928-4931(19)30184-5</ArticleId>
            <ArticleId IdType="doi">10.1016/j.msec.2019.110079</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31546399</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-0191</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>105</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Dec</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Materials science &amp; engineering. C, Materials for biological applications</Title>
                <ISOAbbreviation>Mater Sci Eng C Mater Biol Appl</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Optimization of a low pressure plasma process for fabrication of a Drug Delivery System (DDS) for cancer treatment.</ArticleTitle>
            <Pagination>
                <MedlinePgn>110089</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0928-4931(19)31118-X</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.msec.2019.110089</ELocationID>
            <Abstract>
                <AbstractText>A low pressure ICP plasma setup was utilized to deposit thin organic barrier coatings on various substrates to fabricate DDS with encapsulated Carboplatin as a drug and Methylene Blue as a drug model. Choice of the substrates and optimal plasma parameters were discussed for the fabrication of DDS with required characteristics. Prepared thin films were analysed by FTIR, SEM, and the barrier properties were studied by measuring drug concentration released into the medium by UV-VIS and ICP-MS techniques.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Baitukha</LastName>
                    <ForeName>Alibi</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sorbonne Universités, UPMC Univ Paris 06, CNRS, Laboratoire Interfaces et Systèmes Electrochimiques, 4 place Jussieu, 75005 Paris, France. Electronic address: sad.neva@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Al-Dybiat</LastName>
                    <ForeName>Iman</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sorbonne Paris Cité, UMR Université Paris 7, INSERM U965 Carcinose, Angiogenèse et Recherche Translationnelle, L'Hôpital Lariboisière, 41 Bd de la Chapelle, 75010 Paris, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Valinataj-Omran</LastName>
                    <ForeName>Azadeh</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sorbonne Paris Cité, UMR Université Paris 7, INSERM U965 Carcinose, Angiogenèse et Recherche Translationnelle, L'Hôpital Lariboisière, 41 Bd de la Chapelle, 75010 Paris, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pulpytel</LastName>
                    <ForeName>Jerome</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sorbonne Universités, UPMC Univ Paris 06, CNRS, Laboratoire Interfaces et Systèmes Electrochimiques, 4 place Jussieu, 75005 Paris, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pocard</LastName>
                    <ForeName>Marc</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sorbonne Paris Cité, UMR Université Paris 7, INSERM U965 Carcinose, Angiogenèse et Recherche Translationnelle, L'Hôpital Lariboisière, 41 Bd de la Chapelle, 75010 Paris, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mirshahi</LastName>
                    <ForeName>Massoud</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sorbonne Paris Cité, UMR Université Paris 7, INSERM U965 Carcinose, Angiogenèse et Recherche Translationnelle, L'Hôpital Lariboisière, 41 Bd de la Chapelle, 75010 Paris, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Arefi-Khonsari</LastName>
                    <ForeName>Farzaneh</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Sorbonne Universités, UPMC Univ Paris 06, CNRS, Laboratoire Interfaces et Systèmes Electrochimiques, 4 place Jussieu, 75005 Paris, France. Electronic address: farzaneh.arefi@sorbonne-universite.fr.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Mater Sci Eng C Mater Biol Appl</MedlineTA>
            <NlmUniqueID>101484109</NlmUniqueID>
            <ISSNLinking>0928-4931</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>03</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31546399</ArticleId>
            <ArticleId IdType="pii">S0928-4931(19)31118-X</ArticleId>
            <ArticleId IdType="doi">10.1016/j.msec.2019.110089</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31546396</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-0191</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>105</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Dec</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Materials science &amp; engineering. C, Materials for biological applications</Title>
                <ISOAbbreviation>Mater Sci Eng C Mater Biol Appl</ISOAbbreviation>
            </Journal>
            <ArticleTitle>N,S-self-doped carbon quantum dots from fungus fibers for sensing tetracyclines and for bioimaging cancer cells.</ArticleTitle>
            <Pagination>
                <MedlinePgn>110132</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0928-4931(19)30370-4</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.msec.2019.110132</ELocationID>
            <Abstract>
                <AbstractText>In this work, nitrogen and sulfur dual-doped carbon quantum dots (N,S-CDs) from naturally renewable biomaterial fungus fibers were prepared by a biosynthesis and hydrothermal method. The N,S-CDs displayed good water solubility, excellent stability, high quantum yield (QY = 28.11%) as well as remarkable features for fluorescence quenching-based detection and cellular imaging of cancer cells. It was worth mentioning that the heteroatoms doped carbon quantum dots made from the fungus fibers had a satisfactory QY and could be used as a selective, efficient, and sensitive fluorescent probe to determine tetracyclines by the synergistic effects of static quenching and internal filtration effect. The probe demonstrated a wide linear range and low detection limit. For tetracycline, the linear range was 0.5 μM to 47.6 μM, and the corresponding detection limit was 15.6 nM. Significantly, the test papers prepared by using N,S-CDs could detect tetracyclines in aquiculture wastewater rapidly. The produced N,S-CDs did not affect the cell viability and showed great promises for cellular imaging.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Shi</LastName>
                    <ForeName>Cai</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Bio-based Material Science and Technology of Ministry of Education, College of Material Science and Engineering, Northeast Forestry University, Harbin, 150040, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Qi</LastName>
                    <ForeName>Houjuan</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Bio-based Material Science and Technology of Ministry of Education, College of Material Science and Engineering, Northeast Forestry University, Harbin, 150040, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ma</LastName>
                    <ForeName>Rongxiu</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Bio-based Material Science and Technology of Ministry of Education, College of Material Science and Engineering, Northeast Forestry University, Harbin, 150040, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sun</LastName>
                    <ForeName>Zhe</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Bio-based Material Science and Technology of Ministry of Education, College of Material Science and Engineering, Northeast Forestry University, Harbin, 150040, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xiao</LastName>
                    <ForeName>Lidong</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Bio-based Material Science and Technology of Ministry of Education, College of Material Science and Engineering, Northeast Forestry University, Harbin, 150040, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wei</LastName>
                    <ForeName>Guangbiao</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Bio-based Material Science and Technology of Ministry of Education, College of Material Science and Engineering, Northeast Forestry University, Harbin, 150040, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huang</LastName>
                    <ForeName>Zhanhua</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Bio-based Material Science and Technology of Ministry of Education, College of Material Science and Engineering, Northeast Forestry University, Harbin, 150040, China. Electronic address: huangzh1975@163.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Shouxin</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Bio-based Material Science and Technology of Ministry of Education, College of Material Science and Engineering, Northeast Forestry University, Harbin, 150040, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Jian</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Bio-based Material Science and Technology of Ministry of Education, College of Material Science and Engineering, Northeast Forestry University, Harbin, 150040, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dong</LastName>
                    <ForeName>Mengyao</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Integrated Composites Laboratory (ICL), Department of Chemical and Bimolecular Engineering, University of Tennessee, Knoxville, TN, 37996, USA; Key Laboratory of Materials Processing and Mold (Zhengzhou University), Ministry of Education, National Engineering Research Center for Advanced Polymer Processing Technology, Zhengzhou University, Zhengzhou, 450001, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fan</LastName>
                    <ForeName>Jincheng</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Integrated Composites Laboratory (ICL), Department of Chemical and Bimolecular Engineering, University of Tennessee, Knoxville, TN, 37996, USA; College of Materials Science and Engineering, Changsha University of Science and Technology, Changsha, 410114, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Guo</LastName>
                    <ForeName>Zhanhu</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Integrated Composites Laboratory (ICL), Department of Chemical and Bimolecular Engineering, University of Tennessee, Knoxville, TN, 37996, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>31</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Mater Sci Eng C Mater Biol Appl</MedlineTA>
            <NlmUniqueID>101484109</NlmUniqueID>
            <ISSNLinking>0928-4931</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Biosynthesis</Keyword>
            <Keyword MajorTopicYN="N">Cellular imaging</Keyword>
            <Keyword MajorTopicYN="N">Fungus fibers</Keyword>
            <Keyword MajorTopicYN="N">N,S-self-doped carbon dots</Keyword>
            <Keyword MajorTopicYN="N">Tetracyclines</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>01</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31546396</ArticleId>
            <ArticleId IdType="pii">S0928-4931(19)30370-4</ArticleId>
            <ArticleId IdType="doi">10.1016/j.msec.2019.110132</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31546395</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-0191</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>105</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Dec</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Materials science &amp; engineering. C, Materials for biological applications</Title>
                <ISOAbbreviation>Mater Sci Eng C Mater Biol Appl</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Boronic-targeted albumin-shell oily-core nanocapsules for synergistic aromatase inhibitor/herbal breast cancer therapy.</ArticleTitle>
            <Pagination>
                <MedlinePgn>110099</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0928-4931(19)31798-9</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.msec.2019.110099</ELocationID>
            <Abstract>
                <AbstractText>Multi-modality strategies of albumin-mediated drug accumulation in tumor, boronate-based active tumor targeting and synergistic cancer therapy were combined together for effective treatment of breast cancer. Herein we report the development of albumin-shell oily-core nanocapsules (NCs), loaded with novel combination of hydrophobic drugs, exemestane (EXE) and hesperetin (HES), for targeted breast cancer therapy. This protein-lipid nanohybrid carrier was successfully fabricated using a simple protein-coating method based on the electrostatic adsorption of negatively charged albumin shell onto the oily core containing cationic surfactant. While EXE was directly encapsulated into the oily core, HES was pre-formulated in the form of phospholipid complex before solubilization in oily phase. In addition to albumin-mediated binding to albondin and SPARC, phenylboronic acid was chemically coupled to the albumin shell to confer additional tumor targeting. The targeted nanocarrier (TNC) demonstrated enhanced internalization into MCF-7 breast cancer cells resulting in synergistic cytotoxic activity with a combination index (CI) of 0.662 and dose reduction index (DRI) of 8.22 and 1.84 for EXE and HES, respectively. In vivo, TNC displayed superior anti-cancer activity in tumor-bearing mice compared to their non-targeted counterparts and the free drug combination. A significant reduction of both tumor volume (7-folds) and Ki67 expression (3-folds) was obtained by the targeted nanocarriers compared to positive control. Overall, the boronic-targeted albumin NCs offer a promising platform for hydrophobic drug combination against cancer therapy.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Gaber</LastName>
                    <ForeName>Mohamed</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA; Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hany</LastName>
                    <ForeName>Mark</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mokhtar</LastName>
                    <ForeName>Sarah</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Helmy</LastName>
                    <ForeName>Maged W</ForeName>
                    <Initials>MW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Damanhur University, Damanhur, Egypt.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Elkodairy</LastName>
                    <ForeName>Kadria A</ForeName>
                    <Initials>KA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt; Department of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Elzoghby</LastName>
                    <ForeName>Ahmed O</ForeName>
                    <Initials>AO</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt; Department of Industrial Pharmacy, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt; Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Harvard-MIT Division of Health Sciences &amp; Technology (HST), Cambridge, MA 02139, USA. Electronic address: aelzoghby@bwh.harvard.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Mater Sci Eng C Mater Biol Appl</MedlineTA>
            <NlmUniqueID>101484109</NlmUniqueID>
            <ISSNLinking>0928-4931</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Albumin nanocapsules</Keyword>
            <Keyword MajorTopicYN="N">Aromatase inhibitors</Keyword>
            <Keyword MajorTopicYN="N">Boronic targeting</Keyword>
            <Keyword MajorTopicYN="N">Breast cancer</Keyword>
            <Keyword MajorTopicYN="N">Combined therapy</Keyword>
            <Keyword MajorTopicYN="N">Herbal therapy</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31546395</ArticleId>
            <ArticleId IdType="pii">S0928-4931(19)31798-9</ArticleId>
            <ArticleId IdType="doi">10.1016/j.msec.2019.110099</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31546381</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-0191</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>105</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Dec</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Materials science &amp; engineering. C, Materials for biological applications</Title>
                <ISOAbbreviation>Mater Sci Eng C Mater Biol Appl</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Control synthesis, subtle surface modification of rare-earth-doped upconversion nanoparticles and their applications in cancer diagnosis and treatment.</ArticleTitle>
            <Pagination>
                <MedlinePgn>110097</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0928-4931(18)32438-X</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.msec.2019.110097</ELocationID>
            <Abstract>
                <AbstractText>Rare earth doped upconversion nanoparticles (UCNPs) are a new class of luminescent materials that can absorb long-wavelength near-infrared photons and emit short-wavelength UV-visible photons. UCNPs have little damage to biological tissues, have deep tissue penetration ability, have no background fluorescence noise interference, have high imaging sensitivity, and have no photobleaching effect. In the field of biomedicine, especially in the field of diagnosis and treatment of cancer, a wide range of research interests has arisen. In this paper, we briefly introduce the luminescent principle of rare-earth doped UCNPs, discuss several widely used control synthesis and modification methods, and focus on the research progress of UCNPs in detection of cancer cells, photodynamic therapy (PDT) and photothermal therapy (PTT) field. We also summarize the application of UCNPs as a diagnostic and therapeutic integrated nanoplatform in the diagnosis and treatment of cancer. At last, we explore the application challenge and prospect of UCNPs in oncology field.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Hong</LastName>
                    <ForeName>Enlv</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Occupational and Environmental Health, School of Public Health, Tianjin Medical University, Tianjin 300070, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Lumin</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Occupational and Environmental Health, School of Public Health, Tianjin Medical University, Tianjin 300070, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bai</LastName>
                    <ForeName>Liming</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Chemical and Chemical Engineering, Qiqihar University, Qiqihaer 161006, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xia</LastName>
                    <ForeName>Chunhui</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Chemistry, Qiqihaer Medical College, Qiqihaer 161006, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gao</LastName>
                    <ForeName>Lei</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Occupational and Environmental Health, School of Public Health, Tianjin Medical University, Tianjin 300070, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Liwen</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Occupational and Environmental Health, School of Public Health, Tianjin Medical University, Tianjin 300070, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Baiqi</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Occupational and Environmental Health, School of Public Health, Tianjin Medical University, Tianjin 300070, China; Tianjin Key Laboratory of Environment, Nutrition and Public Health, Tianjin 300070, China; National Demonstration Center for Experimental Preventive Medicine Education, Tianjin Medical University, Tianjin 300070, China; The Key Laboratory of Modern Toxicology, Ministry of Education, Nanjing Medical University, Nanjing 211166, Jiangsu, China. Electronic address: wangbaiqi@tmu.edu.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>17</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Mater Sci Eng C Mater Biol Appl</MedlineTA>
            <NlmUniqueID>101484109</NlmUniqueID>
            <ISSNLinking>0928-4931</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Cancer</Keyword>
            <Keyword MajorTopicYN="N">Control synthesis</Keyword>
            <Keyword MajorTopicYN="N">Diagnosis</Keyword>
            <Keyword MajorTopicYN="N">Therapy</Keyword>
            <Keyword MajorTopicYN="N">Upconversion nanoparticles</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>08</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31546381</ArticleId>
            <ArticleId IdType="pii">S0928-4931(18)32438-X</ArticleId>
            <ArticleId IdType="doi">10.1016/j.msec.2019.110097</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31546359</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-0191</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>105</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Dec</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Materials science &amp; engineering. C, Materials for biological applications</Title>
                <ISOAbbreviation>Mater Sci Eng C Mater Biol Appl</ISOAbbreviation>
            </Journal>
            <ArticleTitle>In vitro evaluation of folate-modified PLGA nanoparticles containing paclitaxel for ovarian cancer therapy.</ArticleTitle>
            <Pagination>
                <MedlinePgn>110038</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0928-4931(18)33684-1</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.msec.2019.110038</ELocationID>
            <Abstract>
                <AbstractText>Ovarian cancer is the most lethal gynecological cancer of female reproductive system. In order to improve the survival rate, some modifications on nanoparticles surfaces have been investigated to promote active targeting of drugs into tumor microenvironment. The aim of this study was the development and characterization of folate-modified (PN-PCX-FA) and unmodified PLGA nanoparticles (PN-PCX) containing paclitaxel for ovarian cancer treatment. Nanocarriers were produced using nanoprecipitation technique and characterized by mean particle diameter (MPD), polydispersity index (PDI), zeta potential (ZP), encapsulation efficiency (EE), DSC, FTIR, in vitro cytotoxicity and cellular uptake. PN-PCX and PN-PCX-FA showed MPD &lt; 150 nm and PDI &lt; 0.2 with high EE (about 90%). Cytotoxicity assays in SKOV-3 cells demonstrated the ability of both formulations to cause cellular damage. PCX encapsulated in PN-PCX-FA at 1 nM showed higher cytotoxicity than PN-PCX. Folate-modified nanoparticles showed a 3.6-fold higher cellular uptake than unmodified nanoparticles. PN-PCX-FA is a promising system to improve safety and efficacy of ovarian cancer treatment. Further in vivo studies are necessary to prove PN-PCX-FA potential.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Luiz</LastName>
                    <ForeName>Marcela Tavares</ForeName>
                    <Initials>MT</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Pharmaceutical Science of Ribeirão Preto, University of São Paulo, Avenida do café s/n, 14040-903 Ribeirão Preto, SP, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Abriata</LastName>
                    <ForeName>Juliana Palma</ForeName>
                    <Initials>JP</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Pharmaceutical Science of Ribeirão Preto, University of São Paulo, Avenida do café s/n, 14040-903 Ribeirão Preto, SP, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Raspantini</LastName>
                    <ForeName>Giovanni Loureiro</ForeName>
                    <Initials>GL</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Pharmaceutical Science of Ribeirão Preto, University of São Paulo, Avenida do café s/n, 14040-903 Ribeirão Preto, SP, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tofani</LastName>
                    <ForeName>Larissa Bueno</ForeName>
                    <Initials>LB</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Pharmaceutical Science of Ribeirão Preto, University of São Paulo, Avenida do café s/n, 14040-903 Ribeirão Preto, SP, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fumagalli</LastName>
                    <ForeName>Fernando</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Pharmaceutical Science of Ribeirão Preto, University of São Paulo, Avenida do café s/n, 14040-903 Ribeirão Preto, SP, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>de Melo</LastName>
                    <ForeName>Shaiani Maria Gil</ForeName>
                    <Initials>SMG</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Pharmaceutical Science of Ribeirão Preto, University of São Paulo, Avenida do café s/n, 14040-903 Ribeirão Preto, SP, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Emery</LastName>
                    <ForeName>Flavio da Silva</ForeName>
                    <Initials>FDS</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Pharmaceutical Science of Ribeirão Preto, University of São Paulo, Avenida do café s/n, 14040-903 Ribeirão Preto, SP, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Swiech</LastName>
                    <ForeName>Kamilla</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Pharmaceutical Science of Ribeirão Preto, University of São Paulo, Avenida do café s/n, 14040-903 Ribeirão Preto, SP, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Marcato</LastName>
                    <ForeName>Priscyla Daniely</ForeName>
                    <Initials>PD</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Pharmaceutical Science of Ribeirão Preto, University of São Paulo, Avenida do café s/n, 14040-903 Ribeirão Preto, SP, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Robert</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Pharmaceutics and Pharmaceutical Chemistry, Ohio State University, Columbus, OH, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Marchetti</LastName>
                    <ForeName>Juliana Maldonado</ForeName>
                    <Initials>JM</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Pharmaceutical Science of Ribeirão Preto, University of São Paulo, Avenida do café s/n, 14040-903 Ribeirão Preto, SP, Brazil. Electronic address: jmarchet@usp.br.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>30</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Mater Sci Eng C Mater Biol Appl</MedlineTA>
            <NlmUniqueID>101484109</NlmUniqueID>
            <ISSNLinking>0928-4931</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Active targeting</Keyword>
            <Keyword MajorTopicYN="N">Chemotherapy</Keyword>
            <Keyword MajorTopicYN="N">Folic acid</Keyword>
            <Keyword MajorTopicYN="N">Nanocarrier</Keyword>
            <Keyword MajorTopicYN="N">Ovarian cancer</Keyword>
            <Keyword MajorTopicYN="N">Polymeric nanoparticles</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>12</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>25</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31546359</ArticleId>
            <ArticleId IdType="pii">S0928-4931(18)33684-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.msec.2019.110038</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31546202</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>28</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-4235</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>145</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Dec</Month>
                        <Day>01</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Biosensors &amp; bioelectronics</Title>
                <ISOAbbreviation>Biosens Bioelectron</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Simple and universal signal labeling of cell surface for amplified detection of cancer cells via mild reduction.</ArticleTitle>
            <Pagination>
                <MedlinePgn>111714</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0956-5663(19)30793-6</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bios.2019.111714</ELocationID>
            <Abstract>
                <AbstractText>Membrane protein, a novel surface biomarker, plays an important role in cell recognition and disease diagnosis. Accurate recognition of membrane protein ensure high specificity of cell identification, while introducing signal molecules onto cell membrane is critical to achieve high sensitivity. In this work, we introduced a simple and universal signal labeling approach for cancer cell detection based on mild reduction-mediated cell engineering. This approach included the mild reduction of disulfide bonds within membrane proteins and the introduction of DNA bridge complex-templated silver nanoclusters (DNA bridge-AgNCs) through the thiol-maleimide conjugation. The mild reduction reactions on the cell surface significantly increased the binding sites for signal labeling, and DNA bridge-AgNCs served as a scaffold of signal amplification, resulting in a wide linear range from 50-2 × 10<sup>6</sup> cells, and a detection limit of 15 cells. In addition, the method also showed good selectivity in complex environment. Therefore, this method may have great application space in the field of cell detection and even disease diagnosis in the near future.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Lingling</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Molecular Recognition and Biosensing, School of Life Sciences, Shanghai University, 200444, PR China; Shanghai Key Laboratory of Bio-Energy Crops, Shanghai University, 200444, PR China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Han</LastName>
                    <ForeName>Bing</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Molecular Recognition and Biosensing, School of Life Sciences, Shanghai University, 200444, PR China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Ying</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Molecular Recognition and Biosensing, School of Life Sciences, Shanghai University, 200444, PR China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhao</LastName>
                    <ForeName>Jing</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Molecular Recognition and Biosensing, School of Life Sciences, Shanghai University, 200444, PR China. Electronic address: jingzhao@t.shu.edu.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cao</LastName>
                    <ForeName>Ya</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Molecular Recognition and Biosensing, School of Life Sciences, Shanghai University, 200444, PR China. Electronic address: conezimint@shu.edu.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Biosens Bioelectron</MedlineTA>
            <NlmUniqueID>9001289</NlmUniqueID>
            <ISSNLinking>0956-5663</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Cancer cell detection</Keyword>
            <Keyword MajorTopicYN="N">DNA bridge</Keyword>
            <Keyword MajorTopicYN="N">Electrochemical sensing</Keyword>
            <Keyword MajorTopicYN="N">Mild reduction</Keyword>
            <Keyword MajorTopicYN="N">Silver nanoclusters</Keyword>
            <Keyword MajorTopicYN="N">Thiol-maleimide conjugation</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31546202</ArticleId>
            <ArticleId IdType="pii">S0956-5663(19)30793-6</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bios.2019.111714</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31546198</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>02</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">2210-7762</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>239</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Cancer genetics</Title>
                <ISOAbbreviation>Cancer Genet</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Single nucleotide polymorphism rs10889677 in miRNAs Let-7e and Let-7f binding site of IL23R gene is a strong colorectal cancer determinant: Report and meta-analysis.</ArticleTitle>
            <Pagination>
                <MedlinePgn>46-53</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S2210-7762(19)30084-5</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cancergen.2019.09.003</ELocationID>
            <Abstract>
                <AbstractText>Single nucleotide polymorphisms (SNPs) in the recognition sites of microRNAs (miRNAs), located at 3' untranslated region (UTR) of mRNAs, interfere with posttranslational gene regulation. Deregulation of genes may contribute to some disease susceptibility including colorectal cancer (CRC). In the present study, in a case-control setup, 167 CRC patients and 161 control subjects were studied for allele and genotype frequency of rs10889677 polymorphism in miRNAs Let-7e and Let-7f binding sites at 3' UTR of IL23R gene using PCR-RFLP assay. Also, related articles were retrieved from MEDLINE, Cochrane review, Google Scholar and Scopus databases for meta-analysis study. According to our results, AA genotype of SNP rs10889677 was significantly correlated with increased risk of CRC (OR = 3.10; 95% CI [1.86-5.18]; P: &lt; 0.001). In a meta-analysis on 10 risk estimates for the CC versus AA genotype, we found an inverse association between CC SNPs and risk of all cancer (OR = 0.59; 95% CI [0.49-0.71]; P &lt; 0.001). In conclusion, our results demonstrate that rs10889677 polymorphism is significantly associated with CRC risk.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Mosallaei</LastName>
                    <ForeName>Meysam</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Simonian</LastName>
                    <ForeName>Miganoosh</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Esmaeilzadeh</LastName>
                    <ForeName>Emran</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Neuroscience Research Center, Iran University of Medical Science, Tehran, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bagheri</LastName>
                    <ForeName>Hadi</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Miraghajani</LastName>
                    <ForeName>Maryam</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Salehi</LastName>
                    <ForeName>Ahmad Reza</ForeName>
                    <Initials>AR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mehrzad</LastName>
                    <ForeName>Valiollah</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Salehi</LastName>
                    <ForeName>Rasoul</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran; Gerfa Namayesh Azmayesh (GENAZMA) Science &amp; Research Institute, Isfahan, Iran. Electronic address: r_salehi@med.mui.ac.ir.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Cancer Genet</MedlineTA>
            <NlmUniqueID>101539150</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Colorectal cancer</Keyword>
            <Keyword MajorTopicYN="N">IL23R</Keyword>
            <Keyword MajorTopicYN="N">MicroRNA</Keyword>
            <Keyword MajorTopicYN="N">Single nucleotide polymorphism</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>02</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31546198</ArticleId>
            <ArticleId IdType="pii">S2210-7762(19)30084-5</ArticleId>
            <ArticleId IdType="doi">10.1016/j.cancergen.2019.09.003</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31546197</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>04</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1768-3254</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>183</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Dec</Month>
                        <Day>01</Day>
                    </PubDate>
                </JournalIssue>
                <Title>European journal of medicinal chemistry</Title>
                <ISOAbbreviation>Eur J Med Chem</ISOAbbreviation>
            </Journal>
            <ArticleTitle>1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships.</ArticleTitle>
            <Pagination>
                <MedlinePgn>111700</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0223-5234(19)30852-9</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejmech.2019.111700</ELocationID>
            <Abstract>
                <AbstractText>Anticancer agents are critical for the cancer treatment, but side effects and the drug resistance associated with the currently used anticancer agents create an urgent need to explore novel drugs with low side effects and high efficacy. 1,2,3-Triazole is privileged building block in the discovery of new anticancer agents, and some of its derivatives have already been applied in clinics or under clinical trials for fighting against cancers. Hybrid molecules occupy an important position in cancer control, and hybridization of 1,2,3-triazole framework with other anticancer pharmacophores may provide valuable therapeutic intervention for the treatment of cancer, especially drug-resistant cancer. This review emphasizes the recent advances in 1,2,3-triazole-containing hybrids with anticancer potential, covering articles published between 2015 and 2019, and the structure-activity relationships, together with mechanisms of action are also discussed.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier Masson SAS. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Xu</LastName>
                    <ForeName>Zhi</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Guizhou University of Traditional Chinese Medicine, Guiyang, 550025, PR China. Electronic address: chemorgchem@126.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhao</LastName>
                    <ForeName>Shi-Jia</ForeName>
                    <Initials>SJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Wuhan University of Science and Technology, Wuhan, PR China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Yi</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Wuhan University of Science and Technology, Wuhan, PR China. Electronic address: yiliuchem@whu.edu.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>16</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>France</Country>
            <MedlineTA>Eur J Med Chem</MedlineTA>
            <NlmUniqueID>0420510</NlmUniqueID>
            <ISSNLinking>0223-5234</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">1,2,3-Triazole</Keyword>
            <Keyword MajorTopicYN="N">Action mechanism</Keyword>
            <Keyword MajorTopicYN="N">Anticancer</Keyword>
            <Keyword MajorTopicYN="N">Hybrid molecules</Keyword>
            <Keyword MajorTopicYN="N">Structure-activity relationship</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>08</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31546197</ArticleId>
            <ArticleId IdType="pii">S0223-5234(19)30852-9</ArticleId>
            <ArticleId IdType="doi">10.1016/j.ejmech.2019.111700</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31546196</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>04</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1768-3254</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>183</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Dec</Month>
                        <Day>01</Day>
                    </PubDate>
                </JournalIssue>
                <Title>European journal of medicinal chemistry</Title>
                <ISOAbbreviation>Eur J Med Chem</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Alkynyl Gold(I) complexes derived from 3-hydroxyflavones as multi-targeted drugs against colon cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn>111661</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0223-5234(19)30805-0</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejmech.2019.111661</ELocationID>
            <Abstract>
                <AbstractText>The design of multi-targeted drugs has gained considerable interest in the last decade thanks to their advantages in the treatment of different diseases, including cancer. The simultaneous inhibition of selected targets from cancerous cells to induce their death represents an attractive objective for the medicinal chemist in order to enhance the efficiency of chemotherapy. In the present work, several alkynyl gold(I) phosphane complexes derived from 3-hydroxyflavones active against three human cancer cell lines, colorectal adenocarcinoma Caco-2/TC7, breast adenocarcinoma MCF-7 and hepatocellular carcinoma HepG2, have been synthesized and characterized. Moreover, these compounds display high selective index values towards differentiated Caco-2 cells, which are considered as a model of non-cancerous cells. The antiproliferative effect of the most active complexes [Au(L2b)PPh<sub>3</sub>] (3b) and [Au(L2c)PTA] (4c) on Caco-2 cells, seems to be mediated by the inhibition of the enzyme cyclooxygenase-1/2 and alteration of the activities of the redox enzymes thioredoxin reductase and glutathione reductase. Both complexes triggered cell death by apoptosis, alterations in cell cycle progression and increased of ROS production. These results provide support for the suggestion that multi-targeting approach involving the interaction with cyclooxygenase-1/2 and the redox enzymes that increases ROS production, enhances cell death in vitro. All these results indicate that complexes [Au(L2b)PPh<sub>3</sub>] and [Au(L2c)PTA] are promising antiproliferative agents for further anticancer drug development.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier Masson SAS. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Mármol</LastName>
                    <ForeName>Inés</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departamento de Química Inorgánica, Instituto de Síntesis Química y Catálisis Homogénea-ISQCH, Universidad de Zaragoza-C.S.I.C., 50009, Zaragoza, Spain; Departamento de Farmacología y Fisiología, Unidad de Fisiología, Universidad de Zaragoza, CIBERobn, IIS Aragón, IA2, 50013, Zaragoza, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Castellnou</LastName>
                    <ForeName>Pilar</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departamento de Química Inorgánica, Instituto de Síntesis Química y Catálisis Homogénea-ISQCH, Universidad de Zaragoza-C.S.I.C., 50009, Zaragoza, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Alvarez</LastName>
                    <ForeName>Raquel</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departamento de Farmacología y Fisiología, Unidad de Fisiología, Universidad de Zaragoza, CIBERobn, IIS Aragón, IA2, 50013, Zaragoza, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gimeno</LastName>
                    <ForeName>M Concepción</ForeName>
                    <Initials>MC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departamento de Química Inorgánica, Instituto de Síntesis Química y Catálisis Homogénea-ISQCH, Universidad de Zaragoza-C.S.I.C., 50009, Zaragoza, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rodríguez-Yoldi</LastName>
                    <ForeName>M Jesús</ForeName>
                    <Initials>MJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departamento de Farmacología y Fisiología, Unidad de Fisiología, Universidad de Zaragoza, CIBERobn, IIS Aragón, IA2, 50013, Zaragoza, Spain. Electronic address: mjrodyol@unizar.es.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cerrada</LastName>
                    <ForeName>Elena</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Departamento de Química Inorgánica, Instituto de Síntesis Química y Catálisis Homogénea-ISQCH, Universidad de Zaragoza-C.S.I.C., 50009, Zaragoza, Spain. Electronic address: ecerrada@unizar.es.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>France</Country>
            <MedlineTA>Eur J Med Chem</MedlineTA>
            <NlmUniqueID>0420510</NlmUniqueID>
            <ISSNLinking>0223-5234</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Alkynyl</Keyword>
            <Keyword MajorTopicYN="N">COX</Keyword>
            <Keyword MajorTopicYN="N">Gold complexes</Keyword>
            <Keyword MajorTopicYN="N">Hidroxyflavones</Keyword>
            <Keyword MajorTopicYN="N">Multi-target</Keyword>
            <Keyword MajorTopicYN="N">ROS</Keyword>
            <Keyword MajorTopicYN="N">Thioredoxin reductase</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31546196</ArticleId>
            <ArticleId IdType="pii">S0223-5234(19)30805-0</ArticleId>
            <ArticleId IdType="doi">10.1016/j.ejmech.2019.111661</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31546023</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>09</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1872-7980</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>466</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Dec</Month>
                        <Day>01</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cancer letters</Title>
                <ISOAbbreviation>Cancer Lett.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Regulation of F-box proteins by noncoding RNAs in human cancers.</ArticleTitle>
            <Pagination>
                <MedlinePgn>61-70</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0304-3835(19)30472-0</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.canlet.2019.09.008</ELocationID>
            <Abstract>
                <AbstractText>F-box proteins (FBPs) are proteins containing an F-box domain and are one of three subunits in SKP1-Cullin1-F-box protein (SCF) E3 ligase complexes. Accumulated evidence has shown that FBP regulates tumorigenesis and the progression of human cancer via ubiquitination and degradation of downstream substrates, which can be oncoproteins or tumor suppressors. Emerging evidence has revealed that noncoding RNAs (ncRNAs) govern the expression of FBP in human cancers. Specifically, microRNAs (miRNAs), long ncRNAs (lncRNAs), and circular RNAs (circRNAs) have been shown to govern FBP expression in malignancies. Therefore, in this review article, we discuss how miRNAs target FBPs and participate in tumorigenesis and tumor progression. Moreover, we briefly highlight the role of lncRNAs and circRNAs in the regulation of FBPs in cancer. Therefore, targeting ncRNAs could be a novel approach to regulate FBPs for anticancer therapy.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lin</LastName>
                    <ForeName>Min</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325027, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xu</LastName>
                    <ForeName>Yichi</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325027, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gao</LastName>
                    <ForeName>Ying</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325027, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pan</LastName>
                    <ForeName>Chunyu</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325027, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhu</LastName>
                    <ForeName>Xueqiong</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325027, China. Electronic address: zjwzzxq@163.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Zhi-Wei</ForeName>
                    <Initials>ZW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325027, China; Department of Biochemistry and Molecular Biology, School of Laboratory Medicine, Bengbu Medical College, Bengbu, Anhui, 233030, China; Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. Electronic address: zwang6@bidmc.harvard.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>20</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Ireland</Country>
            <MedlineTA>Cancer Lett</MedlineTA>
            <NlmUniqueID>7600053</NlmUniqueID>
            <ISSNLinking>0304-3835</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">FBXW7</Keyword>
            <Keyword MajorTopicYN="N">MiRNA</Keyword>
            <Keyword MajorTopicYN="N">Skp2</Keyword>
            <Keyword MajorTopicYN="N">Ubiquitination</Keyword>
            <Keyword MajorTopicYN="N">β-TrCP</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31546023</ArticleId>
            <ArticleId IdType="pii">S0304-3835(19)30472-0</ArticleId>
            <ArticleId IdType="doi">10.1016/j.canlet.2019.09.008</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31546010</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>29</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1096-3650</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                        <Day>20</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Seminars in cancer biology</Title>
                <ISOAbbreviation>Semin. Cancer Biol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>What patents tell us about drug repurposing for cancer: A landscape analysis.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S1044-579X(19)30281-0</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.semcancer.2019.09.010</ELocationID>
            <Abstract>
                <AbstractText>Intellectual property documents (patents and their published applications) are not only collections of legal exclusivity claims but also repositories of scientific and technical information, even though they are not peer reviewed. We have identified and analyzed international disclosures concerning drug repurposing for cancer that were published under the Patent Convention Treaty during the past five years, and show this burgeoning field from an angle that is not routinely captured in review papers of the field. We find that patenting activity for cancer-related new uses for known compounds has been quite constant recently and has targeted mainly small molecule active ingredients that are currently marketed as drugs. Universities contributed most applications, closely followed by corporations. The strong representation of non-academic research institutes from the public and private sector and foundations was surprising and indicates that drug repurposing for cancer has transcended the classical corporate-academia dichotomy. Many of the identified patent documents report findings that are not reflected in the peer review literature (e.g., sumatriptan for mycosis fungoides) or appear there only later (e.g., ibudilast for glioblastoma). Synergistic combinations of several repurposed compounds were also identified, as were two documents related to the repurposing of vaccines. Our findings underscore the necessity for drug repurposers as well as for oncologists to investigate patent documents in addition to the usual peer review literature search to obtain a comprehensive perspective of the state of the art.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Mucke</LastName>
                    <ForeName>Hermann A M</ForeName>
                    <Initials>HAM</Initials>
                    <AffiliationInfo>
                        <Affiliation>H. M. Pharma Consultancy, Enenkelstr. 28/32, A-1160 Wien, Austria. Electronic address: h.mucke@hmpharmacon.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>20</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Semin Cancer Biol</MedlineTA>
            <NlmUniqueID>9010218</NlmUniqueID>
            <ISSNLinking>1044-579X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Drug repositioning</Keyword>
            <Keyword MajorTopicYN="N">Intellectual property</Keyword>
            <Keyword MajorTopicYN="N">Neoplasms</Keyword>
            <Keyword MajorTopicYN="N">Patents as topic</Keyword>
            <Keyword MajorTopicYN="N">Vaccine</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31546010</ArticleId>
            <ArticleId IdType="pii">S1044-579X(19)30281-0</ArticleId>
            <ArticleId IdType="doi">10.1016/j.semcancer.2019.09.010</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31545985</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>26</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1879-0712</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>863</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>European journal of pharmacology</Title>
                <ISOAbbreviation>Eur. J. Pharmacol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>ER-mediated anti-tumor effects of shikonin on breast cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn>172667</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0014-2999(19)30619-3</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejphar.2019.172667</ELocationID>
            <Abstract>
                <AbstractText>Estrogen receptor (ER) is expressed in most Breast cancer (BC) patients. G protein-coupled estrogen receptor (GPER), which is a membrane-bound estrogen receptor, is associated with the tumor development and progression in BC. Shikonin (SK) is a natural compound that is known to have anti-tumor effects. This study aims to assess the effects of shikonin on the cell proliferation, cell cycle and cell apoptosis of BC and whether the effects are related to ER/GPER signaling pathway. The results demonstrated that shikonin inhibited the cellular proliferation of MCF-7 BC cells via G<sub>0</sub>/G<sub>1</sub> arrest and apoptosis in concentration-dependent manner. The anti-proliferative effect of SK on SK-BR-3 BC cells was associated with apoptosis. Both ERα and GPER were expressed in MCF-7 cells, while ERα were negative and GPER were positive in SK-BR-3 cells. Furthermore, shikonin downregulated the expression of ERα and GPER, and this effect was not affected by the estrogen environment. In addition, shikonin downregulated the EGFR and p-ERK expression in MCF-7 and SK-BR-3, which was also not affected by the estrogen environment. EGFR and p-ERK were still suppressed by co-treatment with the selective GPER against G1 or antagonist G15. In conclusion, these results suggest that shikonin shows anti-tumor effects on MCF-7 and SK-BR-3 cells. The effects seem to be associated with EGFR/p-ERK downregulation via ERα and GPER inhibition.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Yang</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gao</LastName>
                    <ForeName>Wenya</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tao</LastName>
                    <ForeName>Shiying</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China. Electronic address: taoshiying@bucm.edu.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Yanxia</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Dongzhimen Hospital Affiliated with Beijing University of Chinese Medicine, Beijing, 100029, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Niu</LastName>
                    <ForeName>Jianzhao</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhao</LastName>
                    <ForeName>Piwen</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Life Sciences, Beijing University of Chinese Medicine, Beijing, 100029, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rao</LastName>
                    <ForeName>Chenchen</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Lei</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Dongfang Hospital Affiliated with Beijing University of Chinese Medicine, Beijing, 100029, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>20</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Eur J Pharmacol</MedlineTA>
            <NlmUniqueID>1254354</NlmUniqueID>
            <ISSNLinking>0014-2999</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Breast cancer</Keyword>
            <Keyword MajorTopicYN="N">Estrogen receptor</Keyword>
            <Keyword MajorTopicYN="N">G protein-coupled estrogen receptor</Keyword>
            <Keyword MajorTopicYN="N">Shikonin</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>04</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31545985</ArticleId>
            <ArticleId IdType="pii">S0014-2999(19)30619-3</ArticleId>
            <ArticleId IdType="doi">10.1016/j.ejphar.2019.172667</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">31545955</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>21</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>22</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1872-7786</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>313</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>01</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Chemico-biological interactions</Title>
                <ISOAbbreviation>Chem. Biol. Interact.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The anti-cancer drug doxorubicin induces substantial epigenetic changes in cultured cardiomyocytes.</ArticleTitle>
            <Pagination>
                <MedlinePgn>108834</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0009-2797(19)31136-6</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cbi.2019.108834</ELocationID>
            <Abstract>
                <AbstractText>The anthracycline doxorubicin (DOX) is widely used in cancer therapy with the limitation of cardiotoxicity leading to the development of congestive heart failure. DOX-induced oxidative stress and changes of the phosphoproteome as well as epigenome were described but the exact mechanisms of the adverse long-term effects are still elusive. Here, we tested the impact of DOX treatment on cell death, oxidative stress parameters and expression profiles of proteins involved in epigenetic pathways in a cardiomyocyte cell culture model. Markers of oxidative stress, apoptosis and expression of proteins involved in epigenetic processes were assessed by immunoblotting in cultured rat myoblasts (H9c2) upon treatment with DOX (1 or 5 μM for 24 or 48 h) in adherent viable and detached apoptotic cells. The apoptosis markers cleaved caspase-3 and fractin as well as oxidative stress markers 3-nitrotyrosine and malondialdehyde were dose-dependently increased by DOX treatment. Histone deacetylases (SIRT1 and HDAC2), histone lysine demethylases (KDM3A and LSD1) and histone lysine methyltransferases (SET7 and SMYD1) were significantly regulated by DOX treatment with generation of cleaved protein fragments and posttranslational modifications. Overall, we found significant decrease in histone 3 acetylation in DOX-treated cells. DOX treatment of cultured cardiomyocyte precursor cells causes severe cell death by apoptosis associated with cellular oxidative stress. In addition, significant regulation of proteins involved in epigenetic processes and changes in global histone 3 acetylation were observed. However, the significance and clinical impact of these changes remain elusive.</AbstractText>
                <CopyrightInformation>Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Hanf</LastName>
                    <ForeName>Alina</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Cardiology, Department of Cardiology - Molecular Cardiology, University Medical Center, 55131, Mainz, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Oelze</LastName>
                    <ForeName>Matthias</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Cardiology, Department of Cardiology - Molecular Cardiology, University Medical Center, 55131, Mainz, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Manea</LastName>
                    <ForeName>Adrian</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Cellular Biology and Pathology &quot;Nicolae Simionescu&quot; of the Romanian Academy, 8, B.P. Hasdeu Street, 050568, Bucharest, Romania.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Huige</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacology, Johannes Gutenberg University Medical Center, 55131, Mainz, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Münzel</LastName>
                    <ForeName>Thomas</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Cardiology, Department of Cardiology - Molecular Cardiology, University Medical Center, 55131, Mainz, Germany; Partner Site Rhine-Main, German Center for Cardiovascular Research (DZHK), Langenbeckstr. 1, 55131, Mainz, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Daiber</LastName>
                    <ForeName>Andreas</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Cardiology, Department of Cardiology - Molecular Cardiology, University Medical Center, 55131, Mainz, Germany; Partner Site Rhine-Main, German Center for Cardiovascular Research (DZHK), Langenbeckstr. 1, 55131, Mainz, Germany. Electronic address: daiber@uni-mainz.de.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>20</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Ireland</Country>
            <MedlineTA>Chem Biol Interact</MedlineTA>
            <NlmUniqueID>0227276</NlmUniqueID>
            <ISSNLinking>0009-2797</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000903">Antibiotics, Antineoplastic</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D006657">Histones</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>80168379AG</RegistryNumber>
                <NameOfSubstance UI="D004317">Doxorubicin</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>BBX060AN9V</RegistryNumber>
                <NameOfSubstance UI="D006861">Hydrogen Peroxide</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 1.14.11.-</RegistryNumber>
                <NameOfSubstance UI="D056466">Histone Demethylases</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 1.14.11.-</RegistryNumber>
                <NameOfSubstance UI="C557089">LSD1 protein, rat</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 3.5.1.98</RegistryNumber>
                <NameOfSubstance UI="D006655">Histone Deacetylases</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>EC 3.5.1.98</RegistryNumber>
                <NameOfSubstance UI="C000624330">histone demethylase KDM3a, rat</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000903" MajorTopicYN="N">Antibiotics, Antineoplastic</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D066126" MajorTopicYN="N">Cardiotoxicity</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004317" MajorTopicYN="N">Doxorubicin</DescriptorName>
                <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D044127" MajorTopicYN="N">Epigenesis, Genetic</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006655" MajorTopicYN="N">Histone Deacetylases</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D056466" MajorTopicYN="N">Histone Demethylases</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006657" MajorTopicYN="N">Histones</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006861" MajorTopicYN="N">Hydrogen Peroxide</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D032383" MajorTopicYN="N">Myocytes, Cardiac</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
                <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
                <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Anticancer drug</Keyword>
            <Keyword MajorTopicYN="N">Cardiomyocyte</Keyword>
            <Keyword MajorTopicYN="N">Cardiomyopathy</Keyword>
            <Keyword MajorTopicYN="N">Doxorubicin</Keyword>
            <Keyword MajorTopicYN="N">Epigenetic reprogramming</Keyword>
            <Keyword MajorTopicYN="N">Epigenetics</Keyword>
            <Keyword MajorTopicYN="N">Oxidative stress</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31545955</ArticleId>
            <ArticleId IdType="pii">S0009-2797(19)31136-6</ArticleId>
            <ArticleId IdType="doi">10.1016/j.cbi.2019.108834</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31545907</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1208-6002</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                        <Day>23</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Biochemistry and cell biology = Biochimie et biologie cellulaire</Title>
                <ISOAbbreviation>Biochem. Cell Biol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Extracellular pyruvate kinase M2 facilitates cell migration by upregulating claudin-1 expression in colon cancer cells.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1139/bcb-2019-0139</ELocationID>
            <Abstract>
                <AbstractText>Extensive studies have been reported the non-canonical functions of pyruvate kinase M2 (PKM2) as kinase, transcriptional regulator and even cell-to-cell communicator, emphasizing its importance in various signaling pathways. However, the role of secreted PKM2 in cancer progression and its signaling pathway is yet to be elucidated. In this study, we found that extracellular PKM2 enhanced the migration of low-metastatic, benign colon cancer cells by upregulating claudin-1 expression and internalizing it to the cytoplasm and nucleus. Knock down of claudin-1 significantly reduced extracellular PKM2-induced cell migration. Inhibition of either protein kinase C (PKC) or epidermal growth factor receptor (EGFR) resulted in a reduction of extracellular PKM2 mediated claudin-1 expression, suggesting EGFR-PKC-claudin-1 as a signaling pathway in the extracellular PKM2-mediated tumorigenesis of colon cancer cells.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Hyunju</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Korea Institute of Science and Technology, 58975, Seoul, Korea (the Republic of) ; red-moon-414@hanmail.net.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Seong Ho</ForeName>
                    <Initials>SH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Korea Institute of Science and Technology, 58975, Seoul, Korea (the Republic of).</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Korea University of Science and Technology, Division of Bio-Medial Science and Technology, Seoul, Korea (the Republic of) ; H14513@kist.re.kr.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hwang</LastName>
                    <ForeName>Dohyeon</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Korea Institute of Science and Technology, 58975, Seoul, Korea (the Republic of) ; engus8992@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>An</LastName>
                    <ForeName>Jinsu</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Korea Institute of Science and Technology, 58975, Seoul, Seoul, Korea (the Republic of).</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Korea University of Science and Technology, Division of Bio-Medical Science and Technology, Seoul, Korea (the Republic of) ; h16009@kist.re.kr.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chung</LastName>
                    <ForeName>Hak Suk</ForeName>
                    <Initials>HS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Korea Institute of Science and Technology, 58975, Seoul, Korea (the Republic of).</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Korea University of Science and Technology, Division of Bio-Medical Science and Technology, Seoul, Korea (the Republic of) ; hschung@kist.re.kr.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Eun Gyeong</ForeName>
                    <Initials>EG</Initials>
                    <AffiliationInfo>
                        <Affiliation>Korea Institute of Science and Technology, 58975, Seoul, Korea (the Republic of) ; eunyang@kist.re.kr.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>So Yeon</ForeName>
                    <Initials>SY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Korea Institute of Science and Technology, 58975, Biomedical Research Institute, Seoul, Korea (the Republic of).</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Korea University of Science and Technology, Division of Bio-Medical Science and Technology, Seoul, Korea (the Republic of) ; soyeonkim@kist.re.kr.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Canada</Country>
            <MedlineTA>Biochem Cell Biol</MedlineTA>
            <NlmUniqueID>8606068</NlmUniqueID>
            <ISSNLinking>0829-8211</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31545907</ArticleId>
            <ArticleId IdType="doi">10.1139/bcb-2019-0139</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31545905</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1205-7541</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                        <Day>23</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Canadian journal of physiology and pharmacology</Title>
                <ISOAbbreviation>Can. J. Physiol. Pharmacol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Effects of Somatostatin, Curcumin and Quercetin on the fatty acid profile of breast cancer cell membranes.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1139/cjpp-2019-0352</ELocationID>
            <Abstract>
                <AbstractText>We used MCF-7 and MDA-MB231 breast cancer cells incubated with Curcumin and Quercetin for 24h, in the absence and presence of Somatostatin, at their EC50 concentrations, to evaluate membrane fatty acid-based functional lipidomics together with the follow-up of EGFR and MAPK signaling pathways. The two cell lines gave different membrane free fatty acid reorganization: in MCF-7 cells, the following changes observed: increase of omega-6 linoleic acid in the cells incubated with Somatostatin+Quercetin and Quercetin and decrease of omega-3 acids in the cells incubated with Somatostatin+Curcumin compared to Somatostatin, and significant increases of monounsaturated fatty acid (MUFA), mono-trans arachidonic acid levels and docosapentaenoic acid for the cells incubated with Somatostatin+Quercetin compared to the control cells. In MDA-MB231 cells, incubations with Curcumin, Quercetin and Somatostatin+Quercetin induced the most significant membrane remodeling with the increase of stearic acid, diminution of omega-6 linoleic, arachidonic acids and omega-3 (docosapentaenoic and docosahexaenoic acids). Distinct signaling pathway changes were found for these cell lines. In MCF-7 cells, separate or combined incubations with Somatostatin and Quercetin, significantly decreased EGFR and incubation with Curcumin decreased MAPK signaling. In MDA-MB231 cells, incubation with Curcumin decreased AKT1 and p-AKT1(Thr308) levels. Incubation with Curcumin and Quercetin decreased the EGFR levels.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Hanikoglu</LastName>
                    <ForeName>Aysegul</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Akdeniz University, 37502, Department of Biochemistry, Faculty of Medicine, Antalya, Turkey ; aysegulhanikoglu@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kucuksayan</LastName>
                    <ForeName>Ertan</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Alanya Alaaddin Keykubat University, 450199, Department of Biochemistry, Faculty of Medicine, Alanya, Antalya, Turkey ; ertankucuksayan@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hanikoglu</LastName>
                    <ForeName>Ferhat</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Biruni University, 420479, Department of Biochemistry, Faculty of Medicine, Istanbul, Topkapi, Turkey ; ferhathanikoglu@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ozben</LastName>
                    <ForeName>Tomris</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Akdeniz University, 37502, Department of Biochemistry, Faculty of Medicine, Antalya, Turkey ; ozben@akdeniz.edu.tr.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Menounou</LastName>
                    <ForeName>Georgia</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Consiglio Nazionale delle Ricerche, 9327, ISOF,, Via Piero Gobetti 101, 40129 Bologna, Lazio, Italy ; gewrgiamenounou@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sansone</LastName>
                    <ForeName>Anna</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Consiglio Nazionale delle Ricerche, 9327, ISOF, Via Piero Gobetti 101, 40129 Bologna, Lazio, Italy ; anna.sansone@isof.cnr.it.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chatgilialoglu</LastName>
                    <ForeName>Chrys</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Consiglio Nazionale delle Ricerche, 9327, ISOF, Via Piero Gobetti 101, 40129 Bologna, Lazio, Italy ; c.chatgilialoglu@inn.demokritos.gr.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Di Bella</LastName>
                    <ForeName>Giuseppe</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Di Bella, 411540, Foundation, Via G. Marconi 51, 40122 Bologna, Italy ; posta@giuseppedibella.it.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ferreri</LastName>
                    <ForeName>Carla</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Consiglio Nazionale delle Ricerche, 9327, ISOF, Via Piero Gobetti 101, , 40129 Bologna, Italy ; carla.ferreri@isof.cnr.it.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Canada</Country>
            <MedlineTA>Can J Physiol Pharmacol</MedlineTA>
            <NlmUniqueID>0372712</NlmUniqueID>
            <ISSNLinking>0008-4212</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31545905</ArticleId>
            <ArticleId IdType="doi">10.1139/cjpp-2019-0352</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31545835</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>14</Volume>
                    <Issue>9</Issue>
                    <PubDate>
                        <Year>2019</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Mexican BRCA1 founder mutation: Shortening the gap in genetic assessment for hereditary breast and ovarian cancer patients.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e0222709</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0222709</ELocationID>
            <Abstract>
                <AbstractText>The deletion of exons 9 to 12 of BRCA1 (9-12 del BRCA1) is considered a founder mutation in the Mexican population. We evaluate the usefulness of the target detection of 9-12 del BRCA1 as the first molecular diagnostic strategy in patients with Hereditary Breast and Ovarian Cancer (HBOC). We performed the genetic assessment of 637 patients with suspected HBOC. The region corresponding to the breakpoints for the 9-12 del BRCA1 was amplified by polymerase chain reaction (PCR). An analysis of the clinical data of the carriers and non-carriers was done, searching for characteristics that correlated with the deletion. The 9-12 del BRCA1 was detected in 5% of patients with suspected HBOC (30/637). In patients diagnosed with ovarian cancer, 13 of 30 were 9-12 del BRCA1 carriers, which represents 43%. We found a significant association between the 9-12 del BRCA1 carriers with triple negative breast cancer and high-grade papillary serous ovarian cancer. We concluded that the detection of the 9-12 del BRCA1 is useful as a first molecular diagnostic strategy in the Mexican population. In particular, it shortens the gap in genetic assessment in patients with triple negative breast cancer and ovarian cancer.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Fragoso-Ontiveros</LastName>
                    <ForeName>Veronica</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hereditary Cancer Clinic, National Cancer Institute, Mexico city, Mexico.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Velázquez-Aragón</LastName>
                    <ForeName>Jose Antonio</ForeName>
                    <Initials>JA</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-3617-8148</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Molecular Biology Laboratory, National Paediatrics Institute, Mexico city, Mexico.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nuñez-Martínez</LastName>
                    <ForeName>Paulina Maria</ForeName>
                    <Initials>PM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hereditary Cancer Clinic, National Cancer Institute, Mexico city, Mexico.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>de la Luz Mejía-Aguayo</LastName>
                    <ForeName>Maria</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hereditary Cancer Clinic, National Cancer Institute, Mexico city, Mexico.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Vidal-Millán</LastName>
                    <ForeName>Silvia</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hereditary Cancer Clinic, National Cancer Institute, Mexico city, Mexico.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pedroza-Torres</LastName>
                    <ForeName>Abraham</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Research Direction, National Cancer Institute, Mexico city, Mexico.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sánchez-Contreras</LastName>
                    <ForeName>Yuliana</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hereditary Cancer Clinic, National Cancer Institute, Mexico city, Mexico.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ramírez-Otero</LastName>
                    <ForeName>Miguel Angel</ForeName>
                    <Initials>MA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hereditary Cancer Clinic, National Cancer Institute, Mexico city, Mexico.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Muñiz-Mendoza</LastName>
                    <ForeName>Rodolfo</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Research Direction, National Cancer Institute, Mexico city, Mexico.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Domínguez-Ortíz</LastName>
                    <ForeName>Julieta</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hereditary Cancer Clinic, National Cancer Institute, Mexico city, Mexico.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wegman-Ostrosky</LastName>
                    <ForeName>Talia</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Hereditary Cancer Clinic, National Cancer Institute, Mexico city, Mexico.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bargalló-Rocha</LastName>
                    <ForeName>Juan Enrique</ForeName>
                    <Initials>JE</Initials>
                    <AffiliationInfo>
                        <Affiliation>Breast Cancer Department, National Cancer Institute, Mexico city, Mexico.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gallardo-Rincón</LastName>
                    <ForeName>Dolores</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Oncology Department, National Cancer Institute, Mexico city, Mexico.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Reynoso-Noveron</LastName>
                    <ForeName>Nancy</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Epidemiology Department, National Cancer Institute, Mexico city, Mexico.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Arriaga-Canon</LastName>
                    <ForeName>Cristian</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Research Direction, National Cancer Institute, Mexico city, Mexico.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Meneses-García</LastName>
                    <ForeName>Abelardo</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>General Direction, National Cancer Institute, Mexico city, Mexico.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Herrera-Montalvo</LastName>
                    <ForeName>Luis Alonso</ForeName>
                    <Initials>LA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Research Direction, National Cancer Institute, Mexico city, Mexico.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Alvarez-Gomez</LastName>
                    <ForeName>Rosa Maria</ForeName>
                    <Initials>RM</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-5458-7201</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Hereditary Cancer Clinic, National Cancer Institute, Mexico city, Mexico.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CoiStatement>The authors have declared that no competing interest exist.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>02</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31545835</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0222709</ArticleId>
            <ArticleId IdType="pii">PONE-D-19-04852</ArticleId>
            <ArticleId IdType="pmc">PMC6756553</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Epidemiol Biomarkers Prev. 2015 Mar;24(3):498-505</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25371446</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Rev Invest Clin. 2017 Mar-Apr;69(2):94-102</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28453507</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>BMC Cancer. 2019 Jul 22;19(1):722</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31331294</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Ann Oncol. 2016 Sep;27(suppl 5):v103-v110</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27664246</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Ann Intern Med. 2014 Feb 18;160(4):271-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24366376</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Genet. 1997 Nov;17(3):341-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9354803</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>JAMA. 2015 Apr 7;313(13):1347-61</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25849179</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nucleic Acids Res. 2002 Jun 15;30(12):e57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12060695</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer. 2015 Feb 1;121(3):372-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25236687</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Natl Compr Canc Netw. 2017 Jan;15(1):9-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28040716</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Breast Cancer Res Treat. 2007 Jul;103(3):349-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17063270</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Clin Oncol. 2013 Jan 10;31(2):210-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23233716</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1666-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16030099</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Pathogenetics. 2008 Nov 03;1(1):4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19014668</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Breast Cancer Res Treat. 2007 Jun;103(2):225-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17080309</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Breast Cancer Res Treat. 2009 Oct;117(3):679-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19333752</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Res. 2008 Sep 1;68(17):7006-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18703817</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Fam Cancer. 2013 Mar;12(1):119-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23117300</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Hum Mutat. 2018 May;39(5):593-620</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29446198</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Genet. 2017 Mar;91(3):482-487</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27357818</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Natl Cancer Inst. 2013 Jun 5;105(11):812-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23628597</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Fam Cancer. 2015 Jun;14(2):287-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25678442</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Hum Mutat. 2000;16(2):123-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10923033</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Salud Publica Mex. 2016 Apr;58(2):101-3</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27557368</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Medicine (Baltimore). 1998 May;77(3):208-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9653432</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1615-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17646271</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncologist. 2016 Jul;21(7):832-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27286788</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2014 Sep 30;111(39):14205-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25192939</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Geburtshilfe Frauenheilkd. 2018 May;78(5):481-492</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29880983</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Lancet Oncol. 2015 Oct;16(14):1405-38</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26522157</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Hum Mutat. 2004 Dec;24(6):534</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15532023</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Cancer. 2004 Sep;4(9):665-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15343273</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2003 Oct 24;302(5645):643-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14576434</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Gynecol Oncol. 2015 Jan;136(1):3-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25238946</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Breast Cancer Res Treat. 2015 Apr;150(2):389-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25716084</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nucleic Acids Res. 2018 Jan 4;46(D1):D1062-D1067</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29165669</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Genet. 1996 Oct;14(2):185-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8841191</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31545701</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1724-6075</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                        <Day>23</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Urologia</Title>
                <ISOAbbreviation>Urologia</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Prostate cancer pathology: What has changed in the last 5 years.</ArticleTitle>
            <Pagination>
                <MedlinePgn>391560319876821</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1177/0391560319876821</ELocationID>
            <Abstract>
                <AbstractText>Prostate cancer is the most frequent non-cutaneous malignancy in men in the United States. In the last few years, many recommendations have been made available from the 2014 International Society of Urologic Pathology consensus conference, 2016 World Health Organization blue book and 2018 8th edition of American Joint Committee on Cancer Staging System. Here, we focus on four topics which are considered relevant on the basis of their common appearance in routine practice, clinical importance and 'need to improve communication between pathology reports and clinicians': prostate cancer classification, prostate cancer grading, prostate cancer staging, and current definition of clinically significant prostate cancer. Tissue biomarkers that can predict significant disease and/or upgrading and tissue-based genomics for the purpose of diagnosis and prognosis are mentioned briefly.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Cimadamore</LastName>
                    <ForeName>Alessia</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Section of Pathological Anatomy, Marche Polytechnic University, School of Medicine, United Hospitals, Ancona, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Scarpelli</LastName>
                    <ForeName>Marina</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Section of Pathological Anatomy, Marche Polytechnic University, School of Medicine, United Hospitals, Ancona, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Raspollini</LastName>
                    <ForeName>Maria Rosaria</ForeName>
                    <Initials>MR</Initials>
                    <AffiliationInfo>
                        <Affiliation>Histopathology and Molecular Diagnostics, Careggi University Hospital, Florence, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Doria</LastName>
                    <ForeName>Andrea</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Section of Pathological Anatomy, Marche Polytechnic University, School of Medicine, United Hospitals, Ancona, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Galosi</LastName>
                    <ForeName>Andrea Benedetto</ForeName>
                    <Initials>AB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Urology, Marche Polytechnic University, School of Medicine, United Hospitals, Ancona, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Massari</LastName>
                    <ForeName>Francesco</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Oncology, Policlinico Sant'Orsola-Malpighi Hospital, Bologna, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Di Nunno</LastName>
                    <ForeName>Vincenzo</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Oncology, Policlinico Sant'Orsola-Malpighi Hospital, Bologna, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cheng</LastName>
                    <ForeName>Liang</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lopez-Beltran</LastName>
                    <ForeName>Antonio</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology and Surgery, Faculty of Medicine, University of Cordoba, Cordoba, Spain.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Montironi</LastName>
                    <ForeName>Rodolfo</ForeName>
                    <Initials>R</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-3938-610X</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Section of Pathological Anatomy, Marche Polytechnic University, School of Medicine, United Hospitals, Ancona, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Urologia</MedlineTA>
            <NlmUniqueID>0417372</NlmUniqueID>
            <ISSNLinking>0391-5603</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Prostate cancer</Keyword>
            <Keyword MajorTopicYN="N">classification</Keyword>
            <Keyword MajorTopicYN="N">clinically significant PCa</Keyword>
            <Keyword MajorTopicYN="N">grading</Keyword>
            <Keyword MajorTopicYN="N">staging</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31545701</ArticleId>
            <ArticleId IdType="doi">10.1177/0391560319876821</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31545552</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>08</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1878-0261</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>13</Volume>
                    <Issue>11</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Molecular oncology</Title>
                <ISOAbbreviation>Mol Oncol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Klotho-mediated targeting of CCL2 suppresses the induction of colorectal cancer progression by stromal cell senescent microenvironments.</ArticleTitle>
            <Pagination>
                <MedlinePgn>2460-2475</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/1878-0261.12577</ELocationID>
            <Abstract>
                <AbstractText>Senescent microenvironments play an important role in tumor progression. Here, we report that doxorubicin (DOX)-pretreated or replicative senescent stromal cells (WI-38 and HUVEC) promote colorectal cancer (CRC) cell growth and invasion in vitro and in vivo. These pro-tumorigenic effects were attenuated by exogenous administration of Klotho, an anti-aging factor. We subsequently identified several senescence-associated secretory phenotype (SASP)-associated genes, including CCL2, which were significantly upregulated in both types of senescent stromal cells during replication and DNA damage-induced senescence. Importantly, we found that the secretion of CCL2 by senescent stromal cells was significantly higher than that seen in nonsenescent cells or in senescent cells pretreated with Klotho. Notably, CCL2 was found to accelerate CRC cell proliferation and invasion, while this effect could be blocked by administration of a specific CCR2 antagonist. We further show that Klotho can suppress NF-κB activation during DOX-induced senescence and thus block CCL2 transcription. Low expression of Klotho, or high expression of CCL2 in patient tumor tissues, correlated with poor overall survival of CRC patients. Collectively, our findings suggest that senescent stromal cells are linked to progression of CRC. Klotho can suppress the senescent stromal cell-associated triggering of CRC progression by inhibiting the expression of SASP factors including CCL2. The identification of key SASP factors such as CCL2 may provide potential therapeutic targets for improving CRC therapy.</AbstractText>
                <CopyrightInformation>© 2019 The Authors. Published by FEBS Press and John Wiley &amp; Sons Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Yangyang</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Institution of Gastroenterology, Zhejiang University, Hangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterology, The Sixth Affiliated Hospital of Wenzhou Medical University, Lishui People's Hospital, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pan</LastName>
                    <ForeName>Jie</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institution of Gastroenterology, Zhejiang University, Hangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Endocrinology and Metabolism, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pan</LastName>
                    <ForeName>Xia</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Institution of Gastroenterology, Zhejiang University, Hangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wu</LastName>
                    <ForeName>Lunpo</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Institution of Gastroenterology, Zhejiang University, Hangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bian</LastName>
                    <ForeName>Jun</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Institution of Gastroenterology, Zhejiang University, Hangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lin</LastName>
                    <ForeName>Zhenghua</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Institution of Gastroenterology, Zhejiang University, Hangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xue</LastName>
                    <ForeName>Meng</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Institution of Gastroenterology, Zhejiang University, Hangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Su</LastName>
                    <ForeName>Tingting</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institution of Gastroenterology, Zhejiang University, Hangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lai</LastName>
                    <ForeName>Sanchuan</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Institution of Gastroenterology, Zhejiang University, Hangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Fei</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Institution of Gastroenterology, Zhejiang University, Hangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ge</LastName>
                    <ForeName>Qiwei</ForeName>
                    <Initials>Q</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Institution of Gastroenterology, Zhejiang University, Hangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Luyi</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institution of Gastroenterology, Zhejiang University, Hangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ye</LastName>
                    <ForeName>Shufang</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterology, The Sixth Affiliated Hospital of Wenzhou Medical University, Lishui People's Hospital, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhu</LastName>
                    <ForeName>Yabi</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterology, The Sixth Affiliated Hospital of Wenzhou Medical University, Lishui People's Hospital, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Shujie</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institution of Gastroenterology, Zhejiang University, Hangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Liangjing</ForeName>
                    <Initials>L</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0001-8227-8855</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterology, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Institution of Gastroenterology, Zhejiang University, Hangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>2016YFC0107003</GrantID>
                    <Agency>National Key R&amp;D Program of China</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>2016YFC1303200</GrantID>
                    <Agency>National Key R&amp;D Program of China</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>81602047</GrantID>
                    <Agency>National Natural Science Foundation of China</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>81702308</GrantID>
                    <Agency>National Natural Science Foundation of China</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Mol Oncol</MedlineTA>
            <NlmUniqueID>101308230</NlmUniqueID>
            <ISSNLinking>1574-7891</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">CCL2</Keyword>
            <Keyword MajorTopicYN="N">Klotho</Keyword>
            <Keyword MajorTopicYN="N">colorectal cancer</Keyword>
            <Keyword MajorTopicYN="N">senescence</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>02</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31545552</ArticleId>
            <ArticleId IdType="doi">10.1002/1878-0261.12577</ArticleId>
            <ArticleId IdType="pmc">PMC6822285</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Oncogene. 2008 Oct 9;27(46):5975-87</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18711403</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncol Lett. 2017 Nov;14(5):5526-5532</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29142604</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Stem Cells Int. 2018 Aug 12;2018:6013728</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30158986</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Lett. 2015 Jul 1;362(2):149-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25827069</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncotarget. 2016 Dec 13;7(50):82324-82337</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27384989</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Protoc. 2009;4(12):1798-806</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20010931</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Cancer Res. 2015 Oct;13(10):1398-407</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26113466</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Tumour Biol. 2011 Aug;32(4):729-35</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21523445</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2017 Mar 8;12(3):e0171922</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28273155</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Cell Biol. 2011 Feb 21;192(4):547-56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21321098</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Cancer Res Clin Oncol. 2015 Jun;141(6):961-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25086986</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Annu Rev Pathol. 2010;5:99-118</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20078217</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biochim Biophys Acta Mol Basis Dis. 2018 Jan;1864(1):238-251</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28982613</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Oncol. 2014 Dec;8(8):1729-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25091736</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Rep. 2014 Oct 9;9(1):75-89</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25263564</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Pathol Oncol Res. 2019 Oct;25(4):1553-1565</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30612312</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Lett. 2015 Jan 28;356(2 Pt A):204-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24486217</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2004 Nov 18;432(7015):332-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15549095</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Drug Resist Updat. 2012 Feb-Apr;15(1-2):123-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22365330</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Am J Cancer Res. 2011;1(1):111-119</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21969138</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Biol. 2008 Dec 2;6(12):2853-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19053174</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Genes Dev. 2011 Oct 15;25(20):2125-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21979375</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Clin Invest. 2007 Nov;117(11):3421-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17975672</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Commun. 2016 Jun 08;7:11762</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27272654</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biochim Biophys Acta. 2009 Oct;1790(10):1049-58</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19230844</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Cancer. 2010 Jan;10(1):51-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20029423</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Br J Cancer. 2016 Mar 15;114(6):697-703</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26889977</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncogene. 2019 Feb;38(6):794-807</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30232408</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Trends Immunol. 2015 Apr;36(4):217-28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25801910</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Rep. 2015 Jul 14;12(2):244-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26146082</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Annu Rev Physiol. 2013;75:685-705</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23140366</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Metastasis Rev. 2010 Jun;29(2):273-83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20390322</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncogene. 2008 May 1;27(20):2801-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18193093</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Am J Respir Cell Mol Biol. 2006 Jan;34(1):83-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16166741</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Res. 2017 Apr 15;77(8):1968-1982</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28202509</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 1997 Nov 6;390(6655):45-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9363890</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Oncol. 2011 Oct;39(4):989-99</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21814715</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2005 Sep 16;309(5742):1829-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16123266</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Cancer Res. 2017 Jan;15(1):3-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27678171</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31545548</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>25</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1878-0261</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                        <Day>23</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Molecular oncology</Title>
                <ISOAbbreviation>Mol Oncol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Metallopeptidase inhibitor 1 (TIMP-1) promotes receptor tyrosine kinase c-Kit signaling in colorectal cancer.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/1878-0261.12575</ELocationID>
            <Abstract>
                <AbstractText>Colorectal cancer (CRC) is the third most prevalent cancer worldwide causing an estimated 700 000 deaths annually. Different types of treatment are available for patients with advanced metastatic colorectal cancer, including targeted biological agents, such as cetuximab, a monoclonal antibody that targets EGFR. We have previously reported a study indicating multiple levels of interaction between metallopeptidase inhibitor 1 (TIMP-1) and the epidermal growth factor (EGF) signaling axis, which could explain how TIMP-1 levels can affect the antitumor effects of EGFR inhibitors. We also reported an association between TIMP-1-mediated cell invasive behavior and KRAS status. To gain insight into the molecular mechanisms underlying the effects of TIMP-1 in CRC, we examined by transcriptomics, proteomics, and kinase activity profiling a matched pair of isogenic human CRC isogenic DLD-1 CRC cell clones, bearing either an hemizygous KRAS wild-type allele or KRAS G13D mutant allele, exposed, or not, to TIMP-1. Omics analysis of the two cell lines identified the receptor tyrosine kinase c-Kit, a proto-oncogene that can modulate cell proliferation and invasion in CRC, as a target for TIMP-1. We found that exposure of DLD-1 CRC cells to exogenously added TIMP-1 promoted phosphorylation of c-Kit, indicative of a stimulatory effect of TIMP-1 on the c-Kit signaling axis. In addition, TIMP-1 inhibited c-Kit shedding in CRC cells grown in the presence of exogenous TIMP-1. Given the regulatory roles that c-Kit plays in cell proliferation and migration, and the realization that c-Kit is an important oncogene in CRC, it is likely that some of the biological effects of TIMP-1 overexpression in CRC may be exerted through its effect on c-Kit signaling.</AbstractText>
                <CopyrightInformation>© 2019 The Authors. Published by FEBS Press and John Wiley &amp; Sons Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Nordgaard</LastName>
                    <ForeName>Cathrine</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Doll</LastName>
                    <ForeName>Sophia</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Novo Nordisk Foundation Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Matos</LastName>
                    <ForeName>Ana Laura de Souza Almeida</ForeName>
                    <Initials>ALSA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Høeberg</LastName>
                    <ForeName>Mikkel</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Uddin Kazi</LastName>
                    <ForeName>Julhash</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Translational Cancer Research and Lund Stem Cell Center, Lund University, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Friis</LastName>
                    <ForeName>Stine</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stenvang</LastName>
                    <ForeName>Jan</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rönnstrand</LastName>
                    <ForeName>Lars</ForeName>
                    <Initials>L</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0003-1275-5809</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Division of Translational Cancer Research and Lund Stem Cell Center, Lund University, Sweden.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Division of Oncology, Skåne University Hospital, Lund, Sweden.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mann</LastName>
                    <ForeName>Matthias</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried, Germany.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Novo Nordisk Foundation Center for Protein Research, Faculty of Health Sciences, University of Copenhagen, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Manuel Afonso Moreira</LastName>
                    <ForeName>José</ForeName>
                    <Initials>J</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-9944-1214</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>n/a</GrantID>
                    <Agency>Savvaerksejer Jeppe Juhl og Hustru Ovita Juhls Mindelegat</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>n/a</GrantID>
                    <Agency>Kathrine og Vigo Skovgaard's Fond</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <Agency>Agnes og Poul Friis Foundation</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Mol Oncol</MedlineTA>
            <NlmUniqueID>101308230</NlmUniqueID>
            <ISSNLinking>1574-7891</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">c-Kit</Keyword>
            <Keyword MajorTopicYN="N">cetuximab</Keyword>
            <Keyword MajorTopicYN="N">colorectal cancer</Keyword>
            <Keyword MajorTopicYN="N">invasion</Keyword>
            <Keyword MajorTopicYN="N">omics</Keyword>
            <Keyword MajorTopicYN="N">predictive biomarkers</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>03</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31545548</ArticleId>
            <ArticleId IdType="doi">10.1002/1878-0261.12575</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31545515</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>10</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-3468</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                        <Day>23</Day>
                    </PubDate>
                </JournalIssue>
                <Title>FEBS letters</Title>
                <ISOAbbreviation>FEBS Lett.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>ATM/miR-34a-5p axis regulates a p21-dependent senescence-apoptosis switch in non-small cell lung cancer: a Boolean model of G1/S checkpoint regulation.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/1873-3468.13615</ELocationID>
            <Abstract>
                <AbstractText>MicroRNA-34a-5p regulates the G1/S checkpoint in non-small cell lung cancer (NSCLC) cells. Forced expression of miR-34a-5p enhances p21 expression and promotes cellular senescence, whereas knockout of miR-34a-5p decreases senescence and increases apoptosis. This suggests that p21 is the main effector of a senescence-apoptosis switch in NSCLC cells; however, the molecular mechanisms controlling this switch are unclear. In this work, we propose a Boolean model of G1/S checkpoint regulation, contemplating the regulatory influences of p21 by miR-34a-5p. The predicted probabilities of our model are in excellent agreement with experimental data. Our model supports that p21 is the main effector of a senescence/apoptosis switch and that the disruption of the positive feedback involving ATM, miR-34a-5p, and the histone deacetylase HDAC1 abrogates senescence.</AbstractText>
                <CopyrightInformation>© 2019 Federation of European Biochemical Societies.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Gupta</LastName>
                    <ForeName>Shantanu</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Physics, Universidade Federal de Santa Maria, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Silveira</LastName>
                    <ForeName>Daner A</ForeName>
                    <Initials>DA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Physics, Universidade Federal de Santa Maria, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mombach</LastName>
                    <ForeName>José Carlos M</ForeName>
                    <Initials>JCM</Initials>
                    <Identifier Source="ORCID">https://orcid.org/0000-0002-6602-3905</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Physics, Universidade Federal de Santa Maria, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>145708/2017-9</GrantID>
                    <Agency>Conselho Nacional de Desenvolvimento Científico e Tecnológico</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <Agency>Coordenação de Aperfeiçoamento de Pessoal de Nível Superior</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016422">Letter</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>FEBS Lett</MedlineTA>
            <NlmUniqueID>0155157</NlmUniqueID>
            <ISSNLinking>0014-5793</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">ATMmiR-34a-5p axis</Keyword>
            <Keyword MajorTopicYN="N">Boolean model</Keyword>
            <Keyword MajorTopicYN="N">G1/S checkpoint</Keyword>
            <Keyword MajorTopicYN="N">Senescence-Apoptosis switch</Keyword>
            <Keyword MajorTopicYN="N">p21</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31545515</ArticleId>
            <ArticleId IdType="doi">10.1002/1873-3468.13615</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31545503</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1791-2431</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>42</Volume>
                    <Issue>5</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Oncology reports</Title>
                <ISOAbbreviation>Oncol. Rep.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Diagnostic and prognostic values of C‑X‑C motif chemokine ligand 3 in patients with colon cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1996-2008</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3892/or.2019.7326</ELocationID>
            <Abstract>
                <AbstractText>The diagnostic and prognostic mechanisms of C‑X‑C motif chemokine ligand 3 (CXCL3) in colon cancer (CC) have not yet been reported. Therefore, the objective of the present study was to use cohorts of patients from Guangxi Medical University and the Gene Expression Omnibus (GEO) database to investigate and validate CXCL3 for the diagnosis and prognosis of CC, and to explore its prospective molecular mechanism. Reverse transcription‑quantitative PCR (RT‑qPCR) analysis of 38 paired tumor and non‑tumor tissues, and immunohistochemistry (IHC) of 212 tumor and 46 non‑tumor tissues was conducted to explore the expression of CXCL3 and its diagnostic and prognostic significance in the Guangxi Medical University CC cohort. A GEO dataset, GSE40967, was used to validate the prognostic significance of CXCL3. Gene set enrichment analysis (GSEA) was also conducted to explore the potential molecular mechanisms underlying the effects of CXCL3 in CC. The RT‑qPCR results indicated that CXCL3 expression was significantly higher in cancer tissues compared with adjacent normal tissues, suggesting that it may have high diagnostic value for CC. Multivariate Cox analysis based on the IHC results suggested that there was no appreciable association between CXCL3 positivity and the overall survival (OS) time of CC. However, a stratified analysis revealed that high expression of CXCL3 was associated with considerably increased mortality in the subgroup of CC patients with tumor size &lt;5 cm (adjusted P=0.042, adjusted HR=2.298, 95% CI=1.030‑5.126) and with tumor thrombus (adjusted P=0.019, adjusted HR=5.096, 95% CI=1.306‑19.886). In the GSE40967 dataset, high expression of CXCL3 was closely associated with poor OS in CC (adjusted P=0.049, adjusted HR=1.416, 95% CI=1.002‑2.003). Furthermore, GSEA indicated that the high expression of CXCL3 was closely associated with DNA repair, cell cycle process, cell apoptosis process and the P53 regulation pathway. In summary, these result suggest that CXCL3 might serve as a novel biomarker in the diagnosis and prognosis of CC.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ruan</LastName>
                    <ForeName>Guo-Tian</ForeName>
                    <Initials>GT</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Colorectal and Anal Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gong</LastName>
                    <ForeName>Yi-Zhen</ForeName>
                    <Initials>YZ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Colorectal and Anal Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liao</LastName>
                    <ForeName>Xi-Wen</ForeName>
                    <Initials>XW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Shuai</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Colorectal and Anal Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huang</LastName>
                    <ForeName>Wei</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Colorectal and Anal Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Xiang-Kun</ForeName>
                    <Initials>XK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhu</LastName>
                    <ForeName>Guang-Zhi</ForeName>
                    <Initials>GZ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liao</LastName>
                    <ForeName>Cun</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Colorectal and Anal Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gao</LastName>
                    <ForeName>Feng</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Colorectal and Anal Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Greece</Country>
            <MedlineTA>Oncol Rep</MedlineTA>
            <NlmUniqueID>9422756</NlmUniqueID>
            <ISSNLinking>1021-335X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>02</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31545503</ArticleId>
            <ArticleId IdType="doi">10.3892/or.2019.7326</ArticleId>
            <ArticleId IdType="pmc">PMC6787997</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Int Urol Nephrol. 2016 May;48(5):701-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26837773</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Exp Metastasis. 2004;21(7):571-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15787094</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncotarget. 2017 Aug 29;8(44):76574-76586</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29100333</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Science. 2015 Jan 23;347(6220):1260419</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25613900</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Cell Proteomics. 2014 Feb;13(2):397-406</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24309898</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nucleic Acids Res. 2017 Jul 3;45(W1):W98-W102</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28407145</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS Med. 2013;10(5):e1001453</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23700391</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Transl Gastroenterol. 2017 Jul 27;8(7):e109</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28749454</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>BMC Cancer. 2016 Aug 22;16:664</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27549406</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncotarget. 2016 Dec 27;7(52):87147-87160</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27894087</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Sci (Lond). 2003 Jan;104(1):47-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12519087</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Am J Physiol Heart Circ Physiol. 2005 Nov;289(5):H1976-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15937099</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cytogenet Cell Genet. 1999;84(1-2):39-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10343098</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>PLoS One. 2018 Jul 5;13(7):e0200315</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29975776</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Surg Clin North Am. 2015 Oct;95(5):979-89</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26315518</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Bioinformatics. 2003 Feb 12;19(3):368-75</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12584122</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Leukoc Biol. 1997 Nov;62(5):588-97</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9365113</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Oncol. 2007;29(4):301-13</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17641414</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Ups J Med Sci. 2014 Mar;119(1):19-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24172202</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):E4061-E4070</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29632181</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Methods Mol Biol. 2016;1418:93-110</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27008011</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Sci Rep. 2016 Jun 03;6:27426</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27255419</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Prostate Cancer. 2013;2013:560857</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23476788</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Biol Rep. 2012 May;39(5):5727-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22193626</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26808342</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16199517</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biomed Res Int. 2017;2017:2421459</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29209625</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Eur J Cancer Prev. 2012 Jan;21(1):15-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21946864</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncol Lett. 2017 Jan;13(1):129-136</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28123532</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Am J Hum Genet. 2018 Mar 1;102(3):401-414</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29478780</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Leukoc Biol. 2011 Nov;90(5):875-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21750124</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Biol Chem. 1996 Aug 23;271(34):20545-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8702798</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Colorectal Cancer. 2016 Sep;15(3):195-203</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26964802</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Tumour Biol. 2014 May;35(5):4619-28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24500664</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Onco Targets Ther. 2016 Aug 10;9:4959-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27570459</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>CA Cancer J Clin. 2018 Nov;68(6):394-424</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30207593</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Curr Cancer Drug Targets. 2014;14(3):294-309</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24605943</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Colorectal Dis. 2010 May;25(5):573-81</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20162422</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31545499</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>06</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1791-2431</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>42</Volume>
                    <Issue>6</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Dec</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Oncology reports</Title>
                <ISOAbbreviation>Oncol. Rep.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>RSK4 inhibits breast cancer cell proliferation and invasion in vitro, and is correlated with estrogen receptor upregulation in breast cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn>2777-2787</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3892/or.2019.7328</ELocationID>
            <Abstract>
                <AbstractText>Estrogen (E2) receptor (ER) upregulation has been associated with tumor progression and is the most commonly used clinical biomarker in breast cancer. X‑linked ribosomal S6 kinase 4 (RSK4) is downregulated in breast cancer and may act as a tumor suppressor gene. In order to understand the association between the ER and RSK4, the present study studied the effects of RSK4 on ER‑positive (ER+) breast cancer cell function, and the effects of E2 on RSK4 function and RSK4 methylation. Furthermore, the disease‑free survival of patients with breast cancer with RSK4 hypermethylation/hypomethylation was investigated to establish the link between RSK4 methylation on patient prognosis. The expression levels of RSK4 were increased and RSK4 promoter methylation was decreased in ER+ breast cancer tissues and cell lines compared with ER‑negative breast cancer tissues and cell lines, respectively. ER expression was negatively correlated with RSK4 expression and positively associated with RSK4 methylation. In vitro overexpression of RSK4 decreased the proliferation, clone formation, migration and angiogenesis and increased apoptosis of breast cancer cells. Patients with RSK4 hypomethylation exhibited a longer disease‑free survival compared with patients with RSK4 hypermethylation. E2 stimulation of breast cancer cells increased ER expression and RSK4 methylation, which was associated with decreased RSK4 expression. Furthermore, ER upregulation was proposed to be related to the decreased expression of RSK4 in ER+ breast cancer. E2 signaling may therefore act upstream of RSK4 to promote cancer progression. The results obtained in the current study suggested that RSK4 inhibited breast cancer cell invasiveness and that RSK4 promoter hypomethylation may serve as a novel prognostic marker for patients with breast cancer.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Huo</LastName>
                    <ForeName>Hong</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Breast Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ye</LastName>
                    <ForeName>Xinqing</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Honghe</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Breast Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Qiuyun</ForeName>
                    <Initials>Q</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Breast Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jiang</LastName>
                    <ForeName>Yi</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Breast Surgery, Guangxi Medical University Cancer Hospital, Nanning, Guangxi Zhuang Autonomous Region 530021, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>20</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Greece</Country>
            <MedlineTA>Oncol Rep</MedlineTA>
            <NlmUniqueID>9422756</NlmUniqueID>
            <ISSNLinking>1021-335X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>04</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31545499</ArticleId>
            <ArticleId IdType="doi">10.3892/or.2019.7328</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31545498</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>06</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1791-2431</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>42</Volume>
                    <Issue>6</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Dec</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Oncology reports</Title>
                <ISOAbbreviation>Oncol. Rep.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Receptor‑interacting serine/threonine‑protein kinase 1 promotes the progress and lymph metastasis of gallbladder cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn>2435-2449</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3892/or.2019.7331</ELocationID>
            <Abstract>
                <AbstractText>Receptor‑interacting serine/threonine‑protein kinase 1 (RIP‑1) is highly expressed in gallbladder cancer, and is very important in promoting tumor proliferation and invasion. The underlying mechanism in this promotion is the RIP‑1‑nuclear factor κ‑B (NF‑κB) and activator protein 1 (AP‑1)‑vascular endothelial growth factor‑C (VEGF‑C) signaling pathways. However, the precise mechanisms by which RIP‑1 regulates VEGF‑C expression are still unknown. The current study aims to clarify the detailed mechanisms by which RIP‑1 upregulates VEGF‑C expression. In the current study, the authors constructed various VEGF‑C promoter deletions, VEGF‑C promoter mutations and RIP‑1 overexpression plasmids, and silenced RIP‑1 with a small interfering RNA. Promoter analysis, an electrophoretic mobility shift assay, a chromatin immunoprecipitation assay was then performed, and an orthotopic transplantation model in nude mice was established by modified methods previously used. The authors also found that the core region for luciferase activity in the VEGF‑C promoter was ‑332 to ‑190 nt, in which there are two overlapping AP‑1 sites and an NF‑κB site. RIP‑1 was demonstrated to activate transcription factors NF‑κB and AP‑1 to combine with the core region and enhance VEGF‑C promoter activity. In conclusion, the current study illustrated the mechanisms by which RIP‑1 regulates VEGF‑C expression, by activating NF‑κB and AP‑1 to combine with the ‑332 to ‑190 nt area of the VEGF‑C promoter. By establishing an orthotopic mouse model of gallbladder cancer tumors, it was further elucidated that RIP‑1 promotes gallbladder cancer metastasis. The findings provide evidence that targeting RIP‑1 may prove to be useful in the treatment of gallbladder cancer.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Zhu</LastName>
                    <ForeName>Guangwei</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Hepatobiliary Surgery and Fujian Institute of Hepatobiliary Surgery, Union Hospital, Fujian Medical University, Fuzhou, Fujian 350001, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Du</LastName>
                    <ForeName>Qiang</ForeName>
                    <Initials>Q</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Hepatobiliary Surgery and Fujian Institute of Hepatobiliary Surgery, Union Hospital, Fujian Medical University, Fuzhou, Fujian 350001, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Xiao</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Hepatobiliary Surgery and Fujian Institute of Hepatobiliary Surgery, Union Hospital, Fujian Medical University, Fuzhou, Fujian 350001, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Xiaoqian</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Hepatobiliary Surgery and Fujian Institute of Hepatobiliary Surgery, Union Hospital, Fujian Medical University, Fuzhou, Fujian 350001, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tang</LastName>
                    <ForeName>Nanhong</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Hepatobiliary Surgery and Fujian Institute of Hepatobiliary Surgery, Union Hospital, Fujian Medical University, Fuzhou, Fujian 350001, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>She</LastName>
                    <ForeName>Feifei</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Ministry of Education for Gastrointestinal Cancer and Key Laboratory of Tumor Microbiology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian 350001, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Yanling</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Hepatobiliary Surgery and Fujian Institute of Hepatobiliary Surgery, Union Hospital, Fujian Medical University, Fuzhou, Fujian 350001, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Greece</Country>
            <MedlineTA>Oncol Rep</MedlineTA>
            <NlmUniqueID>9422756</NlmUniqueID>
            <ISSNLinking>1021-335X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31545498</ArticleId>
            <ArticleId IdType="doi">10.3892/or.2019.7331</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31545492</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1791-3004</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>20</Volume>
                    <Issue>5</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Molecular medicine reports</Title>
                <ISOAbbreviation>Mol Med Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Gambogic acid increases the sensitivity to paclitaxel in drug‑resistant triple‑negative breast cancer via the SHH signaling pathway.</ArticleTitle>
            <Pagination>
                <MedlinePgn>4515-4522</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3892/mmr.2019.10697</ELocationID>
            <Abstract>
                <AbstractText>Paclitaxel is the most frequently used therapy regimen for triple‑negative breast cancer (TNBC). However, chemoresistance frequently occurs, leading to enhanced failure rates of chemotherapy in TNBC; therefore, novel biological therapies are urgently needed. Gambogic acid (GA) has potent anticancer effects and inhibits tumor growth in several types of human cancer. However, the effects of GA on paclitaxel‑resistant TNBC remain unknown. In the present study, the Cell Counting Kit‑8 assay was used to examine the effect of GA and/or paclitaxel on the viability of TNBC cells; flow cytometry was used to examine the effects of GA on cell apoptosis; and western blotting and reverse transcription‑quantitative PCR were used to determine the effects of GA on the expression of sonic hedgehog (SHH) signaling pathway target genes. The present results indicated that GA significantly inhibited the viability and enhanced the rate of apoptosis in paclitaxel‑resistant MDA‑MB‑231 cells via activating the SHH signaling pathway. In vivo experiments confirmed that GA treatment enhanced the sensitivity of MDA‑MB‑231 cells to paclitaxel via the SHH signaling pathway. In conclusion, the combination of GA with paclitaxel may increase the antitumor effects on paclitaxel‑resistant TNBC via downregulating the SHH signaling pathway.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Yonghui</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Breast Surgery, Weifang People's Hospital, Weifang, Shandong 261041, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sui</LastName>
                    <ForeName>Yana</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Emergency Department of Weifang Traditional Chinese Hospital, Weifang, Shandong 261041, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tao</LastName>
                    <ForeName>Yinggang</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of General Surgery, Weifang Second People's Hospital, Weifang, Shandong 261041, P.R. China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Greece</Country>
            <MedlineTA>Mol Med Rep</MedlineTA>
            <NlmUniqueID>101475259</NlmUniqueID>
            <ISSNLinking>1791-2997</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2017</Year>
                <Month>08</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>06</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31545492</ArticleId>
            <ArticleId IdType="doi">10.3892/mmr.2019.10697</ArticleId>
            <ArticleId IdType="pmc">PMC6797991</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Biochem Cell Biol. 2012 Dec;90(6):718-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23194187</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Br J Cancer. 2013 May 28;108(10):2097-105</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23591201</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Onco Targets Ther. 2016 Jun 02;9:3359-68</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27330316</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Sci. 2014 Aug;105(8):1063-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24890366</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Sci (Lond). 2015 Nov;129(9):809-22</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26201092</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Chem Biol Interact. 2015 Jun 25;235:76-84</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25824409</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Biochem Biophys. 2013 Sep;67(1):199-206</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23436279</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Tumour Biol. 2016 Feb;37(2):1853-62</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26318432</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>World J Gastroenterol. 2015 May 28;21(20):6194-205</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26034354</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Cancer. 2013 Oct;13(10):714-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24060863</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Basic Clin Pharmacol Toxicol. 2013 Jan;112(1):25-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22759348</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Methods. 2001 Dec;25(4):402-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11846609</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biochem Cell Biol. 2008 Oct;86(5):386-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18923540</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Front Pharmacol. 2013 Mar 14;4:28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23504227</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Chin Med J (Engl). 2013;126(9):1642-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23652044</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>CA Cancer J Clin. 2017 Jan;67(1):7-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28055103</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancers (Basel). 2016 Feb 15;8(2):null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26891329</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Anticancer Res. 2014 Sep;34(9):4685-92</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25202045</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Chin J Nat Med. 2015 Jan;13(1):41-51</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25660287</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31545289</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1950-6007</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>118</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie</Title>
                <ISOAbbreviation>Biomed. Pharmacother.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>RAD54B potentiates tumor growth and predicts poor prognosis of patients with luminal A breast cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn>109341</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0753-3322(19)33282-2</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biopha.2019.109341</ELocationID>
            <Abstract>
                <AbstractText>RAD54B, a human paralog of RAD54 L, belongs to the SW12/SNF2 superfamily of helicases. Up to now, few studies have reported the role of RAD54B in breast cancer (BC). In this study, we reported that RAD54B was amplified and the expression of RAD54B was elevated in BC, as identified through a bioinformatics analysis of open databases (cBioPortal and Oncomine) and an immunohistochemical analysis of a tissue microarray (TMA). Analysis of Kaplan-Meier plotter (KM plotter) showed that high RAD54B transcription activity was critically linked with poor prognosis of BC patients, in particular those with the luminal A subtype. Gene set enrichment analysis (GSEA) performed on dataset GSE1456 demonstrated that gene expression signatures associated with survival, proliferation, cell cycle, apoptosis and p53 signaling were crucially enriched, when the level of RAD54B was elevated. Further, gain-of-function studies were conducted on luminal A BC cell lines MCF-7 and ZR-751 to validate these findings. Consistently, RAD54B knockdown suppressed cell proliferation in vitro, as well as delayed tumor growth in vivo. Collectively, our results address the biological role of RAD54B in the neoplastic process of luminal A BC. Bioinformatics analysis, additionally, indicates RAD54B with a predictive value for this BC subtype.</AbstractText>
                <CopyrightInformation>Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Zeyu</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Biology Research Center (Key Laboratory of the Ministry of Education) and Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Xiaoting</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Biology Research Center (Key Laboratory of the Ministry of Education) and Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Han</LastName>
                    <ForeName>Yingyan</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Biology Research Center (Key Laboratory of the Ministry of Education) and Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ji</LastName>
                    <ForeName>Teng</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Biology Research Center (Key Laboratory of the Ministry of Education) and Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huang</LastName>
                    <ForeName>Xiaoyuan</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Biology Research Center (Key Laboratory of the Ministry of Education) and Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gao</LastName>
                    <ForeName>Qinglei</ForeName>
                    <Initials>Q</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Biology Research Center (Key Laboratory of the Ministry of Education) and Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China. Electronic address: qlgao@tjh.tjmu.edu.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ma</LastName>
                    <ForeName>Ding</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Cancer Biology Research Center (Key Laboratory of the Ministry of Education) and Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>France</Country>
            <MedlineTA>Biomed Pharmacother</MedlineTA>
            <NlmUniqueID>8213295</NlmUniqueID>
            <ISSNLinking>0753-3322</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Breast cancer</Keyword>
            <Keyword MajorTopicYN="N">Luminal A</Keyword>
            <Keyword MajorTopicYN="N">Prognosis</Keyword>
            <Keyword MajorTopicYN="N">Proliferation</Keyword>
            <Keyword MajorTopicYN="N">RAD54B</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31545289</ArticleId>
            <ArticleId IdType="pii">S0753-3322(19)33282-2</ArticleId>
            <ArticleId IdType="doi">10.1016/j.biopha.2019.109341</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31545270</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1950-6007</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>118</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie</Title>
                <ISOAbbreviation>Biomed. Pharmacother.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Hydroxychloroquine potentiates the anti-cancer effect of bevacizumab on glioblastoma via the inhibition of autophagy.</ArticleTitle>
            <Pagination>
                <MedlinePgn>109339</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0753-3322(19)32665-4</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biopha.2019.109339</ELocationID>
            <Abstract>
                <AbstractText>Bevacizumab (BEV) is widely used for the treatment of patients with recurrent glioblastoma (GBM), but recent evidence demonstrated that BEV induced cytoprotective autophagy, which allows tumor cells to survive. Hydroxychloroquine (HCQ) inhibits lysosomal acidification and blocks autophagy via influencing autophagosome fusion and degradation. HCQ is often used to enhance the efficacy of chemoradiotherapy. However, whether HCQ sensitizes GBM cells to BEV and the molecular mechanism of this effect are not clear. We showed that high concentrations of BEV increased the LC3-II/LC3-I ratio and caused the degradation of Beclin1 in the LN18 and LN229 cell lines, indicating that high concentrations of BEV induced the autophagy of the LN18 and LN229 cells. However, BEV (100 μg/ml) did not influence the autophagy of the LN18 and LN229 cells, and HCQ at less than 5 μg/ml significantly accumulated LC3B-II and p62 proteins and blocked the autophagy process. Importantly, we found that HCQ (5 μg/ml) potentiated the anti-cancer effect of BEV (100 μg/ml). Therefore, HCQ is a novel strategy that may augment the efficacy of BEV for GBM via the inhibition of autophagy.</AbstractText>
                <CopyrightInformation>Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Lin-Qing</ForeName>
                    <Initials>LQ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Geriatrics, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230036, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Shi-Bing</ForeName>
                    <Initials>SB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province &amp; Clinical Research Institute, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, 310014, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shao</LastName>
                    <ForeName>Yan-Fei</ForeName>
                    <Initials>YF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacy, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, 310014, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shi</LastName>
                    <ForeName>Jia-Na</ForeName>
                    <Initials>JN</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacy, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, 310014, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Wei</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacy, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, 310014, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Wan-Yuan</ForeName>
                    <Initials>WY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, 310014, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ye</LastName>
                    <ForeName>Zi-Qi</ForeName>
                    <Initials>ZQ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacy, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jiang</LastName>
                    <ForeName>Jin-Ying</ForeName>
                    <Initials>JY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacy, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, 310014, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fang</LastName>
                    <ForeName>Qing-Xia</ForeName>
                    <Initials>QX</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacy, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, 310014, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Guo-Bing</ForeName>
                    <Initials>GB</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacy, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, 310014, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xuan</LastName>
                    <ForeName>Zi-Xue</ForeName>
                    <Initials>ZX</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacy, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, 310014, China. Electronic address: xuanzixue0222@163.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>France</Country>
            <MedlineTA>Biomed Pharmacother</MedlineTA>
            <NlmUniqueID>8213295</NlmUniqueID>
            <ISSNLinking>0753-3322</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Anti-tumor</Keyword>
            <Keyword MajorTopicYN="N">Autophagy</Keyword>
            <Keyword MajorTopicYN="N">Bevacizumab</Keyword>
            <Keyword MajorTopicYN="N">HCQ</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>06</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31545270</ArticleId>
            <ArticleId IdType="pii">S0753-3322(19)32665-4</ArticleId>
            <ArticleId IdType="doi">10.1016/j.biopha.2019.109339</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31545265</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1950-6007</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>118</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie</Title>
                <ISOAbbreviation>Biomed. Pharmacother.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Aberrant N-cadherin expression in cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn>109320</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0753-3322(19)32584-3</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biopha.2019.109320</ELocationID>
            <Abstract>
                <AbstractText>Neural (N)-cadherin is a calcium-dependent single-chain transmembrane glycoprotein that mediates homotypic and heterotypic cell-cell adhesion. As an important member of the cadherin family, N-cadherin plays an important role in the developmental and functional regulation of the nervous system, brain, heart, skeletal muscles, blood vessels and hematopoietic microenvironment. However, aberrant expression of N-cadherin has been found in many cancers, such as lung cancer, breast cancer, prostate cancer and squamous cell carcinoma. It is increasingly recognized that aberrant expression of N-cadherin is closely related to aspects of malignant tumor progression in humans, such as transformation, adhesion, apoptosis, angiogenesis, invasion and metastasis, suggesting that N-cadherin can be a therapeutic target for tumor invasion and metastasis. This minireview summarizes the diverse roles of N-cadherin in cancer progression and the regulatory factors that affect the expression of N-cadherin in cancer, findings that increase our awareness of the importance of developing new therapeutic agents targeting N-cadherin.</AbstractText>
                <CopyrightInformation>Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Cao</LastName>
                    <ForeName>Zhan-Qi</ForeName>
                    <Initials>ZQ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacy, Affiliated Hospital of Qingdao University, Qingdao, 266003, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Zhi</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacy, Affiliated Hospital of Qingdao University, Qingdao, 266003, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Leng</LastName>
                    <ForeName>Ping</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacy, Affiliated Hospital of Qingdao University, Qingdao, 266003, China. Electronic address: 18661808926@163.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>France</Country>
            <MedlineTA>Biomed Pharmacother</MedlineTA>
            <NlmUniqueID>8213295</NlmUniqueID>
            <ISSNLinking>0753-3322</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Aberrant expression</Keyword>
            <Keyword MajorTopicYN="N">Cancer</Keyword>
            <Keyword MajorTopicYN="N">Metastasis</Keyword>
            <Keyword MajorTopicYN="N">N-cadherin</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31545265</ArticleId>
            <ArticleId IdType="pii">S0753-3322(19)32584-3</ArticleId>
            <ArticleId IdType="doi">10.1016/j.biopha.2019.109320</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31545260</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1950-6007</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>118</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie</Title>
                <ISOAbbreviation>Biomed. Pharmacother.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Negative regulators of Wnt signaling in non-small cell lung cancer: Theoretical basis and therapeutic potency.</ArticleTitle>
            <Pagination>
                <MedlinePgn>109336</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0753-3322(19)32452-7</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biopha.2019.109336</ELocationID>
            <Abstract>
                <AbstractText>Significant advances in the treatment of non-small cell lung cancer (NSCLC) have been made over the past decade, and they predominantly involve molecular targets such as epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) rearrangements. However, despite the initial good response, drug resistance eventually develops. The Wnt signaling pathway has recently been considered important in embryonic development and tumorigenesis in many cancers, particularly NSCLC. Moreover, the aberrant Wnt pathway plays a significant role in NSCLC and is associated with cancer cell proliferation, metastasis, invasion and drug resistance, and the suppression of canonical or noncanonical Wnt signaling through various biological or pharmacological negative regulators has been proven to produce specific anticancer effects. Thus, blocking the Wnt pathway via its negative regulators may overcome the resistance of current treatment methods and lead to new treatment strategies for NSCLC. Therefore, in this review, we summarize recent studies on the role of negative regulators in Wnt signaling in NSCLC and the therapeutic potency of these molecules as agents and targets for NSCLC treatments.</AbstractText>
                <CopyrightInformation>Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Song</LastName>
                    <ForeName>Zikuan</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>West China School of Basic Medical Science and Forensic Medicine, Sichuan University, Chengdu, Sichuan 610041, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Haoyu</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>West China School of Basic Medical Science and Forensic Medicine, Sichuan University, Chengdu, Sichuan 610041, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Shuang</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, China. Electronic address: shuang.zhang@scu.edu.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>France</Country>
            <MedlineTA>Biomed Pharmacother</MedlineTA>
            <NlmUniqueID>8213295</NlmUniqueID>
            <ISSNLinking>0753-3322</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Carcinogenesis</Keyword>
            <Keyword MajorTopicYN="N">Negative regulators</Keyword>
            <Keyword MajorTopicYN="N">Non-small cell lung carcinoma (NSCLC)</Keyword>
            <Keyword MajorTopicYN="N">Wnt signaling</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31545260</ArticleId>
            <ArticleId IdType="pii">S0753-3322(19)32452-7</ArticleId>
            <ArticleId IdType="doi">10.1016/j.biopha.2019.109336</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31545251</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1950-6007</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>118</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie</Title>
                <ISOAbbreviation>Biomed. Pharmacother.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Inhibition of AKT enhances the anti-cancer effects of Artemisinin in clear cell renal cell carcinoma.</ArticleTitle>
            <Pagination>
                <MedlinePgn>109383</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0753-3322(19)32235-8</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biopha.2019.109383</ELocationID>
            <Abstract>
                <AbstractText>Given studies have shown that Artemisinin (ART) reduces cancer cell proliferation, migration, invasion, tumorigenesis and metastasis. In this study, we evaluated the roles of ART in clear cell renal cell carcinoma (ccRCC) progression. We measured the eﬀ ;ects of ART on cancer cell proliferation, colony formation, migration, invasion and tumorigenesis. CCK-8 assay demonstrated that ART inhibited cell growth with IC50 values 31.30 ± 0.73 μM in UMRC-2 and 23.97 ± 0.92 μM in CAKI-2, respectively. Colony formation assay shown that ART inhibited cell colony formation. Transwell migration and invasion assay shown that ART inhibited RCC migration and invasion. Realtime-qPCR assay shown that ART decreased the mRNA levels of proliferation related genes c-Myc, cyclin D1 and PCNA, and reduced the mRNA levels of mesenchymal genes N-cadherin, Vimentin and Snail, but increased the mRNA levels of epithelial marker E-cadherin. Moreover, ART inhibited AKT signaling pathway. In the presence of AKT inhibitor VIII, a pan-AKT inhibitor, ART reduced more cell proliferation, migration and invasion than in the absence of AKT inhibitor VIII, suggesting combination of ART and AKT inhibitor enhanced the anti-cancer effects of ART. Furthermore, the in vivo xenograft tumor model results suggested that ART decreased tumor size and weight, and suppressed AKT signaling. Taken together, our results indicated that ART inhibited ccRCC cell proliferation, colony formation, migration, invasion and tumorigenesis. Combination of ART and AKT inhibitor enhanced the anti-cancer cell proliferation, migration and invasion.</AbstractText>
                <CopyrightInformation>Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Yu</LastName>
                    <ForeName>Congcong</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacy, The Affiliated Hospital of Jiaxing University (The First Hospital of Jiaxing), Jiaxing 314000, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sun</LastName>
                    <ForeName>Peiyu</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacy, The Affiliated Hospital of Jiaxing University (The First Hospital of Jiaxing), Jiaxing 314000, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Yuehong</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacy, The Affiliated Hospital of Jiaxing University (The First Hospital of Jiaxing), Jiaxing 314000, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shen</LastName>
                    <ForeName>Bin</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacy, The Affiliated Hospital of Jiaxing University (The First Hospital of Jiaxing), Jiaxing 314000, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Meihua</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacy, The Affiliated Hospital of Jiaxing University (The First Hospital of Jiaxing), Jiaxing 314000, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wu</LastName>
                    <ForeName>Lingzhi</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacy, The Affiliated Hospital of Jiaxing University (The First Hospital of Jiaxing), Jiaxing 314000, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kong</LastName>
                    <ForeName>Min</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Anesthesiology, The Affiliated Hospital of Jiaxing University (The First Hospital of Jiaxing), Jiaxing 314000, China. Electronic address: sdjx10666@163.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>30</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>France</Country>
            <MedlineTA>Biomed Pharmacother</MedlineTA>
            <NlmUniqueID>8213295</NlmUniqueID>
            <ISSNLinking>0753-3322</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">AKT</Keyword>
            <Keyword MajorTopicYN="N">Artemisinin</Keyword>
            <Keyword MajorTopicYN="N">Cancer progression</Keyword>
            <Keyword MajorTopicYN="N">Clear cell renal cell carcinoma</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>09</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31545251</ArticleId>
            <ArticleId IdType="pii">S0753-3322(19)32235-8</ArticleId>
            <ArticleId IdType="doi">10.1016/j.biopha.2019.109383</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31545253</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1950-6007</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>118</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie</Title>
                <ISOAbbreviation>Biomed. Pharmacother.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Upregulated circ_0005576 facilitates cervical cancer progression via the miR-153/KIF20A axis.</ArticleTitle>
            <Pagination>
                <MedlinePgn>109311</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0753-3322(19)32247-4</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biopha.2019.109311</ELocationID>
            <Abstract>
                <AbstractText>Circular RNAs (circRNAs) are a novel group of noncoding RNAs characterized by a covalently closed loop. An increasing evidence suggests that deregulated circRNAs exert their essential regulatory roles in oncogenesis. However, little is explored on the biological role of novel circRNAs in cervical cancer (CC) progression. In the present study, we analyzed two GSE microarrays to screen for CC-specific circRNAs and found two circRNAs both expressed in CC cells and tissues. Among them, circ_0005576 was significantly overexpressed in both CC tissues and cell lines. Furthermore, upregulated circ_0005576 was positively associated with advanced FIGO stage, lymph node metastasis, but was negatively related with overall survival of CC patients. Additionally, circ_0005576 knockdown induced a suppressed cell growth, colony formation and metastasis of HeLa and SiHa cells. Mechanistically, circ 0005576 was mainly located in the cytoplasm and served as a sponge of miR-153-3p to increase kinesin family member 20A (KIF20A) expression. Rescue assays further validated the effects of circ_0005576/miR-153-3p/KIF20A axis on CC proliferation, migration and invasion. In conclusion, our research reveals a novel circ_0005576/miR-153-3p/KIF20A axis promoting CC progression, which may suggest a new insight into the pathogenesis of CC.</AbstractText>
                <CopyrightInformation>Copyright © 2019 The First Affiliated Hospital of Sun Yat-sen University. Published by Elsevier Masson SAS.. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ma</LastName>
                    <ForeName>Hanyu</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tian</LastName>
                    <ForeName>Tian</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Xubin</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xia</LastName>
                    <ForeName>Meng</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gynecology and Obstetrics, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Cancan</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mai</LastName>
                    <ForeName>Lianxi</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China; Department of Oral &amp; Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xie</LastName>
                    <ForeName>Shule</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China; Department of Oral &amp; Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China. Electronic address: xieshuleah@163.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yu</LastName>
                    <ForeName>Li</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China. Electronic address: liyusysu201@163.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>France</Country>
            <MedlineTA>Biomed Pharmacother</MedlineTA>
            <NlmUniqueID>8213295</NlmUniqueID>
            <ISSNLinking>0753-3322</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Cervical cancer (CC)</Keyword>
            <Keyword MajorTopicYN="N">Circular RNA</Keyword>
            <Keyword MajorTopicYN="N">KIF20A</Keyword>
            <Keyword MajorTopicYN="N">miR-153-3p</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31545253</ArticleId>
            <ArticleId IdType="pii">S0753-3322(19)32247-4</ArticleId>
            <ArticleId IdType="doi">10.1016/j.biopha.2019.109311</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31545242</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1950-6007</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>118</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie</Title>
                <ISOAbbreviation>Biomed. Pharmacother.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>RBCK1 contributes to chemoresistance and stemness in colorectal cancer (CRC).</ArticleTitle>
            <Pagination>
                <MedlinePgn>109250</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0753-3322(19)31975-4</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biopha.2019.109250</ELocationID>
            <Abstract>
                <AbstractText>Chemotherapy is an essential treatment for colorectal cancer (CRC). However, colorectal cancer cells often develop resistance to chemotherapeutic drugs, resulting in relapse and poor patient prognosis. Growing studies indicate that tumor cells with stem cell-like features could promote resistance to chemotherapeutic agents. In this study, we demonstrated that RANBP2-type and C3HC4-type zinc finger-containing 1 (RBCK1) expression was markedly increased by cancer-associated fibroblasts (CAFs). First, we found that RBCK1 was over-expressed in chemoresistant CRC tumors and promoted chemoresistance in CRC cells. High RBCK1 expression was significantly correlated with poor prognosis in CRC patients. RBCK1 inhibition promoted sensitivity to chemotherapeutic drugs, and prevented migration and invasion in CRC cells. In addition, RBCK1 knockdown reduced cancer stemness by decreasing the expression of Nanog, Oct4, Sox2 and Klf4 in CRC cell lines. Furthermore, RBCK1 expression was significantly up-regulated in CRC cells cultured with conditioned medium (CM) derived from CAFs. Moreover, CAF-derived CM enhanced stemness and chemoresistance in CRC cells by over-expressing RBCK1. The in vivo experiments confirmed that RBCK1 knockdown promoted the chemotherapeutic drug sensitivity in a xenograft model. Taken together, these finding indicated that RBCK1 modulated chemosensitivity in CRC, and could be served as a promising therapeutic target for CRC prevention.</AbstractText>
                <CopyrightInformation>Copyright © 2019. Published by Elsevier Masson SAS.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Min-Li</ForeName>
                    <Initials>ML</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Medical College of Yan'an University, Yan'an,Shaanxi 716000, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zang</LastName>
                    <ForeName>Feng</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Anus &amp; Intestine Surgery, The First Hospital of Zibo, Zibo, Shandong, 255200, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Sheng-Jun</ForeName>
                    <Initials>SJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of General Surgery, Affliated Hospital of Yan'an University, Yan'an, Shaanxi, 716000, China. Electronic address: lml1209@foxmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>France</Country>
            <MedlineTA>Biomed Pharmacother</MedlineTA>
            <NlmUniqueID>8213295</NlmUniqueID>
            <ISSNLinking>0753-3322</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Cancer associated fibroblasts (CAFs)</Keyword>
            <Keyword MajorTopicYN="N">Cancer stemness</Keyword>
            <Keyword MajorTopicYN="N">Chemoresistance</Keyword>
            <Keyword MajorTopicYN="N">Colorectal cancer</Keyword>
            <Keyword MajorTopicYN="N">RBCK1</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>04</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31545242</ArticleId>
            <ArticleId IdType="pii">S0753-3322(19)31975-4</ArticleId>
            <ArticleId IdType="doi">10.1016/j.biopha.2019.109250</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31545234</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1950-6007</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>118</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie</Title>
                <ISOAbbreviation>Biomed. Pharmacother.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Chicoric acid (CA) induces autophagy in gastric cancer through promoting endoplasmic reticulum (ER) stress regulated by AMPK.</ArticleTitle>
            <Pagination>
                <MedlinePgn>109144</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0753-3322(19)31821-9</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biopha.2019.109144</ELocationID>
            <Abstract>
                <AbstractText>Gastric cancer is one of the most common cancers leading to tumor-related deaths worldwide. Chicoric acid (CA) exhibits a variety of protective effects in different diseases. However, its role in regulating tumor progression has not been reported. Autophagy, as a conserved catabolic process, sustains cellular homoeostasis responding to stress to modulate cell fate. In the study, the effects of CA on gastric cancer were investigated. The results indicated that CA treatment markedly reduced the cell viability and induced apoptosis in gastric cancer cells, and prevented tumor growth in an established xenograft gastric cancer model. Furthermore, CA exposure significantly induced autophagy both in gastric cancer cells and tumor samples, as evidenced by the up-regulated expression of LC3II. Moreover, phosphorylated AMP-activated protein kinase (AMPK) and p70S6 kinase (p70s6k) expression were obviously promoted by CA in vitro and in vivo. Importantly, blocking AMPK activation abrogated CA-induced expression of LC3II in gastric cancer cells. In addition, endoplasmic reticulum (ER) stress in tumor samples or cells was markedly induced by CA treatment through promoting the expression of associated signals such as Parkin, protein kinase RNA-like ER kinase (PERK), activating transcription factors 4 (ATF4) and ATF6. Importantly, these effects were abolished by the inhibition of AMPK signaling. Collectively, our findings indicated that CA prevents human gastric cancer progression by inducing autophagy partly through the activation of AMPK, and represents an effective therapeutic strategy against gastric cancer development.</AbstractText>
                <CopyrightInformation>Copyright © 2019. Published by Elsevier Masson SAS.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sun</LastName>
                    <ForeName>Xiaoli</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of General Surgery, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Xinwu</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of General Surgery, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhai</LastName>
                    <ForeName>Hongjun</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of General Surgery, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, China. Electronic address: 2923999408@qq.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Di</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of General Surgery, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ma</LastName>
                    <ForeName>Shuangyu</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of General Surgery, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>France</Country>
            <MedlineTA>Biomed Pharmacother</MedlineTA>
            <NlmUniqueID>8213295</NlmUniqueID>
            <ISSNLinking>0753-3322</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">AMPK</Keyword>
            <Keyword MajorTopicYN="N">Autophagy</Keyword>
            <Keyword MajorTopicYN="N">Chicoric acid</Keyword>
            <Keyword MajorTopicYN="N">ER stress</Keyword>
            <Keyword MajorTopicYN="N">Gastric cancer</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>04</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31545234</ArticleId>
            <ArticleId IdType="pii">S0753-3322(19)31821-9</ArticleId>
            <ArticleId IdType="doi">10.1016/j.biopha.2019.109144</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31545228</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1950-6007</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>118</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie</Title>
                <ISOAbbreviation>Biomed. Pharmacother.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Enhancement of anticancer activity of docetaxel by combination with Fuzheng Yiliu decoction in a mouse model of castration-resistant prostate cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn>109374</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0753-3322(19)31647-6</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biopha.2019.109374</ELocationID>
            <Abstract>
                <AbstractText>Docetaxel (Doc) is the gold standard of care for castration-resistant prostate cancer (CRPC) patients, although the therapeutic effects are modest. Fuzheng Yiliu decoction (FZYL) comprises multiple herbs, and has been used for &gt;10 years to treat various cancers, including hepatocellular tumors, malignant gastrointestinal tumors, and prostate cancer. In the study reported, we evaluated the anticancer effects of FZYL and of a combination of Doc and FZYL in CRPC tumor-bearing mice, and explored the underlying mechanisms. PC-3 tumor-bearing mice were treated with FZYL, Doc, Doc + FZYL or vehicle solution. Tumor volume was monitored, and tumor weight, proliferation and apoptosis of tumor tissues were measured. Deep sequencing was used to profile the miRNA expression patterns in tumor tissues. Our results suggested that FZYL alone could depress tumor growth, and the combination of Doc and FZYL treatment exhibited enhanced anticancer effects. Doc + FZYL regulated the expression of 10 miRNAs: miR-34b-5p, miR-674-3p, miR-140-3p, miR-342-3p, miR-214-3p, miR-149-5p, miR-378c, miR-29b-3p, miR-218-5p, and miR-378a-3p, involving in the PI3K-Akt pathway in the treatment of CRPC.</AbstractText>
                <CopyrightInformation>Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Fu</LastName>
                    <ForeName>Wei</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Shenzhen Bao'an Traditional Chinese Medicine Hospital Group, Guangzhou University of Chinese Medicine, Shenzhen 518133, People's Republic of China. Electronic address: 598356001@qq.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hong</LastName>
                    <ForeName>Zhiming</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, 518033, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>You</LastName>
                    <ForeName>Xujun</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Shenzhen Bao'an Traditional Chinese Medicine Hospital Group, Guangzhou University of Chinese Medicine, Shenzhen 518133, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Din</LastName>
                    <ForeName>Jing</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Shenzhen Bao'an Traditional Chinese Medicine Hospital Group, Guangzhou University of Chinese Medicine, Shenzhen 518133, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Baishu</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Shenzhen Bao'an Traditional Chinese Medicine Hospital Group, Guangzhou University of Chinese Medicine, Shenzhen 518133, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhao</LastName>
                    <ForeName>Beibei</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Shenzhen Bao'an Traditional Chinese Medicine Hospital Group, Guangzhou University of Chinese Medicine, Shenzhen 518133, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yuan</LastName>
                    <ForeName>Gengyan</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Shenzhen Bao'an Traditional Chinese Medicine Hospital Group, Guangzhou University of Chinese Medicine, Shenzhen 518133, People's Republic of China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Qixin</ForeName>
                    <Initials>Q</Initials>
                    <AffiliationInfo>
                        <Affiliation>Shenzhen Bao'an Traditional Chinese Medicine Hospital Group, Guangzhou University of Chinese Medicine, Shenzhen 518133, People's Republic of China. Electronic address: liqixin6831@163.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>03</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>France</Country>
            <MedlineTA>Biomed Pharmacother</MedlineTA>
            <NlmUniqueID>8213295</NlmUniqueID>
            <ISSNLinking>0753-3322</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Castration-resistant prostate cancer</Keyword>
            <Keyword MajorTopicYN="N">Docetaxel</Keyword>
            <Keyword MajorTopicYN="N">Fuzheng Yiliu decoction</Keyword>
            <Keyword MajorTopicYN="N">PI3K-Akt pathway</Keyword>
            <Keyword MajorTopicYN="N">miRNA</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>04</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31545228</ArticleId>
            <ArticleId IdType="pii">S0753-3322(19)31647-6</ArticleId>
            <ArticleId IdType="doi">10.1016/j.biopha.2019.109374</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31545230</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>24</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1950-6007</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>118</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie</Title>
                <ISOAbbreviation>Biomed. Pharmacother.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>FAM83H-AS1 is upregulated and predicts poor prognosis in colon cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn>109342</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0753-3322(19)31727-5</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biopha.2019.109342</ELocationID>
            <Abstract>
                <AbstractText>Long noncoding RNAs (LncRNAs) have been proven to participate in many principal pathways during colonic mucosa tumourigenesis. FAM83H-AS1 has been identified as one of the LncRNAs that is dysregulated in multi-type cancers. Here, our purpose was to determine the expression pattern and clinical significance of FAM83H-AS1 and further analyse its prognostic value in colon cancer. FAM83H-AS1 expression was examined in 90 patients with colon cancer by RNAscope in situhybridization, and the expression levels were analysed with the overall survival (OS) rates for patients with colon cancer. TCGA datasets derived from colon cancer (COAD) were used to further validate the main findings. We demonstrated that the expression of FAM83H-AS1 was significantly higher in cancer tissues than in paired normal mucosa from colon cancer patients (P &lt; 0.001). The prognostic analysis indicated that the OS rates for colon cancer patients with high levels of FAM83H-AS1 were significantly lower than those for patients with low levels of FAM83H-AS1 (P = 0.013). The higher levels of FAM83H-AS1 were found to be associated with a lower expression of SMAD1/5/9, which is involved in TGF-β signalling in colon cancer tissues (P = 0.0174). In HCT116 and SW480 cell lines, the down regulation of FAM83H-AS1 promoted the expression of SMAD1. Our investigations suggest that the upregulation of FAM83H-AS1 serves as a promising predictor and might be conducive for clinicians to estimate OS time. FAM83H-AS1 might serve as an inhibitor of TGF-β signalling.</AbstractText>
                <CopyrightInformation>Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Lei</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Research Center, Beijing Chao-yang Hospital, Capital Medical University, China. Electronic address: yl6649084@163.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cui</LastName>
                    <ForeName>Jinpeng</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Clinical Laboratory, Yantai Yantaishan Hospital, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Yakun</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Medical Research Center, Beijing Chao-yang Hospital, Capital Medical University, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tan</LastName>
                    <ForeName>Jinjing</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Cellular and Molecular Biology, Beijing Chest Hospital, Capital Medical University &amp; Beijing Tuberculosis and Thoracic Tumor Research Institute, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>France</Country>
            <MedlineTA>Biomed Pharmacother</MedlineTA>
            <NlmUniqueID>8213295</NlmUniqueID>
            <ISSNLinking>0753-3322</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Colon cancer</Keyword>
            <Keyword MajorTopicYN="N">FAM83H-AS1</Keyword>
            <Keyword MajorTopicYN="N">Long noncoding RNA</Keyword>
            <Keyword MajorTopicYN="N">Prognosis</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>04</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31545230</ArticleId>
            <ArticleId IdType="pii">S0753-3322(19)31727-5</ArticleId>
            <ArticleId IdType="doi">10.1016/j.biopha.2019.109342</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31545212</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>05</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1879-1298</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>238</Volume>
                    <PubDate>
                        <Year>2020</Year>
                        <Month>Jan</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Chemosphere</Title>
                <ISOAbbreviation>Chemosphere</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Spatial variability of arsenic in Indo-Gangetic basin of Varanasi and its cancer risk assessment.</ArticleTitle>
            <Pagination>
                <MedlinePgn>124623</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0045-6535(19)31847-8</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.chemosphere.2019.124623</ELocationID>
            <Abstract>
                <AbstractText>The Indo-Gangetic alluvium is prime region for intensive agricultural. In some areas of this region, groundwater is now becoming progressively polluted by contamination with poisonous substances like arsenic. Intensive irrigation with arsenic contaminated ground water in dry spell results in the formation of As(III) which is more toxic. Thus groundwater quality assessment of Gangetic basin has become essential for its safer use. Therefore we under took study on the spatial variability of arsenic by collecting georeferred groundwater samples on grid basis from various water sources like dug well, bore and hand pumps covering the river bank region of Ganga basin. Water quality was investigated through determination pH, EC, TDS, salinity, Na, K, Ca, Mg, SAR, SSP, CO<sub>3</sub>, HCO<sub>3</sub>, RSC, Cl, As, Fe, Zn, Mn and Cu, etc. Results pointed severe As contamination in ground water of three sites of the study area. ARC GIS software is now able to process maps along with tabular data and compare them well, to provide the spatial visualization of information and using this tool, the Geographical Information System (GIS) of arsenic was developed. It was noticed from spatial maps that concentration of arsenic was more near the meandering points of Ganga.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Chattopadhyay</LastName>
                    <ForeName>Arghya</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Soil Science and Agricultural Chemistry, Institute of Agricultural Science, Banaras Hindu University, Varanasi, 221005, Uttar Pradesh, India. Electronic address: arghya.chattopadhyay1@bhu.ac.in.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Singh</LastName>
                    <ForeName>Anand Prakash</ForeName>
                    <Initials>AP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Soil Science and Agricultural Chemistry, Institute of Agricultural Science, Banaras Hindu University, Varanasi, 221005, Uttar Pradesh, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Singh</LastName>
                    <ForeName>Satish Kumar</ForeName>
                    <Initials>SK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Soil Science and Agricultural Chemistry, Institute of Agricultural Science, Banaras Hindu University, Varanasi, 221005, Uttar Pradesh, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Barman</LastName>
                    <ForeName>Arijit</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Soil and Crop Management, Central Soil Salinity Research Institute, Karnal, Haryana, 132001, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Patra</LastName>
                    <ForeName>Abhik</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Soil Science and Agricultural Chemistry, Institute of Agricultural Science, Banaras Hindu University, Varanasi, 221005, Uttar Pradesh, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mondal</LastName>
                    <ForeName>Bhabani Prasad</ForeName>
                    <Initials>BP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Agricultural Physics, Indian Agricultural Research Institute, New Delhi, 110012, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Banerjee</LastName>
                    <ForeName>Koushik</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Agricultural Physics, Indian Agricultural Research Institute, New Delhi, 110012, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Chemosphere</MedlineTA>
            <NlmUniqueID>0320657</NlmUniqueID>
            <ISSNLinking>0045-6535</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">ARC GIS</Keyword>
            <Keyword MajorTopicYN="N">Arsenic</Keyword>
            <Keyword MajorTopicYN="N">Groundwater quality</Keyword>
            <Keyword MajorTopicYN="N">Risk assessment</Keyword>
            <Keyword MajorTopicYN="N">Spatial variability map</Keyword>
            <Keyword MajorTopicYN="N">Varanasi</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31545212</ArticleId>
            <ArticleId IdType="pii">S0045-6535(19)31847-8</ArticleId>
            <ArticleId IdType="doi">10.1016/j.chemosphere.2019.124623</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31545114</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>15</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1464-522X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>43</Volume>
                    <Issue>5</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Jul</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of medical engineering &amp; technology</Title>
                <ISOAbbreviation>J Med Eng Technol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A survey of breast cancer screening techniques: thermography and electrical impedance tomography.</ArticleTitle>
            <Pagination>
                <MedlinePgn>305-322</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/03091902.2019.1664672</ELocationID>
            <Abstract>
                <AbstractText>Breast cancer is a disease that threat many women's life, thus, the early and accurate detection play a key role in reducing the mortality rate. Mammography stands as the reference technique for breast cancer screening; nevertheless, many countries still lack access to mammograms due to economic, social and cultural issues. Last advances in computational tools, infra-red cameras and devices for bio-impedance quantification allowed the development of parallel techniques like, thermography, infra-red imaging and electrical impedance tomography, these being faster, reliable and cheaper. In the last decades, these have been considered as complement procedures for breast cancer diagnosis, where many studies concluded that false positive and false negative rates are greatly reduced. This work aims to review the last breakthroughs about the three above-mentioned techniques describing the benefits of mixing several computational skills to obtain a better global performance. In addition, we provide a comparison between several machine learning techniques applied to breast cancer diagnosis going from logistic regression, decision trees and random forest to artificial, deep and convolutional neural networks. Finally, it is mentioned several recommendations for 3D breast simulations, pre-processing techniques, biomedical devices in the research field, prediction of tumour location and size.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Zuluaga-Gomez</LastName>
                    <ForeName>J</ForeName>
                    <Initials>J</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-6947-2706</Identifier>
                    <AffiliationInfo>
                        <Affiliation>FEMTO-ST Institute, University Bourgogne Franche-Comté, CNRS, ENSMM , Besançon , France.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Electrical Engineering, University of Oviedo , Gijon , Spain.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Universidad Autonoma Del Caribe , Barranquilla , Colombia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zerhouni</LastName>
                    <ForeName>N</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>FEMTO-ST Institute, University Bourgogne Franche-Comté, CNRS, ENSMM , Besançon , France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Al Masry</LastName>
                    <ForeName>Z</ForeName>
                    <Initials>Z</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-6673-0140</Identifier>
                    <AffiliationInfo>
                        <Affiliation>FEMTO-ST Institute, University Bourgogne Franche-Comté, CNRS, ENSMM , Besançon , France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Devalland</LastName>
                    <ForeName>C</ForeName>
                    <Initials>C</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-4128-9264</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Hospital Nord Franche-Comte , Belfort , France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Varnier</LastName>
                    <ForeName>C</ForeName>
                    <Initials>C</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-3435-4643</Identifier>
                    <AffiliationInfo>
                        <Affiliation>FEMTO-ST Institute, University Bourgogne Franche-Comté, CNRS, ENSMM , Besançon , France.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>J Med Eng Technol</MedlineTA>
            <NlmUniqueID>7702125</NlmUniqueID>
            <ISSNLinking>0309-1902</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Breast cancer</Keyword>
            <Keyword MajorTopicYN="N">computer aided diagnosis</Keyword>
            <Keyword MajorTopicYN="N">electrical impedance tomography</Keyword>
            <Keyword MajorTopicYN="N">machine learning techniques</Keyword>
            <Keyword MajorTopicYN="N">thermography</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31545114</ArticleId>
            <ArticleId IdType="doi">10.1080/03091902.2019.1664672</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31545001</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1098-2744</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>58</Volume>
                    <Issue>12</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Dec</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Molecular carcinogenesis</Title>
                <ISOAbbreviation>Mol. Carcinog.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A shift from membranous and stromal syndecan-1 (CD138) expression to cytoplasmic CD138 expression is associated with poor prognosis in breast cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn>2306-2315</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/mc.23119</ELocationID>
            <Abstract>
                <AbstractText>Syndecan-1 (CD138) is a transmembrane proteoglycan expressed in normal and malignant tissues. It is of interest because of a possible prognostic effect in tumors and as a target for Indatuximab, a monoclonal antibody coupled to a cytotoxic agent. To assess the prognostic role of CD138 expression in breast cancer (BCa), a tissue microarray containing 1535 BCa specimens was analyzed by immunohistochemistry. Cytoplasmic, membranous, and stromal CD138 staining was separately analyzed. In normal breast tissue, CD138 staining was limited to epithelial cell membranes. In cancers, membranous staining tended to become weaker or even disappeared (38.3% of cancers with absence of membranous staining) but cytoplasmic and stromal staining newly appeared in 29.7% and 58.1% of cancers. Loss of membranous epithelial CD138 staining as well as presence of cytoplasmic and stromal CD138 positivity were-to a variable degree-associated with high pT, high grade, nodal metastasis, estrogen receptor-negative, progesterone receptor-negative, human epidermal growth factor receptor 2+, and poor overall patient survival. A combined analysis of epithelial and stromal CD138 expression revealed a link to overall patient survival (P &lt; .0001) with best prognosis for patients with stromal positivity and absence of cytoplasmic staining, the worst prognosis for cancers with cytoplasmic staining and stromal negativity and intermediate prognosis for patients having either cytoplasmic staining or stromal negativity. In multivariate analyses, CD138 was not independent of established prognostic features. In summary, these data reveal a compartment depending prognostic effect of CD138 expression in BCa with cytoplasmic positivity being linked to aggressive cancer and stromal CD138 being linked to a more favorable prognosis.</AbstractText>
                <CopyrightInformation>© 2019 The Authors. Molecular Carcinogenesis published by Wiley Periodicals, Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kind</LastName>
                    <ForeName>Simon</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jaretzke</LastName>
                    <ForeName>Annika</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Büscheck</LastName>
                    <ForeName>Franziska</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Möller</LastName>
                    <ForeName>Katharina</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dum</LastName>
                    <ForeName>David</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Höflmayer</LastName>
                    <ForeName>Doris</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hinsch</LastName>
                    <ForeName>Andrea</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Weidemann</LastName>
                    <ForeName>Sören</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fraune</LastName>
                    <ForeName>Christoph</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Möller-Koop</LastName>
                    <ForeName>Christina</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hube-Magg</LastName>
                    <ForeName>Claudia</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Simon</LastName>
                    <ForeName>Ronald</ForeName>
                    <Initials>R</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-0158-4258</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wilczak</LastName>
                    <ForeName>Waldemar</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lebok</LastName>
                    <ForeName>Patrick</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Witzel</LastName>
                    <ForeName>Isabell</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Müller</LastName>
                    <ForeName>Volkmar</ForeName>
                    <Initials>V</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schmalfeldt</LastName>
                    <ForeName>Barbara</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Paluchowski</LastName>
                    <ForeName>Peter</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gynecology, Regio Clinic Pinneberg, Pinneberg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wilke</LastName>
                    <ForeName>Christian</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gynecology, Regio Clinic Elmshorn, Elmshorn, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Heilenkötter</LastName>
                    <ForeName>Uwe</ForeName>
                    <Initials>U</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gynecology, Clinical Centre Itzehoe, Itzehoe, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>von Leffern</LastName>
                    <ForeName>Ingo</ForeName>
                    <Initials>I</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gynecology, Albertinen Clinic Schnelsen, Hamburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Krech</LastName>
                    <ForeName>Till</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Pathology, Clinical Centre Osnabrück, Osnabrück, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Krech</LastName>
                    <ForeName>Rainer H</ForeName>
                    <Initials>RH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Pathology, Clinical Centre Osnabrück, Osnabrück, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>von der Assen</LastName>
                    <ForeName>Albert</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Breast Centre Osnabrück, Niels-Stensen-Clinic, Osnabrück, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bawahab</LastName>
                    <ForeName>Ahmed Abdulwahab</ForeName>
                    <Initials>AA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Pathology, University of Jeddah, Jeddah, Saudi Arabia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Burandt</LastName>
                    <ForeName>Eike</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Mol Carcinog</MedlineTA>
            <NlmUniqueID>8811105</NlmUniqueID>
            <ISSNLinking>0899-1987</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">CD138</Keyword>
            <Keyword MajorTopicYN="N">SDC1</Keyword>
            <Keyword MajorTopicYN="N">breast cancer</Keyword>
            <Keyword MajorTopicYN="N">immunohistochemistry</Keyword>
            <Keyword MajorTopicYN="N">prognosis</Keyword>
            <Keyword MajorTopicYN="N">staining pattern</Keyword>
            <Keyword MajorTopicYN="N">tissue microarray</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>06</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31545001</ArticleId>
            <ArticleId IdType="doi">10.1002/mc.23119</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31545000</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1098-2744</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>58</Volume>
                    <Issue>12</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Dec</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Molecular carcinogenesis</Title>
                <ISOAbbreviation>Mol. Carcinog.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>LncRNA DANCR promotes tumor growth and angiogenesis in ovarian cancer through direct targeting of miR-145.</ArticleTitle>
            <Pagination>
                <MedlinePgn>2286-2296</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/mc.23117</ELocationID>
            <Abstract>
                <AbstractText>Differentiation antagonizing non-protein coding RNA (DANCR) is a newly identified oncogenic long noncoding RNA found in various cancers. However, the functional role of DANCR in tumor angiogenesis and the underlying mechanisms are still unclear. The expression of DANCR was determined in ovarian malignant tissues and cell lines. The functional role of DANCR in tumor angiogenesis was revealed by the following methods: CD31 staining of ovarian tumor tissues, matrigel-plug assay tissues, HUVEC-related tube formation assay, and invasion assay. Enzyme-linked immunosorbent assay, Western blotting, luciferase assay, and rescue experiments were used to investigate the underlying mechanisms of DANCR-regulating angiogenesis. DANCR was upregulated in ovarian malignant tissues and ovarian cancer cells. Knockdown of DANCR efficiently impaired ovarian tumor growth through inhibition of tumor angiogenesis. Furthermore, the conditional culture medium from DANCR-knockdown ovarian cells significantly inhibited tube formation and invasion of HUVEC in vitro. Mechanistic investigation indicated that vascular endothelial growth factor A (VEGF-A, VEGF) plays a crucial role during DANCR inhibition of tumor angiogenesis in ovarian cancer. Further results demonstrated that miR-145 is the direct binding target of DANCR during regulation of VEGF expression and tumor angiogenesis in ovarian cancer cells. Collectively, DANCR plays a promotional role in tumor angiogenesis in ovarian cancer through regulation of miR-145/VEGF axis. Therefore, DANCR may be a novel therapy target for ovarian cancer.</AbstractText>
                <CopyrightInformation>© 2019 Wiley Periodicals, Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lin</LastName>
                    <ForeName>Xiaojuan</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Fan</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Qi</LastName>
                    <ForeName>Xiaorong</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Qingli</ForeName>
                    <Initials>Q</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Danqing</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yi</LastName>
                    <ForeName>Tao</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yin</LastName>
                    <ForeName>Rutie</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhao</LastName>
                    <ForeName>Xia</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhong</LastName>
                    <ForeName>Xiaomin</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Key Laboratory for Stem Cells and Tissue Engineering, Ministry of Education, Center for Stem Cell Biology and Tissue Engineering, Department of Biology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bian</LastName>
                    <ForeName>Ce</ForeName>
                    <Initials>C</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-0401-4103</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>2017SZ0141</GrantID>
                    <Agency>Key Research Projects of Science and Technology Department Foundation of Sichuan Province</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>2015-HM01-00018-SF</GrantID>
                    <Agency>Science and Technology R&amp;D Program of Chengdu</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>2016JY0122</GrantID>
                    <Agency>Applied Basic Research Programs of Science and Technology Department Foundation of Sichuan Province</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>2017YFA0105501</GrantID>
                    <Agency>National Key R&amp;D Program of China</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>2015A020212019</GrantID>
                    <Agency>Guangdong Province Science and Technology Project</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Mol Carcinog</MedlineTA>
            <NlmUniqueID>8811105</NlmUniqueID>
            <ISSNLinking>0899-1987</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">DANCR</Keyword>
            <Keyword MajorTopicYN="N">VEGF</Keyword>
            <Keyword MajorTopicYN="N">angiogenesis</Keyword>
            <Keyword MajorTopicYN="N">miR-145</Keyword>
            <Keyword MajorTopicYN="N">ovarian cancer</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>03</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31545000</ArticleId>
            <ArticleId IdType="doi">10.1002/mc.23117</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31544991</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1097-4644</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                        <Day>23</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of cellular biochemistry</Title>
                <ISOAbbreviation>J. Cell. Biochem.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>LINC00365 promotes colorectal cancer cell progression through the Wnt/β-catenin signaling pathway.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/jcb.29359</ELocationID>
            <Abstract>
                <AbstractText>In the past decade, substantial evidence established that long noncoding RNAs are serious about mediating the evolution of malignancies. In previous studies, LINC00365, which has not been reported in colorectal cancer (CRC), was selected using the bioinformatics analysis in GSE109454 and GSE41655 data sets. However, the function and mechanism of LINC00365 are still obscure. In our study, LINC00365 was found upregulated in CRC specimens and intimately connected with the prognosis of patients with CRC. In addition, LINC00365 overexpression enhances the cell abilities of proliferation, migration, and invasion in vitro. Meanwhile, mechanistic studies showed that LINC00365 might involve in CRC cell progression by mediating the Wnt/β-catenin pathway. Furthermore, LINC00365 upregulation increased CDK1 protein expression. In conclusion, this study suggests that LINC00365 acts as a vital part in facilitating CRC progression and might play as a therapeutic target for patients with CRC.</AbstractText>
                <CopyrightInformation>© 2019 Wiley Periodicals, Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Zhu</LastName>
                    <ForeName>Yiping</ForeName>
                    <Initials>Y</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-4738-1125</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Comprehensive Cancer Center, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Oncology, The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bian</LastName>
                    <ForeName>Yinzhu</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Comprehensive Cancer Center, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Department of Oncology, First People's Hospital of Yancheng, Fourth Affiliated Hospital of Nantong University, Yancheng, Jiangsu, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Qun</ForeName>
                    <Initials>Q</Initials>
                    <AffiliationInfo>
                        <Affiliation>Comprehensive Cancer Center, Nanjing Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hu</LastName>
                    <ForeName>Jing</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Comprehensive Cancer Center, Nanjing Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Li</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Comprehensive Cancer Center, Nanjing Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Mi</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Comprehensive Cancer Center, Nanjing Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Qian</LastName>
                    <ForeName>Hanqing</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Comprehensive Cancer Center, Nanjing Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yu</LastName>
                    <ForeName>Lixia</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Comprehensive Cancer Center, Nanjing Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Baorui</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Comprehensive Cancer Center, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Comprehensive Cancer Center, Nanjing Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Qian</LastName>
                    <ForeName>Xiaoping</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Comprehensive Cancer Center, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Comprehensive Cancer Center, Nanjing Drum Tower Hospital, Medical School of Nanjing University, Clinical Cancer Institute of Nanjing University, Nanjing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>BK20161107</GrantID>
                    <Agency>Provincial Natural Science Foundation of Jiangsu</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>KJ2017A262</GrantID>
                    <Agency>Natural Science Research Project of College and Universities in Anhui Province</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>ZKX17012</GrantID>
                    <Agency>Nanjing Health and Family Planning Commission key program</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>H2817042</GrantID>
                    <Agency>Jiangsu Health and Family Planning Commission development program</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>GF2019G11</GrantID>
                    <Agency>Funding of &quot;Peak&quot; Training Program for Scientific Research of Yijishan Hospital,Wannan Medical College</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Cell Biochem</MedlineTA>
            <NlmUniqueID>8205768</NlmUniqueID>
            <ISSNLinking>0730-2312</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">LINC00365</Keyword>
            <Keyword MajorTopicYN="N">Wnt/β-catenin signaling</Keyword>
            <Keyword MajorTopicYN="N">cancer progression</Keyword>
            <Keyword MajorTopicYN="N">colorectal cancer</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>03</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31544991</ArticleId>
            <ArticleId IdType="doi">10.1002/jcb.29359</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31544978</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1097-4652</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                        <Day>23</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of cellular physiology</Title>
                <ISOAbbreviation>J. Cell. Physiol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>MicroRNA-203 diminishes the stemness of human colon cancer cells by suppressing GATA6 expression.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/jcp.29192</ELocationID>
            <Abstract>
                <AbstractText>The interaction between hyaluronan and CD44, an important cancer stem-cell marker, stimulates various tumor cell-specific functions such as the stemness of tumor cells. microRNA-203 (miR-203) can be downregulated by this interaction in human colorectal cancer (CRC) cells, which increases their stemness; however, the underlying mechanism is not yet defined. Here, we show that overexpression and sequestration of miR-203 in HCT-116 and HT-29 human CRC cells reduces and enhances their stemness, respectively. We also show that GATA-binding factor 6 (GATA6) is a direct target of miR-203. Our results indicate that upregulated expression of this transcription factor not only restores the self-renewal abilities of miR-203-overexpressing HCT-116 and HT-29 cells but also promotes the stemness properties of their parental counterparts. More important, we show that silencing the expression of either LRH-1 or Hes-1 is sufficient to diminish the stemness-promoting effects of GATA6 in human CRC cells. Together, our findings delineate the stemness-inhibitory mechanism of miR-203 in human CRC cells and suggest that this miR is a potential therapeutic agent for colorectal cancer.</AbstractText>
                <CopyrightInformation>© 2019 Wiley Periodicals, Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lai</LastName>
                    <ForeName>Hung-Tzi</ForeName>
                    <Initials>HT</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0002-2605-5865</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute of Biopharmaceutical Sciences, School of Pharmaceutical Sciences, National Yang-Ming University, Shi-Pai, Taipei, Taiwan, R.O.C.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tseng</LastName>
                    <ForeName>Wen-Ko</ForeName>
                    <Initials>WK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Program in Molecular Medicine, School of Life Sciences, National Yang-Ming University, Shi-Pai, Taipei, Taiwan, R.O.C.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Colorectal Surgery Department, Chung-Gung Memorial Hospital, Keelung Branch, Keelung, Taipei, Taiwan, R.O.C.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huang</LastName>
                    <ForeName>Shi-Wei</ForeName>
                    <Initials>SW</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Biopharmaceutical Sciences, School of Pharmaceutical Sciences, National Yang-Ming University, Shi-Pai, Taipei, Taiwan, R.O.C.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chao</LastName>
                    <ForeName>Ta-Chung</ForeName>
                    <Initials>TC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Medical Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Faculty of Medicine, School of Medicine, National Yang-Ming University, Shi-Pai, Taipei, Taiwan, R.O.C.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Su</LastName>
                    <ForeName>Yeu</ForeName>
                    <Initials>Y</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-1322-8365</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Institute of Biopharmaceutical Sciences, School of Pharmaceutical Sciences, National Yang-Ming University, Shi-Pai, Taipei, Taiwan, R.O.C.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>Program in Molecular Medicine, School of Life Sciences, National Yang-Ming University, Shi-Pai, Taipei, Taiwan, R.O.C.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>MOST 101-2320-B-010-071-MY3</GrantID>
                    <Agency>Ministry of Science and Technology, Taiwan</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>MOST104-2320-B-010-007</GrantID>
                    <Agency>Ministry of Science and Technology, Taiwan</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>MOST105-2320-B-010-030</GrantID>
                    <Agency>Ministry of Science and Technology, Taiwan</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Cell Physiol</MedlineTA>
            <NlmUniqueID>0050222</NlmUniqueID>
            <ISSNLinking>0021-9541</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">GATA6</Keyword>
            <Keyword MajorTopicYN="N">colon cancer</Keyword>
            <Keyword MajorTopicYN="N">miR-203</Keyword>
            <Keyword MajorTopicYN="N">stemness</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31544978</ArticleId>
            <ArticleId IdType="doi">10.1002/jcp.29192</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31544977</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1097-4652</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                        <Day>23</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of cellular physiology</Title>
                <ISOAbbreviation>J. Cell. Physiol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Deacetylation of LAMP1 drives lipophagy-dependent generation of free fatty acids by Abrus agglutinin to promote senescence in prostate cancer.</ArticleTitle>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/jcp.29182</ELocationID>
            <Abstract>
                <AbstractText>Therapy-induced senescence in cancer cells is an irreversible antiproliferative state, which inhibits tumor growth and is therefore a potent anti-neoplastic mechanism. In this study, low doses of Abrus agglutinin (AGG)-induced senescence through autophagy in prostate carcinoma cells (PC3) and inhibited proliferation. The inhibition of autophagy with 3-methyl adenine reversed AGG-induced senescence, thus confirming that AGG-triggered senescence required autophagy. AGG treatment also led to lipophagy-mediated accumulation of free fatty acids (FFAs), with a concomitant decrease in the number of lipid droplets. Lalistat, a lysosomal acid lipase inhibitor, abrogated AGG-induced lipophagy and senescence in PC3 cells, indicating that lipophagy is essential for AGG-induced senescence. The accumulation of FFAs increased reactive oxygen species generation, a known facilitator of senescence, which was also reduced in the presence of lalistat. Furthermore, AGG upregulated silent mating type information regulator 2 homolog 1 (SIRT1), while the presence of sirtinol reduced autophagy flux and the senescent phenotype in the AGG-treated cells. Mechanistically, AGG-induced cytoplasmic SIRT1 deacetylated a Lys residue on the cytoplasmic domain of lysosome-associated membrane protein 1 (LAMP1), an autolysosomal protein, resulting in lipophagy and senescence. Taken together, our findings demonstrate a novel SIRT1/LAMP1/lipophagy axis mediating AGG-induced senescence in prostate cancer cells.</AbstractText>
                <CopyrightInformation>© 2019 Wiley Periodicals, Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Panda</LastName>
                    <ForeName>Prashanta Kumar</ForeName>
                    <Initials>PK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Life Science, National Institute of Technology Rourkela, Rourkela, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Patra</LastName>
                    <ForeName>Srimanta</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Life Science, National Institute of Technology Rourkela, Rourkela, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Naik</LastName>
                    <ForeName>Prajna Paramita</ForeName>
                    <Initials>PP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Life Science, National Institute of Technology Rourkela, Rourkela, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Praharaj</LastName>
                    <ForeName>Prakash Priyadarshi</ForeName>
                    <Initials>PP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Life Science, National Institute of Technology Rourkela, Rourkela, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mukhopadhyay</LastName>
                    <ForeName>Subhadip</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Life Science, National Institute of Technology Rourkela, Rourkela, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Meher</LastName>
                    <ForeName>Biswa Ranjan</ForeName>
                    <Initials>BR</Initials>
                    <AffiliationInfo>
                        <Affiliation>PG Department of Botany, Berhampur University, Brahmapur, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gupta</LastName>
                    <ForeName>Piyush Kumar</ForeName>
                    <Initials>PK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Verma</LastName>
                    <ForeName>Rama S</ForeName>
                    <Initials>RS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Maiti</LastName>
                    <ForeName>Tapas K</ForeName>
                    <Initials>TK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Biotechnology, Indian Institute of Technology Kharagpur, Kharagpur, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bhutia</LastName>
                    <ForeName>Sujit K</ForeName>
                    <Initials>SK</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0003-0962-3354</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Life Science, National Institute of Technology Rourkela, Rourkela, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>EMR/2016/001246</GrantID>
                    <Agency>Science and Engineering Research Board (SERB)</Agency>
                    <Country/>
                </Grant>
                <Grant>
                    <GrantID>37(1715)/18/EMR-II</GrantID>
                    <Agency>Council for Scientific and Industrial Research</Agency>
                    <Country/>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Cell Physiol</MedlineTA>
            <NlmUniqueID>0050222</NlmUniqueID>
            <ISSNLinking>0021-9541</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Abrus agglutinin</Keyword>
            <Keyword MajorTopicYN="N">LAMP1</Keyword>
            <Keyword MajorTopicYN="N">SIRT1</Keyword>
            <Keyword MajorTopicYN="N">free fatty acid</Keyword>
            <Keyword MajorTopicYN="N">lipophagy</Keyword>
            <Keyword MajorTopicYN="N">reactive oxygen species</Keyword>
            <Keyword MajorTopicYN="N">senescence</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>02</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31544977</ArticleId>
            <ArticleId IdType="doi">10.1002/jcp.29182</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31544800</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>28</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">0973-7731</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>98</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of genetics</Title>
                <ISOAbbreviation>J. Genet.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Association between genetic polymorphisms of long noncoding RNA H19 and cancer risk: a meta-analysis.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">81</ELocationID>
            <Abstract>
                <AbstractText>Long noncoding RNA (lncRNA) H19, a well-known oncogenic lncRNA, is overexpressed in various cancers. Several studies have investigated the association between polymorphisms in lncRNA H19 and the risk of various cancer types; however, the findings were inconsistent. In this study, we performed a meta-analysis to identify the precise association between H19 polymorphisms and cancer risk. Appropriate studies were retrieved from searching Web of Science, PubMed, Scopus, and Google scholar databases, updated 25 November 2018. The pooled odds ratios (ORs with 95% confidence intervals (CIs) were calculated to estimate the strength of the association between H19 polymorphisms and cancer risk. Our findings revealed that the H19-rs217727 C&gt;T polymorphism is significantly associated with an increased risk of overall cancer in homozygous codominant (OR=1.28, 95% CI=1.04-1.57, <i>P</i> =0.020, TT vs CC), dominant (OR=1.20, 95% CI=1.04-1.37, <i>P</i> =0.010, CT+TT vs CC), recessive (OR=1.21, 95% CI=1.00-1.46, <i>P</i> =0.048, TT vs CT+CC), and allele (OR=1.16, 95% CI=1.05-1.28, <i>P</i> =0.003, T vs C) genetic models. No significant correlations were observed between H19: rs2839698 G&gt;A, rs2107425 C&gt;T, rs2735971 C&gt;T, rs3024270 G&gt;C, rs3741219 T&gt;C, rs2839701 C&gt;G, rs2735469 C&gt;T, rs17658052 G&gt;A, and rs3741216 T&gt;A polymorphisms and overall cancer risk. Stratified analysis by cancer type proposed that the rs217727 variant is associated with increased risk of oral squamous cell carcinoma (OSCC) and lung cancer, whereas the rs2839698 variant is associated with increased risk of gastrointestinal cancer. Taken together, these findings support an association between H19 rs217727, and rs2839698 polymorphisms and cancer susceptibility. Larger and well-designed studies are necessary to further confirm these findings in detail.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Hashemi</LastName>
                    <ForeName>Mohammad</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Genetics of Non-communicable Disease Research Centre, Zahedan University of Medical Sciences, Zahedan 9816743181, Iran. mhd.hashemi@gmail.com; hashemim@zaums.ac.ir.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Moazeni-Roodi</LastName>
                    <ForeName>Abdolkarim</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sarabandi</LastName>
                    <ForeName>Sahel</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Karami</LastName>
                    <ForeName>Shima</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ghavami</LastName>
                    <ForeName>Saeid</ForeName>
                    <Initials>S</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>India</Country>
            <MedlineTA>J Genet</MedlineTA>
            <NlmUniqueID>2985113R</NlmUniqueID>
            <ISSNLinking>0022-1333</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31544800</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31544773</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>28</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">0973-7731</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>98</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of genetics</Title>
                <ISOAbbreviation>J. Genet.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Association between the SNPs in trace element-related metabolic genes and the risk of gastric cancer: a case-control study in Xianyou of China.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">67</ELocationID>
            <Abstract>
                <AbstractText>This study aims to analyse the potential relationship between single-nucleotide polymorphism (SNPs) in trace element related metabolic genes <i>GSTM3</i>, <i>GSTP1</i>, <i>GPX1</i> and <i>NKG2D</i> and the risk of gastric cancer. A case-control study was conducted in the hospital of Xianyou, Fujian, China. In this study, a total of 299 patients with histopathological diagnosis in gastric cancer and 295 healthy control subjects were involved. Association between the SNPs in trace element-related metabolic genes and gastric cancer risk was analysed using the unconditional logistic regression model. No relationship was found between the SNPs of <i>GSTM3</i> and <i>GPX1</i> genes and gastric cancer risk. However, the risk of gastric cancer is related to the SNPs of <i>NKG2D</i> gene (rs1049174). Patients who carry the rs1049174 GG genotype have a higher incidence of the gastric cancer and a multivariate odds ratio (OR) of 1.85 (95% confidence intervals (CI): 1.02-3.38). Through haplotype analysis, two haplotypes (i.e. A_rs1746123-T_rs10431294-G_rs1049174 and T_rs1746123-T_rs10431294-C_rs1049174), OR of 0.29 (95% CI: 0.15-0.56) and 0.33, (95% CI: 0.22-0.50), respectively, were found to have lower incidence of gastric cancer. Meanwhile, another two haplotypes (T_rs1746123-C_rs10431294-C_rs1049174 and T_rs1746123-T_rs10431294-G_rs1049174), OR of 1.81 (95% CI: 1.40-2.34) and 3.09 (95% CI: 2.30-4.16), respectively, were found to have a higher incidence of gastric cancer. Further, no influence of the haplotype on the risk of cardia gastric cancer was found. However, the haplotype T_rs1746123-T_rs10431294-C_rs1049174 had lower incidence of noncardia gastric cancer by 46%. Our data showed that polymorphisms of trace element-related metabolic genes are important in gastric cancer pathology.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Zheng</LastName>
                    <ForeName>Weiwei</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Gastroenterology, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350001, Fujian Province, People's Republic of China. fzdoctorlby@sina.com; 78926674@qq.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Hongtu</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Baoying</ForeName>
                    <Initials>B</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wu</LastName>
                    <ForeName>Chuancheng</ForeName>
                    <Initials>C</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>India</Country>
            <MedlineTA>J Genet</MedlineTA>
            <NlmUniqueID>2985113R</NlmUniqueID>
            <ISSNLinking>0022-1333</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31544773</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31544590</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>06</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1551-4005</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>18</Volume>
                    <Issue>22</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Cell cycle (Georgetown, Tex.)</Title>
                <ISOAbbreviation>Cell Cycle</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Melanoma-derived exosomes induce reprogramming fibroblasts into cancer-associated fibroblasts via Gm26809 delivery.</ArticleTitle>
            <Pagination>
                <MedlinePgn>3085-3094</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/15384101.2019.1669380</ELocationID>
            <Abstract>
                <AbstractText>Cancer-associated fibroblasts (CAFs) are activated fibroblasts and can interact with cancer cells to promote tumor progression. The process of how tumor cells reprogram normal fibroblasts (NFs) to tumor-promoting CAFs regulated by long non-coding RNA (lncRNA) remains incompletely understood. The tumor cells-released exosomes can induce reprogramming of NFs into CAFs. This study aimed to explore the role of melanoma-derived exosomes in regulating NF-CAF transition and to clarify whether lncRNA Gm26809 was involved in this process. The results showed that the exosomes secreted by melanoma cell B16F0 induced reprogramming of fibroblast NIH/3T3 cells into CAFs, as evidenced by increased expression of CAFs markers (α-SMA and FAP) and facilitated cell migration. Mechanistically, B16F0-secreted exosome delivered Gm26809 into NIH/3T3 cells where Gm26809 mediated reprogramming of fibroblast NIH/3T3 cells into CAFs. Furthermore, the conditioned medium from the co-culture of NIH/3T3 cells and B16F0-exosomes facilitated cell proliferation and migration in a melanoma cell line (Cloundman S91), and the effect was abrogated by Gm26809 knockdown in B16F0 cells. In summary, melanoma-derived exosomes facilitate melanoma cell proliferation and migration through reprogramming fibroblasts into tumor-promoting CAFs via transferring Gm26809.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Hu</LastName>
                    <ForeName>Tairan</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Dermatology, Renmin Hospital of Wuhan University , Wuhan , China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hu</LastName>
                    <ForeName>Jiacai</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Traditional Chinese Medicine, Renmin Hospital of Wuhan University , Wuhan , China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Cell Cycle</MedlineTA>
            <NlmUniqueID>101137841</NlmUniqueID>
            <ISSNLinking>1551-4005</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Gm26809</Keyword>
            <Keyword MajorTopicYN="N">Melanoma</Keyword>
            <Keyword MajorTopicYN="N">cancer-associated fibroblasts</Keyword>
            <Keyword MajorTopicYN="N">exosome</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="pmc-release">
                <Year>2020</Year>
                <Month>09</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31544590</ArticleId>
            <ArticleId IdType="doi">10.1080/15384101.2019.1669380</ArticleId>
            <ArticleId IdType="pmc">PMC6816427</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>FEBS J. 2018 Mar;285(6):1033-1050</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29399967</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Immunol Res. 2015;2015:848790</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26090502</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Commun. 2016 Mar 29;7:11150</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27021436</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancers (Basel). 2015 Dec 11;7(4):2443-58</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26690480</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Genes Dev. 2016 May 1;30(9):1002-19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27151975</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Noncoding RNA Res. 2016 Nov 24;1(1):83-86</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30159415</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Ann N Y Acad Sci. 2006 Sep;1076:29-53</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17119192</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Lett. 2018 Feb 1;414:107-115</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29107112</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Front Oncol. 2019 May 03;9:356</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31131261</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Onco Targets Ther. 2018 Jan 09;11:291-299</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29386907</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Cell Biol. 2016 Sep;18(9):1006-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27548915</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Expert Rev Dermatol. 2008 Oct;3(5):569-585</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19649148</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Exp Clin Cancer Res. 2018 Oct 3;37(1):242</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30285793</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Cancer Res. 2018 Jul;16(7):1196-1204</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29636362</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Adv Exp Med Biol. 2016;937:3-17</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27573892</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Cell. 2016 May 9;29(5):653-668</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27117758</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Crit Rev Oncol Hematol. 2019 Jul;139:125-127</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30890387</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Carcinogenesis. 2018 Mar 8;39(3):397-406</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29346528</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Surg Oncol. 2012 Sep;21(3):172-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21963199</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancers (Basel). 2017 May 24;9(6):null</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28538690</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31544294</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1098-2744</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>58</Volume>
                    <Issue>12</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Dec</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Molecular carcinogenesis</Title>
                <ISOAbbreviation>Mol. Carcinog.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>lncRNA CCAT1 is a biomarker for the proliferation and drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1 axis.</ArticleTitle>
            <Pagination>
                <MedlinePgn>2207-2217</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1002/mc.23109</ELocationID>
            <Abstract>
                <AbstractText>Recent evidence indicates that long noncoding RNA colon cancer-associated transcript-1 (lncRNA CCAT1) is abundantly expressed in esophageal cancer and is closely related to the occurrence, development, invasion, metastasis, and drug resistance of this disease. However, the role and molecular mechanisms of CCAT1 in the cell proliferation and chemoresistance of esophageal cancer are largely unknown. The correlation between CCAT1 expression and drug resistance to cisplatin (CDDP) in esophageal squamous cell carcinoma (ESCC) cells was analyzed using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) and quantitative real-time polymerase chain reaction (qRT-PCR) assays. CCAT1 knockdown and miR-143 overexpression or inhibition were used to verify the effects on proliferation and drug resistance via MTT, western blotting, flow cytometry, and immunofluorescence assays. qRT-PCR and western blotting were applied to detect the potential regulatory relationship among CCAT1, miR-143, PLK1, and BUBR1. A xenograft tumor assay was performed to validate the role of CCAT1 in vivo. The expression of CCAT1 was positively correlated with drug resistance in several ESCC cell lines. CCAT1 knockdown and miR-143 overexpression inhibited cell proliferation and CDDP drug resistance. Moreover, the downstream target of CCAT1 was found to be miR-143, which can regulate the expression of PLK1 and BUBR1. In vivo assays showed that CCAT1 knockdown suppressed tumor growth and enhanced the sensitivity of tumors to CDDP in nude mice. Taken together, we discovered a novel mechanism by which CCAT1 promotes cell proliferation and enhances drug resistance by regulating the miR-143/PLK1/BUBR1 signaling axis both in vitro and in vivo. Our findings further suggest that lncRNA CCAT1 may be a potential therapeutic target for overcoming chemoresistance in esophageal cancer.</AbstractText>
                <CopyrightInformation>© 2019 Wiley Periodicals, Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Hu</LastName>
                    <ForeName>Min</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Diagnostic Laboratory, Henan Provincial People's Hospital, School of Clinical Medicine, Henan University, Zhengzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Qi</ForeName>
                    <Initials>Q</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Diagnostic Laboratory, Henan Provincial People's Hospital, School of Clinical Medicine, Henan University, Zhengzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tian</LastName>
                    <ForeName>Xiao-Hui</ForeName>
                    <Initials>XH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Diagnostic Laboratory, Henan Provincial People's Hospital, School of Clinical Medicine, Henan University, Zhengzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Jin-Lin</ForeName>
                    <Initials>JL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Diagnostic Laboratory, Henan Provincial People's Hospital, School of Clinical Medicine, Henan University, Zhengzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Niu</LastName>
                    <ForeName>Ya-Xuan</ForeName>
                    <Initials>YX</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Diagnostic Laboratory, Henan Provincial People's Hospital, School of Clinical Medicine, Henan University, Zhengzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Gang</ForeName>
                    <Initials>G</Initials>
                    <Identifier Source="ORCID">http://orcid.org/0000-0001-9509-0878</Identifier>
                    <AffiliationInfo>
                        <Affiliation>Department of Clinical Diagnostic Laboratory, Henan Provincial People's Hospital, School of Clinical Medicine, Henan University, Zhengzhou, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Mol Carcinog</MedlineTA>
            <NlmUniqueID>8811105</NlmUniqueID>
            <ISSNLinking>0899-1987</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">CDDP</Keyword>
            <Keyword MajorTopicYN="N">esophageal cancer</Keyword>
            <Keyword MajorTopicYN="N">lncRNA CCAT1</Keyword>
            <Keyword MajorTopicYN="N">miR-143/PLK1/BUBR1</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31544294</ArticleId>
            <ArticleId IdType="doi">10.1002/mc.23109</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Process" Owner="NLM">
        <PMID Version="1">31543678</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>26</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">2219-2840</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>25</Volume>
                    <Issue>33</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                        <Day>07</Day>
                    </PubDate>
                </JournalIssue>
                <Title>World journal of gastroenterology</Title>
                <ISOAbbreviation>World J. Gastroenterol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Neoadjuvant radiotherapy for rectal cancer management.</ArticleTitle>
            <Pagination>
                <MedlinePgn>4850-4869</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3748/wjg.v25.i33.4850</ELocationID>
            <Abstract>
                <AbstractText>Thirty per cent of all colorectal tumours develop in the rectum. The location of the rectum within the bony pelvis and its proximity to vital structures presents significant therapeutic challenges when considering neoadjuvant options and surgical interventions. Most patients with early rectal cancer can be adequately managed by surgery alone. However, a significant proportion of patients with rectal cancer present with locally advanced disease and will potentially benefit from down staging prior to surgery. Neoadjuvant therapy involves a variety of options including radiotherapy, chemotherapy used alone or in combination. Neoadjuvant radiotherapy in rectal cancer has been shown to be effective in reducing tumour burden in advance of curative surgery. The gold standard surgical rectal cancer management aims to achieve surgical removal of the tumour and all draining lymph nodes, within an intact mesorectal package, in order to minimise local recurrence. It is critically important that all rectal cancer cases are discussed at a multidisciplinary meeting represented by all relevant specialties. Pre-operative staging including CT thorax, abdomen, pelvis to assess for distal disease and magnetic resonance imaging to assess local involvement is essential. Staging radiology and MDT discussion are integral in identifying patients who require neoadjuvant radiotherapy. While Neoadjuvant radiotherapy is potentially beneficial it may also result in morbidity and thus should be reserved for those patients who are at a high risk of local failure, which includes patients with nodal involvement, extramural venous invasion and threatened circumferential margin. The aim of this review is to discuss the role of neoadjuvant radiotherapy in the management of rectal cancer.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Feeney</LastName>
                    <ForeName>Gerard</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of General/Colorectal Surgery, Galway University Hospital, Galway H91 YR71, Ireland. g.feeney3@outlook.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sehgal</LastName>
                    <ForeName>Rishabh</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of General/Colorectal Surgery, Galway University Hospital, Galway H91 YR71, Ireland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sheehan</LastName>
                    <ForeName>Margaret</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Histopathology, Galway University Hospital, Galway H91 YR71, Ireland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hogan</LastName>
                    <ForeName>Aisling</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of General/Colorectal Surgery, Galway University Hospital, Galway H91 YR71, Ireland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Regan</LastName>
                    <ForeName>Mark</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of General/Colorectal Surgery, Galway University Hospital, Galway H91 YR71, Ireland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Joyce</LastName>
                    <ForeName>Myles</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of General/Colorectal Surgery, Galway University Hospital, Galway H91 YR71, Ireland.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kerin</LastName>
                    <ForeName>Michael</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of General/Colorectal Surgery, Galway University Hospital, Galway H91 YR71, Ireland.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>World J Gastroenterol</MedlineTA>
            <NlmUniqueID>100883448</NlmUniqueID>
            <ISSNLinking>1007-9327</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Low anterior resection syndrome</Keyword>
            <Keyword MajorTopicYN="N">Neoadjuvant therapy</Keyword>
            <Keyword MajorTopicYN="N">Rectal cancer</Keyword>
            <Keyword MajorTopicYN="N">Robotic surgery</Keyword>
            <Keyword MajorTopicYN="N">Stoma</Keyword>
            <Keyword MajorTopicYN="N">Trans-anal total mesorectal excision</Keyword>
            <Keyword MajorTopicYN="N">Transanal endoscopic microsurgery</Keyword>
            <Keyword MajorTopicYN="N">Watch and wait</Keyword>
        </KeywordList>
        <CoiStatement>Conflict-of-interest statement: There is no conflict of interest associated with any of the senior authors or other coauthors contributed their efforts in this manuscript.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>09</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31543678</ArticleId>
            <ArticleId IdType="doi">10.3748/wjg.v25.i33.4850</ArticleId>
            <ArticleId IdType="pmc">PMC6737323</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31543507</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1945-4589</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>11</Volume>
                    <Issue>18</Issue>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                        <Day>22</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Aging</Title>
                <ISOAbbreviation>Aging (Albany NY)</ISOAbbreviation>
            </Journal>
            <ArticleTitle>miR-375-3p suppresses tumorigenesis and partially reverses chemoresistance by targeting YAP1 and SP1 in colorectal cancer cells.</ArticleTitle>
            <Pagination>
                <MedlinePgn>7357-7385</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.18632/aging.102214</ELocationID>
            <Abstract>
                <AbstractText>Clinically, one of the principal factors in the failure of advanced colorectal cancer (CRC) treatment is chemoresistance to 5-fluorouracil (5FU)-based chemotherapy. Although microRNA-375-3p (miR-375) is considered a tumor suppressor in multiple cancers, the mechanism of miR-375 in the regulation of drug resistance in CRC remains unclear. In this study, we investigated the chemosensitivity of miR-375 to 5FU in CRC from biological and clinical aspects. We found that miR-375 was significantly downregulated in CRC tissues and cell lines, and low miR-375 expression was strongly correlated with poor overall survival in CRC patients. Overexpression of miR-375 sensitized CRC cells to a broad spectrum of chemotherapeutic drugs <i>in vitro</i> and <i>in vivo</i>. Further mechanistic analysis demonstrated that miR-375 enhanced CRC cell sensitivity to 5FU by directly targeting YAP1 and SP1. MiR-375 downregulated YAP1, resulting in reduced expression of the Hippo-YAP1 pathway downstream genes CTGF, cyclin D1 and BIRC5 (also known as survivin). Overall, miR-375 was confirmed as a prospective molecular biomarker in the chemoresistance and prognosis of CRC patients, and the synergy between miR-375 and chemotherapeutic drugs could be a promising therapeutic strategy for CRC patients, especially with chemoresistance.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Xu</LastName>
                    <ForeName>Xueni</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Medicine, Southeast University, Nanjing 210009, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Xiaoxiang</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Medicine, Southeast University, Nanjing 210009, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xu</LastName>
                    <ForeName>Mu</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Xiangxiang</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pan</LastName>
                    <ForeName>Bei</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Qin</LastName>
                    <ForeName>Jian</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xu</LastName>
                    <ForeName>Tao</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zeng</LastName>
                    <ForeName>Kaixuan</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Medicine, Southeast University, Nanjing 210009, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pan</LastName>
                    <ForeName>Yuqin</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>He</LastName>
                    <ForeName>Bangshun</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sun</LastName>
                    <ForeName>Huiling</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sun</LastName>
                    <ForeName>Li</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Laboratory Medicine, The Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Shukui</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>School of Medicine, Southeast University, Nanjing 210009, China.</Affiliation>
                    </AffiliationInfo>
                    <AffiliationInfo>
                        <Affiliation>General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Aging (Albany NY)</MedlineTA>
            <NlmUniqueID>101508617</NlmUniqueID>
            <ISSNLinking>1945-4589</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Hippo-YAP1 signaling pathway</Keyword>
            <Keyword MajorTopicYN="N">SP1</Keyword>
            <Keyword MajorTopicYN="N">YAP1</Keyword>
            <Keyword MajorTopicYN="N">chemoresistance</Keyword>
            <Keyword MajorTopicYN="N">miR-375-3p</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>05</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31543507</ArticleId>
            <ArticleId IdType="doi">10.18632/aging.102214</ArticleId>
            <ArticleId IdType="pii">102214</ArticleId>
            <ArticleId IdType="pmc">PMC6781994</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Cancer. 2014 Sep 1;135(5):1011-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24166096</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2015 May 14;521(7551):S1</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25970450</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8538-48</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16361535</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Cancer. 2010 Jan 1;126(1):2-10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19634138</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Drug Resist Updat. 2015 May;20:39-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26027741</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Ther Nucleic Acids. 2017 Jun 16;7:181-189</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28624193</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Res. 2008 Jan 15;68(2):425-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18199536</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Cancer. 2015 Mar 07;14:56</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25890196</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Int J Cancer. 2009 Dec 1;125(11):2631-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19672860</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Folia Histochem Cytobiol. 2015;53(2):105-19</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26160682</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nanomedicine. 2017 Nov;13(8):2507-2516</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28577837</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncogene. 2013 Apr 25;32(17):2220-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22689061</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Pathol. 2017 Jun;242(2):221-233</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28337746</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Drug Discov. 2017 Mar;16(3):203-222</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28209991</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>FEBS J. 2014 Oct;281(20):4718-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25156775</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cancer Cell Int. 2018 Jun 8;18:83</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29977158</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell. 2017 Jul 27;170(3):411-413</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28753421</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Sci Rep. 2017 Feb 06;7:41942</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28165066</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Cancer Res. 2012 Sep 15;18(18):4919-30</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22850566</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Theranostics. 2017 Feb 27;7(5):1114-1132</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28435452</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Cancer Res. 2007 Feb 15;13(4):1123-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17317820</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Cancer. 2015 Feb;15(2):73-79</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25592648</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncol Rep. 2016 Jul;36(1):487-93</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27222350</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Proc Natl Acad Sci U S A. 2017 May 2;114(18):E3729-E3738</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28416665</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Epigenetics. 2019 Feb 11;11(1):25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30744689</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Physiol Rev. 2016 Oct;96(4):1297-325</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27535639</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncol Rep. 2013 Aug;30(2):877-89</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23760062</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Physiol Biochem. 2013;32(5):1225-37</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24335172</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Biochem Biophys Res Commun. 2010 Apr 9;394(3):623-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20226166</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Gastroenterology. 2019 Mar;156(4):843-851.e2</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30776340</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26808342</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Clin Oncol. 2011 Apr 1;29(10):1382-91</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21220596</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncogene. 2019 Apr;38(14):2627-2644</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30531836</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>FEBS Lett. 2013 Mar 1;587(5):488-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23337879</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>CA Cancer J Clin. 2014 Sep-Oct;64(5):311-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25104502</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Development. 2011 Sep;138(17):3781-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21795284</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell. 2009 Jan 23;136(2):215-33</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19167326</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Drug Resist Updat. 2013 Jul-Nov;16(3-5):47-59</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23757365</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Acta Biochim Biophys Sin (Shanghai). 2013 Feb;45(2):80-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23178914</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncogene. 2013 Feb 28;32(9):1173-82</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22508479</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Drug Resist Updat. 2011 Dec;14(6):280-96</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21955833</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Drug Resist Updat. 2007 Feb-Apr;10(1-2):59-67</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17350322</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nature. 2004 Sep 16;431(7006):350-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15372042</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Carcinog. 2018 Nov;57(11):1608-1615</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30074279</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>EBioMedicine. 2018 Sep;35:142-154</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">30111512</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Semin Cancer Biol. 2018 Oct;52(Pt 2):189-197</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29501787</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Expert Opin Ther Targets. 2015;19(8):1017-26</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">26107137</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Clin Cancer Res. 2015 Jun 1;21(11):2580-90</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25739674</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Eur Rev Med Pharmacol Sci. 2016 Jul;20(15):3223-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27466996</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Oncol. 2015 Jun;9(6):1169-85</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25759163</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>J Cachexia Sarcopenia Muscle. 2019 Jun;10(3):536-548</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31091026</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Crit Rev Oncol Hematol. 2017 May;113:1-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28427500</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Crit Rev Oncol Hematol. 2017 Oct;118:70-78</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">28917272</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Cancer Ther. 2010 Dec;9(12):3126-36</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20940321</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Oncotarget. 2017 Jul 19;8(47):82294-82302</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29137264</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nat Rev Cancer. 2013 Apr;13(4):246-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23467301</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Nucleic Acids Res. 2015 Feb 18;43(3):1593-608</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">25609695</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cells. 2019 May 03;8(5):</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">31058846</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Front Oncol. 2013 May 16;3:123</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23720711</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Cell Death Dis. 2018 Feb 7;9(2):188</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">29416005</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
        <ReferenceList>
            <Reference>
                <Citation>Mol Cancer. 2016 Nov 10;15(1):70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">27832783</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31543467</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">1665-2681</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Aug</Month>
                        <Day>20</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Annals of hepatology</Title>
                <ISOAbbreviation>Ann Hepatol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Obesity and liver cancer.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S1665-2681(19)32201-X</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.aohep.2019.07.004</ELocationID>
            <Abstract>
                <AbstractText>Obesity prevalence is rapidly increasing worldwide. It is associated with huge economic and health costs due to its clinical consequences, which includes increased incidence of type 2 diabetes, cardiovascular diseases, and development of different malignancies. In particular, obesity is an independent risk factor for the development of hepatocellular carcinoma (HCC). Indeed, obesity is highly prevalent in patients with non-alcoholic fatty liver disease (NAFLD) that is becoming one of the most frequent causes of liver disease worldwide. NAFLD-related HCC is the most rapidly growing indication for liver transplantation in many countries. The higher mortality rates found in obese HCC patients might be related not only to a worse outcome after HCC treatments, but also to a delayed diagnosis related to a low frequency and a poorer quality of abdominal ultrasonography surveillance that is the test universally used for HCC screening. Given its diffusion, obesity is frequently present in patients with chronic liver diseases related to different etiologies, and in these cases it may increase the HCC risk, acting as an additional co-factor. Indeed, growing evidence demonstrates that a healthy diet and regular physical activity may have an impact in reducing the overall HCC risk. Finally, an impact of obesity in the development of intrahepatic cholangiocarcinoma has been postulated, but more extensive studies are needed to definitively confirm this association.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Saitta</LastName>
                    <ForeName>Carlo</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Clinical and Molecular Hepatology, Department of Internal Medicine, University Hospital of Messina, Italy. Electronic address: csaitta@unime.it.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pollicino</LastName>
                    <ForeName>Teresa</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Clinical and Molecular Hepatology, Department of Internal Medicine, University Hospital of Messina, Italy; Division of Clinical and Molecular Hepatology, Department of Human Pathology, University of Messina, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Raimondo</LastName>
                    <ForeName>Giovanni</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of Clinical and Molecular Hepatology, Department of Internal Medicine, University Hospital of Messina, Italy; Division of Clinical and Molecular Hepatology, Department of Clinical and Experimental Medicine, University of Messina, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>20</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Mexico</Country>
            <MedlineTA>Ann Hepatol</MedlineTA>
            <NlmUniqueID>101155885</NlmUniqueID>
            <ISSNLinking>1665-2681</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Hepatocellular carcinoma</Keyword>
            <Keyword MajorTopicYN="N">Intrahepatic cholangiocarcinoma</Keyword>
            <Keyword MajorTopicYN="N">Non-alcoholic fatty liver disease</Keyword>
            <Keyword MajorTopicYN="N">Non-alcoholic steatohepatitis</Keyword>
            <Keyword MajorTopicYN="N">Obesity</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31543467</ArticleId>
            <ArticleId IdType="pii">S1665-2681(19)32201-X</ArticleId>
            <ArticleId IdType="doi">10.1016/j.aohep.2019.07.004</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31542979</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>23</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1029-2292</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                        <Day>23</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Growth factors (Chur, Switzerland)</Title>
                <ISOAbbreviation>Growth Factors</ISOAbbreviation>
            </Journal>
            <ArticleTitle>An oncogenic activity of PDGF-C and its splice variant in human breast cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1-15</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/08977194.2019.1662415</ELocationID>
            <Abstract>
                <AbstractText>Despite strong evidence for the involvement of PDGF signaling in breast cancer, little is known about the PDGF ligand responsible for PDGFR activation during breast cancer progression. Here, we found PDGF-C to be highly expressed in breast carcinoma cell lines. Immunohistochemical analysis of invasive breast cancer revealed an association between increased PDGF-C expression and lymph node metastases, Ki-67 proliferation index, and poor disease-free survival. We also identified a PDGF-C splice variant encoding truncated PDGF-C (t-PDGF-C) isoform lacking the signal peptide and the N-terminal CUB domain. While t-PDGF C homodimer is retained intracellularly, it can be secreted as a heterodimer with full-length PDGF-C (FL-PDGF-C). PDGF-C downregulation reduced anchorage-independent growth and matrigel invasion of MDA-MB-231 cells. Conversely, ectopic expression of t-PDGF-C enhanced phenotypic transformation and invasion in BT-549 cells expressing endogenous FL-PDGF-C. The present study provides new insights into the functional significance of PDGF-C and its splice variant in human breast cancer.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Bottrell</LastName>
                    <ForeName>Alyssa</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Wayne State School of Medicine , Detroit , MI , USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Meng</LastName>
                    <ForeName>Yong Hong</ForeName>
                    <Initials>YH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Wayne State School of Medicine , Detroit , MI , USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Najy</LastName>
                    <ForeName>Abdo J</ForeName>
                    <Initials>AJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Wayne State School of Medicine , Detroit , MI , USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hurst</LastName>
                    <ForeName>Newton</ForeName>
                    <Initials>N</Initials>
                    <Suffix>Jr</Suffix>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Wayne State School of Medicine , Detroit , MI , USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Seongho</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Oncology, Wayne State School of Medicine , Detroit , MI , USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Chong Jai</ForeName>
                    <Initials>CJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Wayne State School of Medicine , Detroit , MI , USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Eun-Sook</ForeName>
                    <Initials>ES</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Pharmacy, Duksung Women's University , Seoul , Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Moon</LastName>
                    <ForeName>Aree</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Pharmacy, Duksung Women's University , Seoul , Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Eun Joo</ForeName>
                    <Initials>EJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Seoul National University Bundang Hospital , Seongnam , Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Park</LastName>
                    <ForeName>So Yeon</ForeName>
                    <Initials>SY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Seoul National University Bundang Hospital , Seongnam , Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Hyeong-Reh Choi</ForeName>
                    <Initials>HC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, Wayne State School of Medicine , Detroit , MI , USA.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>23</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Growth Factors</MedlineTA>
            <NlmUniqueID>9000468</NlmUniqueID>
            <ISSNLinking>0897-7194</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Breast cancer</Keyword>
            <Keyword MajorTopicYN="N">growth factors: structure and function</Keyword>
            <Keyword MajorTopicYN="N">oncogenic activity</Keyword>
            <Keyword MajorTopicYN="N">prognostic marker</Keyword>
            <Keyword MajorTopicYN="N">tumor cell invasion</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31542979</ArticleId>
            <ArticleId IdType="doi">10.1080/08977194.2019.1662415</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31542717</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>19</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1090-2120</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>92</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Bioorganic chemistry</Title>
                <ISOAbbreviation>Bioorg. Chem.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Design, synthesis, and biological activity of Plastoquinone analogs as a new class of anticancer agents.</ArticleTitle>
            <Pagination>
                <MedlinePgn>103255</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0045-2068(19)30245-7</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bioorg.2019.103255</ELocationID>
            <Abstract>
                <AbstractText>In this paper, based on Plastoquinone (PQ) analogs possessing substituted aniline containing alkoxy group(s), new 2,3-dimethyl-5-amino-1,4-benzoquinones (PQ1-15) were designed and synthesized in either two steps or one-pot reaction. Specifically, the substituted amino moiety containing mono or poly alkoxy group(s) with various positions and groups were mainly explored to understand the structure-activity relationships for the cytotoxic activity against three human cancer cell lines (K562, Jurkat, and MT-2) and human peripheral blood mononuclear cells (PBMC). PQ2 was found to be most effective anticancer compound on K562 and Jurkat cell lines with IC<sub>50</sub> values of 6.40 ± 1.73 μM and 7.72 ± 1.49 μM, respectively. Interestingly, the compound was non-cytotoxic to normal PBMC and also MT-2 cancer cells. PQ2 which showed significant selectivity in MTT assay was chosen for apoptotic/necrotic evaluation and results exhibited that it induced apoptosis in K562 cell line after 6 h of treatment. PQ2 showed anti-Abelson kinase 1 (Abl1) activity with different inhibitory profile than Imatinib in the panel of eight kinases. The binding mode of PQ2 into Abl ATP binding pocket was predicted in silico showing the formation of some key interactions. In addition, PQ2 induced Bcr-Abl1 mediated ERK pathway in human chronic myelogenous leukemia (CML) cells. Furthermore, DNA-cleaving capability of PQ2 was clearly enhanced by iron (II) complex system. Afterward, a further in silico ADMET prediction revealed that PQ2 possesses desirable drug-like properties and favorable safety profile. These results indicated that PQ2 has multiple mechanism of action and two of them are anti-Bcr-Abl1 and DNA-cleaving activity. This study suggests that Plastoquinone analogs could be potential candidates for multi-target anticancer therapy.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Bayrak</LastName>
                    <ForeName>Nilüfer</ForeName>
                    <Initials>N</Initials>
                    <AffiliationInfo>
                        <Affiliation>Chemistry Department, Engineering Faculty, Istanbul University-Cerrahpasa, Avcilar, 34320 Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yıldırım</LastName>
                    <ForeName>Hatice</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Chemistry Department, Engineering Faculty, Istanbul University-Cerrahpasa, Avcilar, 34320 Istanbul, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yıldız</LastName>
                    <ForeName>Mahmut</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Chemistry Department, Gebze Technical University, Gebze 41400, Kocaeli, Turkey.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Radwan</LastName>
                    <ForeName>Mohamed O</ForeName>
                    <Initials>MO</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Drug Discovery, Science Farm Ltd., Kumamoto 860-0802, Japan; Department of Bioorganic Medicinal Chemistry, School of Pharmacy, Kumamoto University, Kumamoto 862-0973, Japan; Chemistry of Natural Compounds Department, Pharmaceutical and Drug Industries Research Division, National Research Centre, Dokki 12622, Cairo, Egypt.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Otsuka</LastName>
                    <ForeName>Masami</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Drug Discovery, Science Farm Ltd., Kumamoto 860-0802, Japan; Department of Bioorganic Medicinal Chemistry, School of Pharmacy, Kumamoto University, Kumamoto 862-0973, Japan.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fujita</LastName>
                    <ForeName>Mikako</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Research Institute for Drug Discovery, School of Pharmacy, Kumamoto University, Kumamoto 862-0973, Japan. Electronic address: mfujita@kumammot-u.ac.jp.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tuyun</LastName>
                    <ForeName>Amaç Fatih</ForeName>
                    <Initials>AF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Engineering Sciences Department, Engineering Faculty, Istanbul University-Cerrahpasa, Avcilar, 34320 Istanbul, Turkey. Electronic address: aftuyun@istanbul.edu.tr.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ciftci</LastName>
                    <ForeName>Halil I</ForeName>
                    <Initials>HI</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Drug Discovery, Science Farm Ltd., Kumamoto 860-0802, Japan; Department of Bioorganic Medicinal Chemistry, School of Pharmacy, Kumamoto University, Kumamoto 862-0973, Japan. Electronic address: hiciftci@kumamoto-u.ac.jp.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>07</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Bioorg Chem</MedlineTA>
            <NlmUniqueID>1303703</NlmUniqueID>
            <ISSNLinking>0045-2068</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Aminoquinone</Keyword>
            <Keyword MajorTopicYN="N">Apoptosis</Keyword>
            <Keyword MajorTopicYN="N">Bcr-Abl</Keyword>
            <Keyword MajorTopicYN="N">DNA-cleavage</Keyword>
            <Keyword MajorTopicYN="N">Plastoquinone</Keyword>
            <Keyword MajorTopicYN="N">Structure-activity relationship (SAR)</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>02</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31542717</ArticleId>
            <ArticleId IdType="pii">S0045-2068(19)30245-7</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bioorg.2019.103255</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31542707</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>08</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1476-928X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>83</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                        <Day>03</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Computational biology and chemistry</Title>
                <ISOAbbreviation>Comput Biol Chem</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Predictive biomarkers of colorectal cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn>107106</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S1476-9271(19)30004-0</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.compbiolchem.2019.107106</ELocationID>
            <Abstract>
                <AbstractText>Colorectal cancer is one of the top leading causes of cancer mortality worldwide, especially in China. However, most of the current treatments are invasive and can only be applied to very few cancers. The earlier a malignant tumor is diagnosed, the higher the patient's survival rate. In this study, we proposed a computational framework to identify highly-reliable and easierly-detectable biomarkers capable of secreting into blood, urine and saliva by integrating transcriptomics and proteomics data at the system biology level. First, a large number of transcriptome data were processed to identify candidate biomarkers for colorectal cancer. Second, three classified models are constructed to predict biomarkers for colorectal cancer capable of secreting into blood, urine and saliva, which are effective disease diagnosis media to facilitate clinical screening. Then biological functions and molecular mechanisms of the candidate biomarkers of colorectal cancer are inferred utilizing multi-source biological knowledge and literature mining. Furthermore, the classification power of different combinations of candidate biomarkers is verified by machine learning models. In addition, the targeted drugs of the predicted biomarkers are further analyzed to provide assistance for clinical treatment of colorectal cancer. In this paper, our proposed computational model not only provides the effective candidate biomarkers ESM1, CTHRC1, AZGP1 for colorectal cancer capable of secreting into blood, urine and saliva, but also helps to understand the molecular mechanism of colorectal cancer. This computational framework can span the huge gap between transcriptome and proteomics, which can easily be applied to the biomarker research for other types of tumor.</AbstractText>
                <CopyrightInformation>Copyright © 2019. Published by Elsevier Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ding</LastName>
                    <ForeName>Di</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Computer Science and Technology, Jilin University, Changchun, China; Key Laboratory of Symbol Computation and Knowledge Engineer of Ministry of Education, College of Computer Science and Technology, Jilin University, Changchun, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Han</LastName>
                    <ForeName>Siyu</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Computer Science and Technology, Jilin University, Changchun, China; Key Laboratory of Symbol Computation and Knowledge Engineer of Ministry of Education, College of Computer Science and Technology, Jilin University, Changchun, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Hui</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Computer Science and Technology, Jilin University, Changchun, China; Key Laboratory of Symbol Computation and Knowledge Engineer of Ministry of Education, College of Computer Science and Technology, Jilin University, Changchun, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>He</LastName>
                    <ForeName>Ye</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Computer Science and Technology, Jilin University, Changchun, China; Key Laboratory of Symbol Computation and Knowledge Engineer of Ministry of Education, College of Computer Science and Technology, Jilin University, Changchun, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Ying</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>College of Computer Science and Technology, Jilin University, Changchun, China; Key Laboratory of Symbol Computation and Knowledge Engineer of Ministry of Education, College of Computer Science and Technology, Jilin University, Changchun, China. Electronic address: liying@jlu.edu.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>03</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Comput Biol Chem</MedlineTA>
            <NlmUniqueID>101157394</NlmUniqueID>
            <ISSNLinking>1476-9271</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Blood</Keyword>
            <Keyword MajorTopicYN="N">Cancer biomarkers</Keyword>
            <Keyword MajorTopicYN="N">Colorectal cancer</Keyword>
            <Keyword MajorTopicYN="N">Differential expressed genes</Keyword>
            <Keyword MajorTopicYN="N">Enrichment analysis</Keyword>
            <Keyword MajorTopicYN="N">Saliva</Keyword>
            <Keyword MajorTopicYN="N">Urine</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>01</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31542707</ArticleId>
            <ArticleId IdType="pii">S1476-9271(19)30004-0</ArticleId>
            <ArticleId IdType="doi">10.1016/j.compbiolchem.2019.107106</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31542648</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>20</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-5347</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>239</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Oct</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Social science &amp; medicine (1982)</Title>
                <ISOAbbreviation>Soc Sci Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>From decision to incision: Ideologies of gender in surgical cancer care.</ArticleTitle>
            <Pagination>
                <MedlinePgn>112550</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0277-9536(19)30544-1</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.socscimed.2019.112550</ELocationID>
            <Abstract>
                <AbstractText>In this paper, I draw on the narratives of 57 individuals whose gender identities and decisions about their bodies trouble the medical protocols for breast and gynecological cancer care. I focus here on the decision-making process for three groups of elective surgeries: hysterectomy, prophylactic bilateral and contralateral mastectomy, and breast reconstruction. These elective surgeries illustrate places in medical interactions where patients and providers rely on frames of gender to determine whether a given surgery is an appropriate option for cancer prevention or care. These cases also explain how patient experiences of medical interactions are shaped by and thus reproduce ideologies of gender through the bodies of patients. While clinical practice and medical decisions are supposedly determined through the principles of evidence-based medicine and patient-centered care, I show that ideas about gender can actually supersede both medical evidence and patient desires for their bodies in the care of gynecological and breast cancers.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sledge</LastName>
                    <ForeName>Piper</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Bryn Mawr College, USA. Electronic address: psledge@brynmawr.edu.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Soc Sci Med</MedlineTA>
            <NlmUniqueID>8303205</NlmUniqueID>
            <ISSNLinking>0277-9536</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Cancer</Keyword>
            <Keyword MajorTopicYN="N">Embodiment</Keyword>
            <Keyword MajorTopicYN="N">Gender</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>11</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31542648</ArticleId>
            <ArticleId IdType="pii">S0277-9536(19)30544-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.socscimed.2019.112550</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31542643</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>01</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-4367</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>184</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                        <Day>14</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Colloids and surfaces. B, Biointerfaces</Title>
                <ISOAbbreviation>Colloids Surf B Biointerfaces</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Dual-functional supramolecular nanohybrids of quantum dot/biopolymer/chemotherapeutic drug for bioimaging and killing brain cancer cells in vitro.</ArticleTitle>
            <Pagination>
                <MedlinePgn>110507</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0927-7765(19)30651-4</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.colsurfb.2019.110507</ELocationID>
            <Abstract>
                <AbstractText>Glioblastoma (GBM) is the utmost aggressive and lethal primary brain cancer, which has a poor prognosis and remains virtually incurable. Nanomedicine with emerging disruptive nanotechnology alternatives, including designed supramolecular nanohybrids has excellent potential as multimodal tools against cancer by combining nanomaterials, biomacromolecules, and drugs. Thus, we developed and constructed for the first time quantum dot-biopolymer-drug nanohybrids based on host-guest chemistry for simultaneous bioimaging, targeting, and anti-cancer drug delivery against GBM cells in vitro. ZnS fluorescent quantum dots (ZnS-QDs) were produced using chemically modified polysaccharide, carboxymethylcellulose (CMC), as water-soluble capping ligand and biofunctional layer via a facile one-step eco-friendly aqueous colloidal process at room temperature and physiological pH. These hybrid inorganic-organic nanocolloids (ZnS@CMC) were electrostatically conjugated with doxorubicin (DOX) anti-cancer drug forming innovative supramolecular complexes (ZnS@CMC-DOX) for amalgamating bioimaging and killing cancer cells. These nanoconjugates were characterized regarding their optical and physicochemical properties combined with morphological and structural features. The cytocompatibility was evaluated by MTT assay using healthy and GBM cells. The results showed that ultra-small ZnS-QDs were expertly produced uniform nanocolloids (average size = 3.6 nm). They demonstrated photoluminescence emission within the visible range of spectra. The cell viability results in vitro showed no cytotoxicity of ZnS@CMC nanohybrids towards both cell types. In summary, the novelty of this research relies on using a nanotheranostic strategy for developing ZnS@CMC-DOX nanohybrids with supramolecular vesicle-like structures. They behaved simultaneously as active fluorescent nanoprobes and nanocarriers with modulated drug release for bioimaging and killing malignant glioma cells proving the high potential for applications in cancer nanomedicine.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Mansur</LastName>
                    <ForeName>Alexandra A P</ForeName>
                    <Initials>AAP</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center of Nanoscience, Nanotechnology and Innovation - CeNano(2)I, Department of Metallurgical and Materials Engineering, Federal University of Minas Gerais - UFMG, Av. Antônio Carlos, 6627, Belo Horizonte, MG, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Caires</LastName>
                    <ForeName>Anderson J</ForeName>
                    <Initials>AJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center of Nanoscience, Nanotechnology and Innovation - CeNano(2)I, Department of Metallurgical and Materials Engineering, Federal University of Minas Gerais - UFMG, Av. Antônio Carlos, 6627, Belo Horizonte, MG, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Carvalho</LastName>
                    <ForeName>Sandhra M</ForeName>
                    <Initials>SM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center of Nanoscience, Nanotechnology and Innovation - CeNano(2)I, Department of Metallurgical and Materials Engineering, Federal University of Minas Gerais - UFMG, Av. Antônio Carlos, 6627, Belo Horizonte, MG, Brazil; Department of Preventive Veterinary Medicine, Veterinary School, Federal University of Minas Gerais - UFMG, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Capanema</LastName>
                    <ForeName>Nadia S V</ForeName>
                    <Initials>NSV</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center of Nanoscience, Nanotechnology and Innovation - CeNano(2)I, Department of Metallurgical and Materials Engineering, Federal University of Minas Gerais - UFMG, Av. Antônio Carlos, 6627, Belo Horizonte, MG, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Carvalho</LastName>
                    <ForeName>Isadora C</ForeName>
                    <Initials>IC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center of Nanoscience, Nanotechnology and Innovation - CeNano(2)I, Department of Metallurgical and Materials Engineering, Federal University of Minas Gerais - UFMG, Av. Antônio Carlos, 6627, Belo Horizonte, MG, Brazil.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mansur</LastName>
                    <ForeName>Herman S</ForeName>
                    <Initials>HS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center of Nanoscience, Nanotechnology and Innovation - CeNano(2)I, Department of Metallurgical and Materials Engineering, Federal University of Minas Gerais - UFMG, Av. Antônio Carlos, 6627, Belo Horizonte, MG, Brazil. Electronic address: hmansur@demet.ufmg.br.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Colloids Surf B Biointerfaces</MedlineTA>
            <NlmUniqueID>9315133</NlmUniqueID>
            <ISSNLinking>0927-7765</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Cancer nanotheranostic</Keyword>
            <Keyword MajorTopicYN="N">Fluorescent nanoparticles</Keyword>
            <Keyword MajorTopicYN="N">Nanocarriers</Keyword>
            <Keyword MajorTopicYN="N">Nanocolloids</Keyword>
            <Keyword MajorTopicYN="N">Nanoconjugates</Keyword>
            <Keyword MajorTopicYN="N">Nanohybrids</Keyword>
            <Keyword MajorTopicYN="N">Nanomedicine</Keyword>
            <Keyword MajorTopicYN="N">Nanoparticles</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31542643</ArticleId>
            <ArticleId IdType="pii">S0927-7765(19)30651-4</ArticleId>
            <ArticleId IdType="doi">10.1016/j.colsurfb.2019.110507</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31542615</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>11</Month>
            <Day>08</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1950-6007</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>120</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Biomedicine &amp; pharmacotherapy = Biomedecine &amp; pharmacotherapie</Title>
                <ISOAbbreviation>Biomed. Pharmacother.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Downregulation of CircRNA CDR1as specifically triggered low-dose Diosbulbin-B induced gastric cancer cell death by regulating miR-7-5p/REGγ axis.</ArticleTitle>
            <Pagination>
                <MedlinePgn>109462</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0753-3322(19)33563-2</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biopha.2019.109462</ELocationID>
            <Abstract>
                <AbstractText>Diosbulbin-B (DB) was the main compound of Dioscorea bulbifera L, which was widely used for cancer treatment in Asia. However, the hepatotoxicity induced by high-dose DB seriously limited its possibility using for gastric cancer (GC) treatment in clinic. In this study, we found that DB inhibited GC cells and hepatocytes cell viability in a dose- and time-dependent manner. Specifically, high-dose DB (50μM) significantly inhibited cell proliferation and promoted cell apoptosis, while low dose DB (12.5μM) had little effects on cell viability. Besides, high-dose DB (50μM) significantly decreased CircRNA CDR1as levels in gastric cancer cells instead of hepatocytes. Notably, knock-down of CircRNA CDR1as triggered low-dose DB (12.5μM) induced GC cell death, but had little effects on hepatocytes proliferation and apoptosis. Further results showed that CircRNA CDR1as increased REGγ expressions in GC cells by sponging miR-7-5p, and high-dose DB (50μM) increased miR-7-5p levels and inhibited REGγ expressions in GC cells instead of hepatocytes. In addition, either downregulated miR-7-5p or overexpressed REGγ reversed the promoting effects of downregulated CircRNA CDR1as on low-dose DB-induced GC cell death. Taken together, we concluded that knock-down of CircRNA CDR1as specifically promoted the cytotoxic effects of low-dose DB on GC cells instead of hepatocytes by regulating miR-7-5p/REGγ axis.</AbstractText>
                <CopyrightInformation>Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Chunfeng</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Gastrointestinal Surgical Ward, Harbin Medical University Cancer Hospital, Haping Road 150, Harbin, Heilongjiang, China. Electronic address: lichunfeng328@163.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Man</ForeName>
                    <Initials>M</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Endoscopy, Harbin Medical University Cancer Hospital, Haping Road 150, Harbin, Heilongjiang, China. Electronic address: liman6566@163.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xue</LastName>
                    <ForeName>Yingwei</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Gastrointestinal Surgical Ward, Harbin Medical University Cancer Hospital, Haping Road 150, Harbin, Heilongjiang, China. Electronic address: xueyingwei215@163.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>France</Country>
            <MedlineTA>Biomed Pharmacother</MedlineTA>
            <NlmUniqueID>8213295</NlmUniqueID>
            <ISSNLinking>0753-3322</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">CircRNA CDR1as</Keyword>
            <Keyword MajorTopicYN="N">Diosbulbin-B</Keyword>
            <Keyword MajorTopicYN="N">Gastric cancer</Keyword>
            <Keyword MajorTopicYN="N">miR-7-5p</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>07</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31542615</ArticleId>
            <ArticleId IdType="pii">S0753-3322(19)33563-2</ArticleId>
            <ArticleId IdType="doi">10.1016/j.biopha.2019.109462</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31542518</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>30</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1878-5905</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>224</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Dec</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Biomaterials</Title>
                <ISOAbbreviation>Biomaterials</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Visible light-induced apoptosis activatable nanoparticles of photosensitizer-DEVD-anticancer drug conjugate for targeted cancer therapy.</ArticleTitle>
            <Pagination>
                <MedlinePgn>119494</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0142-9612(19)30593-9</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biomaterials.2019.119494</ELocationID>
            <Abstract>
                <AbstractText>The therapeutic efficacy of photodynamic therapy (PDT) in cancer treatment is attributed to the conversion of tumor oxygen into reactive singlet oxygen (<sup>1</sup>O<sub>2</sub>) using photosensitizers. However, poor tissue penetration and rapid oxygen depletion have limited the effectiveness of PDT. Therefore, we have developed visible light-induced apoptosis activatable nanoparticles of the photosensitizer (Ce6)-caspase 3 cleavable peptide (Asp-Glu-Val-Asp, DEVD)-anticancer drug monomethyl auristatin E (MMAE) conjugate, resulting in Ce6-DEVD-MMAE nanoparticles. The average size of self-assembled Ce6-DEVD-MMAE nanoparticles was 90.8 ± 18.9 nm. Compared with conventional PDT based on high-energy irradiation, the new therapy uses lower-energy irradiation to induce apoptosis of cancer cells, and activation of caspase 3 to successfully cleave the anticancer drug MMAE from the Ce6-DEVD-MMAE nanoparticles, resulting in strong cytotoxic effects in cancer cells. Notably, the one-time activation of MMAE in the Ce6-DEVD-MMAE nanoparticles further amplified the cytotoxic effect resulting in additional cell death in the absence of visible light irradiation. Furthermore, Ce6-DEVD-MMAE nanoparticles passively accumulated in the targeted tumor tissues via enhanced permeation and retention (EPR) effect in mice with squamous cell carcinoma (SCC7). The high levels of toxicity were retained after exposure to lower-energy irradiation. However, Ce6-DEVD-MMAE nanoparticles did not show any toxicity in the absence of exposure to visible light irradiation, in contrast to the toxicity of free MMAE (1-10 nM). Thus, the light-induced therapeutic strategy based on apoptotic activation of Ce6-DEVD-MMAE nanoparticles can be used to treat solid tumors inaccessible to conventional PDT.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Um</LastName>
                    <ForeName>Wooram</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Hwarangno 14-gil 5, Seongbuk-gu, Seoul, 02792, Republic of Korea; Department of Chemical Engineering, Sungkyunkwan University, Seobu-ro 2066, Jangan-gu, Suwon, 08066, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Park</LastName>
                    <ForeName>Jooho</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Hwarangno 14-gil 5, Seongbuk-gu, Seoul, 02792, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ko</LastName>
                    <ForeName>Hokyung</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Hwarangno 14-gil 5, Seongbuk-gu, Seoul, 02792, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lim</LastName>
                    <ForeName>Seungho</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Hwarangno 14-gil 5, Seongbuk-gu, Seoul, 02792, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yoon</LastName>
                    <ForeName>Hong Yeol</ForeName>
                    <Initials>HY</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Hwarangno 14-gil 5, Seongbuk-gu, Seoul, 02792, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shim</LastName>
                    <ForeName>Man Kyu</ForeName>
                    <Initials>MK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Hwarangno 14-gil 5, Seongbuk-gu, Seoul, 02792, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Sangmin</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pharmacy, Wonkwang University, Iksan-daero 460, Iksan-si, Jeonbuk, 54538, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ko</LastName>
                    <ForeName>Young Ji</ForeName>
                    <Initials>YJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>KU-KIST Graduate School of Converging Science and Technology, Korea University, Anam-no 145, Seongbuk-gu, Seoul, 02841, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Min Ju</ForeName>
                    <Initials>MJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>KU-KIST Graduate School of Converging Science and Technology, Korea University, Anam-no 145, Seongbuk-gu, Seoul, 02841, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Park</LastName>
                    <ForeName>Jae Hyung</ForeName>
                    <Initials>JH</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Chemical Engineering, Sungkyunkwan University, Seobu-ro 2066, Jangan-gu, Suwon, 08066, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lim</LastName>
                    <ForeName>Dong-Kwon</ForeName>
                    <Initials>DK</Initials>
                    <AffiliationInfo>
                        <Affiliation>KU-KIST Graduate School of Converging Science and Technology, Korea University, Anam-no 145, Seongbuk-gu, Seoul, 02841, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Byun</LastName>
                    <ForeName>Youngro</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, 08826, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kwon</LastName>
                    <ForeName>Ick Chan</ForeName>
                    <Initials>IC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Hwarangno 14-gil 5, Seongbuk-gu, Seoul, 02792, Republic of Korea; KU-KIST Graduate School of Converging Science and Technology, Korea University, Anam-no 145, Seongbuk-gu, Seoul, 02841, Republic of Korea.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Kwangmeyung</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Hwarangno 14-gil 5, Seongbuk-gu, Seoul, 02792, Republic of Korea; KU-KIST Graduate School of Converging Science and Technology, Korea University, Anam-no 145, Seongbuk-gu, Seoul, 02841, Republic of Korea. Electronic address: kim@kist.re.kr.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Biomaterials</MedlineTA>
            <NlmUniqueID>8100316</NlmUniqueID>
            <ISSNLinking>0142-9612</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Apoptosis</Keyword>
            <Keyword MajorTopicYN="N">Cytotoxic prodrug</Keyword>
            <Keyword MajorTopicYN="N">Nanomedicine</Keyword>
            <Keyword MajorTopicYN="N">Photodynamic therapy</Keyword>
            <Keyword MajorTopicYN="N">Self-assembly</Keyword>
            <Keyword MajorTopicYN="N">Targeted cancer therapy</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>04</Month>
                <Day>01</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31542518</ArticleId>
            <ArticleId IdType="pii">S0142-9612(19)30593-9</ArticleId>
            <ArticleId IdType="doi">10.1016/j.biomaterials.2019.119494</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31542515</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>09</Month>
            <Day>30</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1878-5905</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>224</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Dec</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Biomaterials</Title>
                <ISOAbbreviation>Biomaterials</ISOAbbreviation>
            </Journal>
            <ArticleTitle>In situ thermal ablation of tumors in combination with nano-adjuvant and immune checkpoint blockade to inhibit cancer metastasis and recurrence.</ArticleTitle>
            <Pagination>
                <MedlinePgn>119490</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0142-9612(19)30589-7</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biomaterials.2019.119490</ELocationID>
            <Abstract>
                <AbstractText>Tumor ablation therapies provide a minimally invasive approach to treat cancer. However, inhibition of cancer metastasis and recurrence after ablation is still a challenge in clinical trials. Here, we propose a strategy using combinatorial thermal ablation, adjuvants and immune checkpoint blockade (ICB) to inhibit metastatic tumor and recurrence via antitumor immune responses post tumor thermal ablation, which are frequently used in the clinic. Furthermore, a strong immune memory against cancer was observed 80 days after the primary tumor was ablated. Considering that all components in our design are approved by Food and Drug Administration (FDA), we provide a strategy based on clinically used cancer treatment technique that is promising in clinical translation.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Han</LastName>
                    <ForeName>Xiao</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Functional Nano &amp; Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-based Functional Materials and Devices, Soochow University, Suzhou, Jiangsu, 215123, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Rui</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Shanghai Institute of Ultrasound in Medicine, Shanghai, 200233, PR China; Shanghai Jiaotong University Affiliated Sixth People's Hospital, the Department of Ultrasound in Medicine, Shanghai, 200233, PR China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Xu</LastName>
                    <ForeName>Jun</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Functional Nano &amp; Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-based Functional Materials and Devices, Soochow University, Suzhou, Jiangsu, 215123, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Qian</ForeName>
                    <Initials>Q</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Functional Nano &amp; Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-based Functional Materials and Devices, Soochow University, Suzhou, Jiangsu, 215123, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liang</LastName>
                    <ForeName>Chao</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Functional Nano &amp; Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-based Functional Materials and Devices, Soochow University, Suzhou, Jiangsu, 215123, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Jiawen</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Functional Nano &amp; Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-based Functional Materials and Devices, Soochow University, Suzhou, Jiangsu, 215123, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhao</LastName>
                    <ForeName>Jiayue</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Functional Nano &amp; Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-based Functional Materials and Devices, Soochow University, Suzhou, Jiangsu, 215123, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chu</LastName>
                    <ForeName>Jiacheng</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Functional Nano &amp; Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-based Functional Materials and Devices, Soochow University, Suzhou, Jiangsu, 215123, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fan</LastName>
                    <ForeName>Qin</ForeName>
                    <Initials>Q</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Functional Nano &amp; Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-based Functional Materials and Devices, Soochow University, Suzhou, Jiangsu, 215123, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Archibong</LastName>
                    <ForeName>Edikan</ForeName>
                    <Initials>E</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Medicine, University of North Carolina at Chapel Hill, Raleigh, NC, 27695, United States.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jiang</LastName>
                    <ForeName>Lixin</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>Shanghai Institute of Ultrasound in Medicine, Shanghai, 200233, PR China; Shanghai Jiaotong University Affiliated Sixth People's Hospital, the Department of Ultrasound in Medicine, Shanghai, 200233, PR China. Electronic address: jinger_28@sina.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Chao</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Functional Nano &amp; Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-based Functional Materials and Devices, Soochow University, Suzhou, Jiangsu, 215123, China. Electronic address: cwang@suda.edu.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Zhuang</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Functional Nano &amp; Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-based Functional Materials and Devices, Soochow University, Suzhou, Jiangsu, 215123, China. Electronic address: zliu@suda.edu.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Biomaterials</MedlineTA>
            <NlmUniqueID>8100316</NlmUniqueID>
            <ISSNLinking>0142-9612</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Cancer immunotherapy</Keyword>
            <Keyword MajorTopicYN="N">Imiquimod</Keyword>
            <Keyword MajorTopicYN="N">Immune checkpoint blockade</Keyword>
            <Keyword MajorTopicYN="N">Thermal ablation therapy</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2018</Year>
                <Month>10</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31542515</ArticleId>
            <ArticleId IdType="pii">S0142-9612(19)30589-7</ArticleId>
            <ArticleId IdType="doi">10.1016/j.biomaterials.2019.119490</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31542504</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>07</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1878-7568</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Sep</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Acta biomaterialia</Title>
                <ISOAbbreviation>Acta Biomater</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Recombinant virus-like particles presenting IL-33 successfully modify the tumor microenvironment and facilitate antitumor immunity in a model of breast cancer.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S1742-7061(19)30636-1</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.actbio.2019.09.024</ELocationID>
            <Abstract>
                <AbstractText>Recently, interleukin (IL)-33 has been closely associated with a variety of clinical cancers. IL-33 presents both protumorigenic, and less frequently, antitumorigenic functions depending on disease conditions. IL-33 signaling appears to be a possible target for the treatment of applicable tumor diseases. This study aimed to develop an effective approach to intervene in IL-33 functioning in tumors and reveal the immunotherapeutic potential of anti-IL-33 active immunization. Recombinant truncated hepatitis B virus core antigen (HBcAg), presenting mature IL-33 molecules on the surface of virus-like particles (VLPs), was prepared and used to immunize BALB/c mice in a model of murine 4T1 breast cancer. The immunization was performed through either a preventive or therapeutic strategy in two separate studies. Anti-IL-33 immunization with VLPs elicited a persistent and highly titrated specific antibody response and significantly suppressed orthotopic tumor growth in the preventive study and lung metastasis in both studies. The underlying mechanisms might include promoting tumor-specific Th1 and CTL-mediated cellular responses and the expression of the effector molecule interferon-γ (IFN-γ), suppressing T-helper type 2 (Th2) responses, and significantly reducing the infiltration of immunosuppressive Treg (regulatory T) cells and myeloid-derived suppressor cells (MDSCs) into tumor tissues in the immunized mice. In conclusion, anti-IL-33 active immunization employing recombinant VLPs as an antigen delivery platform effectively modified the tumor microenvironment and promoted antitumor immunity, indicating the potential of this approach as a new and promising immunotherapeutic strategy for the treatment of cancers where IL-33 plays a definite protumorigenic role. STATEMENT OF SIGNIFICANCE: Interleukin (IL)-33 is closely associated with a variety of clinical cancers. IL-33 signaling appears to be a possible target for the treatment of applicable tumor diseases. Recombinant truncated hepatitis B virus core antigen (HBcAg), presenting mature IL-33 molecules on the surface of virus-like particles (VLPs), was prepared and used to immunize BALB/c mice in a model of murine 4T1 breast cancer. The immunization was performed through either a preventive or therapeutic strategy in two separate studies. Anti-IL-33 immunization with VLPs elicited a persistent and highly titrated specific antibody response and significantly suppressed orthotopic tumor growth and lung metastasis in both studies. Furthermore, anti-IL-33 active immunization employing recombinant VLPs as an antigen delivery platform effectively modified the tumor microenvironment and promoted antitumor immunity, indicating its potential as a new and promising immunotherapeutic strategy for the treatment of cancers where IL-33 plays a definite protumorigenic role.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Feng</LastName>
                    <ForeName>Xuejun</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Molecular Immunology, Institute of Medical Biology, Chinese Academy of Medical Science &amp; Peking Union Medical College, China; Department of Experimental Center, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Hongxian</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Molecular Immunology, Institute of Medical Biology, Chinese Academy of Medical Science &amp; Peking Union Medical College, China; Yunnan Key Laboratory of Vaccine Research &amp; Development on Severe Infectious Disease, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chu</LastName>
                    <ForeName>Xiaojie</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Molecular Immunology, Institute of Medical Biology, Chinese Academy of Medical Science &amp; Peking Union Medical College, China; Yunnan Key Laboratory of Vaccine Research &amp; Development on Severe Infectious Disease, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sun</LastName>
                    <ForeName>Pengyan</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Molecular Immunology, Institute of Medical Biology, Chinese Academy of Medical Science &amp; Peking Union Medical College, China; Yunnan Key Laboratory of Vaccine Research &amp; Development on Severe Infectious Disease, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huang</LastName>
                    <ForeName>Weiwei</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Molecular Immunology, Institute of Medical Biology, Chinese Academy of Medical Science &amp; Peking Union Medical College, China; Yunnan Key Laboratory of Vaccine Research &amp; Development on Severe Infectious Disease, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Cunbao</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Molecular Immunology, Institute of Medical Biology, Chinese Academy of Medical Science &amp; Peking Union Medical College, China; Yunnan Key Laboratory of Vaccine Research &amp; Development on Severe Infectious Disease, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Xu</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Molecular Immunology, Institute of Medical Biology, Chinese Academy of Medical Science &amp; Peking Union Medical College, China; Yunnan Key Laboratory of Vaccine Research &amp; Development on Severe Infectious Disease, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sun</LastName>
                    <ForeName>Wenjia</ForeName>
                    <Initials>W</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Molecular Immunology, Institute of Medical Biology, Chinese Academy of Medical Science &amp; Peking Union Medical College, China; Yunnan Key Laboratory of Vaccine Research &amp; Development on Severe Infectious Disease, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bai</LastName>
                    <ForeName>Hongmei</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Molecular Immunology, Institute of Medical Biology, Chinese Academy of Medical Science &amp; Peking Union Medical College, China; Yunnan Key Laboratory of Vaccine Research &amp; Development on Severe Infectious Disease, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ma</LastName>
                    <ForeName>Yanbing</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Laboratory of Molecular Immunology, Institute of Medical Biology, Chinese Academy of Medical Science &amp; Peking Union Medical College, China; Yunnan Key Laboratory of Vaccine Research &amp; Development on Severe Infectious Disease, China. Electronic address: mayanbing1969@hotmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Acta Biomater</MedlineTA>
            <NlmUniqueID>101233144</NlmUniqueID>
            <ISSNLinking>1742-7061</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Anti-cytokine active immunization</Keyword>
            <Keyword MajorTopicYN="N">Interleukin (IL)-33</Keyword>
            <Keyword MajorTopicYN="N">Tumor</Keyword>
            <Keyword MajorTopicYN="N">Virus-like particle (VLP)</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>03</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>04</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31542504</ArticleId>
            <ArticleId IdType="pii">S1742-7061(19)30636-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.actbio.2019.09.024</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="In-Data-Review" Owner="NLM">
        <PMID Version="1">31542354</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>09</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1872-7980</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>466</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Dec</Month>
                        <Day>01</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cancer letters</Title>
                <ISOAbbreviation>Cancer Lett.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Inhibition of hydrogen sulfide synthesis reverses acquired resistance to 5-FU through miR-215-5p-EREG/TYMS axis in colon cancer cells.</ArticleTitle>
            <Pagination>
                <MedlinePgn>49-60</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0304-3835(19)30470-7</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.canlet.2019.09.006</ELocationID>
            <Abstract>
                <AbstractText>Acquired resistance to 5-fluorouracil (5-FU) is a major barrier to benefit from chemotherapy in colon cancer patients. Hydrogen sulfide (H<sub>2</sub>S), mainly produced by cystathionine-β-synthase (CBS), has been reported to promote the proliferation and migration of colon cancer cells. In this study, the effect of inhibiting H<sub>2</sub>S synthesis on the sensitivity of colon cancer cell lines to 5-FU was investigated. Increased expression of CBS was validated in online database and tissue microarrays. Inhibiting H<sub>2</sub>S synthesis significantly sensitized colon cancer cell lines to 5-FU both in vitro and in vivo. Decreasing H<sub>2</sub>S synthesis utilizing shRNA lentiviruses significantly reversed the acquired resistance to 5-FU. MicroRNA sequencing was performed and miR-215-5p was revealed as one of the miRNAs with most significantly altered expression levels after CBS knock down. Epiregulin (EREG) and thymidylate synthetase (TYMS) were predicted to be potential targets of miR-215-5p. Decreasing H<sub>2</sub>S synthesis significantly decreased the expression of EREG and TYMS. These results demonstrate that inhibiting H<sub>2</sub>S synthesis can reverse the acquired resistance to 5-FU in colon cancer cells.</AbstractText>
                <CopyrightInformation>Copyright © 2019 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Shanwen</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of General Surgery, Peking University First Hospital, Beijing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yue</LastName>
                    <ForeName>Taohua</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of General Surgery, Peking University First Hospital, Beijing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huang</LastName>
                    <ForeName>Zhihao</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of General Surgery, Peking University First Hospital, Beijing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhu</LastName>
                    <ForeName>Jing</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of General Surgery, Peking University First Hospital, Beijing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bu</LastName>
                    <ForeName>Dingfang</ForeName>
                    <Initials>D</Initials>
                    <AffiliationInfo>
                        <Affiliation>Central Laboratory, Peking University First Hospital, Beijing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Xin</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of General Surgery, Peking University First Hospital, Beijing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pan</LastName>
                    <ForeName>Yisheng</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of General Surgery, Peking University First Hospital, Beijing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Yucun</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of General Surgery, Peking University First Hospital, Beijing, China.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Pengyuan</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Division of General Surgery, Peking University First Hospital, Beijing, China. Electronic address: pengyuan_wang@bjmu.edu.cn.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Ireland</Country>
            <MedlineTA>Cancer Lett</MedlineTA>
            <NlmUniqueID>7600053</NlmUniqueID>
            <ISSNLinking>0304-3835</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">5-Fluorouracil</Keyword>
            <Keyword MajorTopicYN="N">Cystathionine-β-synthase</Keyword>
            <Keyword MajorTopicYN="N">Hydrogen sulfide</Keyword>
            <Keyword MajorTopicYN="N">Resistance</Keyword>
            <Keyword MajorTopicYN="N">miR-215-5p</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31542354</ArticleId>
            <ArticleId IdType="pii">S0304-3835(19)30470-7</ArticleId>
            <ArticleId IdType="doi">10.1016/j.canlet.2019.09.006</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">31542397</PMID>
        <DateCompleted>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>21</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>10</Month>
            <Day>22</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1872-7786</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>313</Volume>
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Nov</Month>
                        <Day>01</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Chemico-biological interactions</Title>
                <ISOAbbreviation>Chem. Biol. Interact.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Beneficial role of insect-derived bioactive components against inflammation and its associated complications (colitis and arthritis) and cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn>108824</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="pii" ValidYN="Y">S0009-2797(19)30746-X</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cbi.2019.108824</ELocationID>
            <Abstract>
                <AbstractText>Insect-based bioactive components are emerging as novel sources of drugs, effective against various diseases. Inflammation is considered to be an innate immune response developed by different organisms against foreign pathogens and cellular stress. However, repetitive elevated inflammation is considered to be responsible for development of many other diseases including colitis and arthritis. Due to the limited activities and side effects of non-steroidal anti-inflammatory drugs, researchers are continuously looking for alternative sources of drug molecules to alleviate the inflammatory related complications. Recently, insect-based bioactive components, such as venoms, haemocytes, cecropin A, papiliocin, N-acetyldopamine dimers, cecropin-TY1 peptide, cop A3 peptide, glycosaminoglycan, coprisin peptide, silk fibroin microparticles, and silk fibroin nanoparticles have been found to be active against different inflammatory mechanisms and associated diseases. Cancers, are some of the deadliest diseases, which are mainly treated by chemotherapy, radiation therapy and surgery. However, such treatments, mainly chemotherapy, is associated with enormous side effects. Therefore, as an alternative, less hazardous option, compounds from insects with anti-cancerous activity are being explored. Insect-derived compounds, such as cantharidin, norcantharidin, isocoumarin, plancyols A, plancypyrazine A, pancratistatin, narciclasine, and ungeremine, show potential anti-cancerous activity. In this review, we will be discussing the role of different potential drug molecules of insect origin with special emphasis on anti-inflammation and their association with health disorders and cancer.</AbstractText>
                <CopyrightInformation>Copyright © 2019. Published by Elsevier B.V.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Dutta</LastName>
                    <ForeName>Prachurjya</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Biological Science and Technology Division, CSIR-North East Institute of Science and Technology (CSIR-NEIST), Jorhat, 785006, Assam, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, Uttar Pradesh, India. Electronic address: duttaprachurjya@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sahu</LastName>
                    <ForeName>Ravi Kumar</ForeName>
                    <Initials>RK</Initials>
                    <AffiliationInfo>
                        <Affiliation>Biological Science and Technology Division, CSIR-North East Institute of Science and Technology (CSIR-NEIST), Jorhat, 785006, Assam, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, Uttar Pradesh, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dey</LastName>
                    <ForeName>Tapan</ForeName>
                    <Initials>T</Initials>
                    <AffiliationInfo>
                        <Affiliation>Biological Science and Technology Division, CSIR-North East Institute of Science and Technology (CSIR-NEIST), Jorhat, 785006, Assam, India; Centre for Biotechnology and Bioinformatics, Dibrugarh University, Dibrugarh, 786004, Assam, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lahkar</LastName>
                    <ForeName>Manisha Datta</ForeName>
                    <Initials>MD</Initials>
                    <AffiliationInfo>
                        <Affiliation>Biological Science and Technology Division, CSIR-North East Institute of Science and Technology (CSIR-NEIST), Jorhat, 785006, Assam, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Manna</LastName>
                    <ForeName>Prasenjit</ForeName>
                    <Initials>P</Initials>
                    <AffiliationInfo>
                        <Affiliation>Biological Science and Technology Division, CSIR-North East Institute of Science and Technology (CSIR-NEIST), Jorhat, 785006, Assam, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, Uttar Pradesh, India.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kalita</LastName>
                    <ForeName>Jatin</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Biological Science and Technology Division, CSIR-North East Institute of Science and Technology (CSIR-NEIST), Jorhat, 785006, Assam, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, Uttar Pradesh, India. Electronic address: kalitajk74@gmail.com.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D016454">Review</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Ireland</Country>
            <MedlineTA>Chem Biol Interact</MedlineTA>
            <NlmUniqueID>0227276</NlmUniqueID>
            <ISSNLinking>0009-2797</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000970">Antineoplastic Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D001688">Biological Products</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000970" MajorTopicYN="N">Antineoplastic Agents</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001168" MajorTopicYN="N">Arthritis</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001688" MajorTopicYN="N">Biological Products</DescriptorName>
                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003092" MajorTopicYN="N">Colitis</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName>
                <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D007313" MajorTopicYN="N">Insecta</DescriptorName>
                <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
                <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
            </MeshHeading>
        </MeshHeadingList>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Cancer</Keyword>
            <Keyword MajorTopicYN="N">Inflammation</Keyword>
            <Keyword MajorTopicYN="N">Insects</Keyword>
            <Keyword MajorTopicYN="N">Macromolecules</Keyword>
            <Keyword MajorTopicYN="N">Peptides</Keyword>
            <Keyword MajorTopicYN="N">Venom</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>08</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>09</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>10</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31542397</ArticleId>
            <ArticleId IdType="pii">S0009-2797(19)30746-X</ArticleId>
            <ArticleId IdType="doi">10.1016/j.cbi.2019.108824</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>



</PubmedArticleSet>